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Abstract 
Odour discrimination is a combinatorial phenomenon, as odorant molecules are known to bind to 
multiple olfactory receptors. It is also considered that the absolute configuration of a molecule is of 
crucial importance in determining the human perception of odour. Additionally, it is also recognised that 
a substance evokes a sense of smell provided that its molecular shape is compatible with the 
complementary space within the olfactory receptor.  
 
Since the benzo[b][1,4]dioxepin-3-one scaffold represents the essential structural characteristics of the 
synthetic marine odorant family, we were therefore interested in the effect of modulating the molecular 
shape via an aromatic/aliphatic ring exchange. By the substitution of the aromatic functionality with a 
saturated ring counterpart we endeavoured to discover the molecular interactions of the carbocyclic 
ring systems with olfactory receptor sites, including any potential chiral interactions occurring within the 
receptor(s).  
 
Our initial results revealed that an aromatic ring system was necessary for binding to the marine odorant 
receptor(s) and that the addition of an alkene or methyl substituent had little effect on receptor affinity. 
The synthesised aliphatic benzo[b][1,4]dioxepin-3-one analogues instead exhibited a plethora of 
odorant descriptors and consequently it was speculated that perhaps altogether new odorant families 
could be targeted by further chemical synthesis. It was also questioned if the fusion of 
1,4-dioxepan-6-one heterocyclic rings onto naturally occurring terpenoid odorants could 
merge/synergise existing fragrance classes. The chemical synthesis and olfactory characterisation of a 
variety of aliphatic benzo[b][1,4]dioxepin-3-one analogues, as well as a series of 2-substituted and 
2,3-annulated 1,4-dioxepan-6-one analogues is hereby reported. 
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Chapter 1 – Introduction 
 
1.1 – Preamble  
The 2004 Nobel prize in physiology or medicine was awarded to Richard Axel and Linda Buck for their 
discovery of olfactory receptors and the organisation of the olfactory system.[1-2] Their work generated 
high expectations for scientific advancement in the field of olfaction. This expectation was perhaps 
unjustified as it was also revealed that each odorant molecule triggers a combination of olfactory 
receptors and that any given odour perception corresponds to a highly complex neuronal activation 
pattern.[3-4] 
 
A subtle molecular alteration of an odorant may affect its binding affinities to a number of olfactory 
receptors. This makes correctly predicting a pattern of receptor activity far less accurate than the 
corresponding prediction of receptor activity involving a pharmaceutical drug. There also exists multiple 
layers of neurotransmission between an olfactory receptor and the cerebrum where individual signal 
components may be amplified, weakened or altered before being consciously perceived.[5] An individual 
molecule of a complex mixture can additionally act as an agonist or antagonist to a given olfactory 
receptor adding further complexity.[6] It therefore remains nearly impossible to accurately predict the 
olfactory properties of a molecule.[4-5] An example that illustrates the difficulty in connecting molecular 
structure with olfactory properties is delineated in Figure 1.1. Compounds 1–4 all smell camphoraceous, 
or like camphor (3), despite wildly different molecular structures and functional groups.  
 
 
 
 
Figure 1.1: Camphoraceous odorants 1–4, with different molecular structures.[5] 
 
 
 Introduction 
2 
 
Scientific research into the field of olfaction involves multiple disciplines including psychology, 
physiology, biochemistry, genetics and chemistry (Figure 1.2).[7] The study of olfaction also involves 
multiple systems and organs including the olfactory cortex, olfactory bulbs and olfactory receptors. The 
chemical synthesis of olfactory properties is still an emerging discipline and predicting the olfactory 
properties of a new molecule by rational design remains challenging.[5] In the human brain the 
perception of odour is strongly linked to memory and emotion.[8] It is perhaps therefore unsurprising that 
despite the difficulties associated with odorant design, the production of fragrances is a multibillion dollar 
industry.[9] 
 
 
 
 
 
Figure 1.2: Overview of the science of olfaction.[10] 
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1.2 – The Chemical Senses 
1.2.1 – General Physiology of Olfaction 
The perception of odour and taste are a direct result of the interaction of chemical compounds with 
peripheral receptor systems.[6] The physiological structure involved in odorant detection is the olfactory 
epithelium, a specialised tissue located inside the nasal cavity (Figure 1.3). The olfactory epithelium 
consists of up to 30 million primary sensor cells accompanied by a larger number of supporting and 
basal cells.[6] An olfactory neuron contains cilia that point out of the olfactory epithelium and into a 
mucosa which is ca. 60 microns thick.[11] The olfactory mucosa is a lipid-rich secretion produced by 
Bowman’s glands which reside in the olfactory epithelium. The mucus layer is rich in odorant-binding 
proteins which are theorised to be involved in the transport of hydrophobic odorant molecules across 
the mucus layer to the olfactory receptors.[12] The olfactory system is also responsible for the detection 
of chemical signals, known as pheromones, released by many animals and involved in stimulating 
hormonal and behavioral responses.[3] 
 
 
 
Figure 1.3: The mammalian olfactory system.[1] Copyright The Nobel Assembly at the Karolinska Institutet, 
Sweden. Reproduced with permission. 
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Olfactory receptors are expressed in the cell membranes of olfactory receptor neurons. To maintain 
high sensitivity, each olfactory neuron expresses only one type of olfactory receptor. [13] Olfactory 
neurons are bipolar neuron cells with dendrites pointing into the olfactory epithelium and axons passing 
through the ethmoid bone that separates the nasal cavity from the brain. The axons reach a structure 
in the brain called the olfactory bulb where they converge with post-synaptic cells to form glomeruli 
(Figure 1.4).[6] All axons of a single class of olfactory receptor neuron converge on a single 
glomerulus.[14] The binding of an odorant molecule to an olfactory receptor triggers depolarisation of the 
cell membrane. This process involves a change in electrochemical gradient across the axonal surface 
by an influx of positively charged cations. The resting potential of a neural cell is ca. −70 mV. The influx 
of positively charged ions lowers the electronegativity of the cytosol, and at ca. −40 mV, triggers the 
depolarisation of the membrane by a change in ion entry to produce an electrical transmission down 
the length of the neuron.[6] 
 
The human olfactory bulb appears as two halves with mirrored medial and lateral surfaces.[7, 15] The 
activity patterns of glomeruli within the olfactory bulb code for odour impression, the information being 
transferred by mitral cells to the olfactory cortex of the brain where higher level processing takes place.[6] 
The human olfactory bulb contains about 2500 glomeruli.[15] A given odorant can activate certain 
glomeruli strongly whilst affecting other glomeruli weakly, or not at all.[16] Glomeruli activation patterns 
within the olfactory bulb are therefore thought to represent the quantity and quality of the odorant being 
detected. 
 
 
Figure 1.4: Graphical representation of a typical neuron cell.[17]  
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In addition to the olfactory nerve, the trigeminal nerve also plays a role in olfactory perception. [18] The 
trigeminal nerve is responsible for the sensations of heating, cooling and tingling. This nerve and its 
associated receptors are situated in the mucosa of the nose and tongue, and its impulses are not 
transmitted to the olfactory bulb, but are processed independently.[6] Few chemosensory stimulants 
produce exclusively olfactory or trigeminal sensations, the vast majority of odorant molecules 
possessing characteristics of both odour and irritation.[11, 19] Some notable ligands of both neural 
systems include menthol (mint) and allyl isothiocyanate (horseradish).[11] 
 
1.2.2 – Olfactory Receptors  
The human olfactory receptor repertoire is comprised of over 900 genes of which more than 50% are 
pseudogenes deactivated by frame-shift mutations.[6, 20-21] The genes involved in olfaction are coded on 
53 different loci on 21 human chromosomes,[22] the exceptions being chromosome 20 and the 
sex-determining Y chromosome.[20] The chromosomal distribution of olfactory genes is extremely 
biased, with six chromosomes (1, 6, 9, 11, 14, and 19) accounting for 73% of the repertoire.[20] 
Chromosome 11 alone contains 42% of the olfactory receptor genes.[20] Genetic sequences involved in 
olfaction total to about three percent of the total human genome.[23] Owing to the decreased number of 
functioning olfactory receptors in comparison to other primate species, it was suggested that the role of 
olfaction for survival and reproductive success has decreased during human evolution.[24-25] It was 
shown that negative selection of olfactory receptors is still relaxed in modern humans which suggests 
that a plateau of minimum function has yet to be reached and that therefore future human evolution of 
olfactory capability may still be decreasing.[24] 
 
For a molecule to interact with the olfactory system it must possess certain molecular properties. 
Generally, odorants are small hydrophobic, non-ionic molecules that also must display a certain 
amphiphilic character to pass though the mucus layer that covers the receptors.[6, 26] In addition to these 
characteristics, an odorant must also possess a sufficiently high vapour pressure; no known odorant 
possess a molecular weight greater than 294 atomic mass units.[27] Each individual olfactory receptor 
class displays an affinity for a range of ligands, and conversely, a single odorant molecule may bind to 
a number of olfactory receptors.[3]  
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The olfactory system is able to distinguish a practically infinite number of chemical compounds owing 
to the sheer quantity of dissimilar olfactory receptor types coupled with the combinatorial nature of 
ligand receptor affinity.[11] Olfactory receptors are a member of the class A rhodopsin-like family of 
G protein-coupled receptors (GPCR).[28] This class of receptor contains seven transmembrane α-helix 
structures that span the cell membrane and additionally feature extracellular loops.[6] The extracellular 
loop structures form a cavity which is assumed to serve as a binding pocket for ligand molecules. [6, 25] 
The family of G protein-coupled receptors includes receptors for many neurotransmitters including 
serotonin, dopamine, and histamine, as well as proteins involved in photoreception.[7]  
 
Different olfactory receptor proteins have different variable domains that form different binding 
cavities.[6, 25] These domains bind to odorant ligands in a non-covalent manner, including van der Waals 
forces, Coulomb attractions and hydrogen bonding.[6] The binding of an odorant to a receptor initiates 
an allosteric change in the quaternary structure of the receptor. This activates the G protein on the 
intracellular side of the olfactory neuron by the dissociation and phosphorylation of inactive guanosine 
diphosphate (GDP) to give active guanosine triphosphate (GTP) (Figure 1.5).[6, 29]  
 
G proteins, also known as guanine nucleotide-binding proteins, are a family of enzymes that act as a 
molecular switch. Once activated, the G protein in turn activates adenylate cyclase (AC) enzymes that 
convert adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP), the secondary 
messenger.[30] The cAMP acts to open cyclic nucleotide-gated ion channels which allow cations such 
as Na+ and Ca2+ to enter the cytosol, depolarising the cell and triggering an action potential which is 
propagated along the axon.[6] Although there is scientific evidence for alternative secondary 
messengers (such as inositol trisphosphate and cyclic guanosine monophosphate), it is generally 
agreed that cAMP is the dominant secondary messenger involved in the process of olfaction.[31-33] 
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Figure 1.5: Graphical representation of the cAMP mediated transduction pathway operating in olfactory receptor 
neurons. GDP: guanosine diphosphate; GTP: guanosine triphosphate; ATP: adenosine triphosphate; 
cAMP: cyclic adenosine monophosphate; AC: adenylate cyclase.[6] Reproduced with permission 
from Professor Hanns Hatt of Ruhr University Bochum, Germany. 
 
1.3 – Structure-Odour Relationships (SOR) 
1.3.1 – Quantitative and Qualitative Olfactory Descriptions 
The olfactory properties of an odorant molecule can be classified according to two parameters; potency 
and character. Newly synthesised molecules are generally described by perfumers as a solution of the 
compound absorbed onto blotter paper. Odorants are commonly evaluated at high concentration levels 
to reveal nuances besides just the dominant accord. The olfactory impression of a molecule is described 
in either a semantic way or by direct comparison to benchmark odorants.[26, 34] Both methods of analysis 
give rise to a multidimensional description that relies heavily on reference to common descriptors.[6]  
 
A fragrance wheel is a classification chart that endeavours to demonstrate the relationship between 
different classes of odour. This method of classification can be applied to complex mixtures such as 
perfumes, or simple components such as individual molecules. The wheel displayed in Figure 1.6 
includes four major families; floral, oriental, woody and fresh, each further divided into subgroups.[35] 
The location of each subgroup demonstrates its olfactory relationship and ability to blend into the next 
subgroup.  
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When the human olfactory system is scientifically understood and cellular expression technology is 
sufficiently advanced as to be available to screen novel odorant molecules, it is conceivable that odour 
descriptions will be given in the form of activation patterns of olfactory receptors and glomeruli. Until 
that point in time, odorant descriptions must rely on inaccurate semantic or comparative methods of 
description. 
 
 
Figure 1.6: Fragrance wheel.[35] Copyright Michael Edwards. Reproduced with permission. 
 
The potency of an odorant is a quantitative measurement of the average minimal quantity that can be 
detected by the human olfactory system. This quantity is known as an odour threshold value and is 
generally reported in nanograms per litre (ng/L) or parts per billion (ppb). The value differs depending 
on the physiological and psychological condition of an individual. In general, females exhibit higher 
sensitivity than males, both sexes reaching their highest sensitivity immediately after puberty.[6] A 
threshold value depends heavily on the method of measurement.[36] The experimental differences 
between threshold values for a given compound measured in water or air can be pronounced 
(Figure 1.7).  
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Ideally, threshold values are measured in air using a technique named Gas Chromatography – 
Olfactometry (GC-O). This technique relies on human assessors to detect and evaluate gas-phase 
odorants eluting from a gas chromatograph mediated separation.[26, 37] A threshold value for a molecule 
can be established by injecting dilutions of the sample substance in a descending order of concentration 
until the panellist fails to detect the odorant.[38] The panellist detects in blind and if the recorded detection 
time matches the chromatographic retention time, the sample would be further diluted. Owing to 
variation in human olfactory ability, threshold values are usually established for multiple persons and 
an average value reported.[37] 
 
 
Figure 1.7: Air and water odour threshold differences of anti-3-mercapto-2-methylpentanol diastereomers.[39] 
 
1.3.2 – Structure-Odour Correlation 
The Roman philosopher Lucretius proposed the first structure-odour activity theory when he stated that 
pleasant smelling odours were composed of particles with smooth geometries, whilst harsh smelling 
odours were of hooked geometries.[6] The first scientific attempt to link olfactory properties with 
molecular structure was the stereochemical theory, proposed in 1951 by Amoore.[40] The theory 
proposed a concept of primary odours from which all other odours are composed, analogous to the 
theory of primary colours within the sense of vision. Seven primary odours were proposed, each with 
their own hypothetical receptor binding site: ethereal, camphoraceous, musty, floral, minty, pungent and 
putrid.[26, 41] Pungent and putrid odour impressions were thought to depend on the electronic nature, 
rather than the size or shape of the molecule.[6] It was theorised that strongly nucleophilic molecules 
exhibited a putrid odour whilst strongly electrophilic molecules exhibited a pungent odour.[42] Studies 
into specific anosmia, the inability to detect a particular odour, were undertaken in an attempt to offer 
evidence for the theory.[26] 
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Another theory of olfaction is the vibrational theory, first proposed by Dyson and later extended by 
Wright.[43-44] The theory states that the olfactory properties of a molecule are the direct result of 
vibrational frequencies in the infrared range.[26] A further adaption of this theory which stated that a 
quantum electron tunnelling mechanism could explain the link between the odorant properties and 
vibrational spectra of a molecule was proposed by Turin.[45] He attempted to apply the theory in the 
explanation of paradoxes such as molecules with near identical molecular shapes but dissimilar odours, 
and molecules with similar odours but dissimilar molecular shapes.  
 
The current scientifically accepted theory of olfaction is known as shape theory. The theory proposes 
that the olfactory properties of a molecule are related to molecular shape, molecular size and functional 
groups present.[46] Examples of how these parameters can affect olfactory properties are delineated in 
Figure 1.8. The lily-of-the-valley aldehyde Lyral® (7) and γ-bicyclohomofarnesal (9) both represent 
potent commercially available odorants. The Δ1 isomer (8) of Lyral® (7) is completely odourless owing 
to a different orientation of the carbonyl osmophore functionality. The β-alkene isomer (10) of 
γ-bicyclohomofarnesal (9) is also odourless owing to steric hindrance of the osmophore preventing 
interaction with olfactory receptor(s). Another noteworthy example is that the olfactory properties of the 
constitutional isomers β-damascone (11) and β-ionone (12) are amalgamated in the corresponding 
bis-ketone compound 13. This phenomenon occurs because of keto-enol tautomerism; compound 13 
exists as an equilibrium of the two enol forms and thus contains olfactory properties of both parent 
materials.[6] 
 
Structure-activity relationship research has generally been limited to focussing on distinct odorant 
groups such as ambergris, musk and sandalwood, largely owing to that fact that these odorant groups 
contain compounds with rigid molecular structures. Flexible molecules can adopt a larger range of 
energetically favourable conformations, each of which may be responsible for interacting with a different 
olfactory receptor.[26] With a substantial data set, a computational model linking molecular structure and 
olfactory properties can be created. This type of model is a specific case of a Quantitative Structure-
Activity Relationship (QSAR) model, and is referred to as an olfactophore model.[6] These types of 
models correlate the activity of a ligand and a given receptor site or receptor class. 
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Figure 1.8: Molecular shape, molecular size and functional groups affect odorant properties.[6] 
 
There exist two major difficulties associated with the development of accurate structure-odour 
relationship models. The first arises from an incomplete understanding of the mechanism of olfaction. 
The second problem involves the difficulty associated with measurement; odour quality is a subjective 
quality dependent on concentration and organoleptic state, as opposed to chemical purity. [26]  
 
1.3.3 – Osmophores and Functional Groups 
For a given molecule to exhibit olfactory activity it needs to interact with olfactory receptors and is 
therefore generally required to contain at least one H–bond acceptor or donor functionality.[6, 47] 
Functional groups involved in hydrogen bonding to olfactory receptors are referred to as osmophoric 
groups. Such functionalities include carbonyl, hydroxyl, ester and alkoxy moieties, as well as their 
heterocyclic equivalents. Alkene and alkyne functionalities are also recognised to have the ability to act 
as osmophores.  
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A hydrogen-bond acceptor or donor functionality can be exchanged for a corresponding group with little 
alteration in the olfactory properties of the molecule.[6] This effect is demonstrated effectively in 
benzaldehyde (14). An exchange of the H–bond acceptor functionality from an aldehyde (14) to a nitrile 
(15), nitro (16) or azide (17) functionality provides a compound that retains the characteristic almond 
fragrance of the parent material (Figure 1.9).[6] 
 
 
Figure 1.9: Exchanging H–bond acceptors; almond smelling analogues of benzaldehyde (14).[6] 
 
The exchange of an O–atom for an S–atom generally leads to a dramatic alteration in olfactory 
properties. The H–bond geometries of thioether, thioester and thioketone functionalities differ 
substantially to their corresponding oxa-analogues. Thionated compounds therefore bind to olfactory 
receptors in a different manner, often resulting in completely unrelated olfactory properties.[6] An 
example of this effect is demonstrated during the thionation of musk odorant Exaltolide® (18). 
Thiolactone 21 no longer contains musk nuances, instead containing roasted and burnt notes and a 
much higher threshold value of 60 ng/L air, substantially weaker than the parent material (18). The 
thioketone analogue 22 is even weaker with a threshold value of 100 ng/L air, but does still possess 
some musk nuances. Replacement of both oxygen atoms with sulphur atoms gives near odourless 
compound 23 (th >300 ng/L air) (Figure 1.10).[48]  
 
The difference in electronegativity between sulphur and oxygen atoms, as well as the ca. 20% larger 
van der Waals radius of sulphur additionally contribute to the altered binding properties. A sulphur atom 
is actually a better replacement for a C=C alkene moiety.[6] This is demonstrated in thioether compound 
20 which retains the musk note and low threshold value of parent alkene 19.[48] Interestingly it was 
discovered that human sensitivity to musk odorant Exaltolide® (18) varies with hormonal conditions 
during the menstrual cycle.[6] It was also found that endogenous estrogens increase sensitivity to musk 
odorants whilst androgens decrease sensitivity to musk odorants.[49-50] 
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Figure 1.10: Commercially available musk odorants 18 and 19, and thionated analogues 20–23.[6, 48, 51] 
 
The strategic substitution of an oxygen atom with a sulphur atom can lead to insights into 
structure-odour relationships by revealing which functionalities are acting as osmophoric groups. The 
substitution of a carbon atom with a silicon atom is also a useful tool for the exploration of structure-
odour relationships. A C–Si bond is ca. 20% longer than a C–C bond therefore making substitution a 
useful tool for exploring the molecular volume of a receptor, particularly the hydrophobic section.[6]  
 
Although seldom useful, it is possible to substitute a tertiary carbon atom with any Group 14 atom. A 
variety of tertiary carbon atom substituted analogues of benzyl(dimethyl)carbinol (24) are displayed in 
Figure 1.11. The only Group 14 analogue that retained the fresh floral note of the parent material (24) 
was the silicon substituted analogue 25. The germanium substituted analogue dimerised immediately 
to provide compound 26, for which a soapy and almond fragrance is reported, presumably due to minor 
quantities of the monomer entering the vapour phase. The tin substituted analogue 27 was discovered 
to be completely odourless, presumably too large to fit into an olfactory receptor.[6] 
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Figure 1.11: Group 14 analogues (25–27) of benzyl(dimethyl)carbinol (24).[6] 
 
A bioisostere for a hydrogen atom is a fluorine atom.[6] A variety of fluorine substituted odorants were 
previously synthesised and it was reported that the olfactory properties of the resulting molecules were 
little affected. It was discovered that the same molecules were profoundly affected by the substitution 
of a methyl functionality at the same molecular location.33,34 Other halogen atoms were discovered to 
have a more powerful influence on the olfactory properties of the resulting molecule owing to their larger 
size.[6]  
 
1.3.4 – Stereochemistry and Odour Perception  
A chiral molecule is defined as a molecule which contains geometric properties that are 
non-superimposable upon its mirror image.[52] The majority of biological macromolecules are 
homochiral, with few exceptions. Naturally occurring protein molecules are composed of exclusively 
L-configured amino acid monomers, and nucleic acids, such as RNA and DNA, are composed 
exclusively of D-ribose and D-deoxyribose.[53] Analogous to other protein molecules, receptors are 
composed of L-configured amino acids and therefore exist as chiral molecules themselves. The binding 
pocket of a receptor is consequently chiral and able to discriminate between enantiomers of a given 
molecule.[54] This effect is important in pharmaceutical research as ca. 50% of all active drugs contain 
a stereogenic centre.[6] The effect is also pronounced in the closely related science of gustation; for 
example D-asparagine having a sweet taste and L-asparagine being completely tasteless.[53]  
 
Previously, any olfactory differences between enantiomers were ignored or ascribed to impurities within 
the sample material.[55-56] It is now scientifically recognised that enantiomers can exhibit different 
olfactory properties. It is also recognised that differences in the olfactory properties between 
enantiomers may be present only in minor nuances and thus enantiomeric purity is of utmost importance 
during olfactory analysis.[6] There are four recognised relationships for enantiomers of a given 
odorant.[6, 54] 
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1) Case A: One enantiomer is odoriferous, one enantiomer is weak or odourless. 
This is the case for many highly potent odorant molecules owing to a molecular shape that is 
perfectly complimentary to a receptor site.  
2) Case B: Both enantiomers smell similar but possess different intensities. 
The most common case between odorant enantiomers. Neither enantiomer fits perfectly into 
the receptor but both enantiomers are interacting with the same receptor. 
3) Case C: Both enantiomers smell similar and possess similar intensities. 
This is the case when both enantiomers possess low receptor affinity and that therefore the 
chiral portion of the molecule is not differentiated by the receptor. Both enantiomers can be 
expected to be of low potency.  
4) Case D: Both enantiomers smell different. 
The rarest case between odorant enantiomers. Both enantiomers interact with different 
olfactory receptors leading to completely different odour descriptions and odour threshold 
values. 
 
Some typical enantiomeric pairs of odorants are delineated in Figure 1.12. The enantiomers of carvone 
are perhaps the most striking example of enantioselectivity in odour perception. Pure samples of 
(+)-(S)- and (−)-(R)-carvone (28 and 29, respectively) had been isolated by fractional distillation of the 
essential oils of caraway and spearmint and were recognised to have different odour profiles.[54, 57] It 
remained a possibility that the olfactory discrepancies were due to minor impurities and therefore it was 
not scientifically accepted that the two enantiomers could have different olfactory properties. 
Unequivocal evidence for olfactory enantiodiscrimination was provided in two simultaneously released 
publications.[58-59] One study concentrated on enantiomeric purification and derivatisation of the parent 
material[58] whilst another study concentrated on chemical interconversion between the two 
enantiomers,[59] together providing undisputable evidence that enantiomeric odorant molecules can 
possess different olfactory properties. 
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Figure 1.12: Chiral odorant pairs illustrating different odour descriptions and odour threshold (th) values.[6] 
 
A naturally occurring odorant with strikingly dissimilar threshold values between its various enantiomers 
is wine lactone (36), an important flavour component in white wine (Figure 1.13).[53] All eight 
stereoisomers were synthesised and evaluated.[60] The variation in odour threshold was discovered to 
range from 0.00001−0.00004 ng/L air to a near odourless threshold value of >1000 ng/L air. The 
naturally occurring (3S,3aS,7aR)-configured stereoisomer was discovered to have the lowest odour 
threshold of the series, and is additionally the most potent odorant molecule known to date.[6, 60] 
 
 
Figure 1.13: Odour threshold values for various stereoisomers of wine lactone (36).[53, 60] 
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Pyrazines are naturally occurring odorant molecules that have previously received attention in terms of 
enantiomeric olfactory variation. Some pyrazine derivatives possess a distinctive capsicum fragrance, 
associated with exceedingly low odour threshold values.[61-62] A variety of synthetic alkoxypyrazine 
compounds were synthesised and their olfactory properties determined (Figure 1.14).[63] The threshold 
values of the prepared analogues were discovered to grow with the increasing alkyl chain length, until 
a length of n = 4, at which time the analogues became most potent. Although odour description 
remained identical, there was significant variation in odour threshold values between (S)- and (R)-
configured enantiomers at higher chain lengths, indicating a Case B relationship between the 
enantiomers.  
 
 
Figure 1.14: Odour comparisons of synthetic alkoxypyrazines.[53, 63] 
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1.4 – Marine Odorants 
1.4.1 – Naturally Occurring Marine Odorants 
Naturally occurring chemicals perceived by the human olfactory system as smelling reminiscent of the 
ocean appear to belong to three distinct chemical families. The primary example of a natural material 
which exhibits a prototypical marine olfactory character is algae. Brown algae (Phaeophyceae) produce 
multiple odoriferous C11H14 to C11H18 linear and alicyclic organic compounds that act as gamete 
pheromones (Figure 1.15).[64-68] The dictyopterenes are a group of such chemical compounds that are 
naturally present in marine and freshwater environments. (+)-Dictyopterene A (38) was the first 
odoriferous compound to be isolated from algae and was discovered to contain the characteristic odour 
of seawater.[66] A sigmatropic rearrangement of 38 gives (−)-dictyopterene C (39),[69] which is 
reminiscent in odour to that of salmon roe.[64] Giffordene (40), with a typical sea-algae odour is the 
principle pheromone of Giffordia mitchellae,[70] whilst (−)-dictyopterene D (41) is more closely 
associated in tonality to green and tomato-leaf nuances, and is secreted by the brown algae Ectocarpus 
siliculosus.[64, 71-72]  
 
 
Figure 1.15: Naturally occurring odorant compounds in algae.[64] 
 
Another naturally occurring class of marine odorant compounds are the brominated phenol analogues 
(Figure 1.16).[73] Bromophenols such as compounds 42−44 have been identified as key flavour 
components in seafood.[74] It is hypothesised that bromophenol compounds make their way into the 
food chain by marine invertebrates feeding on phytoplankton and algae species.[75]  
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A 1999 study revealed that the total bromophenol content of algae was highly varied across species, 
from 0.9 ng/g in the green algae Codium fragile to 2590 ng/g in the red algae Pterocladiella capillacea.[76] 
Multiple species of algae have been shown to contain bromoperoxidase enzymes capable of 
brominating organic substrates.[77] The purpose of these compounds in algae is still yet to be determined 
but is hypothesised to relate to chemical defence or the reduction of peroxide toxin accumulation.[76] 
Multiple odoriferous bromophenol analogues have also been isolated from various species of marine 
acorn worm.[78-79] 
 
 
Figure 1.16: Bromophenol odorants from natural marine sources. 
 
Unsaturated aldehyde compounds resulting from the degradation of fatty acids, such as compounds 
45–47, also contain marine tonalities (Figure 1.17).[73] These compounds naturally occur in melon and 
cucumber, and are also present in algae.[80-81] A variety of chemically related C−8 and C−9 unsaturated 
aldehyde, ketone and hydroxyl compounds were isolated from the terrestrial plant Mertensia maritima, 
known as oyster leaf for its unusual marine nuances.[82] 
 
 
 
Figure 1.17: Naturally occurring unsaturated aldehyde compounds containing marine nuances.  
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1.4.2 – Synthetic Marine Odorants  
Synthetic marine odorants have an important place in the palette of the modern perfumer (Figure 1.18). 
The formerly unestablished marine fragrance category is represented primarily by the synthetic odorant 
Calone 1951® (50). This material is used to convey the scent of seaside plus sea-breeze with floral 
overtones, and is typically present in levels below 1% in fine perfumes.[10] Calone 1951® (50) is the basis 
of most marine fragrance accords, and although often required to be blended with aldehydic, ozonic 
and watermelon-like odorants, to date there is no superior perfumery material to convey the olfactory 
impression of a seashore.[83]  
 
 
 
Figure 1.18: Various synthetic marine odorants.  
 
With the launch of the perfumes “New west for her” (Aramis, 1990) and “Escape for her” (Calvin Klein, 
1991), a marine trend in feminine perfumery was born.[64] The later launch of masculine marine 
fragrances such as “Kenzo pour homme’” (Kenzo, 1991) and “L’Eau d’Issey masc” (Issey Miyake, 1994) 
helped concreate the trend into modern perfumery. The original marine note incorporated just two raw 
materials, Calone 1951® (50) and Tropional® (58), but later evolved to include watermelon notes by the 
addition of the synthetic odorant Melonal® (59). Finally, ozonic aspects were added to the marine and 
watery nuances by the addition of Floralozone® (55) to form the typical aquatic accord found in modern 
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day fragrances.[64] The evolution of the marine/aquatic accord in modern perfumery is delineated in 
Table 1.1.  
 
 
“New west 
for her” 
(1990) 
“Escape 
for her” 
(1991) 
“L’Eau 
d’Issey” 
(1992) 
“L’Eea 
d’Eden” 
(1996) 
“Cool 
water fem” 
(1996) 
 
“Polo Sport  
W” (1996) 
 
Calone 1951® (50) 1.2% 0.8% 0.6% 0.17% 0.4% 0.45% 
Tropional® (58) 7.5% 3.7% 2% 1.5% 4.3% 4.8% 
Melonal® (59) - - 0.02% 0.03% 0.02% 0.12% 
Floralozone® (55) - - - 0.1% 0.07% 0.04% 
Ratio 50 : 58 0.21 0.16 0.3 0.11 0.09 0.09 
 
Table 1.1: Evolution of the marine/aquatic accord in modern perfumery.[64] 
 
The popularity of the marine fragrance trend led to the introduction of additional 
benzo[b][1,4]dioxepin-3-one marine odorant compounds including Transluzone® (51, Firmenich), 
Aldolone® (52, Firmenich),[73, 84] and Azurone® (53, Givaudan).[83] All analogues share the marine and 
watermelon-like olfactory characteristics of Calone 1951® (50), differing primarily in intensity and lasting 
power.[38] Both the benzo[b][1,4]dioxepin-3-one (49–53) and 4,5-dihydrobenzo[b]oxepin-3-one (48) 
molecular scaffolds have been discovered to contain marine accords, although the latter is reported to 
be much weaker in olfactory impression.[73, 85] Researchers at Firmenich recently described that the 
1,4-dioxepin-6-one moiety of the marine odorant scaffold could be replaced by a 
2,3-dihydrofuran-2-carbaldehyde unit leading to compound 54, for which a powerful aldehydic-green 
marine odour was reported.[86]  
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Unusual molecular structures to contain marine character are Fleuranil® (56, IFF), a nitrile analogue of 
Floralozone® (55, IFF), and alkyl substituted pyridine analogue Maritima® (60, IFF). A variety of alkyl 
substituted pyridine compounds are patented for use as fragrances,[87] although to be noted is that this 
family of odorants has a watery profile often more reminiscent of stagnant water than fresh seaside 
nuances.[73]  
 
1.4.3 – Benzo[b][1,4]dioxepin-3-one Discovery – Pfizer 
The benzo[b][1,4]dioxepin-3-one synthetic marine odorant family was discovered in 1966 by serendipity 
at Pfizer by Beereboom, Cameron and Stephens.[85, 88] The original synthesis involved a Dieckmann 
condensation reaction of various bis-ester compounds (type 61) followed by decarboxylation of the 
resulting intermediate ester (type 62) to furnish the completed odorant (type 63) (Scheme 1.1). The 
Dieckmann condensation route of synthesis remains the commercially employed route of synthesis. [83] 
The odour threshold grew for compounds claimed in the original patent as the substituted alkyl chain 
was increased in size from methyl (0.031 ng/L air, Calone 1951®, 50) through to propyl (0.10 ng/L air, 
Aldolone®, 52) and butyl (0.26 ng/L air), but longer chain analogues were not explored.[6] Calone 1951® 
(50) was the only compound originally commercialised from within the series, initially only used as a 
nuanceur in lily-of-the-valley accords,[83] but now produced on an estimated thirty ton annual scale.[73] 
 
 
Scheme 1.1: Original synthesis of the benzo[b][1,4]dioxepin-3-one and 4,5-dihydrobenzo[b]oxepin-3-one 
analogues by Beereboom, Cameron and Stephens.[85, 88] 
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1.4.4 – Benzo[b][1,4]dioxepin-3-one Structure-Odour Relationship Studies – Givaudan 
In an attempt to synthesise novel odorants containing both marine and musk characteristics, 
researchers at Givaudan, Switzerland discovered that more powerful benzo[b][1,4]dioxepin-3-one 
analogues could be synthesised than was previously hypothesised. A merged note is already present 
in the odorant Musk Alpha® (64) but this compound was removed from the market due to phototoxicity. 
To construct new odorant molecules with merged notes, the molecular structures of polycyclic musk 
odorant Galaxolide® (65) and Calone 1951® (50) were amalgamated (Figure 1.19). Molecular structure 
66 was chosen as the target compound in order to not go beyond the previously established upper 
molecular weight, the tertiary-butyl analogue 51.[83]  
 
 
Figure 1.19: Marine nitro musk odorant 64, polycyclic musk odorant 65 and target compound 66.[83] 
 
Compound 66 was discovered to not contain the required olfactory characteristics but instead contained 
floral aspects that interested perfumers. To that effect a library of 7,8-annulated (66, 73–74) and 7-alkyl 
substituted (53, 75–86) analogues were synthesised beginning from veratrol (67). The synthetic route 
involved a Friedel–Crafts acylation reaction of veratrol (67) with various carboxylic acid analogues in 
the presence of polyphosphoric acid (PPA) to provide carbonyl intermediates of type 68 (Scheme 1.2). 
It should be noted that if the carboxylic acid analogue contained unsaturation at the C2–C3 position 
within the molecular structure, the intermediate compound would additionally cyclise in a Friedel–Crafts 
alkylation reaction to yield the corresponding annulated bicyclic structure. These unusual 
polyphosphoric acid catalysed Friedel-Crafts reactions of veratrol to yield substituted veratrol or 
indanone analogues were previously explored by Marquardt.[89] The isolated intermediates of type 68 
were subjected to Clemmensen reduction and subsequent demethylation with trimethylsilyl iodide to 
give substituted catechol analogues of type 70. The catechol analogues were then cyclised in a 
Williamson reaction with a bis-halogenated alkylation agent to provide methylene compounds of type 
71, before being oxidised to yield the finished benzo[b][1,4]dioxepin-3-one analogues of compound 
type 72. 
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Scheme 1.2: Synthetic route employed by Kraft et al.[83] in the synthesis of 7,8-annulated and 7-alkyl substituted 
benzo[b][1,4]dioxepin-3-one analogues. 
 
The library of analogues prepared is displayed in Figure 1.20. The most interesting compound of the 
series was discovered to be the 7-isopentyl substituted analogue later commercialised and named 
Azurone® (53).[90] This analogue was described as possessing the intense marine aspects of 
Calone 1951® (50) together with floral-aldehydic nuances. Whilst it was discovered that the intensity 
decreased with more heavy and bulky alkyl substituents, the C5H11 group of 53 increased the intensity 
dramatically.  
 
To explore this effect a variety of C–5 to C–8 analogues were synthesised, with the n-octyl analogue 
appearing to be the upper limit of marine odorant molecular dimensions. Using the odour threshold data 
of the prepared library, as well as data from patent literature, an olfactophore model was generated 
using computational software. Unsurprisingly, Azurone® (53) was discovered to be the optimum ligand. 
The model consisted of three hydrogen-bond acceptors, an aromatic binding site, an aliphatic 
hydrophobe and three excluded volumes inaccessible to the molecule (Figure 1.21).[83]  
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Figure 1.20: Library of 7,8-annulated and 7-alkyl substituted benzo[b][1,4]dioxepin-3-one analogues.[83] 
Experimental odour threshold values (ng/L air) indicated within molecular structure, calculated values outside.  
 
 
Figure 1.21: Marine odorant olfactophore model generated by Kraft et al.[83] Copyright Wiley-VCH Verlag GmbH 
& Co. KGaA. Reproduced with permission. 
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During the synthesis of analogue 89 from eugenol (87) by Dieckmann condensation it was discovered 
that a change of base to potassium tert-butoxide, which can deprotonate irreversibly, yielded a 
compound with a vanilla note accompanying the typical marine fragrance (Scheme 1.3). It was revealed 
that an isomerisation of the alkene functionality to a benzylic position had occurred, giving a 
(E)-7-(prop-1-enyl) substituted analogue (89) which was discovered to be as potent as 
Azurone® (53).[38] This discovery prompted additional research which exposed that potency, and 
therefore receptor binding strength, was increased with conjugated olefinic substituents. 
 
 
Scheme 1.3: Synthesis of analogue 89 from eugenol (87), with alkene isomerisation.[38] 
 
A synthetic sequence beginning from compound 89 was used to construct a library of conjugated 
analogues. Compound 89 was protected as the 1,3-dioxolane derivative using 1,2-ethanediol and 
catalytic quantities of sulphuric acid to give compound 90, followed by Katsuki-Sharpless oxidation to 
provide aldehyde intermediate 91 (Scheme 1.4). The aldehyde intermediate was subjected to Grignard 
reaction with various magnesium halide reagents, followed by an acid-catalysed dehydration and 
deprotection reaction to furnish the completed benzo[b][1,4]dioxepin-3-one analogues of type 92 for 
olfactory analysis.  
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Scheme 1.4: Synthetic route employed by Kraft et al.[38] in the synthesis of conjugated seven-alkenyl substituted 
benzo[b][1,4]dioxepin-3-one analogues. 
 
The alkenyl substituted analogues 93–96 were discovered to have extremely low odour threshold 
values, more potent than the most powerful steroid odorants (Figure 1.22). The extreme potency of the 
new experimental analogues deviated significantly from the predictions of the original marine 
olfactophore model. The model was revised to place the aliphatic hydrophobe in the plane of the 
aromatic binding site and nearly 1 Å further away, now 7.23 Å from the centre of the aromatic binding 
site. Two hydrogen-bond acceptors were found to be sufficient, but six excluded volumes 3.53 Å, 
4.01 Å, 4.30 Å, 5.84 Å, 6.14 Å and 9.3 Å distance to the aromatic binding site were necessary for an 
85% predictability of odour threshold. The revised model could bind both pseudo-twist-boat and 
pseudo-half-chair conformers of the heterocyclic ring system.[38] 
 
 
Figure 1.22: Unsaturated benzo[b][1,4]dioxepin-3-one analogues synthesised by Kraft et al.[38] showing 
experimental odour thresholds and calculated odour thresholds for original and revised olfactophore models.  
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1.4.5 – Benzo[b][1,4]dioxepin-3-one Structure-Odour Relationship Studies – Firmenich 
An extensive library of benzo[b][1,4]dioxepin-3-one analogues were synthesised and evaluated by 
researchers at Firmenich, Switzerland.[73] The publication revealed important information about the 
marine odorant family regarding alkyl substitution, as well as the role of the O–atom(s) within the 
heterocyclic 1,4-dioxepin-6-one moiety (Figure 1.23). Olfactory evaluation of the prepared analogues 
resulted in the following conclusions; a) the presence of alkyl substitution on the aromatic ring is 
beneficial; b) branched alkyl substituents at the benzylic position decease potency; c) aromatic 
bis-substitution deceases potency; d) substitution at C−2 is unfavourable, presumably due to 
interference with the carbonyl osmophore; e) substitution at the C−7 position is favourable over 
substitution at the C−6 position. It was additionally discovered that substitution at the C−7 position was 
preferred for marine and watery nuances, whilst substitution at the C−6 position provided compounds 
with an aldehydic character.[73]  
 
 
 
Figure 1.23: Mono- and bis-deoxygenated benzo[b][1,4]dioxepin-3-one analogues synthesised by 
Gaudin et al.[73] 
 
 
 
 CHAPTER 1 
 
29 
  
The original patent claimed good olfactory properties for both the benzo[b][1,4]dioxepin-3-one and 
4,5-dihydrobenzo[b]oxepin-3-one molecular scaffolds, but precise odour descriptions and potency were 
not reported.[85] The re-synthesis of mono-deoxygenated analogues (97–99) revealed that both 
templates incorporated marine nuances but that the benzo[b][1,4]dioxepin-3-one template was clearly 
the more powerful marine odorant scaffold (Figure 1.23). A series of bis-deoxygenated analogues 
(100−101) were additionally synthesised and were discovered to not have marine characteristics.[73] 
Discrepancies in potency between the sets of analogues led the researchers to suspect that the 
differences could be rationalised by the preferred conformation of the seven-membered heterocyclic 
ring moiety.  
 
Computational models revealed that, whilst the potent benzo[b][1,4]dioxepin-3-one template 
(i.e. Calone 1951®, 50) favoured a pseudo-twist-boat conformation with the carbonyl functionality 
co-planar to the aromatic ring, the much weaker 8,9-dihydro-5H-benzo[7]annulen-7-one derivatives 
(i.e. 101) favoured a pseudo-chair conformation that placed the carbonyl functionality completely out of 
plane. The 4,5-dihydrobenzo[b]oxepin-3-one analogues (i.e. 98) showed intermittent activity between 
the two different conformations (Table 1.2).[73] This contributed to the theory that co-planarity between 
the aromatic ring and the carbonyl functionality was linked to potent marine fragrance character.  
 
 
Pseudo-twist-
boat 
Pseudo-half-
chair 
Marine Odorant 
Activity 
7-Methylbenzo[b][1,4]dioxepin-3-one 
(Calone 1951®, 50) 
0 kcal/mol +2.7 kcal/mol Strong 
7-Methyl-4,5-dihydrobenzo[b]oxepin-3-one 
(98) 
0 kcal/mol –0.2 kcal/mol Weak 
2-Methyl-8,9-dihydro-5H-benzo[7]annulen-7-
one (101) 
0 kcal/mol –2.9 kcal/mol None 
 
Table 1.2: Calculated relative energies of the two main conformers of compounds 50, 98 and 101.[73] 
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Additional research was later conducted by the same research group in order to address questions 
regarding the role of the carbonyl functionality in marine odorant perception. To that effect, a variety of 
analogues with alternative hydrogen-bond acceptor groups in place of the carbonyl moiety (type 102) 
were synthesised and evaluated. In an effort to modify the position and spacial orientation of the 
carbonyl functionality by altering the molecular geometry of the original scaffold, the heterocyclic ring 
system was opened (type 103) and also substituted with a five-membered ring system (type 104) 
(Figure 1.24).[86]  
 
 
Figure 1.24: Targeted benzo[b][1,4]dioxepin-3-one analogue scaffolds of Gaudin et al.[86] 
 
A new more broadly-tuned olfactophore model was generated. The model contained one 
hydrogen-bond acceptor, an aromatic binding site and an aliphatic hydrophobe (Figure 1.25). A variety 
of hydroxyl, ether, acetate and epoxide substituted analogues of compound type 102 were synthesised 
and evaluated. The hydroxyl analogue of Calone 1951® (50) was discovered to retain marine-ozone 
character, but was discovered to be much weaker, presumably due to decreased volatility. The acetate 
and ether analogues were discovered to not contain marine nuances which was subscribed to the fact 
that these functionalities may lose their ability to act as hydrogen-bond acceptors. The odour of the 
epoxide analogue was reminiscent of the fresh marine note, but was not powerful. The results 
successfully confirmed that a carbonyl functionality substituted at the C–3 position is the optimal 
substituent for the benzo[b][1,4]dioxepin-3-one molecular scaffold.[86]  
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Figure 1.25: Marine-ozone olfactophore model generated by Gaudin et al.[86] Copyright Wiley-VCH Verlag GmbH 
& Co. KGaA. Reproduced with permission. 
 
A variety of analogues of compound type 103 were synthesised and evaluated. The motivation in 
opening the seven-membered heterocyclic ring system involved allowing the carbonyl osmophore to 
adopt an optimal conformation for receptor binding. No compounds of this class of analogues were 
discovered to contain ozone or marine character. This was hypothesised to be owing to a potential 
negative interaction of the free methoxy moiety with olfactory receptor(s). The discovery may 
additionally indicate that the oxygen atoms of the benzo[b][1,4]dioxepin-3-one template are more 
important for their conformation effects than for their electronic effects.[86]  
 
The final class of analogues synthesised and evaluated were of compound type 104 (Figure 1.26). It 
was discovered that compound 54 retained potent marine odour characteristics. The introduction of a 
methyl functionality geminal to the aldehyde (105) was clearly unfavourable, presumably due to 
interference with osmophore function. The carba analogues 106–107,[91-92] which have a similar 
molecular conformation, are in general more aldehyde, green, muguet and less ozone-marine. The 
authors noted that this class of molecule can fit into both the marine-ozone and lily-of-the-valley 
olfactophore models, and even hypothesised that these molecules could potentially interact with both 
olfactory receptors depending on their favoured conformation. They also suggested that the olfactory 
receptor for both odorant classes should be molecularly similar.[86] Further evidence for this structural 
relationship arises from the fact that the bis-carba analogue of Calone 1951® (compound 101) was 
described as having lily-of-the-valley-odour.[73] 
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Figure 1.26: Five-membered benzo[b][1,4]dioxepin-3-one analogues displaying marine and 
lily-of-the-valley nuances.[86] 
 
1.4.6 – Benzo[b][1,4]dioxepin-3-one Structure-Odour Relationship Studies – RMIT University  
A variety of substituted benzo[b][1,4]dioxepin-3-one analogues were synthesised and evaluated by 
researchers at RMIT University.[7, 84, 93] Due to difficulties employing the patented Dieckmann 
condensation route in delivering new analogues, particularly those with electron withdrawing 
substituents, a new synthetic route was implemented (Scheme 1.5). The new synthetic route involved 
a Williamson reaction of various catechol analogues (type 108) with a bis-halogenated alkylating agent 
to give an ether intermediate (type 109) which was then deprotected and oxidised to furnish the 
completed odorant molecule (type 111).  
 
 
Scheme 1.5: Synthetic route to benzo[b][1,4]dioxepin-3-one analogues employed by Hügel et al.[84] 
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A variety of aromatic ring substituted analogues were synthesised including nitro-, aldehyde-, bromo- 
and methoxy-substituted derivatives. It was discovered that the nitro- and aldehyde-substituted 
analogues were completely devoid of marine character, with the introduction of fruity, sweet and 
balsamic tonalities, indicative of an absence of any marine receptor binding interaction. Both the 
brominated and tertiary-butylated analogues were discovered to have walnut nuances, hypothesised to 
involve the steric bulk of the substituents. It was concluded that alkyl substitution is critical, but not 
essential, for marine odorant characteristics, and that aromatic substitution modifies the odour 
perception of the benzo[b][1,4]dioxepin-3-one scaffold.[84] 
 
An additional study into the alteration of the polar osmophore functionality revealed that a carbonyl 
moiety is the optimal substituent, the results coinciding with those of Gaudin et al.[86] It was discovered 
that marine tonality remains detectable upon removal of the carbonyl functionality, but that alternative 
dominant accords begin to arise such as aldehydic, sweet and floral-fruity (Figure 1.27). It was 
concluded that a complete removal of the osmophore functionality results in an absence of marine 
tonality.[93] 
 
 
Figure 1.27: Graphical representation of the C–3 benzo[b][1,4]dioxepin-3-one analogues. Adapted 
from Hugel et al.[93] Black: strong; grey: weak; white: absent. 
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1.5 – Isocyclemone Odorants 
1.5.1 – Commercially Available Products 
Iso E Super® (115) was discovered at International Flavors & Fragrances (IFF) in 1973[6] and patented 
in 1975.[94] Iso E Super® (115) possesses a characteristic woody-amber odour and has been one of the 
most influential raw materials in the fragrance industry,[95] its application finding use from fine perfumes 
to detergents.[96] The industrial synthesis commences with an aluminium chloride catalysed Diels–Alder 
reaction of monoterpene myrcene (112) with dienophile (3E)-3-methylpent-3-en-2-one (113) to give 
intermediate compound Precyclemone E (114) (Scheme 1.6). This reaction is followed by a subsequent 
acid-catalysed cyclisation reaction to provide the racemic target product, compound 115.[6, 64] The 
resulting product is a complex mixture of isomeric and diastereomeric compounds structurally related 
to the molecular structure originally proposed as Iso E Super® (115). It was later discovered that the 
major product of the reaction (115) had an odour threshold value of a mere 500 ng/L air, and that a 
minor constituent (116, ca. 5%), with an odour threshold about 100,000 times lower, was determining 
the overall fragrance quality of the commercial material.[97-99] The molecular structure of compound 116 
was proposed by isolation and 2D NMR experimentation, and confirmed by total synthesis, and the 
compound was named Arborone.[97, 100] A raw perfumery material in which compound 116 is enriched 
by a factor of two is now manufactured by a different synthetic process and is commercially available 
under the name Iso Gamma Super®.[101] 
 
 
Scheme 1.6: Commercial synthesis of Iso E Super® (115) from myrcene (112) and 
(3E)-3-methylpent-3-en-2-one (113).[6, 64] 
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The total synthesis of racemic Arborone (116) began from α-ionone (117) with a diastereoselective 
conjugate addition of lithium dimethylcuprate to give compound 118 (Scheme 1.7). Intermediate 118 
was then transformed into intermediate 119 by haloform reaction, esterification and ozonolysis following 
isomerisation with sodium hypochlorite. A Grignard reaction of 119 with ethynylmagnesium bromide 
and subsequent Lindlar hydrogenation provided compound 120. Ireland-Claisen rearrangement and 
methylation of the resulting carboxylic acid provided target compound (±)-116 which was found to be 
chemically identical to the compound isolated from Iso E Super®, thus confirming the molecular 
structure.[6, 64, 97] 
 
 
Scheme 1.7: Total synthesis of racemic Arborone (116) from α-ionone (117).[97] 
 
The synthesis of unadulterated Arborone (116) by the route delineated in Scheme 1.7 is synthetically 
complicated and not suitable for industrial scale. In place of a pure perfumery material composed of 
compound 116, an alternative material named Georgywood® (124) was instead made commercially 
available.[6, 64] Compound 124 was discovered to have an almost equal odour threshold as compound 
116, and was preferred in terms of fragrance characteristics.[64] Compound 124 is produced industrially 
by the Diels–Alder reaction of homomyrcene (121) and 3-methylbut-3-en-2-one (122), followed by 
subsequent acid-catalysed cyclisation of the resulting intermediate (123) to provide target compound 
(±)-124 (Scheme 1.8).[6] Georgywood® possesses a pleasant woody odour that is distinct to the 
fragrances of cedar-wood or sandalwood, which exhibit additional distinctive notes.[100] Analogous to 
Iso E Super®, the commercial material contains an undesired regioisomer, (±)-125, synthesised in near 
equal quantity to (±)-124.[102-103] 
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Scheme 1.8: Commercial synthesis of Georgywood® (124) from homomyrcene (121) and 
3-methylbut-3-en-2-one (122).[6] 
 
1.5.2 – Isocyclemone Structure-Odour Relationship Studies – Harvard University 
An enantioselective total synthesis of the principle odorant of the commercially available material 
Georgywood® was achieved by Hong and Corey, beginning from homomyrcene (121) and 
methacrylaldehyde (126) (Scheme 1.9).[100] The key step in the synthetic sequence is the 
enantioselective Diels–Alder reaction between 121 and 126, catalysed by (S)-oxazaborolidinium salt 
127, to give intermediate 128. This compound is then reacted with methylmagnesium bromide followed 
by Dess-Martin periodinane oxidation of the resulting hydroxyl moiety to give compound 129, followed 
by cyclisation in the presence of methylaluminium chloride to provide the enantiopure Georgywood® 
analogue (–)-124. The synthesis of the antipode of 124 using the (R)-configured oxazaborolidinium 
catalyst revealed that the odour of Georgywood® is mainly due to the (–)-(1R,2S)-configured 
stereoisomer (−)-124, later named Georgyone.[6, 100] 
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Scheme 1.9: Enantioselective synthesis of (–)-Georgyone (124) from homomyrcene (121) and 
methacrylaldehyde (126).[100] 
 
The synthesis of an enantiopure sample of Arborone (116) was also achieved using the same 
oxazaborolidinium catalyst (127). The synthetic sequence began with an enantioselective Diels–Alder 
reaction between 1,3-butadiene (130) and (E)-2-methylbut-2-enal (131) to give enantiopure aldehyde 
132 (Scheme 1.10). Jones oxidation followed by an iodolactonisation and a β-elimination sequence 
provided compound 133 which was then converted to compound 134 by sequential methanolysis and 
pyridinium chlorochromate oxidation. The diastereoselective reaction of 134 with a cyanocuprate 
reagent followed by ozonolysis of the resulting intermediate provided compound 135, which was then 
cyclised by acid-catalysed aldol condensation to give compound 136. This intermediate was then 
converted to compound 137 followed by diisobutylaluminium hydride reduction, oxidation, a Grignard 
reaction with methylmagnesium bromide and subsequent Dess-Martin periodinane oxidation to provide 
dextrorotatory target compound (+)-116. This compound was described as possessing an intense 
woody fragrance. The levorotatory enantiomer of this compound was also prepared by a parallel 
sequence and was discovered to be faint in odour.[100] 
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Scheme 1.10: Enantioselective synthesis of (+)-Arborone (116) from 1,3-butadiene (130) and 
(E)-2-methylbut-2-enal (131).[100] 
 
The enantioselective syntheses of the odour active constituents of Iso E Super® (Arborone, 116) and 
Georgywood® (Georgyone, 124) revealed that the isomers differ in their configuration at the carbon 
atom bearing the acetyl functionality (C–2). Attention was turned to revealing the necessary structural 
components required for the more potent analogue (116) to display powerful fragrance. The synthesis 
of analogues 138–140 containing alteration of the geminal methyl functionalities at C–9 was undertaken 
to understand their role in olfactory recognition (Figure 1.28). It was discovered that only the equatorial 
methyl functionality at C−9 was required for strong odour perception (9R-configuration, 138), and that 
an axial methyl functionality (9S-configuration, 139) gave a compound devoid of the typical woody 
odour. The complete removal of both geminal methyl functionalities (compound 140) was also 
discovered to abolish odour.[100] 
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Figure 1.28: Arborone (116) analogues 138–143 prepared by Hong and Corey.[100] 
 
It was discovered that an analogue that contained only the crucial (9R)-configured methyl functionality, 
but was additionally 6,7-dehydrated (compound 141), still retained the potent odorant characteristics of 
lead compound 116 (Figure 1.28). The odour of 141 was similar to 116 indicating that the addition of 
Δ6,7 unsaturation makes little difference, and thus further analogues of this scaffold were synthesised 
due to ease of synthetic access. Compound 142, devoid of the (R)-configured methyl group at C–1 
typical to both Arborone (116) and Georgyone (124) displayed little odour. The reintroduction of the 
methyl moiety, but a switch in stereochemistry to a (1S)-configuration (compound 143), also provided 
a near odourless compound. The authors determined that the essential molecular features of lead 
compound 116 include the absolute configuration, a flat bicyclic ring system, equatorial methyl moieties 
at C–1 and C–2 and an acetyl functionality at C–2. The authors concluded their research by citing an 
amino acid sequence motif that could potentially be involved in the receptor binding of the isocyclemone 
molecules. Their hypothesis also provided explanation as to why compounds 116 and 124 can have 
different spacial orientations of the acetyl functionality but both retain potent odorant characteristics.[100] 
 
A study by Hicken and Corey used analogous synthetic methodology to prepare analogues of 
Georgyone (124) in which the C–6 methylene unit was replaced by an ether oxygen atom (Figure 1.29). 
The motive for the proposed oxa-analogue synthesis involved both decreasing substrate volatility and 
increasing water solubility and bioavailability of the resulting compounds. Analogues 144 and 145 both 
contained pleasant woody fragrances, not dissimilar to Arborone (116) or Georgyone (124).[104]  
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The strong fragrance of compounds 144 and 145 demonstrated that the olfactory receptors responsible 
for woody odour can accommodate a heteroatom at C–6 and that, unexpectedly, the stereochemistry 
at C–1/C–2 is not as significant in Georgyone (124) analogues as in Arborone (116) analogues.[104] The 
discovery offered additional support to the theory of conformational flexibility at the olfactory receptors 
originally proposed by Hong and Corey.[100]  
 
 
Figure 1.29: Oxa-Georgyone analogues 144 and 145 prepared by Hicken and Corey.[104] 
 
1.5.3 – Isocyclemone Structure-Odour Relationship Studies – Givaudan 
Researchers at Givaudan performed molecular calculations that successfully linked the ionone and 
isocyclemone odorant families which led to the discovery of odorant 146 (Figure 1.30). This compound, 
as well as several chemically related analogues, were synthesised as racemic mixtures by a novel [4+2] 
cycloaddition reaction in the presence of Wilkinson’s catalyst.[105] A subsequent study revealed that the 
(9R,10S)-configured enantiomer (146) was 100x more powerful than its antipode, mimicking that which 
was discovered for Georgywood® (124). Additional cyclopentyl-fused analogues (i.e. 147 and 148) were 
synthesised in an analogous manner. Differences in odour description between the analogues 
demonstrated the importance of a vicinal bis-methyl system displaying trans-configuration.[106]  
 
 
Figure 1.30: Eight-membered isocyclemone analogues 146–148 prepared by Kraft et al.[105-106] 
 
A series of spirocyclic analogues were synthesised and evaluated to study the effect of a more rigid 
molecular geometry on the isocyclemone molecular scaffold (Figure 1.31). The synthesis of spirocyclic 
analogue 149 was achieved beginning from homomyrcene (121). This analogue was discovered to 
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have a pleasant woody odour. To further explore the influence of molecular alteration, analogue 149 
was deprotonated with lithium diisopropylamide followed by methylation using methyl iodide to furnish 
stereoisomers 150 and 151, both potent odorants. A second methylation reaction resulted in geminal 
bis-methyl analogue 152 for which an additional unpleasant green nuance was reported. A series of 
cyclooctyl analogues were additionally synthesised (i.e. 153 and 154) and it was again discovered that 
a trans-configured spatial orientation of the substituted alkyl moieties was an essential feature for potent 
odour character.[99] 
 
 
Figure 1.31: Spirocyclic isocyclemone analogues 149–154 synthesised by Kraft et al.[99] 
 
The series of new analogues synthesised provided insight that the olfactory receptor(s) can indeed 
discriminate between spacial orientations of the substituted alkyl moieties in the isocyclemone family. 
The potency of the prepared analogues also indicated that the receptor binding region is much larger 
than was initially hypothesised by Hong and Corey.[100] Conclusions were also drawn that the receptor 
may be more complex than initially anticipated, and that the highly structure sensitive hydrophobic 
binding cavity may be constructed from more than one α-helix structure.[99]  
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Chapter 2 – Synthesis of Hexahydrobenzo[b][1,4]dioxepin-3-one Stereoisomers 
 
2.1 – Introduction 
2.1.1 – Project Proposal & Rationale 
Odour discrimination and perception are a combinatorial phenomenon. In the olfactory epithelium 
different odorant molecules are detected by varying combinations of olfactory receptors with various 
receptor combinations generating specific odour perceptions.[1-3] It is well-known that the absolute 
configuration of a molecule is of crucial importance in determining the human perception of odour.[4] It 
is also recognised that a substance evokes a sense of smell provided that the molecular shape matches 
a complementary space in the olfactory receptor.[5] We can therefore define the odour of a chemical 
substance by the molecular shape. It is known that the benzo[b][1,4]dioxepin-3-one rings represent the 
essential structural characteristic of the synthetic marine odorant family[6-12] and consequently we are 
interested in the effect of modulating the molecular shape via an aromatic/aliphatic carbocyclic ring 
exchange (Figure 2.1). 
 
 
Figure 2.1: Aromatic/aliphatic ring exchange of the benzo[b][1,4]dioxepin-3-one molecular scaffold.  
 
2.1.2 – Aromatic and Aliphatic Carbocyclic Rings 
The benzo[b][1,4]dioxepin-3-one molecular scaffold consists of an aromatic cyclohexa-1,3,5-triene 
carbocyclic ring fused to a 1,4-dioxepan-6-one oxygenated heterocyclic ring. The organic chemistry 
term ‘aromatic’ was first proposed by August Wilhelm Hofmann in 1855 to describe his work into phenyl 
radicals.[13] The modern use of the term indicates no relationship between chemical and olfactory 
properties. The aromatic cyclohexa-1,3,5-triene molecule, better recognised as a benzene molecule, is 
the simplest aromatic molecule consisting of six carbon atoms and three carbon–carbon alkene double 
bonds. The cyclohexa-1,3,5-triene molecular structure for benzene was first proposed by August Kekulé 
in 1865, and can be viewed as an amalgamation of two different resonance structures (Figure 2.2).[14] 
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Figure 2.2: Top: Two resonance structures of a benzene molecule; Bottom: A more accurate visualisation of 
molecular resonance.  
 
An aromatic benzenoid ring system is a completely planar hexagonal ring. All six carbon–carbon bonds 
are sp² hybridised and are of the same length (1.39 Å), which is intermediate between the typical length 
of a single bond (1.54 Å) and that of a double bond (1.34 Å).[15] Since all atomic p orbitals overlap above 
and below the plane of the hexagonal ring, the six π electrons are completely delocalised and are 
shared equally by each carbon atom within the ring (Figure 2.3). During NMR spectroscopy, the 
circulation of π electrons out of the plane of the aromatic ring produces ring currents that dramatically 
affect the chemical shifts of the nuclei via diamagnetic anisotropy.[15] 
 
 
Figure 2.3: Delocalisation of π-electrons in an aromatic cyclohexa-1,3,5-triene ring.  
 
The aliphatic analogue of a benzenoid system is known as a cyclohexyl system. Unlike benzene, in 
which all planar C–C–C bonds are 120º, the preferred angle between sp3 hybridised carbons is 109.5º; 
a tetrahedral angle. To minimise the resulting ring strain the carbocyclic ring adopts a non-planar 
conformation. The most readily identified conformations are referred to as the chair and boat 
conformations, although a variety of different twist-forms and half-forms are also recognised.  
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The chair is the lowest energy conformation and is therefore the preferred ground-state of the cyclohexyl 
ring system (Figure 2.4).[16] A carbocyclic ring in any non-planar conformation has protons and/or 
substituents situated in two different types of environments known as axial and equatorial positions. 
The two possible forms of the chair conformation cyclohexane molecule rapidly interconvert at room 
temperature, with all axial positions becoming equatorial positions, and vice versa. Multi-substituted 
cyclohexane molecules prefer to place larger substituents in spaces occupying equatorial positions to 
minimise steric repulsion, and thus interconversion between forms is quenched.[15]  
 
 
 
 
 
Figure 2.4: Top: Conformational changes during the inversion of cyclohexane[16]; Bottom: Axial and equatorial 
positions of a chair conformation ring. 
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The synthetic commercial odorant Calone 1951® and its benzo[b][1,4]dioxepin-3-one scaffolded 
relatives contain a planar aromatic ring attached to a 7-membered oxygenated heterocyclic ring 
(Figure 2.5). The quantitative and qualitative olfactory analysis of previously synthesised analogues 
clearly indicate that chemical modification on any position of the benzo[b][1,4]dioxepin-3-one template 
has a significant effect on the resulting olfactory characteristics.[6-7, 9-12] Accordingly we have chosen to 
synthesise a library of benzo[b][1,4]dioxepin-3-one analogues with a saturated cyclohexyl ring system 
in place of the usual planar benzenoid ring system.  
 
 
Figure 2.5: Minimum-energy conformation of 7-methylbenzo[b][1,4]dioxepin-3-one (Calone 1951®) displaying 
pseudo-twist-boat conformation, generated with MOE 2013.0801 software package using the Amber 12 force 
field with Extended Hückel Theory (EHT) parameters.[17] 
 
2.1.3 – Potential Synthetic Pathways to the Benzo[b][1,4]dioxepin-3-one Scaffold 
Multiple synthetic pathways leading the aromatic benzo[b][1,4]dioxepin-3-one scaffold have been 
developed. The original Pfizer synthetic methodology involved the Williamson reaction of various 
catechol derivatives with methyl bromoacetate before subjection of the intermediate bis-ester 
compound to a base-catalysed Dieckmann condensation reaction.[18-19] The resulting β-ketoester 
compound is then decarboxylated in a single-step acid-catalysed reaction to furnish the corresponding 
analogue (Figure 2.6).[18-19] 
 
Analogous synthetic methodology was utilised by Hügel et al.[10, 20] during the synthesis of a library of 
benzo[b][1,4]dioxepin-3-one analogues for odorant evaluation, as well as during research into the 
comparison of yields between conventional heating and microwave irradiation. This synthetic 
methodology was applied by Kraft et al.[7] during the synthesis of a library of conjugated olefinic chain 
benzo[b][1,4]dioxepin-3-one odorant analogues. This pathway was also employed during the synthesis 
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of a library of 1,5-benzodioxepin derivatives in research targeting novel muscarinic M3 receptor 
antagonists.[21] A benzo[b][1,4]dioxepin-3-one compound was recovered as a by-product of Dieckmann 
cyclisation methodologies which were being applied in an attempt to generate novel crown ether 
compounds.[22] 
 
Figure 2.6: Dieckmann condensation route leading the benzo[b][1,4]dioxepin-3-one scaffold. General procedure: 
a) methyl bromoacetate, K2CO3, DMF, 120 ºC. b) KOtBu, THF, ↑↓. c) HCl, EtOH, H2O, ↑↓.  
 
An analogous synthetic route involving a Thorpe-Ziegler reaction was developed during the synthesis 
of a library of 1,5-benzodioxepin analogues for use as β-adrenergic stimulants.[23] The synthetic 
methodology was also assayed as a potential route to the synthesis of novel calcium channel 
antagonists.[24] The synthetic pathway commences with the Williamson reaction of substituted catechol 
analogues with 2-chloroacetonitrile to give a bis-nitrile intermediate. The isolated bis-nitrile compound 
is then subjected to a base-catalysed intramolecular Thorpe-Ziegler cyclisation to yield an enamine 
nitrile compound which is then hydrolysed in an acidic hydrolysis at reflux temperature to yield the 
completed analogue (Figure 2.7).  
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Figure 2.7: Thorpe-Ziegler route leading the benzo[b][1,4]dioxepin-3-one scaffold. a) 2-chloroacetonitrile, K2CO3, 
acetone, ↑↓. b) KOtBu, DMSO. c) H3PO4, AcOH, H2O, ↑↓.  
 
A Williamson reaction cyclisation methodology was developed by Kraft et al.[6] during the synthesis of 
a library of novel benzo[b][1,4]dioxepin-3-one analogues for olfactory evaluation (Figure 2.8, route a/c). 
The cyclisation methodology to give an intermediate 3-methylenebenzo[b][1,4]dioxepine compound 
was developed in 1968 by Schirmann et al.[25] and involved a Williamson reaction between catechol, 
potassium carbonate and 3-chloro-2-(chloromethyl)prop-1-ene to yield the cyclised compound. Kraft 
et al.[6] subsequently developed further synthetic methodologies to oxidise the methylene intermediate 
into the corresponding benzo[b][1,4]dioxepin-3-one analogue by the action of ruthenium tetroxide, 
generated in situ by the action of sodium metaperiodate on ruthenium chloride. 
 
An alternative methodology from patent literature described a parallel reaction pathway leading to an 
unsubstituted analogue (Figure 2.8, route a/d/e).[26] The synthetic pathway began with an analogous 
chemical reaction to Schirmann et al.,[25] instead using caesium carbonate as a base. The isolated 
methylene compound was then oxidised to a vicinal-diol intermediate by the action of osmium tetroxide. 
The vicinal-diol intermediate is then oxidatively cleaved using the oxidant sodium metaperiodate to yield 
the corresponding benzo[b][1,4]dioxepin-3-one analogue. It is not clear why the vicinal-diol compound 
is isolated when the reaction could be performed in a one-step procedure known as the 
Lemieux-Johnson oxidation,[27] but it is presumably done to minimise impurities being generated.  
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A simpler Williamson cyclisation protocol was developed by Gaudin et al.[12] The synthetic methodology 
reacted substituted catechol derivatives with 1,3-dichloropropan-2-one to yield the target compound in 
a one-step procedure (Figure 2.8, route f). This reaction had previously been trialled by Sanchez et al.[24] 
but was found to return only degradation products and starting material. The key difference between 
the two synthetic methodologies was the addition of sodium iodide to the reaction mixture. Sodium 
iodide is understood to undergo SN2 substitution reactions with alkyl chlorides to generate alkyl iodide 
intermediates, thus rendering the compound more reactive. The addition of an alkali metal halide to a 
primary alkyl halide for these purposes is known as a Finkelstein reaction.[28] It should be noted that the 
cyclisation reagent is an extremely hazardous and lachrymatory chemical. 
 
A palladium-catalysed cyclisation reaction between substituted catechol analogues and dimethyl 
(2-methylenepropane-1,3-diyl) dicarbonate to give a 3-methylenebenzo[b][1,4]dioxepine intermediate 
was reported by Sinou et al.[29] (Figure 2.8, route b followed by d/e (one-pot)). The isolated methylene 
intermediate was oxidised to the target compound in a one-step Lemieux-Johnson oxidation. The 
palladium catalyst for the cyclisation reaction is pre-generated before addition to a solution of the 
catechol derivative alongside the dicarbonate compound. The authors noted that the cyclisation scope 
was limited to reactants that did not contain electron-withdrawing groups substituted on the benzene 
ring.  
 
Another synthetic route was developed by Hügel et al.[10] for the synthesis of a library of substituted 
analogues for olfactory evaluation (Figure 2.9, route a/b/d). This route involved the Williamson reaction 
of various catechol derivatives with 2-((1-bromo-3-chloropropan-2-yl)oxy)tetrahydro-2H-pyran to yield 
a cyclised intermediate tetrahydropyranyl-ether compound. The protecting group was then removed by 
the action of a vanadium complex to yield the unprotected racemic alcohol which was then oxidised 
with potassium permanganate to yield the corresponding target compound. An alternative procedure 
for the oxidation of the alcohol derivative using Dess-Martin periodinane was described within a 2008 
patent.[30] 
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Figure 2.8: Williamson ether synthesis routes developed by Kraft et al. (route a/c), Curtin et al. (route a/d/e), 
Sinou et al. (route b followed by d/e (one-pot)) and Gaudin et al. (route f) leading the benzo[b][1,4]dioxepin-3-one 
scaffold. a) 3-chloro-2-(chloromethyl)prop-1-ene, K2CO3, Et2CO, dioxane, ↑↓. b) dimethyl (2-methylenepropane-
1,3-diyl) dicarbonate, Pd2(dba)3, dppb, THF. c) RuCl3, NaIO4, CCl4, MeCN, H2O. d) OsO4, NMO, acetone, tBuOH, 
H2O. e) NaIO4, THF, H2O. f) 1,3-dichloropropan-2-one, NaI, K2CO3, acetone. 
 
Rosnati et al.[31] described the isolation of the same cyclised alcohol when a Williamson reaction was 
performed with 1,3-dichloropropan-2-ol (Figure 2.9, route c/d). It is noted that this compound was 
actually an impurity in a synthesis designed to generate a six-membered heterocyclic compound. To 
verify the molecular structure of the undesired alcohol, an oxidation with potassium permanganate was 
performed which successfully yielded the benzo[b][1,4]dioxepin-3-one compound, which was then 
further functionalised and characterised. 
 
 
Figure 2.9: Williamson ether synthesis route developed by Hügel et al. (route a/b/d) and Rosnati et al. (route c/d) 
leading the benzo[b][1,4]dioxepin-3-one scaffold. a) 2-((1-bromo-3-chloropropan-2-yl)oxy)tetrahydro-2H-pyran, 
K2CO3, DMF, ↑↓. b) V2O5, H2O2, 70 ºC c) 1,3-dichloropropan-2-ol, KOH, 100 ºC. d) KMnO4, KOH, H2O. 
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A synthetic methodology leading to the heterocyclic portion of the benzo[b][1,4]dioxepin-3-one scaffold 
that involved the reaction of bis-hydroxyl compounds with tris-ω,ω,ω-bromomethylacetophenone to 
yield cyclised methylene intermediates was developed by Nerdel et al.[32] (Figure 2.10). The reaction 
involves the in situ cleavage of the acetophenone derivative via the action of an alkoxide intermediate 
to generate 3-bromo-2-(bromomethyl)prop-1-ene. This intermediate then undergoes a standard 
Williamson reaction with the bis-hydroxyl compound to yield the cyclised target material. The authors 
successfully oxidised the methylene intermediate using ozone, before performing a degradation to the 
unsubstituted parent compound as proof of molecular structure.  
 
 
Figure 2.10: Methodology developed by Nerdel et al. leading to the 1,4-dioxepan-6-one scaffold (n = 1); a) NaH, 
THF. b) O3, MeOH. 
 
An alternative synthetic methodology, never applied to the synthesis of benzo[b][1,4]dioxepin-3-one 
analogues, but to substituted 2-dimethylbenzo[b][1,4]dioxepin-3-ol analogues, had been utilised in the 
synthesis of multiple mycotoxin compounds such as paraherquamide A & B and 
9-methoxystrobilurin K.[33-37] The synthetic methodology involves the mono-etherification of a catechol 
analogue with prenyl bromide, followed by epoxidation using meta-chloroperbenzoic acid. The isolated 
epoxide intermediate is then cyclised in a Lewis-acid catalysed reaction to yield the 2-dimethyl-3-
hydroxyl analogue of the benzo[b][1,4]dioxepin-3-one template (Figure 2.11).  
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This synthetic methodology could presumably be modified to synthesise analogues of the 
benzo[b][1,4]dioxepin-3-one scaffold by the substitution of prenyl bromide with allyl bromide. Molecular 
structures bearing a 1,4-dioxepan-6-ol heterocycle were indeed isolated as impurities in two separate 
research studies attempting to create benzodioxane analogues using analogous methodologies, but 
instead using allyl bromide as the etherification reagent.[38-39]  
 
 
Figure 2.11: Epoxide cyclisation route to 2-dimethylbenzo[b][1,4]dioxepin-3-ol scaffold. a) prenyl bromide, 
K2CO3, DMF. b) mCPBA, NaHCO3, CH2Cl2, 0 ºC. c) SnCl4, THF. 
 
Another potential route to the saturated benzo[b][1,4]dioxepin-3-one scaffold is the direct hydrogenation 
of the aromatic scaffold (Figure 2.12). Aromatic hydrogenation is already employed in the fragrance 
industry during the synthesis of (±)-menthol from aromatic monoterpene compound thymol.[40] If applied 
to the benzo[b][1,4]dioxepin-3-one molecule, this synthetic protocol may prove to be problematic owing 
to the target compound being produced as a racemic mixture thus making characterisation difficult. A 
variety of promising catalysts for aromatic ring hydrogenation under mild reaction conditions have been 
reported in recent literature including, but not limited to, palladium, ruthenium and gold nanoparticle 
catalysts absorbed onto various supporting materials.[41-44]  
 
 
Figure 2.12: Potential hydrogenation route to the saturated benzo[b][1,4]dioxepin-3-one scaffold.  
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2.2 – Results and Discussion 
2.2.1 – Synthesis of Calone 1951® by Dieckmann Condensation 
To construct the target aliphatic benzo[b][1,4]dioxepin-3-one molecules it was decided to build the 
dioxepanone heterocycle onto the cyclohexyl carbocycle in a fashion analogous to the synthetic 
pathway originally described in the Pfizer patent for Calone 1951®.[18] To determine if the published 
literature methodology was accurate, the chemical synthesis of lead compound Calone 1951® (50) was 
performed.[10]  
 
The pathway first involved a Williamson reaction of 4-methylcatechol (155) with ethyl bromoacetate 
(156) in dimethylformamide (DMF) using anhydrous potassium carbonate (K2CO3) as a base 
(Scheme 2.1). The methodology required the reaction be heated to 120 ºC for two hours followed by 
pouring the reaction mixture into ice-cold water followed by extraction with dichloromethane (DCM). 
The target compound 157 was isolated in 53% yield from the complex reaction mixture by gradient flash 
chromatography (15 → 20%; ethyl acetate in hexane) as a clear oil. In subsequent Williamson reactions 
it was discovered that superior results were obtained when the extraction solvent was changed from 
dichloromethane to diethylether, as the solubility of dimethylformamide is markedly lower, thereby 
making the extraction process more efficient. 
 
 
Scheme 2.1: Synthesis of Calone 1951® (50) from 4-methylcatechol (155) via Dieckmann methodology.  
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The isolated bis-ester compound 157 was then cyclised by addition to a stirred solution of the strong 
non-nucleophilic base potassium tert-butoxide (KOtBu) in tetrahydrofuran (THF) at 0 ºC, followed by 
heating to 70 ºC for one hour before quenching the reaction with the addition of an ice-cold solution of 
0.2 M hydrochloric acid (HCl). This reaction gave a racemic mixture of regioisomers of the cyclic 
β-ketoester compound. The crude material was then decarboxylated by heating at reflux in 2 M HCl to 
furnish the target compound Calone 1951® (50) as a colourless crystalline solid in a 53% yield. 
Heteronuclear single quantum coherence spectroscopy (1H, 13C, HSQC) analysis revealed that 
Dieckmann cyclisation and decarboxylation were successful in yielding the aromatic 
benzo[b][1,4]dioxepin-3-one molecule (Figure 2.13).  
 
 
 
 
Figure 2.13: 1H, 13C HSQC (CDCl3, 300 MHz) spectrum of compound Calone 1951® (50). 
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The key step in the synthesis of the benzo[b][1,4]]dioxepin-3-one molecular scaffold via this synthetic 
methodology is the Dieckmann condensation reaction. First published in 1894 by German chemist 
Walter Dieckmann, this reaction involves the intramolecular cyclisation of a bis-ester compound to give 
a β-ketoester compound, analogous to the intermolecular Claisen condensation reaction.[45] The 
reaction of the bis-ester compound initiates with the removal of an acidic α-hydrogen resulting in the 
formation of an enolate anion (Figure 2.14). The enolate anion nucleophilically attacks the 
electropositive carbonyl carbon of the adjacent ester moiety, the corresponding alkoxide anion is 
released and the β-ketoester intermediate is formed. This intermediate is then further deprotonated to 
form an enolate from which an acidic workup is required to liberate the final β-ketoester product.  
 
 
Figure 2.14: Proposed reaction mechanism for the Dieckmann condensation reaction leading to the 
benzo[b][1,4]dioxepin-3-one scaffold. 
 
An intramolecular Dieckmann cyclisation reaction to give a seven membered ring is a 7-exo-trig 
cyclisation, indicating that it is predicted to be a favoured cyclisation reaction by Baldwin’s rules 
(Table 2.1). First proposed in a series of papers by Jack E. Baldwin beginning in 1976, these rules 
predict the relative success of ring closing synthetic reactions.[46-47] 
 Synthesis of Hexahydrobenzo[b][1,4]dioxepin-3-one Stereoisomers 
 
61 
  
 3 4 5 6 7 
Type exo endo exo endo exo endo exo endo exo endo 
tet ✓ - ✓ - ✓ X ✓ X ✓ X 
trig ✓ X ✓ X ✓ X ✓ ✓ ✓ ✓ 
dig X ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
 
Table 2.1: Baldwin’s favoured and disfavoured ring closing reactions. 
 
The rules follow a systematic naming convention in the form α–β–γ. α is an integer which details the 
ring size being formed; for a system to exist as a ring it cannot be any fewer than three atoms and the 
rules only remain accurate for rings containing up to seven atoms. β is a prefix of either exo (outside) 
or endo (inside) that refers to whether the chemical bond being broken is inside or outside of the ring 
being formed (Figure 2.15).  
 
 
Figure 2.15: Graphical representation of exo (outside) and endo (inside) ring closing reactions. 
 
The γ term refers to the geometry of the atom being nucleophilically attacked and can be labelled tet, 
trig or dig. The titles arise from if the electrophilic carbon is tetrahedral (sp3 hybridised, tet), trigonal 
(sp2 hybridised, trig) or digonal (sp hybridised, dig) (Figure 2.16). The physical basis of Baldwin’s rules 
lie in the stereochemical requirements of the transition states for the various tetrahedral, trigonal and 
digonal ring closure processes.[46] In order to achieve cyclisation a molecule must have the ability to 
adopt a conformation that allows overlap of the appropriate electron orbitals. The predictions actually 
indicate reaction speed as a reaction that is disfavoured typically does not have a rate that is able to 
compete efficiently with unwanted side-reactions.  
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Figure 2.16: Graphical representation of tet, trig and dig ring closing reactions.  
 
2.2.2 – Synthesis of threo-Configured Hexahydrobenzo[b][1,4]dioxepin-3-one 
The synthetic methodology from within the published literature[10] was shown to be effective in the 
synthesis of the aromatic benzo[b][1,4]dioxepin-3-one scaffold and so attention turned to the synthesis 
of the target aliphatic scaffold. The synthesis of an unsubstituted fully saturated analogue was first 
attempted to aid in the development of a suitable synthetic methodology that would allow access to this 
novel class of compounds, as well as give insight into the conformational alignments in relation to that 
of the original molecular template. 
 
Examination of the planar molecular structure of cyclohexane-1,2-diol indicates that two forms and three 
possibly stereoisomer of the compound can exist. The two different forms arise from which face the two 
hydroxyl groups are oriented in reference to each other. The trans-diol isomer has a 
non-superimposable mirror image and hence is chiral and both (1S,2S) and (1R,2R) enantiomers can 
be successfully synthesised and isolated. The cis-diol isomer has a plane of symmetry and thereby its 
mirror images are identical; this compound is known as the meso-isomer.  
 
Interestingly, the two alternative chair conformations of cis-cyclohexane-1,2-diol are each chiral but 
because they are of the same energy and interconvert rapidly, cis-cyclohexane-1,2-diol is effectively 
meso as predicted by analysis of the planar molecular structures (Figure 2.17).[48] The two enantiomers 
of trans-cyclohexane-1,2-diol have identical chemical properties, although of interest to note is that the 
racemic material has a lower melting point than the pure enantiomeric material. The 
cis-cyclohexane-1,2-diol isomer is a completely different compound and thus has different chemical and 
physical properties to the trans-cyclohexane-1,2-diol isomers.[49] 
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Figure 2.17: Stereochemical relationships of cyclohexane-1,2-diol. The trans-configured isomer exists as two 
enantiomers whilst the cis-configured isomer is a meso compound with different chemical properties.  
 
It was decided that both stereoisomers of the aliphatic benzo[b][1,4]dioxepin-3-one scaffold would be 
synthesised from cyclohexane-1,2-diol, and their chemical and olfactory properties compared. Odorant 
molecules are commonly evaluated as a racemic mixture and are generally only synthesised as the 
pure enantiomeric material when the racemic compound incorporates the target odour. It was thus 
decided to synthesise trans-cyclohexane-1,2-diol as a racemic mixture of (1S,2S) and (1R,2R) 
enantiomers. Following the methodology of Roebuck and Adkins, cyclohexene was dihydroxylated 
using formic acid and hydrogen peroxide to yield an intermediate formate ester (159) which was then 
hydrolysed to the vicinal-diol compound (±)-160 using sodium hydroxide (Scheme 2.2).[50] The reaction 
yielded a racemic mixture of the two enantiomers of trans-cyclohexane-1,2-diol (160) as a colourless 
solid in a 39% yield after recrystallisation from ethyl acetate. 
 
 
Scheme 2.2: Synthesis of rac-cyclohexane-1,2-diol (160) from cyclohexene (158). 
 
An attempt was then made at following the previously successful Williamson reaction methodology by 
reacting rac-cyclohexane-1,2-diol (160) with ethyl bromoacetate (156) using potassium carbonate under 
refluxing conditions (Scheme 2.3). These reaction conditions were found to yield only complex mixtures 
of polymerised products. It was thus revealed that a stronger base would be required to deprotonate 
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the weakly acidic hydroxyl groups. An additional literature search revealed that no heating of the 
reaction would be required owing to the increased nucleophilicity of the alkoxide intermediate in 
reference to the phenoxide intermediate. 
 
The standard base for such aliphatic Williamson reactions is sodium hydride (NaH). The standard 
reaction conditions for such a system comprises of the addition of the bis-hydroxyl compound to a 
suspension of sodium hydride in dimethylformamide at 0 ºC. The reaction mixture is then stirred at 0 ºC 
for one hour to generate the bis-alkoxide intermediate, with the release of hydrogen gas from the 
solvent. This is followed by dropwise addition of the halogenated compound to the newly formed 
alkoxide intermediate, followed by stirring at room temperature overnight. These conditions were 
experimented with for a reaction between rac-cyclohexane-1,2-diol (160) and ethyl bromoacetate (156), 
but were found to yield only polymerised material (Scheme 2.3). 
 
Scheme 2.3: Failed Williamson reactions between rac-cyclohexane-1,2-diol (160) and 
 ethyl bromoacetate (156). 
 
A model reaction was conducted between rac-cyclohexane-1,2-diol (160) and allyl bromide (162) to 
examine if the incompatibility of the ester functionalities of compounds 156/161 with the strongly basic 
bis-alkoxide intermediate was the origin of the problem (Scheme 2.4).[51] The bis-etherified compound 
(±)-163 was successfully isolated in a 72% yield as a clear oil providing strong evidence that functional 
group sensitivity was indeed the origin of the complications associated with the reaction between 
rac-cyclohexane-1,2-diol (160) and ethyl bromoacetate (156). 
 
 
Scheme 2.4: Synthesis of rac-1,2-bis(allyloxy)cyclohexane (163) from rac-cyclohexane-1,2-diol (160), thereby 
providing evidence that the Williamson reaction methodology was correct, but that functional group sensitivity 
was the origin of the problem with the reaction displayed in Scheme 2.3.  
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It was assumed that any successful reaction conditions able to yield target compound (±)-161 would 
require a mild alkylation technique which had a high degree of functional group tolerance. Fortunately, 
additional literature research revealed that both an enantiopure and a racemic analogue of the targeted 
bis-ester compound (±)-161 had been synthesised in an alternative Lewis-acid catalysed etherification 
reaction, thereby circumventing the use of any strongly basic alkoxide intermediates.[52-53] The proposed 
chemical reaction involved the dropwise addition of a catalytic amount of boron trifluoride 
diethyletherate adduct to an ice-cold dichloromethane solution of the bis-hydroxyl compound and ethyl 
diazoacetate, followed by stirring at room temperature for one hour and then at refluxing temperature 
for one hour. 
 
Ethyl diazoacetate (165) was prepared from ethyl glycinate hydrochloride (164), sodium nitrite (NaNO2) 
and sulphuric acid (H2SO4).[54] The reaction involves the in situ generation of nitrous acid (HNO2) by the 
action of sulphuric acid on sodium nitrite. The chemical reaction must be retained below –5 ºC to prevent 
the nitrous acid from decomposing into nitrogen dioxide (NO2), nitric oxide (NO) and water: 
 
 
 
The in situ generated nitrous acid reacts electrophilically with the amine group of ethyl glycinate 
hydrochloride (164), followed by the elimination of two equivalents of water to yield the diazo derivative, 
ethyl diazoacetate (165), as a thin yellow oil in an 83% yield (Scheme 2.5).  
 
 
Scheme 2.5: Synthesis of ethyl diazoacetate (165) from ethyl glycinate hydrochloride (164). 
 
Under the appropriate reaction conditions, a diazo compound can behave as an acid or as a base, as 
a nucleophile or as an electrophile, as a 1,3-dipole or as a carbene source.[55] Diazo compounds can 
be drawn as a mixture of four resonance forms: 
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A boron trifluoride catalysed O–H insertion reaction with ethyl diazoacetate (165) was first reported in 
1950 by Newman and Beal during their research into the Wolff and Curtius rearrangement reactions, 
but has been little used in synthetic procedures to date.[56] Other Lewis-acid catalysts such as aluminium 
chloride and tin(IV) chloride are also reported to be effective catalysts for the transformation.[57] 
 
A wide range of range of primary, secondary and tertiary alcohols have been transformed into alkyl 
ethers by the use of various diazo compounds. Yields are generally good for alkylation with 
diazomethane, although yields are seldom above 50% for higher diazo compounds, such as ethyl 
diazoacetate (165).[55] The mechanism for the Lewis-acid catalysed alkylation reaction is believed to 
involve the boron trifluoride molecule forming a polar coordinate bond with the hydroxyl oxygen atom, 
drawing electrons away and thus activating it. The diazo compound then acts as a nucleophile and 
reacts with the activated hydroxyl group, with the elimination of a neutral nitrogen molecule. This is then 
followed by product dissociation and catalyst regeneration (Figure 2.18). 
 
A more well-known adaptation for this class of alkylation reaction is the use of transition-metal catalysts 
such as copper or rhodium.[58] The mechanism for this type of catalysis is believed to involve the 
decomposition of the diazo compound to give a metal–carbenoid intermediate, which then undergoes 
the O–H insertion.[57]  
 
 
Figure 2.18: Proposed catalytic cycle for a boron trifluoride (BF3) catalysed O–H insertion reaction with a diazo 
compound.[55]  
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The boron trifluoride diethyletherate catalysed reaction between rac-cyclohexane-1,2-diol (160) and 
ethyl diazoacetate (165) was found to successfully yield the bis-ester compound (±)-161 in an adequate 
yield of 35% as a yellow oil after flash chromatography on silica gel (Scheme 2.6, Figure 2.19). The 
isolated bis-ester compound (161) was then subjected to a base-catalysed Dieckmann condensation 
reaction using identical conditions to those used for the aromatic analogue. The reaction yielded a crude 
isomeric mixture of the β-ketoester compound (±)-166 as a thick yellow oil that contained a readily 
identifiable carbonyl signal at δ 205 ppm in the 13C NMR spectrum.  
 
 
Scheme 2.6: Synthesis of threo-configured aliphatic benzo[b][1,4]dioxepin-3-one (±)-167 from 
rac-cyclohexane-1,2-diol (160) via Dieckmann methodology. 
 
Attempts at the isolation of (±)-166 by flash chromatography on silica gel provided only polymerised 
material. It was discovered that to successfully elute the β-ketoester compound without decomposition 
the silica gel used within the flash chromatography column had to be deactivated by pre-elution with a 
5% v/v solution of triethylamine in the regular solvent system. Silica gel contains on average 
4.6 hydroxyl groups per 100 Å2 of particle surface and thus silica is acidic and is known to degrade 
sensitive organic compounds.[59] The addition of an amine base aids in the deactivation of the active 
sites and thereby lowers the destructive capability of the silica adsorbent.  
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Figure 2.19: Various spectra of compound (±)-161. Top: 1H NMR (CDCl3, 300 MHz) spectrum; Middle: 13C NMR 
(CDCl3, 75 MHz) spectrum; Bottom: Mass spectrum (EI) showing molecular ion at m/z 288. 
 
The target compound (±)-166 was finally isolated as a mixture of stereoisomers in a 31% yield as a 
colourless crystalline solid. 1H, 13C HSQC analysis of compound (±)-166 unequivocally proved that the 
cyclisation reaction was successful in yielding the first example of an aliphatic 
benzo[b][1,4]dioxpin-3-one analogue (Figure 2.20). The absence of multiple overlapping signals within 
the NMR spectrum indicated that the compound contained complete symmetry, an achievement 
considering compound (±)-166 contains three chiral centers and presumably exists as an equimolar 
mixture of eight possible diastereomers.  
 
The following synthetic step within the reaction sequence involved an acid-catalysed decarboxylation 
of the β-ketoester compound (166) by heating at reflux in 2 M HCl and ethanol. The reaction was found 
to yield a thick yellow oil that resembled polymerised resin. Flash chromatography on deactivated silica 
gel yielded the target saturated threo-configured benzo[b][1,4]dioxepin-3-one compound (±)-167 as a 
colourless solid in an 87% yield.  
 
 Synthesis of Hexahydrobenzo[b][1,4]dioxepin-3-one Stereoisomers 
 
69 
  
 
Figure 2.20: 1H, 13C HSQC (CDCl3, 300 MHz) spectrum of compound (±)-166. 
 
2.2.3 – Synthesis of erythro-Configured Hexahydrobenzo[b][1,4]dioxepin-3-one  
The synthesis of the alternatively configured aliphatic benzo[b][1,4]dioxepin-3-one molecule, the 
erythro-configured stereoisomer, was conducted. The cis-diol compound, meso-cyclohexane-1,2-diol 
(170), was synthesised from cyclohexene (158) by the catalytic action of osmium tetroxide. Osmium 
tetroxide is expensive, volatile and highly toxic, so the synthetic oxidation methodology that was settled 
upon was the catalytic Upjohn dihydroxylation reaction.[60]  
 
This synthetic methodology fortunately only requires the use of a catalytic quantity of osmium tetroxide 
alongside a tertiary amine N-oxide, such as N-methylmorpholine N-oxide (169), which acts as a catalyst 
regenerator. The catalytic cycle commences with the [3+2] cycloaddition of the osmium(VIII) oxide 
compound to the alkene yielding a five-membered metallacycle intermediate.[61] This is followed by 
hydrolysis to liberate the vicinal-diol compound as well as a reduced osmium(VI) species which is then 
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reoxidised to the active osmium(VIII) oxide species by the oxidative action of the N-methylmorpholine 
N-oxide (Figure 2.21).  
 
 
Figure 2.21: Proposed catalytic cycle of the Upjohn dihydroxylation.[62] 
 
The co-oxidant for this oxidation reaction, N-methylmorpholine N-oxide (169), was synthesised from 
N-methylmorpholine (168) and hydrogen peroxide (Scheme 2.7).[62] Multiple attempts at 
recrystallisation of the crude material from acetone yielded a colourless crystalline solid with a melting 
point below that typically reported for the monohydrate (75–76 ºC) which indicated that the dihydate 
isomer of compound 169 had been isolated. Although not as favourable as the monohydrate due to its 
hygroscopic nature, this compound was used without complication, with allowances made for the larger 
molecular weight.  
 
 
Scheme 2.7: Preparation of N-methylmorpholine N-oxide (NMO) (169) from N-methylmorpholine (168). 
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The synthesis of meso-cyclohexane-1,2-diol (170) was performed using the prepared 
N-methylmorpholine N-oxide (169) co-oxidant alongside a catalytic quantity of osmium tetroxide in a 
polar acetone/water (4:1) solvent system (Scheme 2.8).[62] The reaction was performed under an inert 
atmosphere to limit the quantity of impurities formed by over-oxidation involving atmospheric oxygen. 
When reaction monitoring by thin-layer chromatography (TLC) had deemed that all cyclohexene (158) 
had reacted and thus that the catalytic cycle had ended, the dangerous osmium species was reduced 
by the addition of sodium hydrosulphite, followed by adsorption onto an activated magnesium silicate. 
The reaction mixture was filtered, followed by extraction of the filtrate using the highly polar solvent 
n-butanol. Concentration of the pooled organic extracts under reduced pressure gave a crude brown 
solid that was recrystallised from diisopropylether to yield the target material 170 in an 82% yield as a 
colourless crystalline solid. 
 
 
Scheme 2.8: Synthesis of meso-cyclohexane-1,2-diol (170) from cyclohexane (158) via a Upjohn 
dihydroxylation.  
 
The bis-etherification reaction of meso-cyclohexane-1,2-diol (170) with ethyl diazoacetate (165) proved 
somewhat more problematic than the analogous reaction involving the racemic trans-diol analogue 
(±)-160. Polymerised material was recovered when analogous reaction conditions were experimented 
with. It was discovered that the synthesis of bis-ester compound 171 required careful monitoring of the 
reaction at 0 ºC to prevent polymerisation, as opposed to the 0 ºC → refluxing conditions successful in 
the synthesis the trans-configured bis-ester compound (±)-161. This was the first indication that the 
cis-configured (or erythro-configured) analogues were less stable than their trans-configured (or 
threo-configured) counterparts. The bis-ester compound 171 was finally isolated in a 27% yield as a 
yellow oil after flash chromatography on deactivated silica (Scheme 2.9, Figure 2.22).  
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Scheme 2.9: Synthesis of erythro-configured aliphatic benzo[b][1,4]dioxepin-3-one 173 from 
meso-cyclohexane-1,2-diol (170) via Dieckmann methodology.  
 
 
Figure 2.22: Mass spectrum (EI) of compound 173 showing molecular ion at m/z 170. 
 
Subsequent Dieckmann cyclisation reactions of the isolated erythro-configured bis-ester 171 appeared 
to provide the target β-ketoester compound 172 by NMR experiments, which clearly exhibited a 
carbonyl signal downfield in the 13C NMR spectrum. Attempts at the isolation of the β-ketoester 
compound 172 by flash chromatography on deactivated silica gel, analogous to the isolation and 
characterisation of the threo-configured β-ketoester analogue (±)-166, were discovered to yield only 
polymerised material. Attempts at the acid-catalysed decarboxylation of the crude residue were 
performed in optimism that the completed aliphatic benzo[b][1,4]dioxepin-3-one scaffold may offer 
additional stability relative to the 2-ethyl carboxylate intermediate. The hypothesis proved correct and 
the target compound 173 was isolated as a colourless crystalline solid in 17% yield after flash 
chromatography. The mechanism of such acid-catalysed decarboxylation reactions is delineated in 
Figure 2.23. 
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Figure 2.23: Proposed mechanism for acid-catalysed decarboxylation of a β-ketoester intermediate to yield the 
saturated benzo[b][1,4]dioxepin-3-one analogue. 
 
2.2.4 – Attempts at Williamson Cyclisation with 2-((1-Bromo-3-chloropropan-2-
yl)oxy)tetrahydro-2H-pyran  
Alternative methodologies for the synthesis of aliphatic benzo[b][1,4]dioxepin-3-one analogues were 
also experimented with owing to differences in reaction yields and stability between the threo- and 
erythro-configured analogues. The synthetic methodology experimented with was a Williamson reaction 
cyclisation methodology developed by Hügel et al.[10] in their pursuit of a library of aromatic analogues 
for olfactory analysis. The publication details a Williamson reaction between various catechol 
derivatives and a tetrahydropyranyl-ether protected analogue of 1-bromo-3-chloropropan-2-ol.[10] 
 
Following the methodology of Hügel et al.,[10] bis-halogenated chain (±)-176 was synthesised beginning 
from racemic epoxide epichlorohydrin (174) (Scheme 2.10). The initial reaction involved an 
acid-catalysed epoxide cleavage with hydrobromic acid to yield rac-1-bromo-3-chloropropen-2-ol (175) 
as a single isomer in a 70% yield after vacuum distillation. The reaction was found to display 
anti-Markovnikov type regioselectivity due to nucleophilic attack preferentially occurring at the least 
substituted oxirane carbon, as is generally observed for this class of chemical reactions.[63] The free 
hydroxyl group was then protected in a solvent-free reaction using dihydropyran and phosphorus 
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pentoxide as a catalyst to yield the tetrahydropyranyl-ether protected chain (±)-176 as a clear oil in an 
81% yield.  
 
Scheme 2.10: Synthesis of tetrahydropyranyl-ether protected chain (±)-176 from epichlorohydrin (174).  
 
A series of model reactions on the aromatic system beginning with catechol (177) were then conducted 
to establish the reproducibility of the literature methodology. The initial step involved a Williamson 
reaction between catechol (177) and bis-halogenated chain (±)-176 in DMF, using potassium carbonate 
as the base to generate the required phenoxide intermediate.[10] This reaction was found to give a yellow 
oil which was partially purified by elution through a plug of silica to give a crude sample of compound 
(±)-178 (Scheme 2.11). The deprotection of compound (±)-178 was performed on the crude residue by 
means of a vanadium pentoxide and hydrogen peroxide system.[64] The reaction involved the 
pre-generation of a peroxovanadium species before its addition to a refluxing solution of compound 
(±)-178 in acetonitrile. This reaction successfully yielded the deprotected racemic alcohol (±)-179 as a 
colourless solid in 34% yield after flash chromatography.  
 
The final synthetic step in the reaction sequence involved the oxidation of the hydroxyl moiety of 
compound (±)-179 to furnish the completed benzo[b][1,4]dioxepin-3-one analogue. The oxidation was 
achieved by the subjection of the compound to an aqueous solution of potassium permanganate and 
potassium hydroxide. The target analogue 49 was finally isolated as a colourless solid in 71% yield after 
flash chromatography. Compound 49 had olfactory characteristics similar to that of Calone 1951® (50), 
albeit weaker and with additional undesired nuances, as was previously reported.[10, 12] 
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Scheme 2.11: Synthesis of benzo[b][1,4]dioxepin-3-one (49) from catechol (177).  
 
Experimental Williamson reactions between rac-cyclohexane-1,2-diol (160) and bis-halogenated chain 
(±)-176 using the previously successful reaction conditions were conducted but all that was recovered 
was the alkene (±)-181. Compound (±)-181 is the dehydrohalogenated analogue of compound (±)-176 
(Scheme 2.12). The reason for the favourability of this side-reaction is presumably related to the 
alkoxide intermediate being too strongly basic in comparison to the phenoxide intermediate. The 
elimination reaction of compound (±)-176 presumably occurs via an E2 mechanism.  
 
 
Scheme 2.12: Attempted Williamson reaction between rac-cyclohexane-1,2-diol (160) and bis-halogenated chain 
(±)-176, leading to dehydrohalogenation to give compound (±)-181. 
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2.2.5 – Attempts at Williamson Cyclisation with Alternative Reagents 
To reduce complications associated with an elimination reaction, a bis-halogenated propane chain with 
a quaternary central carbon atom was essential. Any propane chain that fitted this requirement would 
still require the ability to be deprotected to reveal an oxygenated moiety. One of the simplest reagents 
for such a reaction would be the unprotected carbonyl compound 1-bromo-3-chloropropan-2-one (182). 
Such a synthetic methodology would be analogous to that described by Gaudin et al.,[12] although their 
methodology instead made use of the bis-chlorinated analogue of compound 182. 
 
The oxidation conditions first chosen for testing was a Swern oxidation. This protocol was selected due 
to the mild nature of the reaction alongside its high tolerance for various functional groups. The reaction 
involves the generation of a dimethylchlorosulphonium ion by the action of oxalyl chloride on 
dimethylsulphoxide, followed by dropwise addition of the hydroxyl compound to this mixture.[65] This 
reaction protocol was trialled but was disappointingly discovered to return only unreacted starting 
material (Scheme 2.13). 
 
 
Scheme 2.13: Various oxidation conditions attempted for the synthesis of 182 from (±)-175. 
 
The following set of reaction conditions used for experimentation was a potassium permanganate 
(KMnO4) and copper sulphate pentahydrate (CuSO4∙5H2O) oxidation system.[66] The reaction conditions 
suggest that a 2:1 w/w mixture of KMnO4 and CuSO4∙5H2O, respectively, were to be ground together 
and added to an aromatic hydrocarbon solution of the alcohol, followed by monitoring the reaction at 
reflux for several hours. The role of the CuSO4∙5H2O within the chemical reaction is not completely 
understood but it is hypothesised to be participating in an electron transfer process or acting as a source 
of water.[67] What is understood is that in contrast to usual permanganate reactivity, this solid-support 
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mixture does not chemically react with alkenes, or have the same complications involving over-oxidation 
and therefore the CuSO4∙5H2O can be considered to moderate the oxidation power of the 
permanganate ion.[68],[69]  
 
The reaction conditions were found to successfully yield an oil in a 64% crude yield (Scheme 2.13). 
Upon further investigation however, it was discovered that the product of the oxidation was not pure. 
Analysis by GC-MS revealed that the reaction product contained two impurities, one less volatile and 
one more volatile than the target compound 182 (Figure 2.24). It was discovered by GC-MS library 
match,[70] as well as by 13C NMR correlation to the Spectral Database for Organic Compounds 
(SDBS)[71] that the two impurities were the bis-chlorinated analogue (4.042 minutes) and the 
bis-brominated analogue (6.068 minutes) of the target compound. Attempts at purification by fractional 
distillation under vacuum revealed that the three compounds successfully azeotrope. Repeated 
recrystallisations were discovered to be only moderately successful in bringing the purity of the target 
compound higher.  
 
 
 
Figure 2.24: GC-MS chromatograph of the permanganate oxidation of (±)-175 to 182, showing halogen 
exchange. 4.042 minutes: 1,3-dichloropropan-2-one; 4.980 minutes: 1-bromo-3-chloropropan-2-one (182);  
6.058 minutes: 1,3-dibromopropan-2-one. 
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The exchange of halogen atoms between alkyl halides has been previously reported in published 
literature and is the basis of a chemical reaction known as the Finkelstein reaction, whereby an alkyl 
fluoride, chloride or bromide is transformed into an alkyl iodide by treatment with sodium iodide. This 
reaction is an equilibrium that can be driven forward by the exploitation of halide salt solubilities or by 
the use of large excesses of the halide salt reagent. An adaption of this reaction is used to substitute 
various aryl halide compounds to give alkyl fluoride compounds by the use of potassium fluoride in polar 
aprotic solvents at high temperatures.[72]  
 
Much research has been undertaken to understand the mechanism by which such reactions can 
occur.[73-76] Initial studies into the exchange reaction between tertiary-butyl halides and soluble sources 
of an alternative halide ion hypothesised that the exchange was occurring predominantly by an SN2 
mechanism.[73] Later studies confirmed that exchange can occur by the elimination of a hydrogen halide 
(HX) followed by addition of a different hydrogen halide (HX) to give an exchanged halide compound; 
an E2 mechanism.[74] A later study by Cook and Parker confirmed that an SN2 mechanism can also 
occur by experiments between halide ions and neopentyl halides, which cannot undergo an elimination 
reaction.[75] Halogen exchange reactions have also been reported by the reaction of alkyl halides and 
the various acidic hydrogen halides such as HCl, HBr and HI.[77] These classes of halide exchange 
reaction take the form of: 
 
 
 
Halogen distribution reactions between alkyl halide compounds without the use of soluble alternative 
halides have been reported using an aluminium halide as a catalyst,[78-79] as well as a variety of 
quaternary ammonium and phosphonium halide salt catalysts.[80-81] The reaction has also been reported 
to occur in the gas phase by the passage of alkyl halides through a column filled with alumina coated 
in a phosphonium salt.[82] This class of halide exchange reactions takes the form of: 
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The undesired halogen exchange reaction of compounds 175/182 could therefore be occurring by a 
number of different mechanisms, although an E2 mechanism is believed to be most plausible. It was 
hypothesised that to eliminate the undesired halogen exchange a much milder set of reaction condition 
were mandatory. The reaction conditions investigated involved the use of sodium dichromate as an 
oxidation reagent.[83] The reaction is a variation of the Jones oxidation and is conducted in water and 
the reaction held at room temperature.[84] The mechanism involves the in situ generation of the strong 
oxidant chromic acid by the action of sulphuric acid on sodium dichromate. The oxidation conditions 
were discovered to successfully yield the target compound 182 in near quantitative yield, with no 
observable halogen exchange.  
 
Etherification reactions performed between rac-cyclohexane-1,2-diol (160) and 
1-bromo-3-chloropropan-2-one (182) were discovered to provide only polymerised material (Scheme 
2.14). This was assumed to be due to the alkoxide intermediate having too strongly basic a character 
and thereby removing an acidic α-hydrogen from 182 leading to intermolecular polymerisation, 
presumably by an aldol-type mechanism. It is likely that the same complications were not discovered in 
the aromatic system owing to the decreased basicity of the phenoxide intermediate in comparison to 
the aliphatic alkoxide intermediate.  
 
 
Scheme 2.14: Failed Williamson reaction between rac-cyclohexane-1,2-diol (160) and bis-halogenated 
chain 182.  
 
Owing to the strongly electron-withdrawing nature of the carbonyl moiety it was clear that protection 
would be necessary. The first option for such protection was the conversion of the carbonyl moiety to a 
methylene moiety. Any isolated methylene intermediate compound could be oxidised to the carbonyl 
analogue by the action of several different oxidants, such as O3, OsO4/NaIO4 or RuO4. This sequence 
would be analogous to multiple synthetic pathways previously employed in the synthesis of the aromatic 
benzo[b][1,4]dioxepin-3-one scaffold.[6, 26, 29] 
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Methyltriphenylphosphonium iodide (183) was prepared from methyliodide and triphenylphosphine in 
86% yield according to the methodology of McGeary et al.[85] A chemical reaction was then trialled 
between compound 182 and methylenetriphenylphosphorane, generated in situ by the action of 
n-butyllithium on phosphonium salt 183, but was discovered to give only to polymerised material 
(Scheme 2.15).  
 
The next protecting group experimented with was a cyclic ketal, the 1,3-dioxolane. 1,3-Dioxolanes are 
readily prepared from carbonyl compounds using 1,2-ethanediol (185) by dehydration in the presence 
of an acid-catalyst. The ketalisation reaction requires the use of a Dean-Stark apparatus to aid in the 
removal of water formed within the reaction, thus driving the equilibrium forward towards completion. 
The organic acid, para-toluenesulphonic acid, was discovered not to be a strong enough catalyst owing 
to starting material being recovered from the reaction. A change of catalyst to the strong mineral acid 
sulphuric acid yielded the desired product, although it was discovered that halogen exchange had once 
again occurred (Scheme 2.15). 
 
 
Scheme 2.15: Above: Failed Wittig reaction between bis-halogenated chain 182 and 
methyltriphenylphosphonium iodide (183); Below: Attempted ketalisation of bis-halogenated chain 182  
with 1,2-ethanediol (185) leading to a mixed product due to halide exchange. 
 
To eliminate any difficulties experienced with halide exchange the symmetrical bis-chlorinated analogue 
188 was synthesised (Scheme 2.16). The synthetic pathway employed in the synthesis of compound 
188 was identical to the synthetic pathway outlined for compound 182, except that hydrochloric acid 
was used in place of hydrobromic acid during the initial oxirane ring-opening reaction sequence. 
Ketalisation of compound 188 with 1,2-ethanediol (185) was performed and was found to successfully 
yield the target cyclic ketal 189 as a clear oil in 98% yield (Scheme 2.17). 
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 Scheme 2.16: Synthesis of bis-chlorinated chain 188 from (±)-epichlorohydrin (174). 
 
Unreacted starting materials were recovered when Williamson reactions between 
rac-cyclohexane-1,2-diol (160) and dioxolane 189 were attempted (Scheme 2.17). Additional 
Williamson reactions were conducted at 100 ºC on the assumption that any reactivity problems may be 
associated with steric hindrance, but no reaction was observed. It appeared that ketalisation of the 
carbonyl moiety had rendered the halogenated propane chain unreactive to Williamson cyclisation 
reactivity.  
 
 
Scheme 2.17: Ketalisation of bis-chlorinated chain 188 to give dioxolane 189, and the subsequent 
 failed reaction with rac-cyclohexane-1,2-diol (160).  
 
2.2.6 – Williamson Cyclisation with 3-Chloro-2-(chloromethyl)prop-1-ene 
A publication by Kraft et al.[6] detailed the synthesis of a library of benzo[b][1,4]dioxepin-3-one 
analogues for olfactory evaluation by a Williamson cyclisation reaction between various catechol 
derivatives and 3-chloro-2-(chloromethyl)prop-1-ene (194). Experimental work was first undertaken to 
synthesise the bis-chlorinated chain 194 beginning from pentaerythritol (191) according to the 
methodology of Lynch and Dailey.[86] The synthetic sequence involved the chlorination of pentaerythritol 
(191) with thionyl chloride in pyridine to yield a mixture of trichloride and tetrachloride isomers. Without 
purification, the crude mixture of chlorides was oxidised in hot nitric acid to yield a mixture of 
3-chloro-2,2-bis(chloromethyl)propanoic acid (192) and 1,3-dichloro-2,2-bis(chloromethyl)propane 
(193) (Scheme 2.18).[86-87] Unreacted tetrachloride 193 was readily separated from carboxylic acid 192 
by an acid-base extraction owing to the formation of the carboxylate salt of compound 192, thereby 
making this compound water soluble.  
 
 
  CHAPTER 2 
82 
 
The isolated carboxylic acid compound 192 was destructively distilled by retaining a reaction vessel at 
210 ºC connected to a short-path distillation setup to distil 3-chloro-2-(chloromethyl)prop-1-ene (194) 
as a clear liquid. The formation of 194 occurs via the decarboxylation and elimination of compound 192. 
To remove traces of hydrochloric acid it was discovered that compound 194 needed to be redistilled 
from calcium hydride. 
 
 
Scheme 2.18: Synthesis of bis-chlorinated chain 194 from pentaerythritol (191).  
 
Experimental Williamson reactions were conducted between rac-cyclohexane-1,2-diol (160) and 
3-chloro-2-(chloromethyl)prop-1-ene (194) in dimethylformamide using sodium hydride as a base 
(Scheme 2.19). The reaction successfully yielded the cyclised methylene intermediate compound 
(±)-195 in 23% yield. Additionally, the reaction was discovered to give a cleaner crude reaction mixture 
than etherification with ethyl diazoacetate (165) thereby making isolation of the target material simpler. 
An analogous reaction between meso-cyclohexane-1,2-diol (170) and 3-chloro-2-
(chloromethyl)prop-1-ene (194) was then conducted and was discovered to also successfully give a 
cyclised intermediate (196) in 23% yield (Scheme 2.19).  
 
Importantly, cyclisation reaction yields between the threo- and erythro-configured analogues were 
comparable. It was discovered that the two methylene intermediate compounds also displayed 
interesting olfactory characteristics which were described by perfumers as ‘agrestic and leathery’ and 
‘agrestic, thymol, carvacrol, leathery tar’ by analysis on blotter, for the threo-configured isomer (±)-195 
and erythro-configured isomer 196, respectively (Scheme 2.19). 
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Scheme 2.19: Williamson reaction of both stereoisomers of cyclohexane-1,2-diol with bis-chlorinated  
chain 194 followed by oxidation to the aliphatic benzo[b][1,4]dioxepin-3-one. 
 
The reaction mechanism for the Williamson cyclisation reaction initiates when the aliphatic bis-hydroxyl 
compound reacts with sodium hydride with the release of hydrogen gas to create a bis-alkoxide 
intermediate, stabilised by sodium cations (Figure 2.25). The reaction occurs at the surface of the 
sodium hydride as this reagent remains non-soluble in organic solvents, consistent with the fact that 
the hydrogen anion remains an unknown anion in solution. The bis-alkoxide intermediate 
nucleophilically attacks a chlorinated 1º carbon of the bis-chlorinated chain which results in the 
electronegative chlorine atom leaving as an anion and ultimately forming the neutral ionic species 
sodium chloride. This reaction leads to an intermediate compound which is then intramolecularly 
cyclised by nucleophilic attack of the remaining alkoxide anion onto the remaining chlorinated 1º carbon 
atom, finally yielding the cyclised target compound. 
 
Figure 2.25: Reaction mechanism for the Williamson reaction between substituted cyclohexane-1,2-diol 
analogues and 3-chloro-2-(chloromethyl)prop-1-ene. 
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The subsequent synthetic step within the reaction sequence involved the oxidation of the isolated 
methylene intermediate compound to the target compound. This reaction was achieved by a ruthenium 
tetroxide oxidation, analogous to the methodology applied by Kraft et al.[6] The catalytic reaction 
required in situ generated ruthenium tetroxide, produced by the action of oxidant sodium metaperiodate 
on ruthenium chloride. Experiments suggested that two additions of both the ruthenium catalyst and the 
oxidant spaced up to a day apart were needed for the reaction to be successful, presumably due to 
complications arising from catalyst deactivation. It had also been discovered that the addition of 
acetonitrile leads to a greatly improved oxidation system due to its ability to return deactivated ruthenium 
carboxylate complexes back into the catalytic cycle.[88] The mechanism begins within the aqueous 
phase when RuCl3 reacts with the oxidant to become the solvent soluble species RuO4. The RuO4 
migrates into the non-polar phase, oxidises an organic molecule solubilised within before returning to 
the aqueous phase and thereby completing the catalytic cycle (Figure 2.26).[89]  
 
 
Figure 2.26: Catalytic cycle of a ruthenium tetroxide oxidation.[89] 
 
Ruthenium tetroxide oxidation reactions were attempted and were discovered to be successful in the 
oxidation of both stereoisomers of the saturated system. The reaction yields were again found to be 
comparable for the threo- and erythro-configured stereoisomers. The oxidation reaction was also found 
to be clean, yielding only the target compound and polymerised material which was readily separated 
by flash chromatography. NMR analysis unambiguously proved that the benzo[b][1,4]dioxepin-3-one 
compounds synthesised by both Dieckmann condensation and Williamson cyclisation methodologies 
were identical.  
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2.2.7 – Comparisons of Chemical and Olfactory Properties 
Contrasts in 1H NMR spectra between the unsubstituted aromatic benzo[b][1,4]dioxepin-3-one 
compound (49) and both stereoisomers of the aliphatic benzo[b][1,4]dioxepin-3-one molecule 
(compounds 167 and 173) are delineated in Figure 2.27. Immediate dissimilarities between the aromatic 
and aliphatic analogue spectra include the addition of multiple proton signals from the now saturated 
carbocyclic ring atoms C–6, C–7, C–8 and C–9, accompanying the addition of proton signals from ring 
bridging atoms C–5a and C–9a. Proton signals originating from the carbocyclic ring have moved upfield 
from the aromatic region (~ δ 7 ppm) to the aliphatic region (~ δ 1–2 ppm), as was predicted owing to 
the addition shielding provided by the now localised electron orbitals. 
 
Multiple dissimilarities in 1H NMR spectra between the two stereoisomers of the aliphatic 
benzo[b][1,4]dioxepin-3-one scaffold were obvious even though both stereoisomers displayed full 
symmetry. Proton signals originating from ring bridging carbons C–5a and C–9a appeared further 
downfield for erythro-configured isomer 173 indicating less electron density in the ring bridging area for 
this stereoisomer. 
 
The signals for the protons bonded to carbon atoms adjacent to the carbonyl moiety (C–2 and C–4) 
appeared as doublet signals (J = 16.6/16.8 Hz). This phenomenon is occurring due to the proton signals 
being split by the adjacent proton owing to subtle differences in chemical environment between the 
atoms relating to chirality, as this phenomenon was not observed for the achiral aromatic analogue 49. 
Both stereoisomers gave rise to separate signals for each proton bonded to C–2 or C–4 but due to 
molecular symmetry only two doublet signals are revealed. It was also discovered that the two protons 
bonded to a single cyclohexyl ring carbon atom (C–6, C–7, C–8, C–9) gave rise to signals located in 
two different locations. This indicates that the axial and equatorial protons are in a different chemical 
environments and that conformational ring interconversion has been quenched due to a large energy 
barrier.  
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Figure 2.27: 1H NMR (CDCl3, 300 MHz) spectra of the unsubstituted aromatic and aliphatic 
benzo[b][1,4]dioxepin-3-one analogues: (top) benzo[b][1,4]dioxepin-3-one (49); (middle) 
rac-hexahydrobenzo[b][1,4]dioxepin-3-one (167); (bottom) meso-hexahydrobenzo[b][1,4]dioxepin-3-one (173). 
 
 
 
Figure 2.28: Molecular structure of rac-hexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (167) showing thermal 
ellipsoids at a 50% probability level. Crystal data for 167: a = 6.7129(11) Å, b = 17.188(3) Å, c = 8.1744(12) Å, 
α = 90º β = 113.725(3)º γ = 90º V = 863.5(2) Å3, Z = 4, and space group P 21/n. Crystallographic data has been 
deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 968786.  
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An X-ray crystal structure of threo-configured analogue (±)-167 was successfully obtained from the 
racemic mixture due to the compound crystallising in a space group containing a glide plane; the two 
enantiomers were mirrored in the unit cell and thus a structure could be successfully elucidated. The 
X-ray crystal structure showed that the cyclohexyl ring exists in chair conformation whilst the 
dioxepanone ring exists in pseudo-twist-boat conformation (Figure 2.28). 
 
An X-ray crystal structure was also acquired for erythro-configured analogue 173 with considerable 
difficulty due to the compound having a melting point below room temperature (Figure 2.29). The 
crystals were chilled beforehand with liquid nitrogen to prevent melting whilst being selected and loaded 
into the XRD instrument. The bond lengths for C3–C8, C7–C8, O2–C3 and O3–C8 differ significantly 
between the two stereoisomers, with the erythro-configured analogue 173 having longer bond lengths 
in all cases. The bond angles in the region where the cyclohexyl ring intercepts the dioxepanone ring 
also differ significantly between the two stereoisomers.  
 
The angle for C7–C8–O3 differs by 6.83(9)º and the C8–O3–C9 angle by 2.84(9)º, with the 
erythro-configured analogue 173 once again having the larger value in each case. This phenomenon is 
probably due to repulsion between the hydrogen atoms on C7 and C9, with the shortest H–H distance 
being only 2.07 Å. This may indicate that the erythro-configured analogues are the more strained 
molecular structure and could also explain their instability and lower yields in comparison to the 
threo-configured analogues.  
 
On examination of the molecular structures of the two stereoisomers it can be seen that both of the 
stereoisomeric dioxepanone rings are in pseudo-twist-boat conformation corresponding to that of the 
original benzo[b][1,4]dioxepin-3-one template. In place of the planar benzenoid ring the saturated 
derivatives possess six-membered cyclohexyl rings in chair conformation. The two rings exist in a 
relatively co-planar fashion in the threo-configured analogue (167), with the carbonyl group pointing 
only marginally out of the plane of the cyclohexyl ring. In the erythro-configured analogue (173) the 
carbonyl moiety is completely out of plane in relation to the six-membered ring.  
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Figure 2.29: Molecular structure of meso-hexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (173) showing thermal 
ellipsoids at a 50% probability level. Crystal data for 173: a = 21.883(3) Å, b = 9.2836(12) Å, c = 8.7905(14) Å, 
α = 90º β = 104.695(11)º γ = 90º V = 1727.4(4) Å3, Z = 8, and space group C 2/c. Crystallographic data has been 
deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 968784. 
 
Olfactory evaluations were performed by expert perfumers by blotter analysis with a 10% solution of 
the sample substance in dipropylene glycol (DPG). The odour threshold values were determined by 
GC-Olfactometry (GC-O). Any differences in olfactory properties between the two isomers can be 
ascribed to differences in molecular shape. It was also suspected that due to the non-planar nature of 
the erythro-configured analogue 173 there may be physical difficulty in the molecule making optimal 
receptor binding. The threo-configured analogue 167 was found to have a medicinal, fruity odour with 
additional sweet facets, and an odour threshold of 210 ng/L air (Table 2.2).  
 
The erythro-configured analogue (173) was the more potent analogue of the two, having an odour 
threshold of 141 ng/L air and a rather different odorant profile which was best described as a fruity, 
animalic odour of green tonality with chemical and acidic aspects upon drying down. Neither isomer 
was found to contain marine odorant notes (Table 2.2). Comparisons with the previously reported 
olfactory properties for the unsubstituted benzo[b][1,4]dioxepin-3-one compound (49) revealed strong 
evidence that even the aromatic scaffold fails to display potent marine fragrance notes without 
seven-alkyl substitution. The perfumers employed by Hügel et al.[10] and Gaudin et al.[12] disagreed on 
the exact olfactory properties of 49, possibly due to natural variation in olfactory perception amongst a 
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given population, although did agree on a number of key aspects such as green notes and weak marine 
nuances (Table 2.2). Odour threshold data for compound 49 appears, to the best of the author’s 
knowledge, to have never been measured and/or reported. 
 
# Molecular Structure Description and Threshold 
49 
 
Odour description: Metallic, ozone, watery, cabbage, hot iron, more 
metallic-phenolic, less ozony and much weaker than Calone 1951®.[12] 
Odour description: Green-floral, balsamic odour in the direction of Peru 
and Tolu balsam resinoid, slight marine salty aspect.[10] 
(±)-167 
 
Odour description: Medicinal, fruity odour that is linear in the dry-down 
with additional sweet facets in the fond. 
Odour threshold 210 ng/L air (stan. dev. 176 ng/L air). 
173 
 
Odour description: Fruity, animalic odour of green tonality with chemical 
aspects and acidic facets in the dry-down.  
Odour threshold: 141 ng/L air (stan. dev. 99 ng/L air). 
 
Table 2.2: Olfactory properties of compounds 49, (±)-167 & 173. 
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2.3 – Experimental 
Diethyl 2,2'-((4-methyl-1,2-phenylene)bis(oxy))diacetate (157):[10] 
To a solution of 4-methylcatechol (3 g, 24.17 mmol) and ethyl bromoacetate 
(16.12 g, 96.67 mmol, 4 equiv) in DMF (150 mL) was added K2CO3 (13.36 g, 
96.67 mmol) and the mixture heated to 120 ºC for 2 h. The reaction mixture was 
then poured into H2O (300 mL) and extracted with Et2O (3 x 100 mL). The organic 
extracts were pooled, washed with H2O (100 mL) and saturated NaHCO3 (100 mL), dried (MgSO4) and 
concentrated under reduced pressure. The resulting residue was then purified by flash chromatography on silica 
gel (EtOAc/hexane; 2:8) to give diethyl 2,2'-((4-methyl-1,2-phenylene)bis(oxy))diacetate (3.76 g, 53%) as a clear 
oil. IR (ATR): ṽ = 1754/1733 (v ester C=O), 1509 (v aromatic C=C), 1193 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): 
δ 6.83–6.70 (m, 3H, 3’-,5’-6’-H), 4.70/4.68 (2s, 4H, 2-,1’’-H2), 4.31–4.21 (m, 4H, 3-,3’’-H2), 2.27 (s, 3H, 4’-Me), 
1.33–1.26 (m, 6H, 4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 168.7/168.5 (2s, C-1,-2’’), 147.4/145.5 (2s, C-1’,-2’), 
131.9 (s, C-4’), 122.3/116.1/115.5 (3s, C-3’,-5’,-6’), 66.6/66.2 (2t, C-2,-1’’), 60.6/60.6 (2t, C-3,-3’’) 20.3 (q, 4’-Me), 
13.6/13.6 (2q, C-4,-4’’). HRMS: m/z calculated for C15H20O6: 296.1259 [M]+; Found: 296.1259. 
 
7-Methyl-2H-benzo[b][1,4]dioxepin-3(4H)-one (50):[10] 
A solution of diethyl 2,2'-((4-methyl-1,2-phenylene)bis(oxy))diacetate (3.73 g, 12.59 mmol) 
in THF (50 mL) was added dropwise to a stirred suspension of KOtBu (2.82 g, 25.18 mmol) 
in THF (50 mL) with cooling to 0 ºC. Stirring was continued at 0 ºC for 2 h before being 
quenched by the addition of 0.2 M HCl (300 mL) and ice (300 g). The resulting solution was then extracted with 
DCM (3 x 200 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced pressure. The 
residue was taken up in EtOH (30 mL) and 2 M HCl (150 mL) and the mixture stirred at reflux for 2 h. The solution 
was diluted with H2O (100 mL) and extracted with DCM (3 x 200 mL). The organic extracts were pooled, washed 
with H2O (100 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting residue was purified 
by vacuum distillation (100 ºC, 0.1 torr) to yield 7-methyl-2H-benzo[b][1,4]dioxepin-3(4H)-one (1.19 g, 53%) as a 
colourless solid. mp: 36–38 ºC. (lit. mp: 38–39 ºC (pentane)).[10] IR (ATR): ṽ = 1732 (v C=O), 1503 (v aromatic 
C=C) cm-1. 1H NMR (CDCl3, 300 MHz): δ 6.92–6.75 (m, 3H, 6-,8-,9-H), 4.71/4.69 (2s, 4H, 2-,4-H2), 2.28 (s, 3H, 
7-Me). 13C NMR (CDCl3, 75 MHz): δ 204.8 (s, C-3), 147.9/146.0 (2s, C-5a,-9a), 133.7 (s, C-7), 124.3/121.1/120.6 
(3d, C-6,-8,-9), 75.7/75.4 (2t, C-2,-4), 20.5 (q, 7-Me). HRMS: m/z calculated for C10H10O3: 178.0630 [M]+; Found: 
178.0628. 
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rac-Cyclohexane-1,2-diol (160):[50] 
A 30% solution of hydrogen peroxide (50 mL, 0.5 mol) was added to an 80% solution of formic acid 
(238 mL, 4.89 mol). To this solution was added cyclohexene (29.28 g, 0.36 mol) dropwise over a 
period of 0.5 h. The reaction mixture was retained at 40 ºC for 1 h and then allowed to stand at RT 
overnight. The mixture was then concentrated under reduced pressure before an ice-cold solution of sodium 
hydroxide (28.8 g, 0.72 mmol) in H2O (55 mL) was added dropwise. The reaction mixture was then extracted with 
EtOAc (6 x 100 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced pressure. The 
resulting residue was recrystallised from EtOAc to give rac-cyclohexane-1,2-diol (16.3 g, 39%) as a colourless 
solid. mp: 102–104 ºC. (lit. mp: 101.5–103 ºC).[50] IR (ATR): ṽ = 3357/3262 (v O–H), 2932 (v C–H) cm-1. 1H NMR 
(CDCl3, 300 MHz): δ 3.40–3.29 (m, 2H, 1-,2-H), 3.17–3.10 (s, 2H, 1-,2-OH), 2.02–1.90 (m, 2H, 3-,6-H), 1.76–1.63 
(m, 2H, 4-,5-H), 1.35–1.17 (m, 4H, 3-,4-,5-,6-H). 13C NMR (CDCl3, 75 MHz): δ 75.6 (2d, C-1,-2), 32.8 (2t, C-3,-6), 
24.3 (2t, C-4,-5). HRMS: m/z calculated for C6H12O2: 116.0837 [M]+; Found: 116.0826. 
 
rac-Diethyl 2,2'-(cyclohexane-1,2-diylbis(oxy))diacetate (161):[52] 
To an ice-cool solution of ethyl diazoacetate (10.91 g, 10.05 mL, 95.6 mmol) and 
rac-cyclohexane-1,2-diol (5 g, 43 mmol) in DCM (70 mL) was added dropwise 
BF3·OEt2 (0.5 mL). After addition was complete, stirring was continued at RT for 1 h 
followed by heating at reflux for 1 h. The reaction was allowed to cool to RT before 
being quenched by the addition of a saturated aqueous solution of NaHCO3 (100 mL). The mixture was then 
extracted with EtOAc (3 x 100 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography on silica gel (EtOAc/hexane; 2:8) to yield 
rac-diethyl 2,2'-(cyclohexane-1,2-diylbis(oxy))diacetate (4.35 g, 35%) as a yellow oil. IR (ATR): ṽ = 2934 (v C–H), 
1750 (v ester C=O), 1198 (v ester C–O), 1120 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.33–4.16 (m, 8H, 2-
,3-,1’’-,3’’-H2) 3.37–3.27 (m, 2H, 1’-,2’-H), 2.12–2.04 (m, 2H, 3’-,6’-H), 1.72–1.65 (m, 2H, 4’-,5’-H), 1.39–1.15 (m, 
4H, 3’-,4’-,5’-,6’-H), 1.28 (t, J = 7.1 Hz, 6H, 4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 170.2 (2s, C-1,-2’’), 82.2 (2d, 
C-1’,-2’), 67.2 (2t, C-2,-1’’), 59.8 (2t, C-3,-3’’), 29.6 (2t, C-3’,-6’), 22.9 (2t, C-4’,-5’), 13.5 (2q, C-4,-4’’). HRMS: m/z 
calculated for C14H24O6: 288.1573 [M]+; Found: 288.1591. 
 
rac-1,2-Bis(allyloxy)cyclohexane (163):[51] 
rac-Cyclohexane-1,2-diol (500 mg, 4.3 mmol) in DMF (10 mL) was added dropwise to a 
solution of sodium hydride (520 mg, 12.9 mmol, 60% in mineral oil, 3 equiv) in DMF (5 mL) 
at 0 ºC. After stirring for 1 h at 0 ºC, allyl bromide (2.6 g, 21.5 mmol) was added dropwise 
and the resulting solution allowed to warm to RT and stirred overnight. The solution was quenched by the careful 
addition of H2O (100 mL) and extracted with Et2O (3 x 100 mL). The organic extracts were pooled and dried 
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(MgSO4) before being concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography on silica gel (EtOAc/hexane; 3:97) to give rac-1,2-bis(allyloxy)cyclohexane (610 mg, 72%) as a 
clear oil. IR (ATR): ṽ = 2993/2860 (v C–H), 1080 (v C–O), 916 (v C=C) cm-1. 1H NMR (CDCl3, 300 MHz): δ 6.01–
5.88 (m, 2H, 2’-,2’’-H), 5.33-5.30/5.27-5.24/5.17-5.15/5.13-5.11 (4m, 4H, 3’-,3’’-H2), 4.16–4.12 (m, 4H, 1’-,1’’-H2), 
3.30–3.20 (m, 2H, 1-,2-H), 2.03–1.93 (m, 2H, 3-,6-H), 1.70–1.60 (m, 2H, 4-,5-H), 1.36–1.15 (m, 4H, 3-,4-,5-,6-H). 
13C NMR (CDCl3, 75 MHz): δ 135.4 (2d, C-2’,-2’’), 115.5 (2t, C-3’,-3’’), 80.3 (2d, C-1,-2), 70.5 (2t, C-1’,-1’’), 29.9 
(2t, C-3,-6), 23.1 (2t, C-4,-5).  
 
Ethyl diazoacetate (165):[54] 
A solution of ethyl glycinate hydrochloride (140 g, 1 mol) in H2O (250 mL) was mixed with DCM 
(600 mL) and cooled to –5 ºC. A chilled solution of sodium nitrite (83 g) in H2O (250 mL) was 
added with stirring. The temperature was lowered to –9 ºC and 5% H2SO4 (96 g) was added by dropping funnel 
over a period of five minutes. The reaction mixture was then transferred to a separatory funnel and the organic 
layer ran into a 5% NaHCO3 solution (1 L). The organic phase and NaHCO3 solution was then transferred back to 
the separatory funnel and shaken until no trace of acid remained. The organic phase was collected, dried (MgSO4) 
and concentrated under reduced pressure to give ethyl diazoacetate (96 g, 84%) as a yellow oil. IR (film): ṽ = 2985 
(v C–H), 2111 (N=N), 1693 (C=O) cm-1. 
 
rac-Ethyl 3-oxooctahydro-2H-benzo[b][1,4]dioxepine-2-carboxylate (166): 
A solution of rac-diethyl 2,2'-(cyclohexane-1,2-diylbis(oxy))diacetate (10 g, 
34.68 mmol) in THF (150 mL) was added dropwise to a stirred solution of KOtBu 
(7.78 g, 69.36 mmol) in THF (150 mL) with cooling to 0 ºC. Stirring was continued at 
0 ºC for 2 h before being quenched by the addition of 0.2 M HCl (1 L) and ice (500 g). 
The resulting solution was then extracted with DCM (3 x 200 mL), the organic extracts pooled, dried (MgSO4) and 
concentrated under reduced pressure. The resulting residue was purified by flash chromatography on silica gel 
(EtOAc/hexane; 15:85) to give rac-ethyl 3-oxooctahydro-2H-benzo[b][1,4]dioxepine-2-carboxylate (2.6 g, 31%) as 
colourless crystals. mp: 78–80 ºC. IR (ATR): ṽ = 2928 (v C–H), 1748 (v ester C=O), 1721 (v C=O), 1100 (v C–O) 
cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.98 (s, 1H, 2-H), 4.44–4.27 (m, 4H, 4-,3’-H2), 3.49–3.41/3.33–3.25 (2m, 2H, 
5a-,9a-H), 2.18–2.00 (m, 2H, 6-,9-H), 1.80–1.71 (m, 2H, 7-,8-H), 1.32 (t, J = 7.1 Hz, 3H, 4’-H3) 1.55–1.21 (m, 4H, 
6-,7-,8-,9-H). 13C NMR (CDCl3, 75 MHz): δ 205.6 (s, C-3), 167.0 (s, C-1’), 88.2/88.0 (2d, C-5a,-9a), 83.8 (d, C-2), 
76.7 (t, C-4), 61.6 (t, C-3’), 31.4/31.2 (2t, C-6,-9), 24.0/24.0 (2t, C-7,-8), 14.1 (q, C-4’). HRMS: m/z calculated for 
C12H18O5: 242.1154 [M]+; Found: 242.1177. 
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rac-Hexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (167): 
To a solution of rac-ethyl 3-oxooctahydro-2H-benzo[b][1,4]dioxepine-2-carboxylate (800 mg, 
3.3 mmol) in EtOH (8 mL) was added 2 M HCl (40 mL) and the solution stirred at reflux for 
2 h. After cooling to RT the solution was diluted with H2O (100 mL) and extracted with DCM 
(3 x 50 mL). The organic extracts were pooled, washed with H2O (50 mL), dried (MgSO4) and concentrated under 
reduced pressure. The resulting residue was purified by flash chromatography on silica gel (EtOAc/hexane; 1:9) to 
give rac-hexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (490 mg, 87%) as clear prisms. mp: 48–50 ºC. IR (ATR): 
ṽ = 2939 (v C–H), 1721 (v C=O), 1116 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.31 (d, J = 16.6 Hz, 2H, 2-,4-H), 
4.25 (d, J = 16.6 Hz, 2H, 2-,4-H), 3.34–3.22 (m, 2H, 5a-,9a-H), 2.06–1.97 (m, 2H, 6-,9-H), 1.81–1.66 (m, 2H, 
7-,8-H), 1.44–1.15 (m, 4H, 6-,7-,8-,9-H). 13C NMR (CDCl3, 75 MHz): δ 211.6 (s, C-3), 88.4 (2d, C-5a,-9a), 77.1 (2t, 
C-2,-4), 31.4 (2t, C-6,-9), 24.0 (2t, C-7,-8). HRMS: m/z calculated for C9H14O3: 170.0943 [M]+; Found: 170.0939. 
Odour description: Medicinal, fruity odour that is linear in the dry-down with additional sweet facets in the fond. 
Odour threshold: 210 ng/L air (stan. dev. 176 ng/L air). 
 
N-Methylmorpholine N-oxide dihydrate (169):[62] 
To neat N-methylmorpholine (32.3 g, 0.32 mol) heated to 75 ºC was added dropwise a 30% 
aqueous solution of hydrogen peroxide (32.4 g, 0.29 mol) over a period of 2.5 h. The solution 
was then stirred for 20 h at 75 ºC before a slurry of methanol (50 mL), charcoal (0.5 g) and celite 
(0.5 g) was added. After stirring for 1 h the mixture was filtered and concentrated under reduced pressure to a bath 
temperature of 95 ºC. The resulting oil was then heated to reflux in acetone (25 mL) until a solution was formed, 
and then left overnight to crystallise. The crystals were filtered, washed with cold acetone and dried under vacuum 
to give N-methylmorpholine N-oxide dihydrate (27.17 g, 72%) as a grey solid. mp: 35 ºC−onward. (lit. mp: 
35−60 ºC).[62] 
 
meso-Cyclohexane-1,2-diol (170):[62] 
To a solution of N-methylmorpholine N-oxide (14.8 g, 126.3 mmol) in H2O (20 mL) and acetone 
(40 mL) was added osmium tetroxide (70 mg, 0.27 mmol) and cyclohexene (8.18 g, 10.1 mL, 
99.7 mmol). The solution was stirred at RT under nitrogen for 18 h before being quenched by the 
addition of a slurry of sodium hydrosulfite (0.5 g) and Florisil® (5 g) in H2O (20 mL). The mixture was filtered through 
a pad of celite followed by the addition of 12 N H2SO4 (6.4 mL). The resulting solution was concentrated under 
reduced pressure to remove the organic solvent before being acidified to pH 2 with 12 N H2SO4. The resulting 
solution was extracted with n-butanol (5 x 50 mL), the organic extracts pooled and washed with aqueous NaCl 
(25 mL, 25% w/w solution). The organic solvent was concentrated under reduced pressure to yield a crude solid 
which was extracted with boiling diisopropylether (300 mL). The organic solvent was removed under reduced 
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pressure and the residue recrystallised from diisopropylether to give meso-cyclohexane-1,2-diol (11.6 g, 82%) as 
a colourless solid. mp: 95–96 ºC. (lit. mp: 96–97 ºC).[62] IR (ATR): ṽ = 3391/3258 (v O–H), 2929 (v C–C), 1073 
(v C–O) cm-1. 1H NMR: (CDCl3, 300 MHz): δ 3.81–3.76 (m, 2H, 1-,2-H), 1.92 (s, 2H, 1-,2-OH), 1.83–1.72 (m, 2H, 
3-,6-H), 1.69–1.51 (m, 4H, 3-,4-,5-,6-H), 1.40–1.24 (m, 2H, 4-,5-H). 13C NMR: (CDCl3, 75 MHz): δ 70.6 (2d, C-1,-2), 
29.8 (2t, C-3,-6), 21.4 (2t, C-4,-5). HRMS: m/z calculated for C6H12O2: 116.0837 [M]+; Found: 116.0826. 
 
meso-Diethyl 2,2'-(cyclohexane-1,2-diylbis(oxy))diacetate (171): 
To an ice-cool solution of ethyl diazoacetate (10.91 g, 10.05 mL, 95.6 mmol) and 
meso-cyclohexane-1,2-diol (5 g, 43 mmol) in DCM (70 mL) was added dropwise 
BF3·OEt2 (0.5 mL). After addition was complete, stirring was continued at 0 ºC for 
1 h before being quenched by the addition of a saturated aqueous solution of 
NaHCO3 (100 mL). The mixture was then extracted with EtOAc (3 x 100 mL), the organic extracts pooled, dried 
(MgSO4) and concentrated under reduced pressure. The resulting residue was purified by flash chromatography 
on silica gel (EtOAc/hexane; 2:8) to give meso-diethyl 2,2'-(cyclohexane-1,2-diylbis(oxy))diacetate (3.41 g, 27%) 
as a yellow oil. IR (ATR): ṽ = 2936 (v C–H), 1750 (v ester C=O), 1194 (v ester C–O), 1114 (v C–O) cm-1. 1H NMR 
(CDCl3, 300 MHz): δ 4.29–4.11 (m, 8H, 2-,3-,1’’-,3’’-H2), 3.69–3.64 (m, 2H, 1’-,2’-H), 2.00–1.87 (m, 2H, 3’-,6’-H), 
1.74–1.60 (m, 2H, 4’-,5’-H), 1.59–1.47 (m, 2H, 3’-,6’-H), 1.35–1.20 (m, 2H, 4’-,5’-H), 1.28 (t, J = 7.1 Hz, 6H, 
4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 170.5 (2s, C-1,-2’’), 77.9 (2d, C-1’,-2’), 66.0 (2t, C-2,-1’’), 60.0 (2t, C-3,-3’’), 
27.1 (2t, C-3’,-6’), 21.4 (2t, C-4’,-5’), 13.6 (2q, C-4,-4’’). HRMS: m/z calculated for C14H24O6: 288.1573 [M]+; Found: 
288.1586. 
 
meso-Hexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (173): 
A solution of meso-diethyl 2,2'-(cyclohexane-1,2-diylbis(oxy))diacetate (6.81 g, 23.61 mmol) 
in THF (220 mL) was added dropwise to a stirred solution of KOtBu (5.29 g, 47.22 mmol) in 
THF (220 mL) with cooling to 0 ºC. Stirring was continued at 0 ºC for 2 h before being 
quenched by the addition of 0.2 M HCl (1.5 L) and ice (750 g). The resulting solution was extracted with DCM 
(4 x 300 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced pressure. The residue 
was taken up in EtOH (120 mL) and 2 M HCl (600 mL) and the mixture stirred at reflux for 2 h. After cooling to RT 
the solution was diluted with H2O (300 mL) and extracted with DCM (3 x 300 mL). The combined organic extracts 
were washed with H2O (300 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting residue 
was purified by flash chromatography on silica gel (EtOAc/hexane; 1:9) to give 
mesohexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (700 mg, 17%) as a clear oil. IR (ATR): ṽ = 2943 (v C–H), 
1712 (v C=O), 1119 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.35 (d, J = 16.8 Hz, 2H)/4.06 (d, J = 16.8 Hz, 2H) 
(2-,4-H2), 3.88–3.82 (m, 2H, 5a-,9a-H), 2.06–1.94 (m, 2H, 6-,9-H), 1.71–1.59 (m, 2H, 7-,8-H), 1.58–1.47 (m, 2H, 
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6-,9-H), 1.43–1.30 (m, 2H, 7-,8-H). 13C NMR (CDCl3, 75 MHz): δ 212.0 (s, C-3), 80.7 (2d, C-5a,-9a), 73.6 (2t, 
C-2,-4), 27.5 (2t, C-6,-9), 22.1 (2t, C-7,-8). HRMS: m/z calculated for C9H14O3: 170.0943 [M]+; Found: 170.0921. 
Odour description: Fruity, animalic odour of green tonality with chemical aspects and acidic facets in the dry-down. 
Odour threshold: 141 ng/L air (stan. dev. 99 ng/L air). 
 
rac-1-Bromo-3-chloropropan-2-ol (175):[10] 
A 48% HBr solution (28.3 g) was added dropwise to neat epichlorohydrin (15 g, 162 mmol) within 
2 h with vigorous stirring. The solution was stirred for an additional 0.75 h before being mixed 
with Et2O (150 mL), transferred to a separatory funnel and the organic phase washed with saturated aqueous 
solution of NaHCO3 (3 x 50 mL). The organic phase was dried (MgSO4) and concentrated under reduced pressure 
and the resulting residue distilled under vacuum (75 ºC, 5 torr) to give rac-1-bromo-3-chloropropen-2-ol (17.57 g, 
63%) as a viscous clear oil. IR (ATR): ṽ = 3380 (v O–H), 1037 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.10–
4.00 (m, 1H, 2-H), 3.77–3.66 (m, 2H, 3-H2), 3.58 (d, J = 5.3 Hz, 2H, 1-H2), 2.52 (d, J = 5.2 Hz, 1H, 2-OH). 13C NMR 
(CDCl3, 75 MHz): δ 70.3 (d, C-2), 46.4 (t, C-3), 34.6 (t, C-1). HRMS: m/z calculated for C3H6BrClO: 171.9291 [M]+; 
Found: 171.9256.  
 
rac-2-((1-Bromo-3-chloropropan-2-yl)oxy)tetrahydro-2H-pyran (176):[10] 
To 3,4-dihydro-2H-pyran (8.75 g, 104 mmol) was added rac-1-bromo-3-chloropropen-2-ol 
(16.51 g, 95.22 mmol) followed by phosphorus pentoxide (165 mg). The solution was warmed 
to 60 ºC for 1 h and then cooled to RT and stirred for an additional 1 h. The resulting reaction 
mixture was dissolved in Et2O (500 mL) and washed with a saturated aqueous solution of 
NaHCO3 (3 x 300 mL). The organic phase was then dried (MgSO4) and concentrated under reduced pressure to 
give a crude residue which was distilled under vacuum (80 ºC, 0.8 torr) to give rac-2-((1-bromo-3-chloropropan-2-
yl)oxy)tetrahydro-2H-pyran (19.85 g, 81%) as a clear oil. IR (ATR): ṽ = 2943 (v C–H), 1024 (v C–O) cm-1. 1H NMR 
(CDCl3, 300 MHz): δ 4.82–4.77 (m, 1H, 2-H), 4.09–4.00 (m, 1H, 2’-H), 3.99–3.89 (m, 1H, 6-H), 3.86–3.50 (m, 5H, 
6-H, 1’-,3’-H2), 1.92–1.50 (m, 6H, 3-,4-,5-H2). 13C NMR (CDCl3, 75 MHz): δ 98.6 (d, C-2), 75.3 (d, C-2’), 62.5 (t, 
C-6), 44.1 (t, C-3’), 31.8 (t, C-1’), 30.3 (t, C-3), 25.0 (t, C-5), 19.1 (t, C-4).  
 
rac-3,4-Dihydro-2H-benzo[b][1,4]dioxepin-3-ol (179):[10] 
To a solution of catechol (1.33 g, 12.08 mmol) in DMF (60 mL) was added K2CO3 (6.66 g, 
48.18 mmol) and the mixture heated to 100 ºC. To this solution was added 
2-((1-bromo-3-chloropropan-2-yl)oxy)tetrahydro-2H-pyran (31 g, 12.09 mmol) in DMF 
(60 mL) over a period of 0.5 h and the resulting solution then stirred at 120 ºC for 24 h. The reaction was quenched 
by the addition of H2O (300 mL) followed by extraction with Et2O (3 x 100 mL). The organic extracts were pooled, 
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washed with H2O (100 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting residue was 
purified by flash chromatography on silica gel (EtOAc/hexane; 2:8) to give a crude oil. Vanadium pentoxide 
(280 mg, 1.54 mmol) was added to a 30% aqueous solution of hydrogen peroxide (18 mL) and the mixture stirred 
at 0 ºC for 10 minutes. The mixture was added to a solution of the crude oil in MeCN (80 mL) and the resulting 
solution heated to 70 ºC for 0.5 h. The solution was then concentrated under reduced pressure, diluted with 2 M 
NaHCO3 (200 mL) and extracted with DCM (3 x 100 mL). The organic extracts were pooled, dried (MgSO4) and 
concentrated under reduced pressure. The resulting residue was purified by flash chromatography on silica gel 
(EtOAc/hexane; 25:75) to yield rac-3,4-dihydro-2H-benzo[b][1,4]dioxepin-3-ol (680 mg, 34%) as a colourless solid. 
mp: 49−50 ºC. (lit. mp: 48−50 ºC (pentane)).[10] IR (ATR): ṽ = 3268 (v O–H), 1492 (v aromatic C=C), 1258 (v C–O) 
cm-1. 1H NMR (CDCl3, 300 MHz): δ 7.08–6.94 (m, 4H, 6-,7-,8-,9-H), 4.35–4.25 (m, 2H, 2-,4-H), 4.15–4.05 (m, 3H, 
2-,3-,4-H), 2.67 (d, J = 8.5 Hz, 1H, 3-OH). 13C NMR (CDCl3, 75 MHz): δ 150.9 (2s, C-5a,-9a), 123.8/121.4 (4d, 
C-6,-7,-8,-9), 74.6 (2t, C-2,-4), 69.5 (d, C-3). HRMS: m/z calculated for C9H10O3: 166.0629 [M]+; Found: 166.0629. 
 
2H-Benzo[b][1,4]dioxepin-3(4H)-one (49):[10] 
To a 4% aqueous KOH solution (8 ml) and KMnO4 (480 mg) at 0 ºC was added 
rac-3,4-dihydro-2H-benzo[b][1,4]dioxepin-3-ol (100 mg, 0.602 mmol) and the solution stirred 
for 2.5 h. The solution was then diluted with H2O (50 mL) and extracted with EtOAc 
(3 x 50 mL). The organic extracts were pooled, dried (MgSO4) and concentrated under reduced pressure and the 
resulting residue distilled under vacuum to yield 2H-benzo[b][1,4]dioxepin-3(4H)-one (70 mg, 71%) as a yellow oil. 
IR (ATR): ṽ = 1737 (v C=O), 1490 (v aromatic C=C), 1259 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 7.05–6.94 
(m, 4H, 6-,7-,8-,9-H), 4.73 (s, 4H, 2-,4-H2). 13C NMR (CDCl3, 75 MHz): δ 204.5 (s, C-3), 148.3 (2s, C-5a,-9a), 123.8 
(2d, C-7,-8), 120.9 (2d, C-6,-9), 75.6 (2t, C-2,-4). HRMS: m/z calculated for C9H8O3: 164.0473 [M]+; Found: 
164.0470.  
 
rac-2-((3-Chloroprop-1-en-2-yl)oxy)tetrahydro-2H-pyran (181): 
rac-Cyclohexane-1,2-diol (608 mg, 5.24 mmol) in DMF (15 mL) was added dropwise to a 
solution of sodium hydride (315 mg, 13.1 mmol, 2.5 equiv) in DMF (25 mL) at 0 ºC and the 
solution left to stir for 0.5 h. A solution of rac-2-((1-bromo-3-chloropropan-2-yl)oxy)tetrahydro-
2H-pyran (1.215 g, 4.72 mmol, 0.9 equiv) in DMF (20 mL) was added dropwise over 1 h and 
the resulting solution allowed to warm to RT and stirred overnight. The reaction was quenched by the addition of 
H2O (100 mL) followed by extraction with EtOAc (3 x 100 mL). The combined organic extracts were washed with 
H2O (5 x 100 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting residue was purified by 
flash chromatography (EtOAc/hexane; 25:975) to give 2-((3-chloroprop-1-en-2-yl)oxy)tetrahydro-2H-pyran 
(330 mg, 40%) as a yellow oil. IR (ATR): ṽ = 2945 (v C–H), 1637 (v C=C), 992 (v C=CH2) cm-1. 1H NMR (CDCl3, 
 Synthesis of Hexahydrobenzo[b][1,4]dioxepin-3-one Stereoisomers 
 
97 
  
300 MHz): δ 5.25 (t, J = 3.1 Hz, 1H, 2-H), 4.48 (d, J = 2.2 Hz, 1H, 1’-H), 4.42 (d, J = 2.2 Hz, 1H, 1’-H), 4.00 (s, 2H, 
3’-H2), 3.93–3.85 (m, 1H, 6-H), 3.63–3.56 (m, 1H, 6-H), 2.01–1.83 (m, 1H, 4-H), 1.82–1.75 (m, 2H, 3-H2), 1.73–
1.53 (m, 3H, 4-H, 5-H2). 13C NMR (CDCl3, 75 MHz): δ 155.3 (s, C-2’), 95.5 (d, C-2), 89.5 (t, C-1’), 61.6 (t, C-6), 
45.0 (t, C-3’), 29.7 (t, C-3), 24.9 (t, C-5), 18.3 (t, C-4). HRMS: m/z calculated for C8H13O2: 141.0916 [M-Cl]+; Found: 
141.0928. 
 
1-Bromo-3-chloropropan-2-one (182): 
To a solution of sodium dichromate (9.38 g, 32.5 mmol) and rac-1-bromo-3-chloropropan-2-ol 
(9.98 g , 57.5 mmol) in H2O (6 mL) was added a solution of H2SO4 (11.25 g) in H2O (3 mL) over 
a period of 8 h with care taken to ensure the reaction did not exceed 25 ºC. The solution was then diluted with H2O 
(100 mL) and extracted with EtOAc (3 x 100 mL). The combined organic extracts were washed with saturated 
aqueous solution of NaHCO3 (100 mL), dried (MgSO4) and concentrated under reduced pressure to yield 
1-bromo-3-chloropropan-2-one (9.6 g, 97%) as a clear oil. IR (ATR): ṽ = 1732 (v C=O) cm-1. 1H NMR (CDCl3, 
300 MHz): δ 4.35 (s, 2H, 3-H2), 4.11 (s, 2H, 1-H2). 13C NMR (CDCl3, 75 MHz): δ 194.2 (s, C-2), 45.7 (t, C-3), 31.2 
(t, C-1). HRMS: m/z calculated for C3H4BrClO: 169.9134 [M]+; Found: 169.9122.  
 
Methyltriphenylphosphonium iodide (183):[85] 
Triphenylphosphine (28 g, 106.8 mmol) and iodomethane (16.2 g, 114 mmol) in benzene 
(100 mL) was stirred at RT overnight. The precipitate was filtered and dried with P2O5 under 
high vacuum for 8 h to yield methyltriphenylphosphonium iodide (37.4 g, 86%) as a colourless 
solid. mp: 184–185 ºC 
 
rac-1,3-Dichloropropan-2-ol (187): 
Following general procedure for compound (±)-175 but instead using conc. hydrochloric acid. 
Clear oil, 78% yield. IR (ATR): ṽ = 3371 (v O–H), 1050 (v C–H) cm-1. 1H NMR (CDCl3, 300 MHz): 
δ 4.08 (p, J = 5.3 Hz, 1H, 2-H), 3.71 (d, J = 5.3 Hz, 4H, 1-,3-H2). 13C NMR (CDCl3, 75 MHz): δ 70.7 (d, C-2), 45.6 
(2t, C-1,-3).  
 
1,3-Dichloropropan-2-one (188): 
Following general procedure for compound 182 but instead using 1,3-dichloropropan-2-ol. 
Clear oil, 75% yield. IR (ATR): ṽ = 1738 (v C=O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.33 (s, 4H, 
1-,3-H2). 13C NMR (CDCl3, 75 MHz): δ 194.9 (s, C-2), 46.0 (2t, C-1,-3). HRMS: m/z calculated for C3H4Cl2O: 
125.9639 [M]+; Found: 125.9640.  
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2,2-Bis(chloromethyl)-1,3-dioxolane (189):  
To a solution of 1,3-dichloropropan-2-one (13.6 g, 107.12 mmol) and ethylene glycol (17.42 g, 
280.65 mmol) in toluene (300 mL) was added H2SO4 (1 mL) and the solution heated at reflux in 
a Dean-Stark apparatus overnight, with the removal of H2O. The solution was then diluted with H2O (100 mL) and 
extracted with EtOAc (3 x 100 mL). The organic extracts were pooled, washed with a saturated aqueous solution 
of NaHCO3 (100 mL), dried (MgSO4) and concentrated under reduced pressure to yield 
2,2-bis(chloromethyl)-1,3-dioxolane (18 g, 98%) as a clear oil. IR (ATR): ṽ = 1015 (v C–O) cm-1. 1H NMR (CDCl3, 
300 MHz): δ 4.12 (s, 4H, 4-,5-H2), 3.68 (s, 4H, 2-2CH2Cl). 13C NMR (CDCl3, 75 MHz): δ 107.6 (s, C-2), 66.4 (2t, 
C-4,-5), 44.8 (2t, 2-2CH2C). 
 
3-Chloro-2,2-bis(chloromethyl)propanoic acid (192):[86] 
To a solution of pentaerythritol (139 g, 1.02 mmol) in pyridine (250 mL) was added thionyl chloride 
(378 g, 3.18 mmol) dropwise over a period of 5 h so that the temperature was maintained between 
65-95 ºC. The reaction was heated at 120 ºC overnight before ice-cold H2O (670 mL) was added 
with stirring. The reaction mixture was extracted with CHCl3 (3 x 300 mL), the organic extracts pooled, dried 
(MgSO4) and concentrated under reduced pressure. The resulting crude residue was then heated to 80 ºC and 
conc. HNO3 (15 mL) was added. After 15 minutes, an additional quantity of conc. HNO3 (170 mL) was added 
dropwise over a period of 2 h. The reaction was then maintained at 80 ºC overnight before being poured into 
ice-cold H2O (500 mL) followed by extraction with DCM (4 x 300 mL). The organic extracts were pooled and washed 
with 1 M NaOH (3 x 300 mL), dried (MgSO4) and concentrated under reduced pressure to yield 
3-chloro-2,2-bis(chloromethyl)propanoic acid (30 g, 14%) as a colourless solid. mp: 107–109 ºC. (lit. mp: 107–
109 ºC).[86] IR (ATR): ṽ = 2863 (v acid OH), 1713 (v acid C=O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 11.47 (s, 1H, 
1-COOH), 3.88 (s, 6H, 2-(2CH2Cl), 3-H2). 13C NMR (CDCl3, 75 MHz): δ 175.5 (s, C-1), 55.3 (s, C-2), 42.7 (3t, 
C-2(2CH2Cl),-3). 
 
1,3-Dichloro-2,2-bis(chloromethyl)propane (193):[86] 
The 1 M NaOH washes from 192 were pooled, concentrated to pH 1 with conc. HCl and extracted 
with DCM (4 x 300 mL). The organic extracts were pooled, washed with a saturated aqueous 
solution of NaHCO3 (100 mL), dried (MgSO4) and concentrated under reduced pressure to yield 
1,3-dichloro-2,2-bis(chloromethyl)propane (35 g, 17%) as a yellow solid. mp: 96–97 ºC. (lit. mp: 95–96 ºC 
(cyclohexane)).[86] IR (ATR): ṽ = 696 (v C–Cl) cm-1. 1H NMR (CDCl3, 300 MHz): δ 3.69 (s, 8H, 1-,3-,2-(2CH2Cl)-H2). 
13C NMR (CDCl3, 75 MHz): δ 46.6 (s, C-2). 43.9 (4t, C-1,-3,-2(2CH2Cl). 
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3-Chloro-2-(chloromethyl)prop-1-ene (194):[86] 
A flask of neat 3-chloro-2,2-bis(chloromethyl)propanoic acid (30 g, 146 mmol) was heated to 
210 ºC with a short-path distillation stillhead, condenser and receiver flask. The distillate was 
collected and redistilled from calcium hydride to yield 3-chloro-2-(chloromethyl)prop-1-ene (14 g, 76%) as a clear 
liquid. IR (ATR): ṽ = 931 (v C=CH2), 725 (v C–Cl) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.34 (s, 2H, 1-H2), 4.22 (d, 
J = 1.1 Hz, 4H, 3-H2, 2-CH2Cl). 13C NMR (CDCl3, 75 MHz): δ 141.2 (s, C-2), 119.0 (t, C-1), 44.7 (2t, C-3, 2-CH2Cl). 
HRMS: m/z calculated for C4H6Cl2: 123.9846 [M]+; Found: 123.9846.  
 
rac-3-Methyleneoctahydro-2H-benzo[b][1,4]dioxepine (195): 
rac-Cyclohexane-1,2-diol (608 mg, 5.24 mmol) in DMF (15 mL) was added dropwise to a 
solution of sodium hydride (315 mg, 13.1 mmol, 2.5 equiv) in DMF (30 mL) at 0 ºC and 
left for 1 h. A solution of 3-chloro-2-chloromethyl-propene (655 mg, 5.24 mmol, 1 equiv) 
in DMF (20 mL) was added dropwise over 1 h and the solution allowed to stir at RT overnight. The reaction was 
quenched by the addition of H2O (10 mL) and extracted with Et2O (4 x 100 mL). The combined organic extracts 
were washed with H2O (2 x 100 mL) before being dried (MgSO4) and concentrated under reduced pressure. The 
resulting residue was then purified by flash chromatography on silica gel (EtOAc/hexane; 5:95) to give 
rac-3-methyleneoctahydro-2H-benzo[b][1,4]dioxepine (206 mg, 23%) as a yellow oil. IR (ATR): ṽ = 2933/2860 
(v C–H), 1115 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.90 (t, J = 1.3 Hz, 2H, =CH2), 4.43 (d, J = 14.9 Hz, 2H, 
2-,4-H), 4.31 (d, J = 15.1 Hz, 2H, 2-,4-H), 3.17–3.05 (m, 2H, 5a-,9a-H), 2.03–1.87 (m, 2H, 6-,9-H), 1.79–1.59 
(m, 2H, 7-,8-H), 1.36–1.11 (m, 4H, 6-,7-,8-,9-H). 13C NMR (CDCl3, 75 MHz): δ 148.8 (s, C-3), 109.6 (t, =CH2), 86.1 
(2d, C-5a,-9a), 73.0 (2t, C-2,-4), 31.5 (2t, C-6,-9), 24.0 (2t, C-7,-8). HRMS: m/z calculated for C10H16O2: 168.1150 
[M]+; Found: 168.1160. Odour description: Agrestic, leathery.  
 
meso-3-Methyleneoctahydro-2H-benzo[b][1,4]dioxepine (196): 
Following general procedure for compound 195 but instead using 
meso-cyclohexane-1,2-diol. Yellow oil, 23% yield. IR (ATR): ṽ = 2934 (v C–H), 1110 (v C–
O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.96 (t, J = 1.1 Hz, 2H, =CH2), 4.40 (d, J = 14.4 Hz, 
2H, 2-,4-H), 4.16 (d, J = 14.5 Hz, 2H, 2-,4-H), 3.76-3.70 (m, 2H, 5a-,9a-H), 2.00–1.86 (m, 2H, 6-,9-H), 1.69–1.56 
(m, 2H, 7-,8-H), 1.55–1.43 (m, 2H, 6-,9-H), 1.39–1.22 (m, 2H, 7-,8-H). 13C NMR (CDCl3, 75 MHz): δ 148.4 (s, C-
3), 111.8 (t, =CH2), 78.7 (2d, C-5a,-9a), 69.5 (2t, C-2,-4), 28.3 (2t, C-6,-9), 22.4 (2t, C-7,-8). HRMS: m/z calculated 
for C10H16O2: 168.1150 [M]+; Found: 168.1125. Odour description: Agrestic, thymol, carvacrol, leathery tar.  
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General Procedure for Oxidation of 195→167 or 196→173: 
Methylene compound (180 mg, 1.07 mmol) was dissolved in MeCN (5 mL), H2O (5 mL), and CCl4 (3 mL), and 
sodium metaperiodate (229 mg, 1.07 mmol) and ruthenium trichloride (22 mg, 0.107 mmol) were added. The 
mixture was stirred for 24 h, then further sodium metaperiodate (229 mg, 1.07 mmol) and ruthenium trichloride 
(22 mg, 0.107 mmol) were added. The solution was stirred for an additional 24 h. The reaction mixture was then 
poured into H2O (30 mL), and the resulting mixture was extracted with DCM (3 x 20 mL). The combined organic 
extracts were washed with a saturated aqueous solution of NaHSO3 (20 mL) and with H2O (20 mL), dried (MgSO4), 
and concentrated under reduced pressure. The resulting residue was purified by flash chromatography on silica 
gel (EtOAc/hexane; 1:9) to give the corresponding ketone. 
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Chapter 3 – Synthesis of Additional Analogues of the Aliphatic 
Benzo[b][1,4]dioxepin-3-one System 
 
3.1 – Introduction 
3.1.1 – Olfactory Receptors and Strategies for Addressing Weak Affinity 
The discovery that the threo- and erythro-configured stereoisomers of the unsubstituted aliphatic 
benzo[b][1,4]dioxepin-3-one scaffold did not contain marine odorant nuances was not entirely 
unexpected when previous research regarding the synthetic marine odorant family was reviewed.[1-6] 
The commercially produced benzo[b][1,4]dioxepin-3-one odorant named Azurone® (53) was discovered 
by researchers at Givaudan during the generation of an olfactophore receptor model and was the 
optimum ligand for the original model which consisted of three hydrogen-bond acceptors, an aromatic 
binding site, an aliphatic hydrophobe and three excluded volumes inaccessible to the molecule 
(Figure 3.1).[1] With the later discovery that the (E)-7-(prop-1-enyl)-substituted analogue (89) was as 
potent an odorant as Azurone® (53), the initial olfactophore model was revised placing the aliphatic 
hydrophobe into the plane of the aromatic binding site and nearly 1 Å further away from its centre. Two 
hydrogen-bond acceptors were discovered to be sufficient, but six excluded volumes were necessary 
for an 85% predictability of odour threshold.[2] 
 
 
Figure 3.1: Original marine olfactophore model developed by Kraft et al.,[2] with bound ligands. Copyright Georg 
Thieme Verlag KG. Reproduced with permission.  
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Recently, researchers at Firmenich described that the heterocyclic moiety of the original 
benzo[b][1,4]dioxepin-3-one template could be replaced by a 2,3-dihydrofuran-2-carbaldehyde unit 
leading to compound 54, for which a powerful aldehydic-green marine odour was reported 
(Figure 3.2).[4] A library of analogues led to the proposition of an alternative qualitative olfactophore 
model consisting of one hydrogen-bond acceptor, an aliphatic hydrophobe and an aromatic binding 
site.[4] Both the Givaudan and Firmenich receptor models agree on the requirement of at least one 
potent hydrogen-bond acceptor, for which a carbonyl functionality has now been independently 
confirmed to be optimal by both Gaudin et al.[4] and Hügel et al.[5] 
 
 
Figure 3.2: Potent synthetic marine odorant analogues and their respective odour descriptors.  
 
It was reported by Gaudin et al.[4] that the five-membered heterocyclic ring system required one ether 
functionality to sustain marine odorant characteristics which confirmed the requirement for a second 
hydrogen-bond acceptor. All receptor models feature an aromatic binding site but the question remained 
unanswered as to whether the binding site is an essential binding feature of the receptor or simply a 
molecular spacer.[4] Strategies to increase the receptor affinity of the aliphatic scaffold included alkyl 
substitution as a way to address the aliphatic hydrophobe, as well as the reintroduction of unsaturation 
within the carbocyclic ring system in optimism that an sp2 orbital or π electron interaction with the 
olfactory receptor(s) may offer additional binding capabilities.  
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3.1.2 – Biotransformation of Aromatic Substrates  
The oxidation of aromatic substrates by the enzymes toluene dioxygenase (TDO), naphthalene 
dioxygenase (NDO) and biphenyl dioxygenase (BPDO) can provide uncomplicated access to 
enantiopure cis-diol compounds for chemical synthesis. In wild-type organisms this family of enzymes 
are involved in a process allowing aromatic compounds to be metabolised as a carbon and energy 
source.[7-8] In 1968 Gibson et al.[9-10] reported the first bio-oxidative degradation of simple aromatic 
compounds by fermentation with the bacterium Pseudomonas putida. In 1970 the first reported example 
of a mutant bacterium strain (Pp39D) lacking the enzymes responsible for the further degradation of 
the diene-diol metabolite was isolated (Figure 3.3).[11] This bacterial strain was produced by treatment 
of the original bacterium with N-methyl-N-nitroso-N′-nitroguanidin (MNNG), a potent mutagen.[12]  
 
 
Figure 3.3: Comparison of the degradation pathway of aromatic compounds by wild type P. putida, the knock-out 
mutant (Pp39D) and the bioengineered E. coli strain (JM109 pDTG601).  
 
The set of genes that encoded the enzyme toluene dioxygenase (TDO) were later cloned into a 
recombinant strain of Escherichia coli (JM109 pDTG601A).[13] Unlike the blocked mutant strain of 
P. putida, which required the addition of a known aromatic inducer to initiate protein synthesis, the 
recombinant E. coli bacterium contained the genes for an inducer, isopropyl 
β-D-1-thiogalactopyranoside (IPTG), on the plasmid.[8] A primary advantage of biocatalysis over 
traditional synthetic techniques is enantioselectivity.[14] The reason for the observed selectivity involves 
the specific environment in which the reaction take place within the enzyme. Traditional synthetic 
techniques, if imparting enantioselectivity at all, do so because the control is based on electronic and 
steric properties of the reactant, not the actual environment in which the reaction takes place.[15] 
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Toluene dioxygenase (TDO) and the related enzymatic systems are multicomponent enzymes with 
overlapping substrate specificities. Each enzymatic system uses an electron transport chain to transfer 
electrons from nicotinamide adenine dinucleotide (NADH) to the oxygenase component that consists 
of dissimilar subunits.[16] The toluene dioxygenase (TDO) enzymatic system is comprised of a 
flavoprotein reductase component (TDO-R); a Rieske [2Fe–2S] ferredoxin component (TDO-F) and a 
terminal oxygenase component (TDO-O).[17-18] The Rieske ferredoxin (TDO-F) shuttles electrons from 
NADH via a flavin adenine dinucleotide (FAD) cofactor contained within the reductase component 
(TDO-R) to the dioxygenase component (TDO-O), which catalyses the enantioselective addition of 
dioxygen to the aromatic substrate (Figure 3.4).[17] The genes encoding the reductase, ferredoxin and 
oxygenase systems have been cloned and their respective nucleotide sequences determined.[13] 
 
 
 
Figure 3.4: Dihydroxylation of toluene by the three-component toluene dioxygenase (TDO) enzymatic system.[18] 
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3.2 – Results & Discussion 
3.2.1 – Synthesis of 7-Methylhexahydrobenzo[b][1,4]dioxepin-3-one Analogues  
The optimum choice for the reintroduction of marine fragrance characteristic into the aliphatic system 
was alkyl substitution at the seven-position as a means to address the proposed hydrophobic binding 
site of the olfactory receptor. Methylation at the seven-position would produce an aliphatic analogue of 
lead compound 7-methylbenzo[b][1,4]dioxepin-3-one (Calone 1951®, 50). Compound 50 is reported to 
contain strong marine notes relative to the unmethylated analogue (49).[3, 6] Such a structural 
modification may assist in the docking of the molecule into the marine odorant receptor. The aliphatic 
binding site was predicted to be adjacent to the benzenoid ring system by Gaudin et al.[4] but considered 
7.23 Å distance from the benzenoid ring system by Kraft et al.[2]  
 
Synthetic access to 4-methylcyclohexane-1,2-diol beginning from chiral terpenoid compound 
(R)-(+)-pulegone (197) was envisioned. Conceivably compound 197 could be oxidised to give a 
bis-carbonyl intermediate followed by subsequent reduction to provide a mixture of cis- and 
trans-configured 4-methylcyclohexane-1,2-diol diastereomers in an unknown ratio. The reaction 
conditions for an oxidation using ozone were adapted from a publication by White et al.[19] Reductive 
work-up conditions using methylthiomethane were adapted from multiple synthetic sources 
(Scheme 3.1).[20-21]  
 
 
Scheme 3.1: Failed ozonolysis of pulegone (197) to give bis-carbonyl intermediate 198. 
 
The mechanism for the synthetic reaction involving ozone (O3) was first formulated by Rudolph Criegee 
in 1953.[22] Evidence for this mechanism was later confirmed by 17O NMR spectroscopy.[23] The reaction 
initiates with the 1,3-dipolar cycloaddition of ozone to an alkene to form an intermediate known as a 
molozonide. The unstable molozonide then reverts to the corresponding carbonyl oxide (or Criegee 
intermediate) and carbonyl compound in a retro-1,3-dipolar cycloaddition. This is followed by another 
1,3-dipolar cycloaddition to give a relatively stable trioxolane intermediate (Figure 3.5).[24] Varying 
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synthetic products can be isolated depending on the work-up conditions; reductive work-up conditions 
give alcohols or carbonyl compounds, whilst oxidative work-up conditions give ketones or carboxylic 
acids. 
 
Figure 3.5: Mechanism of an ozonolysis reaction.[22] 
 
The ozonation reaction of compound 197 was discovered to produce a complex mixture that showed 
promising signs that it contained the target compound (198) (Figure 3.6). The 13C NMR spectrum 
exhibited carbonyl signals located at δ 205.6/204.9 ppm which correctly matched NMR prediction 
software.[25] By GC-MS analysis it appeared that the crude reaction material contained multiple 
unknown organics and thus the isolation of compound 198 by flash chromatography on deactivated 
silica was attempted. The isolated yield of the product material appeared far lower than anticipated. 
Further investigation by NMR revealed that the isolated material contained a number of novel signals 
indicating that degradation of the parent material had occurred. Attempts at additional purification by 
chromatography, recrystallisation and vacuum distillation were unsuccessful.  
 
 
Figure 3.6: 13C NMR (CDCl3, 75 MHz) of crude compound 198, reaction displayed in Scheme 3.1. 
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An alternative synthetic route that circumvented the synthesis of an unstable bis-carbonyl intermediate 
(198) appeared essential. A review of the available literature revealed that a sodium borohydride 
reduction of (R)-(+)-pulegone (197) yielded the enantiopure hydroxyl compound cis-pulegol (199).[26-29] 
The reduction reaction is stereospecific due to the high stereoselectivity of sodium borohydride in the 
reduction of α,β-unsaturated carbonyl compounds.[26] The reaction was discovered to successfully 
provide compound 199 as a colourless solid in 92% yield and as single diastereomer (Scheme 3.2). A 
complication that can potentially arise during the reduction of α,β-unsaturated carbonyl compounds is 
the reduction of both the carbonyl and alkene moieties. The addition of cerium chloride to prevent such 
a problem is known as a Luche reduction.[30] Interestingly, the addition of cerium chloride in the reduction 
of (R)-(+)-pulegone (197) to cis-pulegol (199) was reported to be unnecessary.[26] 
 
 
Scheme 3.2: Synthesis of trans- and cis-configured 4-methylcyclohexane-1,2-diols 201 and 202, respectively, 
from pulegone (197) via reduction, ozonolysis and further reduction.  
 
The enantiopure hydroxyl compound 199 was ozonated according to the synthetic methodology of 
Kumar et al.[28] to provide acyloin intermediate 200. Attempts at the chromatographical isolation of 
compound 200 proved problematic owing to instability, mirroring that of bis-carbonyl compound 198. 
The crude reaction material was instead reduced without isolation using sodium borohydride to provide 
a ca. 2:1 mixture of enantiopure 4-methylcyclohexane-1,2-diol diastereomers 201 and 202, 
respectively. The diastereomeric bis-hydroxyl compounds were readily separated by flash 
chromatography on silica gel owing to subtle differences in polarity. The differences in polarity arise 
from the increased ability of the trans-configured diol (201) to hydrogen-bond owing to less steric 
hindrance of the hydroxyl moieties (Figure 3.7).  
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Enantiomerically pure seven-methyl target compounds 204 and 206 were readily synthesised from the 
4-methylcyclohexane-1,2-diol precursor compounds 201 and 202, respectively. Trans-configured diol 
201 was bis-etherified with ethyl diazoacetate in an excellent yield of 78%, followed by Dieckmann 
cyclisation and subsequent decarboxylation to provide threo-configured analogue 204 in 40% yield after 
flash chromatography (Scheme 3.3). It was hypothesised that the threo-configured seven-methyl 
analogue 204 would be similar in molecular conformation to lead compound Calone 1951® (50) and 
may therefore have high olfactory receptor affinity. Unexpectedly, compound 204 contained only minor 
marine character. An X-ray crystal structure was obtained for compound 204 to accurately compare the 
molecular resemblance of the saturated carbocyclic ring system to the aromatic carbocyclic ring system 
(Figure 3.8).  
 
Dissimilarities between the molecular structures were discovered to be minor. The major difference 
involved the planar benzenoid ring system being replaced by a cyclohexyl ring system in chair 
conformation. The fact that the cyclohexyl ring system exists in a non-planar conformation also forces 
the substituted methyl group to be situated at an angle in reference to the plane of the molecule. In 
consideration of the differences, the molecular structure of compound 204 and lead compound 50 were 
discovered to be virtually superimposable. The molecular structure of compound 204 was also 
practically identical to the molecular structure of the unsubstituted threo-configured compound 
(167, Figure 2.28), except for the chiral methyl group (C10) situated 1.531(5) Å from C5 in an equatorial 
position.  
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Figure 3.7: 13C NMR (CDCl3, 75 MHz) spectra of various 4-methylcyclohexane-1,2-diol samples; Top: crude 
mixture of diols 201 and 202; Middle: isolated cis-diol 202; Bottom: isolated trans-diol 201.  
 
 
 
Scheme 3.3: Synthesis of 7-methylhexahydrobenzo[b][1,4]dioxepin-3-one diastereomers 204 and 206 from 
trans- and cis-configured diol compounds 201 and 202, respectively.  
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Figure 3.8: Molecular structure of (5aR,7R,9aR)-7-methylhexahydrobenzo[b][1,4]dioxepin-3-one (204) showing 
thermal ellipsoids at a 50% probability level. Crystal data for 204: a = 8.1940(8) Å, b = 6.1852(4) Å, 
c = 9.7655(11) Å, α = 90º β = 96.136(9)º γ = 90º V = 492.10(8) Å3, Z = 2, and space group P 21. Crystallographic 
data for this structure has been deposited with the Cambridge Crystallographic Data Centre as supplementary 
publication no. CCDC 1020849. 
 
The cis-diol diastereomer 202 was bis-etherified with ethyl diazoacetate to provide compound 205 as a 
yellow oil in 23% yield after flash chromatography. The isolated bis-ester compound was discovered to 
have a non-favourable Dieckmann cyclisation yield, yielding erythro-configured analogue 206 in a mere 
8% yield after acid-catalysed decarboxylation (Scheme 3.3). The sample material obtained for 
compound 206 was discovered to be contaminated with minor quantities of compound 204 owing to 
impurities contained within the original cis-diol sample (202). Traces of threo-configured impurities were 
amplified to levels around four percent owing to yield differences between the alternative stereoisomeric 
configurations. 
 
It was discovered that the erythro-configured analogue was the more potent odorant molecule, mirroring 
that found for the unsubstituted analogues (compounds 167 and 173). The erythro-configured analogue 
206 was discovered to not contain marine character which agreed with theory that the dissimilar 
molecular shape may lead to difficulties with the molecule entering the specific olfactory receptor. The 
stereochemical configuration of the 4-methylcyclohexane,1-2-diol diastereomers was confirmed by 
comparison of the 1H NMR spectra of their aliphatic benzo[b][1,4]dioxepin-3-one derivatives. Signals 
associated with protons adjacent to the carbonyl moiety (C–2 and C–4) show distinct coupling patterns 
which are unmistakably different between the threo- and erythro-configured stereoisomers. 
Undisputable support for the hypothesis was provided by X-ray crystallography of compound 204. 
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3.2.2 – Synthesis of 5a,6,9,9a-Tetrahydrobenzo[b][1,4]dioxepin-3-one Analogues 
Both stereoisomeric configurations of the C7–C8 unsaturated hexahydrobenzo[b][1,4]dioxepin-3-one 
analogue were synthesised in order to investigate the effect of the addition of an alkene moiety/sp2 
electron orbit. The addition may provide the analogue with marine nuances and/or lower the threshold 
value by aiding in receptor binding to the proposed aromatic binding site. The synthetic pathway 
employed to the threo-configured C7–C8 unsaturated analogue involved an anti-dihydroxylation 
reaction of 1,4-cyclohexadiene (207) using meta-chloroperoxybenzoic acid in dichloromethane, 
followed by a sulphuric acid-catalysed epoxide cleavage to yield racemic unsaturated diol (±)-208 as a 
colourless crystalline solid in 34% yield (Scheme 3.4).[31] The isolated trans-diol (208) was etherified 
using ethyl diazoacetate to give bis-ester compound (±)-210 in a low yield of 13% yield. Dieckmann 
cyclisation and decarboxylation provided the unsaturated hexahydrobenzo[b][1,4]-dioxepin-3-one 
analogue (±)-211 in 39% yield as a colourless crystalline solid (Scheme 3.5).  
 
 
Scheme 3.4: Synthesis of rac- and meso-cyclohex-4-ene-1,2-diols (208 and 209, respectively) from 
1,4-cyclohexadiene (207). 
 
The synthetic pathway employed in the synthesis of the erythro-configured C7–C8 unsaturated 
analogue used an osmium tetroxide syn-dihydroxylation reaction of 1,4-cyclohexadiene (207) to yield 
unsaturated cis-diol compound 209 as a crystalline solid. (Scheme 3.4).[32-33] The isolated cis-diol was 
readily bis-etherified with ethyl diazoacetate to yield bis-ester compound 212 as a yellow oil in 32% 
yield. Dieckmann cyclisation reactions proved problematic due to an innate tendency for the compound 
to undergo intermolecular reactions rather than intramolecular cyclisation. The erythro-configured 
unsaturated target compound 213 was finally isolated as a crystalline solid in a meagre 3% yield after 
multiple purifications by flash chromatography (Scheme 3.5). 
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Scheme 3.5: Synthesis of rac- and meso-5a,6,9,9a-tetrahydrobenzo[b][1,4]dioxepin-3-one analogues  
211 and 213 from trans- and cis-configured diols 208 and 209, respectively.  
 
3.2.3 – Synthesis of 6/9-Substituted Aliphatic Benzo[b][1,4]dioxepin-3-one Analogues 
To further investigate the consequence of carbocyclic ring saturation on the 
benzo[b][1,4]dioxepin-3-one molecular template several six- and nine-substituted analogues were 
proposed for synthesis. Three enantiomerically pure cis-diol analogues were biosynthetically produced 
in the laboratories of collaborative researchers in preparation for the task. The cis-diol compounds were 
prepared by potassium azodicarboxylate (PAD) reduction of diene-diol metabolites produced by a 
recombinant strain of Escherichia coli (JM109 pDTG601A)[13] which performs the cis-dihydroxylation of 
the parent aromatic material by the enzymatic action of toluene dioxygenase (TDO) (Scheme 3.6).[7-8] 
 
 
Scheme 3.6: Enzymatic oxidation followed by selective chemical reduction to yield cis-diol compounds 214–216 
from aromatic precursor compounds. Biosynthetic and subsequent synthetic reaction performed in the laboratory 
of Prof. Tomáš Hudlický of Brock University, Canada. 
 
The enantiopure 3-methyl substituted cis-diol compound 214, produced by the microbial fermentation 
of toluene (217),[34] was readily bis-etherified with ethyl diazoacetate to give bis-ester compound 218 in 
34% yield as a yellow oil after flash chromatography (Scheme 3.7). Dieckmann cyclisation and 
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subsequent acid-catalysed decarboxylation provided nine-methyl C8–C9 unsaturated analogue 219 as 
a colourless crystalline solid in 34% yield (Figure 3.9).  
 
 
Scheme 3.7: Synthesis of (5aS,9aR)-9-methyl-5a,6,7,9a-tetrahydrobenzo[b][1,4]dioxepin-3-one (219) from 
toluene (217). 
 
 
Figure 3.9: Mass spectrum (EI) of compound 219 showing molecular ion at m/z 182. 
 
To provide synthetic access to additional enantiopure cis-diol analogues for chemical synthesis, the 
unsaturated 3-methyl cis-diol compound (214) was hydrogenated over palladium on carbon (Pd/C) 
under an atmosphere of hydrogen. The reaction provided a mixture of saturated cis-diol compounds 
222 and 223 in a ca. 3:7 ratio, respectively.[35] Investigations into their resolution by flash 
chromatography revealed that the diastereomers are unseperatable owing to their analogous 
cis-configuration which results in practically identical polarity. 
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The separation of diastereomers by benzoylation is used industrially during the resolution of (±)-menthol 
in a synthetic pathway known as the Haarmann and Reimer process.[36] Following the methodologies 
of Hudlicky et al.[35] the mixture of cis-diol compounds 222 and 223 was benzoylated using 
benzoyl chloride and pyridine. The two monobenzoate compounds were readily resolved by flash 
chromatography to provide 1-benzoyl analogues 220 and 221 in 46% combined yield as a yellow oil 
and colourless solid, respectively. Minor quantities of the mixed configuration bis-benzoyl compound 
were isolated and discarded. The isolated benzoate ester compounds 220 and 221 were hydrolysed in 
methanolic sodium hydroxide at reflux temperature to provide the enantiopure saturated cis-diol 
compounds 222 and 223 in yields of 93% and 92%, respectively (Scheme 3.8).  
 
 
Scheme 3.8: Hydrogenation and benzoylation of unsaturated cis-diol 214, followed by separation and  
hydrolysis to yield enantiopure saturated cis-diol compounds 222 and 223.  
 
The relative configurations of the enantiopure material was confirmed by comparison to literature 
sources,[35, 37] as well as by 1H, 1H NOESY NMR experiments (Figure 3.10). Only in the spectrum 
obtained for the (1S,2R,3S) configured analogue (222) was a Nuclear Overhauser Effect (NOE) 
observed between the doublet signal at δ 1.01 (J = 6.6 Hz) originating from the 3-Me substituent and 
the multiplet signal at δ 3.94–3.99 originating from the proton located at C-1. This correlation indicates 
that the 3-Me and 1-H substituents are on the same face of the cyclohexane ring of compound 222. This 
information, alongside comparisons between known and experimental spectroscopic data, confirms the 
relative configuration and chirality of the 3-Me chiral center of both cis-diol compounds 222 and 223. 
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Figure 3.10: 1H, 1H NOESY NMR (CDCl3, 500 MHz) spectrum of compound 222, showing NOE correlation 
between the doublet signal at δ 1.01 (originating from 3-Me) and the multiplet signal at δ 3.94–3.99 
(originating from 1-H). 
 
The (3S)-methyl configured cis-diol analogue (222) was readily transformed into the aliphatic 
benzo[b][1,4]dioxepin-3-one analogue by Williamson reaction. Etherification of 222 with 
bis-halogenated chain 194 provided methylene intermediate 224 in 65% yield as a yellow oil 
(Scheme 3.9). Katsuki-Sharpless oxidation of 224 successfully gave analogue 225 in 58% yield as a 
colourless crystalline solid. The (3R)-methyl configured cis-diol analogue (223) was similarly 
transformed into the benzo[b][1,4]dioxpin-3-one analogue. The Williamson reaction of compound 223 
with bis-halogenated chain 194 provided methylene intermediate 226 in 42% yield as a yellow oil. A 
ruthenium tetroxide oxidation of compound 226 yielded analogue 227 in 66% yield as a yellow oil. 
Compounds 225 and 227 were both discovered to have marine odorant qualities. 
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Scheme 3.9: Synthesis of 6-methylhexahydrobenzo[b][1,4]dioxepin-3-one diastereomers 225 and 227  
from cis-diol compounds 222 and 223, respectively. 
 
The discovery that the six-methyl substituted erythro-configured analogues 225 and 227 contained 
comparatively strong marine odorant characteristics whilst the seven-methyl substituted 
threo-configured analogue 204 contained only weak marine odorant side-notes hinted at the repulsion 
of the hydrophobic cyclohexyl system by the marine odorant receptor. The erythro-configured 
cyclohexyl ring system is bent at an angle to the heterocyclic ring system, as is apparent in the crystal 
structure of compound 173, and may therefore be avoiding such repulsive interaction. The discovery 
that the seven-methyl substituted erythro-configured analogue 206 possessed no marine odorant 
qualities indicated that a positive hydrophobic interaction at the six-position was occurring between the 
molecules and the olfactory receptor. 
 
To additionally investigate the hypothetical hydrophobic binding location, attention turned to the halogen 
substituted cis-diol compounds 215 and 216. A Dieckmann condensation route of cyclisation was 
nominated owing to unsaturation within the molecular structure of the carbocyclic ring system, thereby 
circumventing potential complications involving ring cleavage. Etherification reactions of the 
halogenated cis-diol analogues with ethyl diazoacetate under boron trifluoride catalysis required 
refluxing conditions to successfully furnish the bis-ester compounds 229 and 232. This phenomenon 
was presumably due to deactivation of the electrophilic nature of the hydroxyl moieties owing to 
changes in electron density due to the closely situated polar haloalkene moiety. 
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The enantiopure three-bromo substituted analogue 215 was successfully bis-etherified with ethyl 
diazoacetate under refluxing conditions to provide compound 229 in 27% yield as a yellow oil 
(Scheme 3.10). Compound 229 was cyclised by Dieckmann condensation followed by subjection to an 
acid-catalysed decarboxylation to give analogue 230 in 20% yield as a yellow oil. The isomeric 
three-iodo substituted analogue 216 was bis-etherified with ethyl diazoacetate to give bis-ester 
compound 232 in 30% yield as a yellow oil. Dieckmann cyclisation and subsequent decarboxylation 
provided vinyl iodide analogue 233 in 23% yield as a yellow oil. Both halogenated analogues (230 and 
233) were discovered to have marine odorant nuances, although more closely associated with seaweed 
and algae. 
 
 
Scheme 3.10: Synthesis of halogenated analogues 230 (R = Br) and 233 (R = I) from bromobenzene (228)  
and iodobenzene (231), respectively. 
 
The hydrogenation of bromo-substituted analogue 215 was attempted to provide further cis-diol 
analogues for chemical synthesis (Scheme 3.11). The reaction was discovered to provide red 
polymerised material which indicated that molecular bromine had been formed. Alkenyl halide 
hydrogenations are recognised to deliver varying quantities of the desired product alongside the 
hydrodehalogenated product.[38] Multiple literature sources report successful reaction conditions to 
perform alkenyl halide to alkyl halide hydrogenation reactions.[38-40] Such reactions are highly reactant 
specific and require metal-ligand catalysts and therefore remained outside the scope of this study. 
 Synthesis of Additional Analogues of the Aliphatic Benzo[b][1,4]dioxepin-3-one System 
 
124 
 
 
Scheme 3.11: Failed hydrogenation reaction of brominated cis-diol compound 215.  
 
A Suzuki reaction was performed between vinyl iodide analogue 233 and boronic acid 235 to investigate 
if the synthesis of additional six- and nine-substituted analogues by coupling reactions were possible. 
Following the methodology of Bhosale et al.,[41] a coupling reaction between compounds 233 and 235 
was performed in dimethoxyethane at elevated temperatures using Pd(PhP3)4 as a catalyst and 
2 M Na2CO3 solution as a base. Care was taken to exclude atmospheric oxygen from the reaction to 
prevent any disruptions to the catalytic cycle. The coupling reaction was discovered to successfully 
yield nine-benzyl substituted analogue 236 as a yellow oil in 72% yield (Scheme 3.12). Although 
successfully characterised, this compound appeared to be unstable.  
 
 
Scheme 3.12: Suzuki coupling between compound 233 and phenylboronic acid (235) to provide 
 (5aS,9aR)-9-phenyl-5a,6,7,9a-tetrahydrobenzo[b][1,4]dioxepin-3-one (236). 
 
The Suzuki reaction, also known as the Suzuki–Miyaura reaction, was first reported in 1979.[42] The 
reaction involves the coupling of an organohalide compound and a boronic acid derivative, catalysed 
by a palladium(0) complex and requiring base to be present. The catalytic cycle initiates with oxidative 
addition of the organohalide to the palladium(0) complex to produce a palladium(II) complex 
(Figure 3.11). This intermediate then reacts with a molecule of base, followed by transmetalation with 
a molecule of the base-activated boronic acid derivative. Reductive elimination yields the coupled 
product and regenerates the palladium(0) catalyst, thereby completing the catalytic cycle.  
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Oxidative addition is typically the rate-determining step in any transition metal-catalysed catalytic cycle. 
The relative reactivity of halides and pseudohalides decreases in order from I > OTf > Br > Cl > F, with 
organochlorides considered unreactive and organofluorides considered non-reactive in a Suzuki 
coupling.[43] A wide range of palladium derived catalysts have been utilised for such cross-coupling 
reactions, although the palladium(0) catalyst Pd(PPh3)4 is the most commonly used catalyst for this type 
of transformation. Palladium(II) catalysts such as PdCl2(PPh3)2 and Pd(OAc)2, alongside 
triphenylphosphine or an alternative phosphine ligand, are also efficient catalysts owing to their air 
stability and ability to be readily reduced to an active palladium(0) complex.[43] A variety of alternative 
transition metal catalysts have also been discovered to be useful for this type of transformation. Much 
attention has been given to nickel catalysed Suzuki–Miyaura coupling reactions due to nickel metal 
being more Earth abundant and also cheaper than palladium metal.[44] 
 
 
 
Figure 3.11: Proposed catalytic cycle for Suzuki coupling reactions.[45] 
 
 
 
 
 
 Synthesis of Additional Analogues of the Aliphatic Benzo[b][1,4]dioxepin-3-one System 
 
126 
 
3.2.4 – Synthesis of Alternative Ring Benzo[b][1,4]dioxepin-3-one Analogues 
To determine the effect of bridged molecular structure on aliphatic benzo[b][1,4]dioxepin-3-one odorant 
properties, as well as the effect of substitution on both C–6 and C–9, a simple tricyclic analogue (240) 
was prepared from bicyclo[2.2.1] compound norbornene (237). The synthetic pathway commenced with 
an osmium tetroxide/N-methylmorpholine N-oxide (NMO) mediated dihydroxylation reaction of 
norbornene (237) to provide diol 238 in 82% yield as a colourless crystalline solid (Scheme 3.13). The 
higher steric hindrance on the endo face leads to a strong preference for the exo-configured diol 
stereoisomer.[46] 
 
Diol 238 was readily transformed into methylene intermediate 239 in 56% yield by Williamson 
cyclisation with bis-halogenated chain 194. The intermediate methylene compound 239 was oxidised 
in a Katsuki-Sharpless oxidation to give bicyclo[2.2.1] saturated analogue 240 in a 62% yield as a 
colourless solid. Analogue 240 had no olfactory similarity to analogue 227. This discovery indicated that 
the hypothetical hydrophobic binding site that provided the six- and nine-substituted analogues 
(compounds 225, 227, 230 and 233) marine odorant characteristics was located externally to the 
benzo[b][1,4]dioxepin-3-one binding pocket, and not situated in the area above the carbocyclic ring 
system. 
 
 
Scheme 3.13: Synthesis of tricyclic analogue 240 from norbornene (237). 
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The synthesis of an alternative bicyclo[2.2.1] trans-configured diol analogue commencing from 
norbornene was also envisioned. Norbornene (237) was epoxidised using meta-chloroperoxybenzoic 
acid to give exo-2,3-epoxynorbornane 241 as a single diastereomer in quantitative yield (Scheme 3.14). 
The sulphuric acid-catalysed ring-opening reaction of compound 241 provided a colourless solid that 
appeared to be a combination of multiple compounds by GC-MS and NMR analysis. Analysis by 
13C NMR revealed multiple sets of distinct signal strengths indicating that a major product was formed 
alongside multiple impurities (Figure 3.12). Flash chromatography was discovered to be ineffective in 
the isolation of the individual components of the complex reaction mixture. Repeated recrystallisations 
were discovered be equally unsuccessful. 
 
 
Scheme 3.14: Failed synthesis of trans-diol (±)-242 from norbornene (237). 
 
 
Figure 3.12: 13C NMR (CDCl3, 75 MHz) of crude material obtained for reaction of compound 241, reaction 
displayed in Scheme 3.14. 
 
An advanced literature search revealed that the ring-opening reaction of epoxide 241 under acidic 
conditions is recognised to yield a mixture of various bis-hydroxyl products owing to a norbornyl cation 
rearrangement reaction (Scheme 3.15).[46-49] Research into the hydrochloric acid-catalysed reaction of 
epoxide 241 revealed that the reaction yielded three isomeric compounds (242–244), as was confirmed 
by X-ray crystallography of the isolated material by Willson et al.[46] (Figure 3.13). The research 
additionally revealed that isomerisation of compound (±)-242 to the thermodynamically favoured 
compound (±)-244 was occurring.[46] The synthesis of compound (±)-242 was therefore abandoned.  
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Scheme 3.15: Acid-catalysed epoxide 241 ring-opening products as reported by Willson et al.[46] 
 
 
Figure 3.13: Product distribution during an acid-catalysed reaction of 241, adapted from Willson et al.[46] 
 
To examine if perhaps an alternative sized carbocyclic ring system would have improved compatibility 
with the receptor binding site, the synthesis of an analogue containing an eight-membered carbocyclic 
ring system was performed. The threo-configured aliphatic analogues, which can be essentially 
superimposed onto the molecular structures of the aromatic lead compounds, were discovered not to 
have any marine odorant qualities. A number of erythro-configured analogues (i.e. 225, 227, 230 and 
233) did contain the desired characteristics, perhaps due to the carbocyclic ring system being situated 
outside the plane of the heterocyclic ring system and thereby avoiding repulsive interaction. The 
synthetic sequence commenced with an Upjohn dihydroxylation reaction of cis-cyclooctene (245) to 
provide cis-diol compound 246 in 69% yield as a colourless crystalline solid. Williamson cyclisation of 
compound 246 with bis-halogen compound 194 successfully gave methylene intermediate 247 in a 58% 
yield. Intermediate compound 247 was oxidised using ruthenium tetroxide to provide the 
 CHAPTER 3 
 
129 
  
eight-membered erythro-configured analogue 248 which was discovered to be completely devoid of 
fragrance (Scheme 3.16). 
 
 
Scheme 3.16: Synthesis of 8-membered analogue 248 from cis-cyclooctene (245). 
 
3.2.5 - Structure-Odour Correlations and Conclusion 
The olfactory properties of the experimental aliphatic benzo[b][1,4]dioxepin-3-one analogues are 
summarised in Table 3.1 and Table 3.2. Olfactory evaluations were performed by expert perfumers on 
blotter using a 10% solution of the sample substance in dipropylene glycol (DPG), odour threshold 
values were determined by a panel using GC−Olfactometry (GC−O). The most potent analogue 
synthesised was the unsubstituted erythro-configured analogue 173 which had an odour threshold of 
141 ng/L air, a near 5000−fold decrease in potency from lead compound Calone 1951® 
(50, th 0.031 ng/L air). The saturated analogues however displayed significantly different odour profiles 
in comparison to their aromatic counterparts, with the exception of 225, 227, 230 and 233 which were 
discovered to have marine fragrance.  
 
The olfactory properties of all other analogues are completely in accordance with the published marine 
olfactophore models[1-2, 4] that require an aromatic binding feature to be present within the molecular 
structure. These compounds are therefore binding to multiple non-marine olfactory receptors, rather 
less specifically and with low affinity. This results in a potpourri of different odour impressions ranging 
from fruity, medicinal and chemical to fruity-green and fatty, and with odour thresholds above 
100 ng/L air they are considered quite weak odorant molecules.  
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Interestingly, the unsaturation of (±)-167(±)-211 and 173213 had a detrimental effect on odour 
strength. Unsaturation of the threo-configured analogue (±)-167 caused the odour threshold to rise from 
210 ng/L air to a threshold value out of the range of what can be considered useful as a perfumery 
ingredient. The unsaturated erythro-analogue 213 had its odour threshold rise by 156 ng/L air in 
comparison to its saturated counterpart 173. The fruity-fatty, slightly animalic odour of 213 was found 
interesting in that it distinctly recalled dark olives, which is a rare and unusual fragrance character. 
Unfortunately, GC−O analysis revealed that compound 213 was too weak to be considered for use as 
commercial perfumery material. 
 
Methyl substitution at the seven-position as a way to address the hydrophobic binding site was not 
effective as compounds 204 and 206 were rather weaker by blotter analysis than 167 and 173. These 
analogues did somewhat address different odour receptors as they were slightly woody-fruity in odour, 
and in the case of 206, more specifically recalling 1-nonanol. The published marine olfactophore models 
require longer alkyl chains to address the hydrophobic binding pocket and this result showed that the 
methyl group of Calone 1951® (50) does not have much affinitive receptor interaction. Longer alkyl 
substituents up to butyl length may conformationally hinder receptor binding as only after a pentyl length 
alkyl chain onwards does a positive receptor affinity result. 
 
The halogenated 5a,6,7,9a-tetrahydrobenzo[b][1,4]dioxepin-3-ones compounds 230 and 233 had 
salty-marine odours that were more reminiscent of seawater and algae, with unpleasant medicinal and 
chemical aspects. The odour profile of vinyl iodide 233 had a distinct iodine connotation, potentially 
indicating that some degradation by nasal enzymes may have liberated iodinated compounds of lower 
molecular weight, or even molecular iodine. This may also explain the chemical and solvent-type 
malodours of vinyl bromide 230. Further studies of halogen substituted analogues would be necessary 
to rule this out; however, cosmetic laws prohibit the use of such halogenated odorants in perfumery. 
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# Molecular Structure Description and Threshold 
(±)-167 
 
Odour description: Medicinal, fruity odour that is linear in the 
dry-down with additional sweet facets in the fond.  
Odour threshold: 210 ng/L air (stan. dev. 176 ng/L air). 
173 
 
Odour description: Fruity, animalic odour of green tonality with 
chemical aspects and acidic facets in the dry-down.  
Odour threshold: 141 ng/L air (stan. dev. 99 ng/L air). 
(±)-211 
 Odour description: Very weak to odourless, and uncharacteristic 
in smell. 
213 
 
Odour description: Fruity-fatty, slightly animalic odour that also 
recalls dark olives, and upon dry-down becomes more balsamic, 
fruity and cinnamate-like.  
Odour threshold: 297 ng/L air (stan. dev. 125 ng/L air). 
204 
 
Odour description: Weak, slightly woody odour that is linear 
upon dry-down and displays slightly marine, watery and salty 
nuances. 
206 
 
Odour description: Odour reminiscent of fatty alcohols, 
especially nonanol, with slightly woody and fruity character and 
green-rubbery aspects in the dry-down. 
240 
 Odour description: Very weak, slightly agrestic and terpenic, 
slightly mouldy. 
248 
 
Odour description: Odourless. 
 
Table 3.1: Experimental aliphatic benzo[b][1,4]dioxepin-3-one library displaying odour descriptions, and odour 
thresholds, where applicable.  
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The aromatic ring system thus appears to be a prerequisite for binding to the marine odour receptor(s) 
and an alkene or methyl substituent had little effect on receptor affinity. The question remained as to 
why compounds 225, 227, 230 and 233 appeared to have residual affinity for the marine odorant 
receptor(s). The superposition analysis of the molecular structures of 167 and 227 on the 
minimum-energy conformer of Calone 1951® (50) may offer some explanation (Figure 3.14).  
 
# Molecular Structure Description and Threshold 
219 
 Odour description: Weak, slightly green odour with a Folrosia 
(4-(1-methylethyl)cyclohexan-1-ol) effect. 
225 
 Odour description: Weak, green-rubbery odour with a marine 
effect.  
Odour threshold: 297 ng/L air (stan. dev. 188 ng/L air). 
227 
 
Odour description: Weak, green, slightly oily medicinal odour 
reminiscent of the medicinal aspects of Calone 1951®, but also 
with marine facets of Calone 1951®.  
Odour threshold: 177 ng/L air (stan. dev. 72 ng/L air). 
230 
 
Odour description: Salty, seawater, algae, solvent-like and 
chemical aspects. 
233 
 
Odour description: Marine, salty, seawater, iodine effect, 
medicinal, slightly spicy, chemical aspects. 
 
Table 3.2: Experimental six- and nine-substituted aliphatic benzo[b][1,4]dioxepin-3-one library displaying odour 
descriptions, and odour thresholds, where applicable.  
 
The threo-configured analogue 167 (blue) overlays agreeably with Calone 1951® (50, black), except 
that it features no methyl substitution, is non-planar and contains no aromatic binding element for the 
receptor. The aromatic binding pocket of the olfactory receptor appears to refuse the cyclohexyl 
hydrophobe: a negative interaction. In the erythro-configured compounds 225 and 227 the cyclohexyl 
ring system is at an angle to the heterocyclic ring system and hence is bent away avoiding such 
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repulsion. The unsaturated analogue 219 is at a shallower angle and is therefore closer to the aromatic 
binding feature of the marine receptor which could explain the lack of marine tonality. 
 
 
 
Figure 3.14: Rigid-body superposition of the X-ray structure of 167 (blue, Figure 2.28) and the structure of 227 
(magenta) derived from X-ray coordinates of 173 (Figure 2.29) on the minimum-energy conformer of Calone 
1951® (50, black) made with the Discovery Studio 4.1 software package using a 100% electrostatic field.[50] 
 
The explanation as to why the parent erythro-configured compounds 173 and 206 do not contain marine 
odour can be deduced from a positive hydrophobic interaction of the six-methyl group with the olfactory 
receptor(s). It was discovered that the C8–C9 unsaturation of the halogenated compounds 230 and 233 
did not prevent marine odorant character as was discovered for the methyl substituted analogues 219, 
225 and 227. It is conceivable that the larger halogen substituents and their polarisability assists the 
molecules in binding to the hypothesised hydrophobic binding site, thereby overcoming some repulsion 
of the cyclohexyl ring system from the olfactory receptor.  
 
It is known that two hydrogen-bond acceptors are sufficient for binding and that therefore a hydrophobic 
methyl unit is tolerated opposite to the remaining ether oxygen atom. In any case, the weak character, 
intensity and persistence of the aliphatic analogues is indicative that the planar aromatic ring structure 
is an indispensable feature of the marine odorant family and that simple modifications such as the 
addition of a methyl group or alkene to the basic molecular structure is not sufficient to aid in receptor 
binding.  
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3.3 – Experimental 
General Procedure A: 
To an ice-cool solution of diol compound (40 mmol) and ethyl diazoacetate (10 g, 88 mmol, 2.2 equiv) in DCM 
(80 mL) was slowly added BF3·OEt2 (0.5 mL). After addition was complete, the solution was held at 0 ºC for 1 h 
before being quenched by the addition of a saturated aqueous solution of NaHCO3 (100 mL). The mixture was then 
extracted with EtOAc (3 × 100 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography on silica gel (EtOAc/hexane; 2:8) to yield the 
corresponding bis-ester compound. 
 
General Procedure B: 
A solution of bis-ester compound (20 mmol) in THF (150 mL) was added dropwise to a stirred suspension of 
KOtBu (4.5 g, 40 mmol, 2 equiv) in THF (100 mL) with cooling to 0 ºC. Stirring was continued at 0 ºC for 2 h before 
being quenched by the addition of 0.2 M HCl (800 mL) and ice (500 g). The resulting solution was then extracted 
with DCM (3 × 200 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced pressure. 
The resulting residue was taken up in EtOH (100 mL) and 2 M HCl (500 mL) and the mixture stirred at reflux for 
2 h. The solution was diluted with H2O (300 mL) and extracted with DCM (3 × 200 mL). The combined organic 
extracts were washed with H2O (200 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting 
residue was purified by flash chromatography on silica gel (EtOAc/hexane; 1:9) to yield the corresponding ketone. 
 
General Procedure C: 
A solution of the diol compound (10.5 mmol) in DMF (30 mL) was added dropwise to a suspension of sodium 
hydride (1.05 g, 26.2 mmol, 60% dispersion in mineral oil) in DMF (60 mL) and the solution left to stir for 1 h. A 
solution of 3-chloro-2-(chloromethyl)-1-propene (1.31 g, 10.5 mmol) in DMF (40 mL) was then added dropwise over 
a period of 1 h, and the solution allowed to stir for 24 h. The reaction was then quenched by the additional of a 
saturated aqueous solution of NaHCO3 (100 mL), extracted with Et2O (4 × 100 mL), the organic extracts pooled 
and washed with H2O (2 × 100 mL) before being dried (MgSO4) and concentrated under reduced pressure. The 
resulting residue was then purified by flash chromatography on silica gel (EtOAc/hexane; 5:95) to yield the 
corresponding methylene compound. 
 
General Procedure D:  
The methylene compound (5 mmol) was dissolved in MeCN (25 mL), H2O (25 mL), and CCl4 (15 mL), and sodium 
metaperiodate (1.07 g, 5 mmol) and ruthenium trichloride (0.1 g, 0.5 mmol) were added. The mixture was stirred 
for 24 h, then further sodium metaperiodate (1.07 g, 5 mmol) and ruthenium trichloride (0.1 g, 0.5 mmol) were 
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added. The solution was stirred for a further 24 h. The reaction mixture was then poured into H2O (100 mL) and 
the resulting mixture was extracted with DCM (3 x 100 mL). The combined organic extracts were washed with a 
saturated aqueous solution of NaHSO3 (100 mL) and with H2O (100 mL), dried (MgSO4), and concentrated under 
reduced pressure. The resulting residue was purified by flash chromatography on silica gel (EtOAc/hexane; 1:9) to 
give the corresponding ketone. 
 
General Procedure E:  
To a solution of alkene (20 mmol) and NMO (22 mmol) in acetone/H2O (4:1, 50 mL) was added OsO4 (100 mg) 
and the resulting solution stirred at RT for 48 h. The reaction was then quenched by the addition of Na2SO3 (1 g) 
and left for 1 h before being concentrated under reduced pressure. The residual oil was then taken up in H2O 
(100 mL), extracted with EtOAc (5 × 100 mL), the organic extracts pooled and dried (MgSO4) before being 
concentrated under reduced pressure. The resulting residue was then recrystallised from EtOAc/hexane to yield 
the corresponding cis-diol compound.  
 
(1R,5R)-5-Methyl-2-(propan-2-ylidene)cyclohexan-1-ol (199):[26] 
A suspension of NaBH4 (4 g, 105.7 mmol) in EtOH (200 mL) was added dropwise to an ice-cold 
solution of (R)-pulegone (15 g, 98.5 mmol) in MeOH (180 mL) and H2O (40 mL). Stirring was 
continued for 2 h at RT. The reaction was then poured into a saturated aqueous solution of NaCl 
(500 mL) and the mixture extracted with hexane (3 x 300 mL). The organic extracts were pooled, dried (MgSO4) 
and concentrated under reduced pressure to yield (1R,5R)-5-methyl-2-(propan-2-ylidene)cyclohexan-1-ol (14.78 g, 
92%) as a colourless solid. [𝛼]  𝐷
23 = –167.3º (c = 1.9, EtOH). mp: 28–39 ºC. (lit. [𝛼]  𝐷
25 = –105.2º (c = 1.9, EtOH). 
mp: 30–31 ºC).[26] Full structural assignment could not be completed. 1H NMR (CDCl3, 300 MHz): δ 4.74–4.69 (m, 
1H), 2.41–2.18 (m, 2H), 1.85–1.39 (m, 11H), 1.20 (d, J = 2.8 Hz, 1H), 1.12 (d, J = 6.9 Hz, 3H). 13C NMR (CDCl3, 
75 MHz): δ 132.4, 125.3, 67.7, 39.3, 31.7, 26.6, 22.1, 21.1, 20.0, 19.3. HRMS: m/z calculated for C10H18O: 154.1358 
[M]+; Found: 154.1354. 
 
Synthesis of diols 201 and 202: 
A solution of (1R,5R)-5-methyl-2-(propan-2-ylidene)cyclohexan-1-ol (13.7 g, 88.8 mmol) in DCM (400 mL) was 
cooled to –78 ºC. The cooled solution was then treated with a continuous steam of ozone and the reaction 
monitored for completion by the absence of starting material. Upon completion the addition of ozone was arrested 
and the reaction mixture purged with nitrogen for 1 h at –78 ºC. Methylthiomethane (70 mL) was then added and 
the resulting mixture stirred at 0 ºC for 1 h followed by at RT overnight. The reaction was then concentrated under 
reduced pressure followed by extraction with EtOAc (4 x 100 mL). The organic extracts were pooled before being 
dried (MgSO4) and concentrated under reduced pressure. The residue obtained was then taken up in MeOH 
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(150 mL) and H2O (25 mL), cooled to 0 ºC before NaBH4 (3 g) in EtOH (150 mL) was added dropwise. Stirring was 
then continued for 2 h at RT. The reaction was poured into a saturated aqueous solution of NaCl (500 mL) and the 
mixture was extracted with EtOAc (3 x 300 mL). The organic extracts were pooled, dried (MgSO4) and concentrated 
under reduced pressure. The resulting oil was purified by flash chromatography on silica gel (EtOAc/hexane; 55:45) 
to yield a 2:1 ratio of (1R,2R,4R)-4-methylcyclohexane-1,2-diol (2.74 g) and (1S,2R,4R)-4-methylcyclohexane-
1,2-diol (1.42 g) in 36% combined yield. 
 
(1R,2R,4R)-4-Methylcyclohexane-1,2-diol (201): 
Colourless solid. [𝛼]  𝐷
24 = –28.5º (c = 0.36, DCM). mp: 62–63 ºC. IR (ATR): ṽ = 3300 (v O–H), 2919 
(v C–H), 1055 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 3.46–3.30 (m, 2H, 1-,2-H), 2.15 (d, 
J = 3.2 Hz, 1H)/2.10 (d, J = 3.5 Hz, 1H) (1-,2-OH), 2.00–1.91 (m, 2H)/1.73–1.46 (m, 2H, 
3-,4-,5-,6-H), 1.40–1.24 (m, 1H, 5-H), 1.09–0.92 (m, 2H, 3-,6-H), 0.94 (d, J = 6.4 Hz, 3H, 4-Me). 13C NMR (CDCl3, 
75 MHz): δ 75.5/75.0 (2d, C-1,-2), 41.3/32.8 (2t, C-3,-6), 32.1 (t, C-5), 31.1 (d, C-4), 21.6 (q, 4-Me). HRMS: 
m/z calculated for C7H14O2: 130.0994 [M]+; Found: 130.1008. 
 
(1S,2R,4R)-4-Methylcyclohexane-1,2-diol (202): 
Colourless solid. [𝛼]  𝐷
26 = +23.2º (c = 0.36, DCM). mp: 88–89 ºC. IR (ATR): ṽ = 3296 (v O–H), 2951 
(v C–H), 1033 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 3.94 (s, 1H, 2-H), 3.66–3.55 (m, 1H, 
1-H), 2.36–2.30 (m, 1H, 2-OH), 2.23 (d, J = 5.6 Hz, 1H, 1-OH), 1.97–1.86 (m, 1H, 3-H) 1.69–1.61 
(m, 1H, 6-H), 1.52–1.12 (m, 5H, 3-,4-,6-H, 5-H2), 0.94 (d, J = 6.2, 3H, 4-Me). 13C NMR (CDCl3, 75 MHz): δ 71.7 (d, 
C-1), 68.5 (d, C-2), 36.9 (t, C-6), 30.9 (d, C-4), 30.3 (t, C-3), 27.3 (t, C-5), 22.0 (q, 4-Me). HRMS: m/z calculated 
for C7H14O2: 130.0994 [M]+; Found: 130.0995.  
 
Diethyl 2,2'-(((1R,2R,4R)-4-methylcyclohexane-1,2-diyl)bis(oxy))diacetate (203): 
Following General Procedure A. Yellow oil, 78% yield. [𝛼]  𝐷
24 = –4.2º (c = 1.07, 
DCM). IR (ATR): ṽ = 1751/1732 (v ester C=O), 1198 (v ester C–O), 1121 (v C–O) 
cm-1. Full structural assignment could not be completed. 1H NMR (CDCl3, 
300 MHz): δ 4.07–3.80 (m, 8H), 3.06–2.90 (m, 2H), 1.82–1.72 (m, 2H), 1.38–1.28 
(m, 1H), 1.20–0.90 (m, 2H), 0.96 (t, J = 7.1 Hz, 6H), 0.75-0.53 (m, 2H), 0.61 (d, J = 6.6 Hz, 3H). 13C NMR (CDCl3, 
75 MHz): δ 170.3, 170.2, 83.2, 82.6, 67.4, 67.4, 59.9, 38.9, 32.0, 30.3, 29.7, 21.0, 13.6. HRMS: m/z calculated for 
C15H26O6: 302.1729 [M]+; Found: 302.1719.  
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(5aR,7R,9aR)-7-Methylhexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (204): 
Following General Procedure B. Colourless solid, 40% yield. [𝛼]  𝐷
26 = –278.1º (c = 1.00, 
DCM). mp: 47–49 ºC. IR (ATR): ṽ = 2945 (v C–H), 1722 (v C=O), 1120 (v C–O) cm-1. 
1H NMR (CDCl3, 300 MHz): δ 4.30 (d, J = 16.6 Hz, 2H, 2-,4-H), 4.24 (d, J = 16.2 Hz, 2H, 
2-,4-H), 3.39–3.25 (m, 2H, 5a-,9a-H), 2.04–1.94 (m, 2H)/1.76–1.66 (m, 1H)/1.62–1.36 (m, 2H)/1.28–0.93 (m, 2H) 
(7-H, 6-,8-,9-H2), 0.97 (d, J = 6.6 Hz, 3H, 7-Me). 13C NMR (CDCl3, 75 MHz): δ 211.6 (s, C-3), 88.3/87.8 (2d, 
C-5a,-9a), 77.2/77.2 (2t, C-2,-4), 39.7/32.6/30.9/30.8 (1d,3t, C-6,-7,-8,-9), 21.5 (q, 7-Me). HRMS: m/z calculated 
for C10H16O3: 184.1099 [M]+; Found: 184.1089. Odour description: Weak, slightly woody odour that is linear upon 
dry-down and displays slightly marine, watery and salty nuances. 
 
Diethyl 2,2'-(((1S,2R,4R)-4-methylcyclohexane-1,2-diyl)bis(oxy))diacetate (205): 
Following General Procedure A. Yellow oil, 23% yield. [𝛼]  𝐷
22 = +4.1º (c = 1.09, 
DCM). IR (ATR): ṽ = 2928 (v C–H), 1750 (v ester C=O), 1197 (v ester C–O), 1117 
(v C–O) cm-1. Full structural assignment could not be completed. 1H NMR (CDCl3, 
300 MHz): δ 4.31–4.12 (m, 8H), 3.94–3.89 (m, 1H), 3.43–3.36 (m, 1H), 2.11–2.02 
(m, 1H), 1.79–1.71 (m, 1H), 1.56–1.21 (m, 11H), 0.94 (d, J = 5.8 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 170.9, 
170.5, 80.7, 74.8, 67.2, 65.3, 60.3, 60.2, 33.8, 31.0, 28.4, 27.7, 21.7, 13.9, 13.9. HRMS: m/z calculated for 
C15H26O6: 302.1729 [M]+; Found: 302.1747. 
 
(5aR,7R,9aS)-7-Methylhexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (206): 
Following General Procedure B. Yellow oil, 8% yield. [𝛼]  𝐷
22  = +176.6º (c = 1.04, DCM). 
IR (ATR): ṽ = 2927 (v C–H), 1721 (v C=O), 1123 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): 
δ 4.43 (d, J = 17 Hz, 1H)/4.25 (d, J = 16.4 Hz, 1H)/4.16 (d, J = 16.4 Hz, 1H)/3.95 (d, J = 
17 Hz, 1H) (2-,4-H2), 3.91–3.80 (m, 2H, 5a-,9a-H), 2.01–1.91 (m, 1H)/1.72 (q, J = 17.9 Hz, 1H)/1.60–1.36 (m, 
4H)/1.26–1.07 (m, 1H) (7-H, 6-,8-,9-H2), 0.98 (d, J = 6.2 Hz, 3H, 7-Me). 13C NMR (CDCl3, 75 MHz): δ 212.0 (s, C-3), 
81.9/78.6 (2d, C-5a,-9a), 77.2/69.9 (2t, C-2,-4), 32.1/31.4/30.5/28.3 (1d,3t, C-6,-7,-8,-9), 22.1 (q, 7-Me). 
HRMS: m/z calculated for C10H16O3: 184.1099 [M]+; Found: 184.1105. Odour description: Odour reminiscent of 
fatty alcohols, especially nonanol, with slightly woody and fruity character and green-rubbery aspects in the 
dry-down.  
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rac-Cyclohex-4-ene-1,2-diol (208):[31] 
To a stirred solution of cyclohexa-1,4-diene (5 g, 62.5 mmol) in DCM (50 mL) at 0 ºC was added 
dropwise mCPBA (14.3 g, 63.75 mmol, ≤77% purity) in DCM (300 mL) over a period of 1 h. After 
addition was complete a 5% aqueous solution of NaHCO3 (175 mL) was added and stirring 
continued for 3 h. The organic layer was then separated and washed with saturated aqueous solutions of 
NaHSO3 (100 mL) and NaHCO3 (100 mL) before being dried (MgSO4) and concentrated under reduced pressure. 
The crude residue was then taken up in THF (425 mL) and cooled to 0 ºC before a 1% H2SO4 solution (425 mL) 
was added dropwise. The resulting solution was then stirred for 4 h at 0 ºC followed by 1 h at RT. The mixture was 
then extracted with EtOAc (3 x 100 mL), the organic extracts pooled, dried (MgSO4) and concentrated under 
reduced pressure. The resulting residue was then recrystallised from EtOAc/hexane to give 
rac-cyclohex-4-ene-1,2-diol (2.39 g, 34%) as a colourless solid. mp: 92–94 ºC. (lit. mp: 95 ºC (EtOAc/hexane)).[31] 
IR (ATR): ṽ = 3318 (v O–H), 1053 (v C–O) cm-1. 1H NMR (d6-DMSO, 300 MHz): δ 5.49–5.47 (m, 2H, 4-,5-H), 4.65–
4.63 (m, 2H, 1-,2-OH), 3.46–3.40 (m, 2H, 1-,2-H), 2.33–2.23 (m, 2H, 3-,6-H), 1.93–1.81 (m, 2H, 3-,6-H). 13C NMR 
(d6-DMSO, 75 MHz): δ 124.6 (2d, C-4,-5), 70.2 (2d, C-1,-2), 32.9 (2t, C-3,-6). HRMS: m/z calculated for C6H10O2: 
114.0681 [M]+; Found: 114.0681. 
 
meso-Cyclohex-4-ene-1,2-diol (209): 
Following General Procedure E. Colourless solid, 46% yield. mp: 77–78 ºC. IR (ATR): ṽ = 3244 
(v C–H), 1057 (C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.64–5.55 (m, 2H, 4-,5-H), 3.99–3.92 
(m, 2H, 1-,2-H), 2.44–2.20 (m, 4H, 3-,6-H2), 2.09 (s, 2H, 1-,2-OH). 13C NMR (CDCl3, 75 MHz): 
δ 123.6 (2d, C-4,-5), 68.8 (2d, C-1,-2), 30.8 (2t, C-3,-6).  
 
rac-Diethyl 2,2'-(cyclohex-4-ene-1,2-diylbis(oxy))diacetate (210): 
Following General Procedure A. Yellow oil, 34% yield. IR (ATR): ṽ = 1750 (v ester 
C=O), 1198 (v ester C–O), 1121 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.55–
5.52 (m, 2H, 4’-,5’-H), 4.36 (d, J = 16.6 Hz, 2H)/4.29 (d, J = 16.4 Hz, 2H)/4.21 (q, 
J = 7 Hz, 4H) (2-,3-,1’’-,3’’-H2), 3.69–3.61 (m, 2H, 1’-,2’-H), 2.64–2.53 (m, 2H, 
3’-,6’-H), 2.22–2.10 (m, 2H, 3’-,6’-H), 1.29 (t, J = 7.1 Hz, 6H, 4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 170.3 (2s, 
C-1,-2’’), 123.5 (2d, C-4’,-5’), 79.0 (2d, C-1’,-2’), 67.6/60.1 (4t, C-2,-3,-1’’,-3’’), 30.6 (2t, C-3’,-6’), 13.7 (2q, C-4,-4’’). 
HRMS: m/z calculated for C14H22O6: 286.1416 [M]+; Found: 286.1424. 
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rac-5a,6,9,9a-Tetrahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (211): 
Following General Procedure B. Colourless solid, 39% yield. mp: 63–64 ºC. IR (ATR): 
ṽ = 1722 (v C=O), 1132 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.57–5.55 (m, 2H, 
7-,8-H), 4.37 (d, J = 16.4 Hz, 2H, 2-,4-H), 4.26 (d, J = 16.4 Hz, 2H, 2-,4-H), 3.70–3.63 (m, 
2H, 5a-,9a-H), 2.59–2.48 (m, 2H, 6-,9-H), 2.26–2.13 (m, 2H, 6-,9-H). 13C NMR (CDCl3, 75 MHz): δ 211.1 (s, C-3), 
124.0 (2d, C-7,-8), 85.0 (2d, C-5a,-9a), 76.7 (2t, C-2,-4), 32.1 (2t, C-6,-9). HRMS: m/z calculated for C9H12O3: 
168.0790 [M]+; Found: 168.0787. Odour description: Very weak to odourless, and uncharacteristic in smell. 
 
meso-Diethyl 2,2'-(cyclohex-4-ene-1,2-diylbis(oxy))diacetate (212): 
Following General Procedure A. Yellow oil, 32% yield. IR (ATR): ṽ = 1749 (v ester 
C=O), 1196 (v ester C–O), 1120 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.62–
5.53 (m, 2H, 4’-,5’-H), 4.33–4.15 (m, 8H, 2-,3-,1’’-,3’’-H2), 3.90–3.84 (m, 2H, 
1’-,2’-H), 2.54–2.25 (m, 4H, 3’-,6’-H2), 1.27 (t, J = 7 Hz, 6H, 4-,4’’-H3). 13C NMR 
(CDCl3, 75 MHz): δ 170.6 (2s, C-1,-2’’), 123.6 (2d, C-4’,-5’), 76.3 (2d, C-1’,-2’), 66.7/60.4 (4q, C-2,-3,-1’’,-3’’), 28.8 
(2t, C-3’,-6’), 13.9 (2t, C-4,-4’’). HRMS: Calculated for C14H22O6Na: 309.1314 [M+Na]+; Found: 309.1675. 
 
meso-5a,6,9,9a-Tetrahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (213): 
Following General Procedure B. Colourless solid, 3% yield. mp: 73–75 ºC. IR (ATR): 
ṽ = 2917 (v C–H), 1720 (v C=O), 1125 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.68–
5.58 (m, 2H, 7-,8-H), 4.43 (d, J = 16.9 Hz, 2H, 2-,4-H), 4.12 (d, J = 16.9 Hz, 2H, 2-,4-H), 
4.07 (t, J = 6.3 Hz, 2H, 5a-,9a-H), 2.65–2.52 (m, 2H 6-,9-H), 2.39–2.26 (m, 2H, 6-,9-H). 13C NMR (CDCl3, 75 MHz): 
δ 211.3 (s, C-3), 123.2 (2d, C-7,-8), 78.2 (2d, C-5a,-9a), 73.9 (2t, C-2,-4), 27.5 (2t, C-6,-9). HRMS: m/z calculated 
for C9H12O3: 168.0786 [M]+; Found: 168.0770. Odour description: Fruity-fatty, slightly animalic odour that also 
recalls dark olives, and upon dry-down becomes more balsamic, fruity and cinnamate-like. Odour threshold: 
297 ng/L air (stan. dev. 125 ng/L air). 
 
Diethyl 2,2'-(((1S,2R)-3-methylcyclohex-3-ene-1,2-diyl)bis(oxy))diacetate (218): 
Following General Procedure A. Yellow oil, 34% yield. [𝛼]  𝐷
19 = –41.1º (c = 1.05, 
DCM). IR (ATR): ṽ = 1750 (v ester C=O), 1198 (v ester C–O), 1106 (v C–O) cm-1. 
1H NMR (CDCl3, 300 MHz): δ 5.53 (s, 1H, 4’-H), 4.49 (d, J = 16.8 Hz, 1H)/4.43 
(d, J = 16.8 Hz, 1H)/4.27–4.07 (m, 6H) (2-,3-,1’’-,3’’-H2), 3.94 (d, J = 3 Hz, 1H)/3.62–
3.55 (m, 1H) (1’-,2’-H), 2.27–2.13 (m, 1H, 5’-H), 2.05–1.89 (m, 2H, 5’-,6’-H), 1.86 (d, J = 1.5 Hz, 3H, 3’-Me), 1.82–
1.70 (m, 1H, 6’-H), 1.32–1.24 (m, 6H, 4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 170.8/170.4 (2s, C-1,-2’’), 132.0 (s, 
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C-3’), 125.5 (d, C-4’), 79.8/77.6 (2d, C-1’,-2’), 69.1/66.0/60.4/60.1 (4t, C-2,-3,-1’’,-3’’), 24.4 (t, C-5), 21.1 (t, C-6), 
20.8 (q, 3’-Me), 13.9/13.9 (2q, C-3,-3’’). HRMS: Calculated for C15H24O6Na: 323.1471 [M+Na]+; Found: 323.1542. 
 
(5aS,9aR)-9-Methyl-5a,6,7,9a-tetrahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (219): 
Following General Procedure B. Colourless solid, 34% yield. [𝛼]  𝐷
22 = –2.8º (c = 1.38, DCM). 
mp: 29–31 ºC. IR (ATR): ṽ = 1729 (v C=O), 1122 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): 
δ 5.75–5.70 (m, 1H, 8-H), 4.43–3.95 (m, 6H, 5a-,9a-H,2-,4-H2), 2.34–2.20 (m, 1H, 7-H), 
2.09–1.93 (m, 2H, 7-,6-H), 1.76–1.73 (m, 3H, 9-Me), 1.72–1.59 (m, 1H, 6-H). 13C NMR (CDCl3, 75 MHz): δ 211.8 
(s, C-3), 130.8 (s, C-9), 128.3 (d, C-8), 80.7/79.6 (2d, C-5a,-9a), 73.9/73.3 (2t, C-2,-4), 24.2 (t, C-6), 22.9 (t, C-7), 
19.8 (q, 9-Me). HRMS: m/z calculated for C10H14O3: 182.0943 [M]+; Found: 182.0948. Odour description: Weak, 
slightly green odour with a Folrosia (4-(1-methylethyl)cyclohexan-1-ol) effect. 
 
Synthesis of benzoylated diols 220 and 221:[35] 
To a solution of (1S,2R)-3-methylcyclohex-3-ene-1,2-diol (4 g) in EtOH (85 mL) and EtOAc (400 mL) was added 
Pd/C (700 mg) and the solution stirred under an atmosphere of H2 for 4 h. The solution was then filtered, 
concentrated under reduced pressure and the resulting residue purified by flash chromatography on silica gel 
(EtOAc/hexane; 4:6) to yield an unseperatable diastereomeric mixture. This crude residue was taken up in 
pyridine (65 mL), cooled to 0 ºC and benzoyl chloride (6.24 mL, 53.74 mmol, 1.2 equiv) was added and the reaction 
left to stir overnight at RT. The reaction was then diluted with Et2O, washed with H2O (2 x 70 mL), washed with a 
saturated aqueous solution of CuSO4 (6 x 70 mL), dried (MgSO4) and concentrated under reduced pressure to 
yield a crude oil which was subsequently purified by flash chromatography on silica gel (EtOAc/hexane; 1:9) to 
yield (1S,2R,3S)-2-Hydroxy-3-methylcyclohexyl benzoate and (1S,2R,3R)-2-hydroxy-3-methylcyclohexyl benzoate 
in 46% combined yield.  
 
(1S,2R,3S)-2-Hydroxy-3-methylcyclohexyl benzoate (220):[35] 
Yellow oil. [𝛼]  𝐷
21 = +65.8º (c = 1.06, DCM). IR (ATR): ṽ = 3485 (v O–H), 2932 (v C–H), 
1698 (v ester C=O), 1269 (v ester C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 8.08 (d, 
J = 6.9 Hz, 2H, 3’-,7’-H), 7.62–7.54 (m, 1H, 5’-H), 7.51–7.41 (m, 2H, 4’-,6’-H), 4.80 (dd, 
J = 10.3, 2.6 Hz, 1H, 2-H), 4.20–4.15 (m, 1H, 1-H), 2.29–2.12 (m, 1H, 3-H), 1.95–1.43 
(m, 5H)/1.30–1.06 (m, 2H) (2-OH, 4-,5-,6-H2), 0.96 (d, J = 6.6 Hz, 3H, 3-Me). 13C NMR (CDCl3, 75 MHz): δ 165.8 
(s, C-1’), 132.5 (d, C-5’), 129.9 (s, C-2’), 129.2 (2d, C-3’,-7’), 127.9 (2d, C-4’,-6’), 80.3 (d, C-2), 67.1 (d, C-1), 
32.3/30.8/30.5/18.7 (1d,3t, C-3,-4,-5,-6), 17.7 (q, 3-Me).  
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 (1S,2R,3R)-2-Hydroxy-3-methylcyclohexyl benzoate (221):[35] 
Colourless solid. [𝛼]  𝐷
23 =–9.7º (c = 0.99, DCM). mp: 84–85 ºC. (lit. mp: 84–85 ºC).[35] 
IR (ATR): ṽ = 3540 (v C–H), 1692 (v C=O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 8.08–
8.03 (m, 2H, 3’-,7’-H), 7.61–7.54 (m, 1H, 5’-H), 7.50–7.42 (m, 2H, 4’-,6’-H), 5.04–4.97 
(m, 1H)/3.99 (q, J = 2.3 Hz, 1H) (1-,2-H), 1.95–1.64 (m, 5H)/1.50–1.35 (m, 3H) (2-OH, 
3-H,4-,5-,6-H2), 1.06 (d, J = 6.8 Hz, 3H, 3-Me). 13C NMR (CDCl3, 75 MHz): δ 165.6 (s, C-1’), 132.6 (d, C-5’), 130.1 
(s, C-2’), 129.3 (2d, C-3’,-7’), 128.0 (2d, C-4’,-6’), 76.2/71.3 (2d, C-1,-2), 35.3/26.3/24.3/23.1 (1d,3t, C-3,-4,-5,-6), 
17.7 (q, 3-Me).  
 
Method of debenzoylation of compounds 220 and 221:[35] 
To a solution of the monobenzoate (4 g) in MeOH (40 ml) was added a 10 M solution of NaOH (4 mL) and the 
solution held at reflux for 1 h. The solvent was then removed under reduced pressure and the crude residue taken 
up in H2O (100 mL), saturated with NaCl and extracted with EtOAc (5 x 100 mL). The organic extracts were pooled, 
dried (MgSO4) and concentrated under reduced pressure to yield the corresponding cis-diol compound. 
 
(1S,2R,3S)-3-Methylcyclohexane-1,2-diol (222):[35] 
Colourless solid. [𝛼]  𝐷
22 = +54.2º (c = 1.06, CHCl3). mp: 69-70 ºC. IR (ATR): ṽ = 3315 (v O–H), 2943 
(v C–H), 1059 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 3.99–3.94 (m, 1H, 1-H), 3.22–3.15 (m, 
1H, 2-H), 2.05–1.86 (m, 3H, 1-,2-OH, 4-H), 1.83–1.38 (m, 5H, 3-H,5-,6-H2), 1.06–0.92 (m, 1H, H-4), 
1.01 (d, J = 6.6 Hz, 3H, 3-Me). 13C NMR (CDCl3, 75 MHz): δ 77.3 (d, C-2), 69.5 (d, C-1), 33.0 (d, C-3), 32.3 (t, C-4), 
31.1 (t, C-6), 19.1 (t, C-5), 18.2 (q, 3-Me). HRMS: m/z calculated for C7H14O2: 130.0994 [M]+; Found: 130.0988.  
 
(1S,2R,3R)-3-Methylcyclohexane-1,2-diol (223):[35] 
Yellow oil. [𝛼]  𝐷
22 = +1.1º (c = 1.03, CHCl3). IR (ATR): ṽ = 3375 (v O–H), 2929 (v C–H), 975 (v C–O) 
cm-1. 1H NMR (CDCl3, 300 MHz): δ 3.75 (s, 1H, 2-H), 3.60–3.50 (m, 1H, 1-H), 2.36 (s, 1H)/2.21 (s, 
1H) (1-,2-OH), 1.75–1.62 (m, 2H)/1.59–1.44 (m, 2H)/1.34–1.19 (m, 3H) (3-H, 4-,5-,6-H2), 1.02 (d, 
J = 6.8 Hz, 3H, 3-Me). 13C NMR (CDCl3, 75 MHz): δ 73.7 (d, C-2), 72.6 (d, C-1), 35.3 (d, C-3), 27.8 (t, C-6), 
26.6/23.5 (2t, C-4,-5), 18.0 (q, 3-Me). HRMS: m/z calculated for C7H14O2: 130.0994 [M]+; Found: 130.1012. 
 
(5aR,6S,9aS)-6-Methyl-3-methyleneoctahydro-2H-benzo[b][1,4]dioxepine (224): 
Following General Procedure C. Yellow oil, 65% yield. [𝛼]  𝐷
24 = +137.4 (c = 1.09, DCM). 
IR (ATR): ṽ = 2929 (v C–H), 1109 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.00/4.92 
(2s, 2H, =CH2), 4.49–4.02 (m, 4H, 2-,4-H2), 3.82–3.77 (m, 1H, 9a-H), 3.29–3.23 (m, 1H, 
5a-H), 2.26–2.10 (m, 1H, 6-H), 1.95–1.84 (m, 1H, 9-H), 1.82–1.71 (m, 1H, 7-H), 1.65–1.37 (m, 3H, 9-H,8-H2), 1.08–
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0.94 (m, 1H, 7-H), 0.97 (d, J = 6.6 Hz, 3H, 6-Me). 13C NMR (CDCl3, 75 MHz): δ 148.4 (s, C-3), 111.0 (t, =CH2), 
83.5 (d, C-5a), 79.0 (d, C-9a), 72.1/65.9 (2q, C-2,-4), 33.1 (t, C-7), 31.2 (t, C-9), 29.0 (d, C-6), 19.8 (t, C-8), 17.9 
(q, 6-Me). HRMS: m/z calculated for C11H18O2: 182.1306 [M]+; Found: 182.1303. 
 
(5aR,6S,9aS)-6-Methylhexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (225): 
Following General Procedure D. Colourless solid, 58% yield. [𝛼]  𝐷
23 = +213.1º (c = 1.08, 
DCM). mp: 47–49 ºC. IR (ATR): ṽ = 2937 (v C–H), 1722 (v C=O), 1114 (v C–O) cm-1. 1H NMR 
(CDCl3, 300 MHz): δ 4.45–3.91 (m, 4H, 2-,4-H2), 3.90–3.86 (m, 1H, 9a-H), 3.44 (dd, J = 10.5, 
2.6 Hz, 1H, 5a-H), 2.30–2.14 (m, 1H, 6-H), 2.04–1.93 (m, 1H, 9-H), 1.87–1.77 (m, 1H, 7-H), 1.60–1.42 (m, 3H, 9-H, 
8-H2), 1.15–0.96 (m, 1H, 7-H), 0.98 (d, J = 6.4 Hz, 3H, 6-Me). 13C NMR (CDCl3, 75 MHz): δ 212.0 (s, C-3), 84.4 (d, 
C-5a), 82.7 (d, C-9a), 76.9/69.8 (2t, C-2,-4), 32.9 (t, C-7), 31.2 (t, C-9), 28.1 (d, C-6), 19.8 (t, C-8), 17.5 (q, 6-Me). 
HRMS: m/z calculated for C10H16O3: 184.1099 [M]+; Found: 184.1105. Odour description: Weak, green-rubbery 
odour with a marine effect. Odour threshold: 297 ng/L air (stan. dev. 188 ng/L air). 
 
(5aR,6R,9aS)-6-Methyl-3-methyleneoctahydro-2H-benzo[b][1,4]dioxepine (226): 
Following General Procedure C. Yellow oil, 42% yield. [𝛼]  𝐷
23 = –92.9º (c = 1.14, DCM). 
IR (ATR): ṽ = 2929 (v C–H), 1116 (v C–O), 902 (v C=CH2) cm-1. 1H NMR (CDCl3, 
300 MHz): δ 5.03–5.00 (m, 1H)/4.96–4.93 (m, 1H) (=CH2), 4.49–4.34 (m, 2H)/4.15–4.04 
(m, 2H) (2-,4-H2), 3.69–3.62 (m, 1H)/3.55–3.52 (m, 1H) (5a-,9a-H), 2.05–1.88 (m, 1H)/1.82–1.73 (m, 1H)/1.59–
1.45 (m, 2H)/1.36–1.17 (m, 3H) (6-H, 7-,8-,9-H2), 0.97 (d, J = 6.8 Hz, 3H, 6-Me). 13C NMR (CDCl3, 75 MHz): δ 148.4 
(s, C-3), 111.7 (t, =CH2), 82.9/78.7 (2d, C-5a,-9a), 73.2/65.9 (2t, C-2,-4), 35.6 (d, C-6), 27.5/24.0/23.9 (3t, 
C-7,-8,-9), 17.5 (q, 6-Me). HRMS: m/z calculated for C11H18O2: 182.1306 [M]+; Found: 182.1304.  
 
(5aR,6R,9aS)-6-Methylhexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (227): 
Following General Procedure D. Yellow oil, 66% yield. [𝛼]  𝐷
24 = –167.2º (c = 1.03, DCM). 
IR (ATR): ṽ = 2932 (v C–H), 1722 (v C=O), 1123 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): 
δ 4.51–3.94 (m, 4H, 2-,4-H2), 3.88–3.81 (m, 1H, 9a-H), 3.64–3.61 (m, 1H, 5a-H), 2.06–1.92 
(m, 1H, 9-H), 1.90–1.81 (m, 1H, 8-H), 1.66–1.52 (m, 2H, 6-,9-H), 1.42–1.13 (m, 3H, 8-H, 7-H2), 1.01 (d, J = 6.8 Hz, 
3H, 6-Me). 13C NMR (CDCl3, 75 MHz): δ 212.1 (s, C-3), 86.7 (d, C-5a), 79.3 (d, C-9a), 77.7/69.8 (2t, C-2,-4), 35.6 
(d, C-6), 27.5 (t, C-7), 23.7 (t, C-8), 22.9 (t, C-9), 17.5 (q, 6-Me). HRMS: m/z calculated for C10H16O3: 184.1099 [M]+; 
Found: 184.1096. Odour description: Weak, green, slightly oily medicinal odour reminiscent of the medicinal 
aspects of Calone 1951®, but also with marine facets of Calone 1951®. Odour threshold: 177 ng/L air (stan. dev. 
72 ng/L air). 
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(1S,2S)-Diethyl 2,2'-((3-Bromocyclohex-3-ene-1,2diyl)bis(oxy))diacetate (229):  
Following General Procedure A, but instead held at reflux for 1 h. Yellow oil, 27% 
yield. [α]
23
𝐷
 = –25.5 (c = 0.91, CH2Cl2). IR (ATR): ṽ = 2924 (v C–H), 1749 (v ester 
C=O), 1201 (v ester C–O), 1123 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 6.23–
6.18 (m, 1H, 4’-H), 4.53 (d, J = 16.4 Hz, 1H)/4.45 (d, J = 16.4 Hz, 1H)/4.32–4.10 (m, 7H) (2’-H, 2-,3-,1’’-,3’’-H2), 
3.79–3.71 (m, 1H, 1’-H), 2.36–2.23 (m, 1H, 5’-H), 2.14–1.96 (m, 2H, 5’-,6’-H), 1.90–1.78 (m, 1H, 6’-H), 1.34–1.24 
(m, 6H, 4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 170.2/169.9 (2s, C-1,-2’’), 133.3 (d, C-4’), 118.3 (s, C-3’), 79.3/78.9 
(2d, C-1’,-2’), 69.3/66.3 (2t, C-2,-1’’), 60.4/60.3 (2t, C-3,-3’’), 25.7 (t, C-5’), 21.2 (t, C-6’), 13.9/13.8 (2q, C-4,-4’’). 
HRMS: m/z calculated for C14H22BrO6: 365.0599 [M+H]+; Found: 365.0569.  
 
(5aS,9aS)-9-Bromo-5a,6,7,9a-tetrahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (230): 
Following General Procedure B. Yellow oil, 20% yield. IR (ATR): ṽ = 2925 (v C–H), 1726 
(v C=O), 1126 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 6.46–6.60 (m, 1H, 8-H), 4.48–
4.00 (m, 6H, 5a-,9a-H, 2-,4-H2), 2.45–2.30 (m, 1H, 7-H), 2.14–2.00 (m, 2H, 6-,7-H), 1.82–
1.67 (m, 1H, 6-H). 13C NMR (CDCl3, 75 MHz): δ 210.9 (s, C-3), 136.1 (d, C-8), 119.1 (s, C-9), 80.5/80.2 (2d, 
C-5a,-9a), 74.5/72.8 (2t, C-2,-4), 24.9/24.2 (2t, C-6,-7). HRMS: m/z calculated for C9H11BrO3: 245.9892 [M]+; 
Found: 245.9884. Odour description: Salty, seawater, algae, solvent-like and chemical aspects. 
 
(1S,2S)-Diethyl 2,2'-((3-Iodocyclohex-3-ene-1,2-diyl)bis(oxy))diacetate (232):  
Following General Procedure A, but instead held at reflux for 1 h. Yellow oil, 
30% yield. [α]
23
𝐷
 = –64.3 (c = 0.56, CH2Cl2). IR (ATR): ṽ = 2930 (v C–H), 1748 
(v ester C=O), 1200 (v ester C–O), 1122 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): 
δ 6.50–6.46 (m, 1H, 4’-H), 4.52 (d, J = 16.2 Hz, 1H)/4.43 (d, J = 16.2 Hz, 1H)/4.27–4.10 (m, 7H) (2’-H, 
2-,3-,1’’-,3’’-H2), 3.82–3.76 (m, 1H, 1’-H), 2.37–2.24 (m, 1H, 5’-H), 2.15–1.98 (m, 2H, 5’-,6’-H), 1.90–1.80 (m, 1H, 
6’-H), 1.33–1.24 (m, 6H, 4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 170.4/170.1 (2s, C-1,-2’’), 141.6 (d, C-4’), 93.0 (s, 
C-3’), 82.0/78.9 (2d, C-1’,-2’), 69.8/66.5 (2t, C-2,-1’’), 60.7/60.5 (2t, C-3,-3’’), 27.8 (t, C-5’), 21.3 (t, C-6’), 14.1/14.0 
(2q, C-4,-4’’). HRMS: m/z calculated for C14H22IO6: 413.0461 [M+H]+; Found: 413.0404. 
 
(5aS,9aS)-9-Iodo-5a,6,7,9a-tetrahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (233): 
Following General Procedure B. Yellow oil, 23% yield. [α]
23
𝐷
 = +95.5 (c = 0.75, CH2Cl2). 
IR (ATR): ṽ = 2919/2889 (v C–H), 1725 (v C=O), 1122 (v C–O) cm–1. 1H NMR (CDCl3, 
300 MHz): δ 6.75–6.68 (m, 1H, 8-H), 4.44–3.97 (m, 6H, 5a-,9a-H, 2-,4-H2), 2.45–2.31 (m, 
1H, 7-H), 2.15–1.95 (m, 2H, 6-,7-H), 1.83–1.71 (m, 1H, 6-H). 13C NMR (CDCl3, 75 MHz): δ 211.0 (s, C-3), 144.4 
 Synthesis of Additional Analogues of the Aliphatic Benzo[b][1,4]dioxepin-3-one System 
 
144 
 
(d, C-8), 95.7 (s, C-9), 81.9/80.8 (2d, C-5a,-9a), 74.6/72.4 (2t, C-2,-4), 25.7/25.1 (2t, C-6,-7). HRMS: m/z calculated 
for C9H11IO3: 293.9753 [M]+; Found: 293.9725. Odour description: Marine, salty, seawater, iodine effect, medicinal, 
slightly spicy, chemical aspects. 
 
(5aS,9aR)-9-Phenyl-5a,6,7,9a-tetrahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (236): 
Nitrogen gas was bubbled through a mixture of dimethoxyethane (15 mL) and 2 M Na2CO3 
(5 mL) for 1 h before (5aS,9aS)-9-iodo-5a,6,7,9a-tetrahydro-2H-benzo[b][1,4]dioxepin-
3(4H)-one (55 mg, 0.188 mmol), phenylboronic acid (27 mg, 0.226 mmol, 1.2 equiv) and 
Pd(PhP3)4 (50 mg) was added and the reaction mixture heated to 90 ºC overnight. The 
reaction was then diluted with H2O (100 mL), extracted with EtOAc (3 x 50 mL), the organic 
extracts pooled, dried (MgSO4) and concentrated under reduced pressure. The resulting residue was purified by 
flash chromatography on silica gel (EtOAc/hexane; 15:85) to yield (5aS,9aR)-9-phenyl-5a,6,7,9a-tetrahydro-2H-
benzo[b][1,4]dioxepin-3(4H)-one (33 mg, 72%) as a yellow oil. [α]
23
𝐷
 = –30.7 (c = 0.23, CH2Cl2). IR (ATR): ṽ = 2923 
(v C–H), 1724 (v C=O), 1126 (v C–O). 1H NMR (CDCl3, 300 MHz): δ 7.38–7.15 (m, 5H), 6.25–6.18 (m, 1H), 4.42–
4.04 (m, 4H), 2.52–2.36 (m, 1H), 2.29–2.06 (m, 2H), 1.80–1.66 (m, 1H). 13C NMR (CDCl3, 75 MHz): δ 211.7, 139.2, 
135.2, 130.9, 128.4, 127.3, 125.8, 79.6, 78.7, 74.1, 73.2, 23.8. HRMS: m/z calculated for C15H16O3: 224.1099 [M]+; 
Found: 224.1115. 
 
(1R,2S,3R,4S)-Bicyclo[2.2.1]heptane-2,3-diol (238): 
Following General Procedure E. Colourless solid, 82% yield. mp: 138–140 ºC. IR (ATR): ṽ = 3239 
(v O–H), 2949 (v C–H), 1059 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 3.68 (d, J = 1.1 Hz, 2H, 
2-,3-H), 2.99 (s, 2H, 2-,3-OH), 2.17–2.10 (m, 2H, 1-,4-H), 1.80–1.73 (m, 1H, 7-H), 1.52–1.41 (m, 
2H, 5-,6-H), 1.15–1.01 (m, 3H, 5-,6-,7-H). 13C NMR (CDCl3, 75 MHz): δ 74.3 (2d, C-2,-3), 42.6 (2d, C-1,-4), 31.4 
(t, C-7), 24.3 (2t, C-5,-6). HRMS: m/z calculated for C7H12O2: 128.0837 [M]+; Found: 128.0842. 
 
(5aR,6S,9R,9aS)-3-Methyleneoctahydro-2H-6,9-methanobenzo[b][1,4]dioxepine (239): 
Following General Procedure C. Clear oil, 56% yield. IR (ATR): ṽ = 2956/2872 (v C–H), 
1107 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 5.03 (s, 2H, =CH2), 4.50 (d, J = 13.2 Hz, 
2H, 2-,4-H), 4.04 (d, J = 13.0 Hz, 2H, 2-,4-H), 3.43 (d, J = 1.3 Hz, 2H, 5a-,9a-H), 2.22–
2.18 (m, 2H, 6-,9-H), 1.93–1.86 (m, 1H, 10-H), 1.51–1.41 (m, 2H, 7-,8-H), 1.11–1.01 (m, 3H, 7-,8-,10-H). 13C NMR 
(CDCl3, 75 MHz): δ 144.7 (s, C-3), 115.1 (t, =CH2), 85.7 (2d, C-5a,-9a), 74.9 (2t, C-2,-4), 41.9 (2d, C-6,-9), 33.0 
(t, C-10), 24.3 (2t, C-7,-8). HRMS: m/z calculated for C11H16O2: 180.1150 [M]+; Found: 180.1165. 
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(5aR,6S,9R,9aS)-Hexahydro-2H-6,9-methanobenzo[b][1,4]dioxepin-3(4H)-one (240): 
Following General Procedure D. Colourless solid, 62% yield. mp: 82–85 ºC. IR (ATR): 
ṽ = 2968/2950/2876 (v C–H), 1709 (v C=O), 1157/1139 (v C–O) cm–1. 1H NMR (CDCl3, 
300 MHz): δ 4.61–4.53 (m, 2H, 2-,4-H), 4.19–4.11 (m, 2H, 2-,4-H), 3.56–3.53 (m, 2H, 
5a-,9a-H), 2.33–2.29 (m, 2H, 6-,9-H), 2.03–1.97 (m, 1H, 10-H), 1.57–1.47 (m, 2H, 7-,8-H), 1.22–1.15 (m, 1H, 10-H), 
1.14–1.05 (m, 2H, 7-,8-H). 13C NMR (CDCl3, 75 MHz): δ 212.9 (s, C-3), 86.4 (2d, C-5a,-9a), 79.0 (2t, C-2,-4), 42.1 
(2d, C-6,-9), 32.9 (t, C-10), 24.2 (2t, C-7,-8). HRMS: m/z calculated for C10H14O3: 182.0943 [M]+; Found: 182.0957. 
Odour description: Very weak, slightly agrestic and terpenic, slightly mouldy. 
 
(1R,2S,4R,5S)-3-Oxatricyclo[3.2.1.02,4]octane (241): 
mCPBA (2.15 g, 9.56 mmol, ≤77% purity) in DCM (50 mL) was added dropwise to a solution of 
norbornene (882 mg, 9.38 mmol) in DCM (20 mL) at 0 ºC over 0.5 h. After addition was complete, 
a 5% aqueous solution of NaHCO3 (30 mL) was added and stirring continued at 0 ºC for 3 h. The mixture was then 
transferred to a separatory funnel, the layers separated and the organic layer washed with a saturated aqueous 
solution of NaHSO3 (15 mL), dried (MgSO4) and concentrated under reduced pressure to yield 
(1R,5S)-3-oxatricyclo[3.2.1.02,4]octane (quant.) as a clear oil. 1H NMR (CDCl3, 300 MHz): δ 3.07 (s, 2H), 2.45 
(s, 2H), 1.55–1.43 (m, 2H), 1.36–1.28 (m, 1H), 1.27–1.17 (m, 2H), 0.73–0.68 (m, 1H). 13C NMR (CDCl3, 75 MHz): 
δ 51.3, 36.5, 26.1, 25.0.  
 
meso-Cyclooctane-1,2-diol (246): 
Following General Procedure E. Colourless solid, 69% yield. mp: 78–80 ºC. IR (ATR): ṽ = 3268 
(v O–H), 2909 (v C–H), 1032 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 3.96–3.86 (m, 2H, 
1-,2-H), 2.10 (bs, 2H, 1-,2-OH), 1.99–1.82 (m, 2H, 3-,8-H), 1.78–1.61 (m, 4H, 3-,4-,7-,8-H ), 
1.61–1.43 (m, 6H, 4-,7-H,5-,6-H2). 13C NMR (CDCl3, 75 MHz): δ 72.8 (2d, C-1,-2), 29.8 (2t, C-3,-8), 26.1 (2t, C-5,-6), 
23.5 (2t, C-4,-7). HRMS: m/z calculated for C8H16O2: 144.1150 [M]+; Found: 144.1151.  
 
meso-3-Methylenedecahydro-2H-cycloocta[b][1,4]dioxepine (247): 
Following General Procedure C. Clear oil, 58% yield. IR (ATR): ṽ = 2917 (v C–H), 1091 
(v C–O), 899 (v C=CH2) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.96–4.93 (m, 2H, =CH2), 
4.40 (d, J = 14.3 Hz, 2H, 2-,4-H), 4.12 (d, J = 14.3 Hz, 2H, 2-,4-H), 3.87–3.80 (m, 2H, 
5a-,11a-H), 2.03–1.86 (m, 2H, 6-,11-H), 1.80–1.41 (m, 10H, 6-,11-H, 7-,8-,9-,10-H2). 13C NMR (CDCl3, 75 MHz): 
δ 148.2 (s, C-3), 110.8 (t, =CH2), 80.9 (2d, C-5a,-11a), 69.6 (2t, C-2,-4), 27.9 (2t, C-6,-11), 25.8/23.8 (4t, 
C-7,-8,-9,-10). HRMS: m/z calculated for C12H21O2: 197.1541 [M+H]+; Found: 197.1516. 
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meso-Octahydro-2H-cycloocta[b][1,4]dioxepin-3(4H)-one (248): 
Following General Procedure D. Clear oil, 51% yield. IR (ATR): ṽ = 2921 (v C–H), 1725 
(v C=O), 1127 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.38 (d, J = 16.8 Hz, 2H, 
2-,4-H), 4.02 (d, J = 17.1 Hz, 2H, 2-,4-H). 3.97 (d, J = 10.0 Hz, 2H, 5a-,11a-H), 2.04–1.88 
(m, 2H, 6-,11-H), 1.83–1.42 (m, 10H, 6-,11-H, 7-,8-,9-,10-H2). 13C NMR (CDCl3, 75 MHz): δ 212.3 (s, C-3), 83.3 
(2d, C-5a,-11a), 73.5 (2t, C-2,-4), 27.3 (2t, C-6,-11), 25.4/24.0 (4t, C-7,-8,-9,-10). HRMS: m/z calculated for 
C11H18O3: 198.1256 [M]+; Found: 198.1250. Odour description: Odourless.  
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Chapter 4 – Synthesis of 2-Substituted and 2,3-Annulated 1,4-Dioxepan-6-ones 
 
4.1 – Introduction 
4.1.1 – Terpenoids and Molecular Fusion  
Terpenes, also known as isoprenoids, are a large and diverse class of organic compounds that are 
assembled biosynthetically from multiple units of isoprene (249). The monomeric isoprene unit itself 
does not undergo the enzyme-catalysed synthetic process, but instead activated isoprene units such 
as isopentenyl pyrophosphate (IPP, 250) and dimethylallyl pyrophosphate (DMAPP, 251) are used 
(Figure 4.1).[1] These monomeric units are combined to form intermediates such as geranyl 
pyrophosphate (GPP, 252) and farnesyl pyrophosphate (FPP, 253), which are then further reacted to 
yield a multitude of different compounds. 
 
 
 
Figure 4.1: Biosynthetic intermediates leading to terpene and terpenoid compounds.  
 
When terpene compounds are modified chemically, such as by enzyme-catalysed oxidation or 
rearrangement reactions, the resulting compounds are referred to as terpenoids. More than 30,000 
terpene and terpenoid molecules have been isolated from plants, microorganisms and animals. [2] 
Molecules that are formed from the modification of a single isoprene unit are known as 
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hemiterpenenoids, molecules formed by the addition of two isoprene units are called 
monoterpenes/monoterpenoids, and molecules formed by the addition of three isoprene units are called 
sesquiterpenes/sesquiterpenoids.[2] Terpenes and terpenoids are important constituents of essential 
oils, although higher terpene and terpenoid compounds (those made from four isoprene units or more) 
are generally not found in essential oils.[2] Shown in Figure 4.2 is the structure and natural source of a 
variety of terpene and terpenoid odorant compounds. 
 
 
Figure 4.2: Various terpene and terpenoid odorants, and their natural source and abundance.[3] 
 
A recent publication by Kraft et al.[4] described efforts into merging marine and musk odorant notes by 
the fusion of the molecular structure of Calone 1951® (50) with that of the polycyclic musk odorant 
Galaxolide® (65) (Figure 4.3). Disappointingly the synthetic analogues were discovered not to contain 
musk notes but instead incorporated marine notes with additional floral aspects.[4] Analogous to this 
concept, attempts were made to synthetically merge marine notes with those of naturally occurring 
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odorant molecules by the fusion of 1,4-dioxepan-6-one heterocyclic ring systems onto substituted 
cyclohexyl terpenoid compounds such as carvone, carvotanacetone, limonene, camphor, pinene and 
menthol.  
 
Figure 4.3: Molecular structure amalgamation of marine odorant Calone 1951® (50) and musk 
 odorant Galaxolide® (65).[4]  
 
4.1.2 – The Seco Synthetic Technique 
The organic chemistry term seco is defined by IUPAC as ‘the cleavage of a ring with addition of one or 
more hydrogen atoms at each terminal group’.[5] The seco analysis of a given molecular structure can 
include the cleavage of chemical bonds between scaffold atoms or the complete removal of scaffold 
atoms from the molecular structure. Perhaps the most well-known example of a seco molecule is the 
secosteroid known as vitamin D (Figure 4.4). This compound is produced photochemically in the 
epidermis from the steroid molecule 7-dehydrocholesterol (260) by the cleavage of the 
9,10 carbon−carbon bond of ring B. This gives a compound known as previtamin D3 which then 
undergoes a 1,7-sigmatropic hydrogen transfer from C–19 to C–9 to yield vitamin D3 (261), as shown 
in Figure 4.4.[6] 
 
 
Figure 4.4: Molecular structures of 7-dehydrocholesterol (260) and cholecalciferol (vitamin D3, 261).  
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The seco principle for targeted odorant design was first introduced into fragrance chemistry in 1962 by 
Sestanj.[7] The removal of two carbon fragments from the molecular structure of β-ionone (262) led to 
acyclic fragment 263 (Figure 4.5). It was reported that the seco target molecule indeed contained the 
same violet odour notes as lead compound β-ionone (262).[7] It is known that not every carbon atom of 
a lead compound is required to interact with a specific olfactory receptor, especially if the atoms are 
situated in the less specific and more voluminous hydrophobic binding pocket(s) of the receptor.[8] The 
removal of carbon atoms can potentially increase receptor affinity owing to the resulting molecular 
structure having more conformational degrees of freedom, as well as increase the volatility of the 
resulting molecule. These effects can result in the target compound having a lower odour threshold 
value than the lead compound.[8]  
 
 
Figure 4.5: Seco analysis of β-ionone (262) to give molecular fragment 263. 
 
The seco synthetic technique has since been widely used in the production of novel captive odorant 
molecules. For example, the dienone musk 264 is an unusual bicyclic musk odorant that differs from 
other polycyclic musk compounds in that it does not contain an indane or benzenoid motif (Figure 4.6).[9] 
First synthesised by Kula et al.[10] from (+)-carotol, the primary sesquiterpenoid from the essential oil of 
carrot seed, this compound has been the target of multiple analogue studies in the search for new 
odorant molecules.[9, 11-12]  
 
Seco-derivatives of compound 264 were first synthesised by Kraft et al.[11] by the removal of C−2 and 
C−6 atoms to give acyclic analogue 265. This compound was discovered to contain potent musk notes, 
as well as ionone notes, and also had a lower odour threshold value than the parent material. The 
ionone notes were not surprising since this compound featured a (E)-hexa-3,5-dien-2-one backbone, 
structurally resembling the previously synthesised seco-ionone molecules (i.e. 263).[12] Due to the 
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positive outcome of the original research additional seco-analogues of compound 264, such as 
compounds 266 and 267, were synthesised and evaluated in a second study (Figure 4.6).[12] 
 
 
Figure 4.6: Analogues 265–267 synthesised from seco analysis of the molecular structure of lead 
compound 264. 
 
The synthesis of additional modified benzo[b][1,4]dioxepin-3-one systems seemed necessary to 
corroborate the lack of binding and weak odour potency of the aliphatic analogues. It was postulated 
that the removal of part or all of the carbocyclic ring system might help overcome the repulsion of the 
molecules from the olfactory receptor. In addition, owing to the fact that the previously synthesised 
aliphatic analogues had demonstrated a multitude of odorant descriptors, our curiosity was aroused to 
investigate whether other odorant families could perhaps be targeted with 1,4-dioxepan-6-one 
analogues. Some of the analogues can be considered seco derivatives of the original 
7-methylbenzo[b][1,4]dioxepin-3-one molecular structure of Calone 1951® (50), others can be 
considered parent compounds or experimental derivatives (Figure 4.7). 
 
 
Figure 4.7: Seco analysis of 7-methylbenzo[b][1,4]dioxepin-3-one (Calone 1951®, 50).  
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4.2 – Results and Discussion 
4.2.1 – Synthesis of 1,4-Dioxepan-6-one Analogues  
Owing to previous conclusions that the aromatic binding region of the marine odorant receptor may be 
physically repelling the now hydrophobic carbocyclic ring system, the synthesis of a library of 
1,4-dioxepan-6-one analogues was envisioned. The initial synthetic methodology investigated was the 
Dieckmann condensation conditions that were developed during the synthesis of the library of aliphatic 
benzo[b][1,4]dioxepin-3-one analogues described within Chapter 2/3. Etherification of 1,2-ethanediol 
(185) using ethyl diazoacetate and boron trifluoride diethyletherate as a Lewis-acid catalyst readily 
afforded bis-ester compound 268 in 74% yield as a yellow oil (Scheme 4.1). This was an unusually high 
yield for this type of bis-etherification reaction, perhaps attributable to free rotation and therefore less 
steric hindrance of the molecule. 
 
Subsequent Dieckmann condensation reactions of compound 268 were discovered to lead 
predominantly to polymerised materials. The target compound, 1,4-dioxepan-6-one (269), was 
eventually isolated as a clear oil in 2% yield, separated from a thick polymer matrix by flash 
chromatography with careful isolation due to its inherent volatility. The synthesis of compound 269 via 
similar Dieckmann cyclisation methodology had been previously reported in patent literature;[13] the 
authors reported a superior yield of 22%, although it should be noted that the methodology made use 
of the weaker non-nucleophilic base sodium tert-butoxide.  
 
 
Scheme 4.1: Synthesis of 1,4-dioxepan-6-one (269) from 1,2-ethanediol (185), showing free rotation. 
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In consideration of the poor yields achieved by Dieckmann condensation it was questioned if perhaps 
Williamson cyclisation may provide improved yields. Reactions were first trialled with 1,2-ethanediol 
(185) to give a direct comparison between the alternative cyclisation routes. The Williamson reaction 
between 1,2-ethanediol (185) and 3-chloro-2-(chloromethyl)prop-1-ene (194) provided methylene 
analogue 270 in 12% yield, lower than anticipated. Subsequent Katsuki-Sharpless oxidation provided 
1,4-dioxepan-6-one (269) in 92% yield as a clear oil (Scheme 4.2). To be noted is that an analogous 
route of synthesis was developed by Nerdel et al.[14] which made use of an in situ generated alkylating 
agent to give methylene compound 270, followed by ozonolysis to yield 1,4-dioxepan-6-one (269) 
(Figure 2.10). 
 
During the course of investigation it was discovered that a change of reaction solvent from carbon 
tetrachloride to dichloromethane allowed for a more simple isolation of the volatile target materials. 
Although the bis-etherification yield of 1,2-ethanediol (185) was poorer, the overall synthetic pathway 
yield was improved from 1.5% to 11% when compared to the Dieckmann condensation methodologies. 
Using the modified Williamson reaction procedure a variety of substituted 1,4-dioxepan-6-one 
analogues (275−278) were synthesised and their olfactory descriptions, and threshold values where 
applicable, were determined (Scheme 4.2, Figure 4.8). 
 
 
 
Scheme 4.2: Williamson reaction methodology to give 1,4-dioxepan-6-one analogues 269, 275–278. 
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Figure 4.8: Library of 1,4-dioxepan-6-one analogues 269, 275–278 displaying odour descriptors and  
odour thresholds (th) values, where applicable.  
 
Only one bis-hydroxyl precursor (leading to compounds 269, 275–278) was not commercially available. 
Therefore, racemic diol precursor 4-methylpentane-1,2-diol (280) was synthesised from 
4-methyl-1-pentene (279) (Scheme 4.3).[15] The proposed synthetic mechanism involves the in situ 
generation of molecular bromine followed by bromoacetoxylation of the alkene to give a 
trans-1,2-bromoacetate intermediate which is then oxidised to a cyclic intermediate assisted 
anchimerically by the acetate group (Figure 4.9). The cyclic intermediate is then opened by the action 
of acetic acid to furnish the cis-hydroxyl acetate or trans-diacetate compound, with the liberated 
molecular bromine recycled back into the catalytic cycle.[16] The final step involves a methanolic 
potassium carbonate hydrolysis to give racemic diol (±)-280 as a yellow oil. 
 
 
Scheme 4.3: Synthesis of racemic 4-methylpentane-1,2-diol (280) from 4-methyl-1-pentene (279). 
 
 
 CHAPTER 4 
 
159 
  
 
Figure 4.9: Proposed catalytic cycle for the dihydroxylation of alkenes by Sudalai et al.[16] 
 
4.2.2 – 1,4-Dioxepan-6-one/Terpenoid Odorant Fusion – (+)-α-Pinene 
A dioxepanone heterocycle fused analogue of (+)-α-pinene (254) was prepared. Both enantiomers of 
α-pinene have harsh, terpene-like odour with the (+)-enantiomer (254) somewhat more resembling 
fresh mint, whilst the (–)-enantiomer (255) is more coniferous.[17] The two enantiomers constitute the 
major component of turpentine. Dihydroxylation of (+)-α-pinene (254) using the standard osmium 
tetroxide oxidation conditions (4:1; acetone/water at room temperature) gave poor yields, leaving 
increasingly large amounts of starting material as the reaction was upscaled. It appeared that the 
reaction was sluggish, presumably due to steric hindrance, and that a catalytic quantity of osmium would 
not be enough to drive the reaction to completion. 
 
Using catalytic quantities of pyridine in a refluxing solution of tert-butanol/water (5:1) was however found 
to provide cis-diol 281 as a colourless solid in 75% yield after flash chromatography.[18-19] Osmium 
dihydroxylation reactions are accelerated by the addition of tertiary amine compounds such as pyridine 
and quinuclidine in a process known as ligand-accelerated catalysis (Figure 4.10).[20] Asymmetric 
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osmium dihydroxylation reactions have been developed using chiral amine ligands such as derivatives 
of the naturally occurring alkaloids dihydroquinidine (DHQD) and dihydroquinine (DHQ).[21]  
 
 
Figure 4.10: Tertiary amine ligands accelerate the reactivity of osmium tetroxide.[20] 
 
The absolute stereochemistry of cis-diol compound 281 was confirmed by comparison to literature 
data.[18-19, 22] Compound 281 was subjected to Williamson cyclisation with 194 to provide compound 282 
in a poor yield of 13%, presumably due to the additional steric hindrance imposed by the tertiary 
hydroxyl moiety. Ruthenium tetroxide oxidation of 282 furnished 2,3-annulated 1,4-dioxepan-6-one 
analogue 283 in 49% yield as a colourless solid (Scheme 4.4). 
 
 
Scheme 4.4: Synthesis of dioxepanone fused (+)-α-pinene analogue 283 from (+)-α-pinene (254). 
 
Heteronuclear single quantum coherence spectroscopy (1H, 13C HSQC) analysis of compound 283 
revealed that carbon atoms C–2 and C–4 contain protons in rather different environments due to the 
non-symmetrical nature of the molecular structure, presumably exacerbated by the tertiary methyl 
moiety attached to bridging carbon C–5a. The bridging carbon atoms (C–5a/9a) could not be resolved 
by heteronuclear multiple bond correlation spectroscopy (1H, 13C HMBC) due to near 
overlapping 13C signals (δ 80.7 and 80.3 ppm) (Figure 4.11). Signals from the methyl moieties attached 
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to C–7 (δ 27.2 and 23.8 ppm) also exist in different environments relating to the axial and equatorial 
positions of the cyclohexyl ring system.  
 
Figure 4.11: 1H, 13C HSQC (CDCl3, 300 MHz) spectrum of compound 283. 
 
4.2.3 – 1,4-Dioxepan-6-one/Terpenoid Odorant Fusion – (R)-Camphor 
Camphor is a naturally occurring chiral bicyclic terpenoid compound. Both enantiomers give rise to the 
same unique odorant description of camphoraceous, meaning warm-minty, medicinal and somewhat 
ethereal.[23] It should be noted that although both enantiomers are found in nature, (R)-camphor (286) 
is far more abundant.[23] The synthesis of a 1,4-dioxepan-6-one heterocycle fused (R)-camphor 
analogue commenced with the synthesis of para-toluenesulfonylhydrazide (285) from 
para-toluenesulfonyl chloride (284) and aqueous hydrazine hydrate in quantitative yields 
(Scheme 4.5).[24] The following step involved the reaction of (R)-camphor (286) and hydrazide 285 using 
hydrochloric acid as a catalyst to give the corresponding tosylhydrazone 287 as a colourless solid in 
52% yield.[25] This hydrazone compound was then subjected to a Shapiro reaction using two equivalents 
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of methyllithium to provide the volatile bicyclo[2.2.1]hept-2-ene compound 288 in 49% yield after careful 
isolation (Scheme 4.6).[25] 
 
 
Scheme 4.5: Synthesis of para-toluenesulfonylhydrazide (285) from para-toluenesulfonyl chloride (284). 
 
The double bond of compound 288 was subjected to an osmium tetroxide/N-methylmorpholine N-oxide 
(NMO) mediated dihydroxylation reaction to provide cis-diol 289 in 61% yield as a colourless solid and 
as a single stereoisomer (Scheme 4.6). It was expected that both the endo/endo and exo/exo 
stereoisomers could be isolated by this methodology but it was discovered that all that was obtained 
was the exo/exo stereoisomer. The absolute configuration of compound 289 was confirmed by 
comparison to literature.[26] 
 
 
Scheme 4.6: Synthesis of cis-diol compound 289 from (R)-camphor (286) and (–)-camphorquinone (290). 
 
The key transformation in the synthetic sequence, the Shapiro reaction,[27] involves the addition of two 
equivalents of a strong organolithium base to the camphor tosylhydrazone 287. The initiating step 
involves the removal of the proton from the hydrazone, followed by the removal of the proton alpha to 
the hydrazone carbon (Figure 4.12). The molecule then undergoes an elimination reaction to create a 
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carbon–carbon double bond with simultaneous expulsion of the tosyl group and formation of a 
diazonium anion, which eliminates as a neutral nitrogen molecule. The resulting anion is quenched by 
the addition of an electrophile (H2O in the case of compound 287) to provide the alkene. This reaction 
is related to the Bamford-Stevens reaction which involves the addition of a strong base as opposed to 
an organolithium reagent, and is also known to follow a different reaction mechanism. The advantage 
of the Shapiro reaction is that the resulting intermediate compounds do not have the same tendency to 
rearrange.[28] 
 
Figure 4.12: Mechanism of the Shapiro reaction of hydrazone compound 287 to give alkene 288.  
 
An alternative methodology to provide cis-diol 289 starting from (–)-camphorquinone (290) was also 
experimented with. Literature reports that a borohydride reduction of (–)-camphorquinone (290) gives 
the same cis-diol stereoisomer as what was discovered for the reaction sequence beginning with 
(R)-camphor (286).[26] The reaction was discovered to be successful, giving compound 289 in 32% yield 
(Scheme 4.6). The isolated exo,exo-camphor-2,3-diol (289) was subjected to a Williamson reaction with 
194 to afford methylene compound 291 in 69% yield as a clear oil after flash chromatography on silica 
gel. Katsuki–Sharpless oxidation provided 2,3-annulated dioxepanone 292 as a colourless solid in 48% 
yield (Scheme 4.7). 
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Scheme 4.7: Synthesis of dioxepanone fused (R)-camphor analogue 292 from cis-diol compound 289.  
 
An alternative literature procedure could potentially be used to synthesise all four bis-hydroxyl 
stereoisomers from (R)-camphor (286). The methodology requires the formation of an enolate 
intermediate using the strong base lithium diisopropylamide, followed by the addition of a molybdenum 
peroxide reagent (MoOPH) to perform an enolate hydroxylation.[29] The molybdenum reagent can be 
synthesised from molybdenum oxide, hydrogen peroxide, hexamethylphosphoric triamide (HMPA) and 
pyridine in a two-step procedure.[29] When reacted with (R)-camphor (286) the reagent provides a 
5:1 endo:exo ratio of the α-hydroxy analogue of (R)-camphor (286). The diastereomers could be 
potentially separated by chromatography and reduced to a mixture of stereoisomeric bis-hydroxyl 
compounds in an unknown ratio. 
 
4.2.4 – 1,4-Dioxepan-6-one/Terpenoid Odorant Fusion – (S)-Carvone and (S)-Carvotanacetone 
The synthesis of a 1,4-dioxepan-6-one heterocycle fused terpenoid odorant beginning from (S)-carvone 
(28) was planned. Carvone has one chiral centre and therefore exists as two stereoisomers, both with 
different fragrance profiles. (S)-Carvone (28) has the odour of caraway and an odour threshold value 
of 7.6 ng/L air, whilst its antipode (R)-carvone (29) has the odour of spearmint and an odour threshold 
value of 0.88 ng/L air.[3] These enantiomers provide good evidence that at least some human olfactory 
receptors are chiral. Interestingly, 8–10% of the population are not able to discern between the 
enantiomers; a specific type of chiral anosmia.[30-31] The initiating step in the synthetic sequence 
involved an epoxidation reaction of (S)-carvone (28) using basified hydrogen peroxide at 0 ºC to give a 
crude mixture of epoxide stereoisomers in 87% yield (Scheme 4.8).[32-34] The mixture was discovered 
by GC-MS to be a 95:5 mixture of cis-carvone oxide (293) and trans-carvone oxide (294), respectively 
(Figure 4.13).[35-36] 
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Figure 4.13: GC-MS chromatograph of the oxidation reaction of (S)-carvone (28). 9.583 minutes: 
trans-carvone oxide (294); 9.793 minutes: cis-carvone oxide (293). 
 
The epoxide stereoisomers (293 and 294) were readily separated by flash chromatography on 
triethylamine deactivated silica gel. The major diastereomer (293) was subjected to an acid-catalysed 
epoxide ring-opening reaction using sulphuric acid to provide compound 295 in 68% yield.[37] Five 
literature publications report the synthesis of diol 295 (or antipode) using analogous methodology. Three 
publications do not specify the stereochemistry of the resulting product,[34, 37-38] one publication specifies 
a (2S,3R,5S) configured product (295)[39] and one publication specifies an equimolar mixture of cis- and 
trans-configured diol compounds,[40] which is improbable as cis-diol compounds are unlikely to arise as 
a major product of an acid-catalysed ring-opening reaction, this type of reaction proceeding 
predominantly by nucleophilic attack at the less hindered face.[41] It is hereby assumed that the 
stereochemistry is (2S,3R,5S). 
 
 
Scheme 4.8: Synthesis of trans-diol 295 from (S)-carvone (28). 
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Multiple attempts at the bis-etherification of trans-diol compound 295 with ethyl diazoacetate provided 
only complex polymerised mixtures, presumably due to complications relating to the unprotected 
carbonyl moiety (Scheme 4.9). To begin the chemical reaction, more boron trifluoride diethyletherate 
was required than would be expected, perhaps owing to chelation with the lone-pair electrons of the 
carbonyl oxygen. The reaction is readily visible by the release of nitrogen gas from the dichloromethane 
solvent. 
 
Scheme 4.9: Failed bis-etherification of trans-diol 295 with ethyl diazoacetate.  
 
As the molecular structure of trans-diol compound 295 contained unsaturation it would be futile to 
attempt Williamson reaction methodologies as the subsequent Katsuki-Sharpless oxidation would be 
likely to oxidise both alkene functionalities. Compound 295 was therefore hydrogenated with palladium 
on carbon (Pd/C) in ethyl acetate under an atmosphere of hydrogen, with catalytic amounts of ethanol 
added to assist in catalyst activation. The reaction successfully provided saturated analogue 297 as a 
yellow oil in 75% yield (Scheme 4.10). 
 
Compound 297 can be viewed as the 2,3-bis-hydoxyl analogue of (S)-carvotanacetone, a naturally 
occurring terpenoid with similar olfactory properties to the parent unsaturated compound 
(S)-carvone (28). An attempt was made at the Williamson reaction of trans-diol 297 with bis-halogen 
194 but the reaction was again discovered to lead to polymer. The origin of the compilations are 
presumably related to the removal of an acidic alpha hydrogen by the sodium hydride reagent, followed 
by aldol-type intermolecular polymerisation. Owing to these complications the synthesis of dioxepanone 
heterocycle fused analogues of (S)-carvone and (S)-carvotanacetone were abandoned. 
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Scheme 4.10: Hydrogenation of diol 295 to give saturated diol 297, followed by failed etherification with 194.  
 
4.2.5 – 1,4-Dioxepan-6-one/Terpenoid Odorant Fusion – (+)-Limonene 
The following terpenoid compound to undergo experimentation was (+)-limonene (299), the major 
odorant within the citrus genus which contains considerable quantities of this terpenoid within their fruits. 
The odour of (+)-limonene (299) is described as ‘fresh citrus and orange-like’ whilst the odour of the 
enantiomer, (–)-limonene, is described as ‘harsh and turpentine like’.[17]  
 
(+)-Limonene (299) was epoxidised using meta-chloroperoxybenzoic acid to give an equimolar mixture 
of trans-limonene oxide (300) and cis-limonene oxide (301), with minor quantities of bis-epoxide 
impurities also identified as being present by GC-MS (Scheme 4.11, Figure 4.14).[42-44] The racemic 
mixture of 300 and 301 is reported to not be separable by standard chromatographic or distillation 
techniques.[45] It is reported in literature that an acidic ring-opening reaction of the diastereomeric 
mixture gives a single trans-diol product.[46] It has been reasoned that this effect occurs due to selective 
axial nucleophilic attack, which can be rationalised by the Fürst-Plattner Rule.[45, 47] A number of 
methods have been established to exploit this effect in the separation of the epoxide diastereomers, 
namely by manipulating the substantially faster reaction rate of the cis-diastereomer 301. 
 
 
Scheme 4.11: Synthesis of trans-diol compound 302 from (+)-limonene (299). 
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Figure 4.14: GC-MS chromatograph of the oxidation reaction of (+)-limonene (299). 5.90 minutes: unreacted 
(+)-limonene (299); 7.52 minutes: cis-limonene oxide (301); 7.58 minutes: trans-limonene oxide (300);  
9.96–10.12: limonene bis-epoxide impurities. 
 
It is reported in literature that a pH 4 buffered solution (NaOAc/AcOH) can react to give complete 
conversion of cis-limonene oxide (301) after 3.5 hours, thus yielding a readily separable mixture of 
optically pure trans-limonene oxide (300) and optically pure trans-diol compound 302 (Figure 4.15).[47] 
It is also reported that a pH 3 buffered solution (K2HPO4/KH2PO4) reacts to give complete conversion 
of both diastereomers to trans-diol 302 after 12 hours of reaction time. Experimentation with a pH 4 
buffered reagent revealed that after an extended reaction time, complete conversion of 300 and 301 to 
the trans-diol stereoisomer 302 was also possible.  
 
 
Figure 4.15: Acid-catalysed ring-opening of cis- and trans-limonene oxides to give trans-diol 302.[47] 
 
 
 CHAPTER 4 
 
169 
  
Compound 302 was bis-etherified using ethyl diazoacetate and boron trifluoride as a Lewis-acid 
catalyst. Isomerisation was discovered to occur with the alkene moiety migrating into the cyclohexyl 
ring. The yield was lower than anticipated, a mere 12% of the isomerised bis-ester product (303) being 
isolated as a yellow oil. Alkene migration was readily confirmed by 1H NMR integration of the alkene 
signal at δ 5.22 (Figure 4.16). The undesired bis-ester (303) was subjected to Dieckmann condensation, 
and after decarboxylation, the 2,3-annulated dioxepanone 304 was isolated in a meagre 8% yield 
(Scheme 4.12).  
 
Scheme 4.12: Synthesis of dioxepanone fused (+)-limonene analogue 304 from trans-diol 302, with 
 alkene isomerisation. 
 
 
Figure 4.16: 1H NMR (CDCl3, 300 MHz) spectrum of dioxepanone fused (+)-limonene analogue 304. 
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The mechanism by which isomerisation occurred may be analogous to the way in which 
(S)-carvone (28) undergoes acid-catalysed aromatisation to give carvacrol (Figure 4.17).[48] The 
sequence begins when π electrons originating from the alkene moiety nucleophilically attack a proton, 
giving a more stable tertiary carbocation. The intermediate then undergoes a 1,2-hydide shift followed 
by elimination of a proton to generate a conjugated alkene compound. Acid-catalysed enolisation then 
provides the highly stable aromatic compound. It can be postulated that a similar mechanism of 
isomerisation occurred with trans-diol compound 302, stopping after carbocation rearrangement and 
proton elimination to give the isomerised product 303.  
 
 
Figure 4.17: Mechanism for the acid-catalysed aromatisation of (S)-carvone to carvacrol.[48] 
 
4.2.6 – 1,4-Dioxepan-6-one/Terpenoid Odorant Fusion – (–)-Menthol 
Menthol is a naturally occurring chiral terpenoid odorant isolated from the mint family. Natural menthol 
exists predominantly as the (1R,2S,5R) stereoisomer, known as (–)-menthol (305), and is described as 
being ‘sweet, fresh, minty and strongly cooling’.[3] In an attempt to fuse a 1,4-dioxepan-6-one 
heterocyclic ring onto (–)-menthol (305) the synthesis of a bis-hydroxyl analogue of the starting material 
was required. A publication by Suemune et al.[49] detailed the synthesis and characterisation of all 
possible stereoisomers of menthol-1,2-diol beginning from alkene (3S,6R)-3-isopropyl-
6-methylcyclohex-1-ene (307), although reaction conditions were not provided for the synthesis of the 
alkene compound. 
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Scheme 4.13: Synthesis of trans-diol compound 308 from (–)-menthol (305). 
 
The reaction of (–)-menthol (305) with methanesulfonyl chloride in pyridine gave the corresponding 
mesylate ester (306) in 92% yield as a yellow oil (Scheme 4.13).[50, 51] Attempts at purification by vacuum 
bulb–bulb distillation (>100 ºC, 0.1 mm/Hg) provided an eliminated alkene product that did not match 
the NMR characterisation data for the required alkene compound (307). The isolated compound instead 
matched predicted 13C NMR data for an alternate elimination reaction to give the higher substituted 
alkene compound (309). Another sample of the crude mesylate (306) was reacted with 
potassium tert-butoxide in dimethyl sulfoxide to provide the correct alkene compound (307) as a thin 
yellow liquid in 90% yield after careful isolation due to volatility (Figure 4.18).[52] 
 
Figure 4.18: 13C NMR (CDCl3, 75 MHz) spectra showing: (top) mesylate 306; (middle) elimination reaction of 306 
with heat to give alkene 309; (bottom) elimination of 306 with KOtBu to give alkene 307. 
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The reaction of mesylate 306 with potassium tert-butoxide follows an E2 elimination mechanism. This 
infers an elimination mechanism with a single transition state and no intermediate compounds. Under 
standard conditions it would be expected that alkene 309 would be the major product formed owing to 
the greater thermodynamic stability that higher substituted alkenes offer (Zaitsev’s rule). Instead, due 
to the steric bulk of potassium tert-butoxide only the removal of the less hindered proton from the 
secondary carbon and not the proton from the tertiary carbon can physically take place 
(Hofmann’s rule). Additionally, the only antiperiplanar C−H atom available, in regards to the C−OMs 
moiety, is at C−6 owing to the configuration of (–)-menthol. This sequence provides alkene 307, the 
Hofmann elimination product. 
 
Mesylate compound 306 underwent an E1 elimination when heated during vacuum distillation. The 
mesylate moiety was eliminated to give a carbocation intermediate followed by the extraction of a proton 
to provide the alkene product. The carbocation intermediate can explain the inseparable impurities 
located by 13C NMR analysis, as carbocation rearrangements are known to occur during this type of 
mechanism. The major isolated product was still alkene 309, which followed Zaitsev’s rules of alkene 
formation by elimination (Figure 4.19). 
 
Figure 4.19: Different elimination products of mesylate compound 306. 
 
The isolated alkene (307) was epoxidised with meta-chloroperoxybenzoic acid to give an intermediate 
epoxide compound, immediately followed by an acidic ring-opening reaction with sulphuric acid to 
provide trans-diol 308 in 66% yield after flash chromatography on silica gel.[49] It was reported that an 
isomeric trans-diol compound would be present in trace quantities,[49] although this diastereomer was 
never identified or isolated.  
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Etherification of trans-diol compound 308 with ethyl diazoacetate was achieved in 9% yield only, 
providing bis-ester 310 as a yellow oil (Scheme 4.14). All attempts to subject compound 310 to 
Dieckmann cyclisation yielded only polymerised material. The Williamson reaction of trans-diol 308 with 
bis-halogen 194 also failed to provide the required product. Computational molecular modelling 
revealed that the isopropyl group of 308/310 is preferentially favoured when situated in an equatorial 
position which thereby forces the hydroxy/ether functionalities into bis-axial positions (Figure 4.20). This 
renders these moieties pointed in opposite directions out of plane and thus makes both the Dieckmann 
cyclisation and Williamson cyclisation reactions problematical. 
 
 
Scheme 4.14: Failed synthesis of dioxepanone fused (–)-menthol analogue 312 from trans-diol compound 308. 
 
 
Figure 4.20: Minimum-energy conformation of (1R,2R,3S,6R)-3-isopropyl-6-methylcyclohexane-1,2-diol (308) 
generated with the HyperChem 8 scripting facility and subjected to brief molecular dynamics to take atoms and 
bonds out of default angles and lengths. The structure was then minimised using the ab initio STO-3G method.[53] 
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4.2.7 - Structure-Odour Correlations and Conclusions 
The olfactory properties of the substituted 1,4-dioxepan-6-one compounds are summarised in 
Table 4.1, and the olfactory properties of the heterocycle fused terpenoid compounds are summarised 
in Table 4.2. Olfactory evaluations were performed by expert perfumers on blotter using a 10% solution 
of the sample substance in dipropylene glycol (DPG), odour threshold values were determined by panel 
using GC-Olfactometry (GC-O). While the two parent 1,4-dioxepan-6-ones, 269 and (±)-275, did 
possess slight marine character, the 2-substituted 1,4-dioxepan-6-one compounds are, with the 
exception of (±)-276, too weak to be useful as perfumery material. This further corroborates the marine 
olfactophore models that feature the aromatic ring as an essential binding motif for marine odorant 
analogues.  
 
This discovery also provided evidence that that the receptor binding energy gained from a molecule 
binding to the aliphatic hydrophobe is lower than that gained from binding to the aromatic site. The 
dioxepanone analogues (±)-276 and (±)-277, as well as various other analogues (i.e. 204) can, in 
theory, still be interacting with the aliphatic hydrophobe adjacent to the aromatic binding site, but remain 
weak non-marine odorants. The results may additionally offer evidence that the receptor models 
developed by Kraft et al.,[4, 54] which place the aliphatic hydrophobe 7.23 Å from the aromatic binding 
site, are more accurate than the model developed by Gaudin et al.[55] which places the same binding 
site adjacent to the carbocyclic ring system.  
 
Although compounds 269 and (±)-275 contain what could be described as marine aspects, the 
association was unpleasant and closer to seawater and algae, not fresh marine nuances. Compounds 
269 and (±)-275 were also discovered to contain a fruity aspect in the direction of melon, but green and 
earthy side aspects would prevent any use of these compounds as perfumery material. Compound 
(±)-275 was distinctly more melon than compound 269, and also less salty, green and earthy. It should 
be noted that the original patent first described benzo[b][1,4]dioxepin-3-one analogues as having a 
watermelon-like odour.[56] The 2-isobutyl substituted 1,4-dioxepan-6-one (±)-277 was devoid of any 
fruity, watermelon or marine odour attributes, but its weak, fatty-oily agrestic odour instead recalled 
linalool with some additional spicy facets. The 2,2,3,3-tetramethyl-1,4-dioxepan-6-one 278 was 
completely odourless. 
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# Molecular Structure Odour Description  
269 
 Odour description: Rather weak, marine, salty, fruity in direction 
of melon with green, earthy aspects, slightly fatty, solvent-like, 
slightly in the direction of petrol. 
(±)-275 
 Odour description: Rather weak, fruity, marine, distinctly melon, 
more fruity than 269, more transparent while less salty, green 
and earthy than 269. 
(±)-276 
 
 
Odour description: Green-floral anisic, hawthorn-type, with 
aspects of cis-jasmone and celery leaves, as well as a cinnamic 
powdery inflection, and slightly metallic facets.  
Odour threshold: 210 ng/L air (stan. dev. 62 ng/L air). 
(±)-277 
 
Odour description: Rather weak, agrestic, linalool, slightly oily, 
fatty, spicy nuances. 
278 
 
Odour description: Odourless. 
 
Table 4.1: Olfactory properties of 1,4-dioxepan-6-one analogues 269, 275–278. 
 
The most potent and also most interesting odorant of the series turned out to be compound (±)-276 
which was initially described as powerful, although its odour threshold was discovered to be a mere 
210 ng/L air. Yet, its rather low molecular weight coupled with an accordingly high vapour pressure 
makes (±)-276 sufficiently intense as a top-note odorant. Its odour profile was however completely out 
of the marine range. The 2-propyl substituted 1,4-dioxepan-6-one (276) instead possessed a 
green-floral anisic, hawthorn-type odour with aspects of cis-jasmone and celery leaves, as well as a 
cinnamic powdery inflection, and slightly metallic facets. 
 
It appeared as if the C–2 propyl substituent of (±)-276 addressed a different odorant family related to 
such green-floral jasminic-anisic notes as celery ketone (3-methyl-5-propylcyclohex-2-enone, 313) and 
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cis-jasmone ((2’Z)-3-methyl-2-pent-2’-en-1’-ylcyclopent-2-en-1-one, 314). It was revealed during 
research by List et al.[57] that the two enantiomers of celery ketone (313) have rather different fragrance 
profiles, of which the stronger (R)-enantiomer, with an odour threshold (th) value of 9.1 ng/L air, is 
responsible for the typical lovage and celery character of the racemate. The (S)-enantiomer was 
discovered to be roughly five times weaker and comprised predominantly of aniseed, liquorice and 
fennel notes. The molecular association of racemic (±)-276 with that of racemic celery ketone (313) 
may give rise to the green notes, the associations being towards both jasmine and aniseed. 
 
A biflexible alignment of the (S)-enantiomer of compound 276 (grey) on (R)-celery ketone (black, 313) 
and cis-jasmone (white, 314) with the Molecular Operation Environment (MOE) software package[53] 
revealed that the C–3 substituent of (S)-276 overlies agreeably with the (2Z)-pent-2-enyl substituent of 
cis-jasmone (314), as well as the propyl side-chain of celery ketone (313) (Figure 4.21). In addition, the 
double bonds of celery ketone (313) and cis-jasmone (314) come to lie in close vicinity to the O–4 ether 
oxygen of (S)-276 indicating that the associated electron density might contribute to receptor binding 
besides the main docking via the carbonyl osmophore. 
 
Since cis-jasmone (314) features no stereocenter the alignment of the (R)-enantiomer (R)-276 on 
(R)-celery ketone (313) and cis-jasmone (314) is comparably good. However, with regard to the 
enantiodiscrimination of celery ketone (313), one could expect some stereodifferentiation of the 
enantiomers of 276. Yet, both celery ketone (313) and cis-jasmone (314) are far more potent than 
racemic 2-propyl-1,4-dioxepan-6-one (276). If the green-floral jasminic-anisic notes of (±)-276 are to be 
explored and improved, both enantiomers of 276 as well as further analogues would need to be 
synthesised. The insight provided by the superposition analysis delineated in Figure 4.21 could then be 
the starting point for a more comprehensive model on green-floral jasminic-anisic odorants. 
 
Only two testable analogues, compounds 283 and 292, were successfully synthesised from the six 
proposed terpenoid based fragrances with fused 1,4-dioxepan-6-one heterocyclic rings (Table 4.2). The 
analogue synthesised from (R)-camphor (286) was discovered to be completely devoid of odour whilst 
the analogue synthesised from (+)-α-pinene (254) had a minty-anisic, anethole-like smell with a 
wet-towel odour which is often encountered when mint and agrestic notes meet, but was rather weak 
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in smell and had no marine connotation at all. These results remain inconclusive regarding if the fusion 
of 1,4-dioxepan-6-one heterocycles onto other odorant molecules could offer additional marine 
nuances. 
 
 
Figure 4.21. Biflexible alignment of the (S)-enantiomer of compound 276 (grey) on (R)-celery ketone (black, 
313), and cis-jasmone (white, 314) generated with the MOE 2014.09 software package.[53] The feature overlap 
(F), which describes the configurational similarity as the negative value of the probability density overlap function, 
has a value of –59.5. The grand alignment score of the probability-density overlap is –37.5. The grand alignment 
score of the (R)-enantiomer of compound 276 on (R)-celery ketone (313) and cis-jasmone (314) is –37.3. 
 
# Molecular Structure Description and Threshold 
283 
 
Odour description: Rather weak, slightly minty-anisic, anethole, 
with a wet-towel odour. 
292 
 
Odour description: Odourless. 
 
Table 4.2: Olfactory properties of 1,4-dioxepan-6-one heterocycle fused terpenoid compounds 283 and 292.  
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4.3 – Experimental Section 
General Procedure A: 
A solution of the diol compound (10.5 mmol) in DMF (30 mL) was added dropwise to a suspension of sodium 
hydride (1.05 g, 26.2 mmol, 60% dispersion in mineral oil) in DMF (60 mL) and the solution left to stir for 1 h. A 
solution of 3-chloro-2-(chloromethyl)-1-propene (1.31 g, 10.5 mmol) in DMF (40 mL) was then added dropwise over 
a period of 1 h, and the solution allowed to stir for 24 h. The reaction was then quenched by the additional of a 
saturated aqueous solution of NaHCO3 (100 mL), extracted with Et2O (4 × 100 mL), the organic extracts pooled 
and washed with H2O (2 × 100 mL) before being dried (MgSO4) and concentrated under reduced pressure. The 
resulting residue was then purified by flash chromatography on silica gel (EtOAc/hexane; 5:95) to yield the 
corresponding methylene compound. 
 
General Procedure B: 
To an ice-cool solution of the diol compound (40 mmol) and ethyl diazoacetate (10 g, 88 mmol, 2.2 equiv) in 
DCM (80 mL) was slowly added BF3·OEt2 (0.5 mL). After addition was complete the solution was held at 0 ºC for 
1 h before being quenched by the addition of a saturated aqueous solution of NaHCO3 (100 mL). The mixture was 
then extracted with EtOAc (3 × 100 mL), the organic extracts pooled, dried (MgSO4) and concentrated under 
reduced pressure. The resulting residue was purified by flash chromatography on silica gel (EtOAc/hexane; 2:8) to 
yield the corresponding bis-ester compound. 
 
General Procedure C:  
The methylene compound (5 mmol) was dissolved in MeCN (25 mL), H2O (25 mL), and DCM (15 mL), and sodium 
metaperiodate (1.07 g, 5 mmol) and ruthenium trichloride (0.1 g, 0.5 mmol) were added. The mixture was stirred 
for 24 h, then further sodium metaperiodate (1.07 g, 5 mmol) and ruthenium trichloride (0.1 g, 0.5 mmol) were 
added. The solution was stirred for a further 24 h. The reaction mixture was then poured into H2O (100 mL) and 
the resulting mixture was extracted with DCM (3 x 100 mL). The combined organic extracts were washed with a 
saturated aqueous solution of NaHSO3 (100 mL) and with H2O (100 mL), dried (MgSO4), and concentrated under 
reduced pressure. The resulting residue was purified by flash chromatography on silica gel (EtOAc/hexane; 1:9) to 
give the corresponding ketone. 
 
General Procedure D: 
A solution of bis-ester compound (20 mmol) in THF (150 mL) was added dropwise to a stirred suspension of 
KOtBu (4.5 g, 40 mmol, 2 equiv) in THF (100 mL) with cooling to 0 ºC. Stirring was continued at 0 ºC for 2 h before 
being quenched by the addition of 0.2 M HCl (800 mL) and ice (500 g). The resulting solution was then extracted 
 CHAPTER 4 
 
179 
  
with DCM (3 × 200 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced pressure. 
The resulting residue was taken up in EtOH (100 mL) and 2 M HCl (500 mL) and the mixture stirred at reflux for 
2 h. The solution was diluted with H2O (300 mL) and extracted with DCM (3 × 200 mL). The combined organic 
extracts were washed with H2O (200 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting 
residue was purified by flash chromatography on silica gel (EtOAc/hexane; 1:9) to yield the corresponding ketone. 
 
General Procedure E:  
To a solution of alkene (20 mmol) and NMO (22 mmol) in acetone/H2O (4:1, 50 mL) was added OsO4 (100 mg) 
and the resulting solution stirred at RT for 48 h. The reaction was then quenched by the addition of Na2SO3 (1 g) 
and left for 1 h before being concentrated under reduced pressure. The residual oil was then taken up in 
H2O (100 mL), extracted with EtOAc (5 × 100 mL), the organic extracts pooled and dried (MgSO4) before being 
concentrated under reduced pressure. The resulting residue was then purified by flash chromatography on silica 
gel (EtOAc/hexane; 3:7) to yield the corresponding cis-diol compound.  
 
Diethyl 2,2'-(ethane-1,2-diylbis(oxy))diacetate (268): 
Following General Procedure B. Yellow oil, 74% yield. IR (ATR): ṽ = 1748 (v ester C=O), 
1201 (v ester C–O), 1128 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.21 (q, J = 7.1 Hz, 
4H, 3-,3’’-H2), 4.15 (s, 4H, 2-,1’’-H2), 3.77 (s, 4H, 1’-,2’-H2), 1.28 (t, J = 7.1 Hz, 6H, 
4-,4’’-H3). 13C NMR (CDCl3, 75 MHz): δ 169.8 (2s, C-1,-2’’), 70.4 (2t, C-1’,-2’), 68.1 (2t, C-
2,-1’’), 60.2 (2t, C-3,-3’’), 13.7 (2q, C-4,-4’’). HRMS: m/z calculated for C10H18O6: 234.1103 [M]+; Found: 234.1132.  
 
1,4-Dioxepan-6-one (269): 
Following General Procedure D. Clear oil, 2% yield (92% via General Procedure C). IR (ATR): 
ṽ = 1720 (v C=O), 1144 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.23 (s, 4H, 5-,7-H2), 3.96 
(s, 4H, 2-,3-H2). 13C NMR (CDCl3, 75 MHz): δ 211.1 (s, C-6), 78.0 (2t, C-5,-7), 75.6 (2t, C-2,-3). 
HRMS: m/z calculated for C5H8O3: 116.0473 [M]+; Found: 116.0462. Odour description: Rather weak, marine, salty, 
fruity in direction of melon with green, earthy aspects, slightly fatty, solvent-like, slightly in the direction of petrol. 
 
6-Methylene-1,4-dioxepane (270): 
Following General Procedure A. Clear oil, 12% yield. IR (ATR): ṽ = 2925/2854 (v C–H), 
1134/1092 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 5.01–4.99 (m, 2H, =CH2), 4.33–4.30 (m, 
4H, 5-,7-H2), 3.77–3.75 (m, 4H, 2-,3-H2). 13C NMR (CDCl3, 75 MHz): δ 148.1 (s, C-6), 111.5 
(t, =CH2), 73.6 (2q, C-5,-7), 73.2 (2q, C-2,-3). HRMS: m/z calculated for C6H10O2: 114.0681 [M]+; Found: 114.0674.  
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rac-2-Methyl-6-methylene-1,4-dioxepane (271): 
Following General Procedure A. Clear oil, 37% yield. IR (ATR): ṽ = 2937/2849 (v C–H), 1104 
(v C–O), 884 (v C=CH2) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.97–4.91 (m, 2H, =CH2), 4.46–
4.19 (m, 4H, 5-,7-H2), 3.88 (dd, J = 12.5, 2.0 Hz, 1H, 3-H), 3.77–3.66 (m, 1H, 2-H), 3.27 (dd, 
J = 12.6, 9.4 Hz, 1H, 3-H), 1.10 (d, J = 6.4 Hz, 3H, 1’-H3). 13C NMR (CDCl3, 75 MHz): δ 148.6 (s, C-6), 110.5 
(t, =CH2), 78.8 (d, C-2), 78.7 (t, C-3), 73.9/72.6 (2t, C-5,-7), 16.9 (q, C-1’). HRMS: m/z calculated for C7H12O2: 
128.0837 [M]+; Found: 128.0842. 
 
rac-6-Methylene-2-propyl-1,4-dioxepane (272): 
Following General Procedure A. Clear oil, 61% yield. IR (ATR): ṽ = 2958/2936 (v C–H), 
1104 (v C–O), 897 (v C=CH2) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.96–4.92 (m, 2H, 
=CH2), 4.46–4.18 (m, 2H, 5-,7-H2), 3.89 (dd, J = 12.5, 2.0 Hz, 1H, 3-H), 3.57–3.49 (m, 
1H, 2-H), 3.29 (dd, J = 12.4, 9.4 Hz, 1H, 3-H), 1.54–1.24 (m, 4H, 1’-,2’-H2), 0.96–0.88 (m, 3H, 3’-H3). 13C NMR 
(CDCl3, 75 MHz): δ 148.8 (s, C-6), 110.5 (t, =CH2), 82.6 (d, C-2), 77.8 (t, C-3), 73.9/72.9 (2t, C-5,-7), 33.4 (t, C-1’), 
18.7 (t, C-2’), 13.9 (q, C-3’). HRMS: m/z calculated for C9H16O2: 156.1150 [M]+; Found: 156.1165. 
 
rac-2-Isobutyl-6-methylene-1,4-dioxepane (273): 
Following General Procedure A. Clear oil, 56% yield. IR (ATR): ṽ = 2954 (v C–H), 1119 
(v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.96–4.92 (m, 2H, =CH2), 4.46–4.18 (m, 4H, 
5-,7-H2), 4.86 (dd, J = 12.5, 2.0 Hz, 1H, 3-H), 3.64–3.55 (m, 1H, 2-H), 3.28 (dd, J = 12.6, 
9.4 Hz, 1H, 3-H), 1.84–1.73 (m, 1H, 2’-H), 1.42–1.32 (m, 1H, 1’-H), 1.10–1.00 (m, 1H, 1’-H), 0.91 (t, J = 6.4 Hz, 
6H, 2’-Me2). 13C NMR (CDCl3, 75 MHz): δ 148.8 (s, C-6), 110.2 (t, =CH2), 81.1 (d, C-2), 78.1 (t, C-3), 73.8/72.8 (2t, 
C-5,-7), 40.0 (t, C-1’), 24.2 (d, C-2’), 23.1/21.8 (2q, 2’-Me2). HRMS: m/z calculated for C10H18O2: 170.1307 [M]+; 
Found: 170.1284. 
 
2,2,3,3-Tetramethyl-6-methylene-1,4-dioxepane (274): 
Following General Procedure A. Yellow oil, 26% yield. IR (ATR): ṽ = 2978 (v C–H), 1152 (v 
C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.90–4.87 (m, 2H, =CH2), 4.26–4.24 (m, 4H, 
5-,7-H2), 1.22 (s, 12H, 2-,3-Me2). 13C NMR (CDCl3, 75 MHz): δ 149.3 (s, C-6), 108.9 (t, =CH2), 
80.7 (2s, C-2,-3), 66.3 (2t, C-5,-7), 22.9 (4q, 2-,3-Me2). HRMS: m/z calculated for C10H18O2Na: 193.1204 [M+Na]+; 
Found: 193.1189. 
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rac-2-Methyl-1,4-dioxepan-6-one (275): 
Following General Procedure C. Yellow oil, 27% yield. IR (ATR): ṽ = 1723 (v C=O), 1160/1113 
(v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.33–4.15 (m, 4H, 5-,7-H2), 4.09 (dd, J = 12.6, 
2.2 Hz, 1H, 3-H), 3.93–3.81 (m, 1H, 2-H), 3.40 (dd, J = 12.6, 9.6 Hz, 1H, 3-H), 1.17 (d, J = 6.4 
Hz, 3H, 1’-H3). 13C NMR (CDCl3, 75 MHz): δ 211.3 (s, C-6), 81.0 (d, C-2), 80.4 (t, C-3), 77.9/76.7 (2t, C-5,-7), 16.8 
(q, C-1’). HRMS: m/z calculated for C6H10O3: 130.0629 [M]+; Found: 130.0603. Odour description: Rather weak, 
fruity, marine, distinctly melon, more fruity than 269, more transparent while less salty, green and earthy than 269. 
 
rac-2-Propyl-1,4-dioxepan-6-one (276): 
Following General Procedure C. Yellow oil, 50% yield. IR (ATR): ṽ = 2959/2837 (v C–H), 
1723 (v C=O), 1154/1111 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.32–4.15 (m, 4H, 
5, 7-H2), 4.11 (dd, J = 12.6, 2.2 Hz, 1H, 3-H), 3.73–3.64 (m, 1H, 2-H), 3.43 (dd, J = 12.5, 
9.7 Hz, 1H, 3-H), 1.58–1.29 (m, 4H, 1’,2’-H2), 0.94 (t, J = 7 Hz, 3H, 3’-H3). 13C NMR (CDCl3, 75 MHz): δ 211.2 
(s, C-6), 84.7 (d, C-2), 79.3 (t, C-3), 77.7/76.8 (2t, C-5,-7), 33.0 (t, C-1’), 18.4 (t, C-2’), 13.7 (q, C-3’). HRMS: m/z 
calculated for C8H14O3: 158.0943 [M]+; Found: 158.0956. Odour description: Green-floral anisic, hawthorn-type, 
with aspects of cis-jasmone and celery leaves, as well as a cinnamic powdery inflection, and slightly metallic facets. 
Odour threshold: 210 ng/L air (stan. dev. 62 ng/L air).  
 
rac-2-Isobutyl-1,4-dioxepan-6-one (277):  
Following General Procedure C. Clear oil, 50% yield. IR (ATR): ṽ = 2956 (v C–H), 1723 (v 
C=O), 1156/1127 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.31–4.15 (m, 4H, 5-,7-H2), 
4.08 (dd, J = 12.5, 2.2 Hz, 1H, 3-H), 3.79–3.70 (m, 1H, 2-H), 3.42 (dd, J = 12.5, 9.7 Hz, 
1H, 3-H), 1.88–1.74 (m, 1H, 2’-H), 1.48–1.38 (m, 1H, 1’-H), 1.16–1.06 (m, 1H, 1’-H), 0.93 (t, J = 6.9 Hz, 6H, 2’-Me2). 
13C NMR (CDCl3, 75 MHz): δ 211.2 (s, C-6), 83.5 (d, C-2), 79.7 (t, C-3), 77.8/76.9 (2t, C-5,-7), 39.8 (t, C-1’), 24.2 
(d, C-2’), 23.0/21.8 (2q, 2’-Me2). HRMS: m/z calculated for C9H16O3: 172.1099 [M]+; Found: 172.1088. Odour 
description: Rather weak, agrestic, linalool, slightly oily, fatty, spicy nuances. 
 
2,2,3,3-Tetramethyl-1,4-dioxepan-6-one (278):  
Following General Procedure C. Low-melting colourless solid, 57% yield. IR (ATR): ṽ = 2984 
(v C–H), 1725 (v C=O), 1152 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.16 (s, 4H, 5-,7-H2), 
1.27 (s, 12H, 2-,3-Me2).13C NMR (CDCl3, 75 MHz): δ 213.1 (s, C-6), 81.6 (2s, C-2,-3), 70.0 (2t, 
C-5,-7), 22.3 (4q, 2-,3-Me2). HRMS: m/z calculated for C9H16O3: 172.1099 [M]+; Found: 172.1088. Odour 
description: Odourless.  
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rac-4-Methylpentane-1,2-diol (280):[15] 
To a solution of 4-methyl-1-pentene (6 mL, 48 mmol) in acetic acid (80 mL) was added NaIO4 
(6.11 g, 28.5 mmol) and LiBr (1.65 g, 19 mmol) and the solution heated to 95 ºC for 14 h. The 
reaction was diluted with H2O (100 mL), washed with a saturated aqueous solution of 
Na2S2O3 (30 mL) followed by washing with a saturated aqueous solution of NaHCO3 (30 mL). The solution was 
extracted with EtOAc (3 × 100 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced 
pressure. The resulting residue was taken up in MeOH (120 mL), K2CO3 (13.1 g, 95 mmol) was added and the 
mixture stirred for 15 h. The reaction was then concentrated under reduced pressure, dissolved in H2O (100 mL) 
followed by extraction with EtOAc (3 × 100 mL). The organic extracts were pooled, dried (MgSO4) and concentrated 
under reduced pressure to yield a crude residue which was purified by flash chromatography on silica gel 
(EtOAc/hexane; 1:1) to yield 4-methylpentane-1,2-diol (5.18 g, 91%) as a yellow oil. IR (ATR): ṽ = 3338 (v O–H), 
2955/2927 (v C–H), 1066/1026 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 3.86–3.76 (m, 1H, 2-H), 3.69–3.61 (m, 
1H, 1-H), 3.46–3.37 (m, 1H, 1-H), 2.15–2.04 (m, 2H, 1-,2-OH), 1.86–1.71 (m, 1H, 4-H), 1.46–1.35 (m, 1H, 3-H), 
1.28–1.15 (m, 1H, 3-H), 0.96 (d, J = 6.6 Hz, 3H, 4-Me), 0.93 (d, J = 6.6 Hz, 3H, 4-Me). 13C NMR (CDCl3, 75 MHz): 
δ 70.3 (d, C-2), 66.9 (t, C-1), 41.8 (t, C-3), 24.3 (d, C-4), 23.2/21.9 (2q, 4-Me2). 
 
(1S,2S,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptane-2,3-diol (281):[18] 
To a solution of (+)-α-pinene (8.83 g, 64.8 mmol) in t-butanol (100 mL), H2O (20mL) and pyridine 
(5 mL) was added OsO4 (100 mg) and NMO (9.1 g, 77.76 mmol, 1.2 equiv) and the solution 
heated at reflux overnight. The reaction was then quenched by the addition of sodium sulphite 
(2 g), and left for 1 h before being concentrated under reduced pressure. The residual oil was then taken up in 
H2O (100 mL), extracted with EtOAc (3 × 100 mL), the organic extracts pooled and dried (MgSO4) before being 
concentrated under reduced pressure. The resulting residue was then purified by flash chromatography on silica 
gel (EtOAc/hexane; 3:7) to yield (1S,2S,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol (8.32 g, 75%) as a 
colourless solid. [α]
22
𝐷
 = +7.2 (c = 0.37, toluene). IR (ATR): ṽ = 3349 (v O–H), 2908 (v C–H), 1082 (v C–O) cm–1. 
1H NMR (CDCl3, 300 MHz): δ 3.39 (s, 1H, 3-H), 2.92/2.61 (2s, 2H, 2-,3-OH), 2.51–2.40 (m, 1H, 4-H), 2.25–2.16 
(m, 1H, 7-H), 2.05–1.99 (m, 1H, 1-H), 1.96–1.89 (m, 1H, 5-H), 1.68–1.59 (m, 1H, 4-H), 1.36 (d, J = 10.3 Hz, 1H, 
7-H), 1.31 (s, 3H, 6-Me), 1.27 (s, 3H, 6-Me), 0.94 (s, 3H, 2-Me). 13C NMR (CDCl3, 75 MHz): δ 73.3 (s, C-2), 68.5 
(d, C-3), 53.5 (d, C-1), 40.1 (d, C-5), 38.4 (s, C-6), 37.5 (t, C-4), 29.4 (q, 6-Me), 27.8 (t, C-7), 27.6 (q, 6-Me), 23.9 
(q, 2-Me). HRMS: m/z calculated for C10H18O2Na: 193.1204 [M+Na]+; Found: 193.1190. 
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(5aS,6S,8S,9aR)-5a,7,7-Trimethyl-3-methyleneoctahydro-2H-6,8-methanobenzo[b][1,4]dioxepine (282): 
Following General Procedure A. Clear oil, 13% yield. [α]
22
𝐷
 = +38.2 (c = 0.51, CH2Cl2). 
IR (ATR): ṽ = 2911 (v C–H), 1101 (v C–O), 905 (v C=CH2) cm–1. 1H NMR (CDCl3, 
300 MHz): δ 4.93–4.90 (m, 2H, =CH2), 4.59–4.49 (m, 2H)/4.25 (d, J = 14.3 Hz, 1H)/4.06 
(d, J = 13.6 Hz, 1H) (2-,4-H2), 3.85–3.79 (m, 1H, 9a-H), 2.38–2.28 (m, 1H, 9-H), 2.19–2.11 (m, 1H, 10-H), 1.90–
1.80 (m, 3H, 6-,8-,9-H), 1.63 (d, J = 10.2 Hz, 1H, 10-H), 1.39 (s, 3H, 5a-Me), 1.24 (s, 3H, 7-Me), 0.91 (s, 3H, 7-Me). 
13C NMR (CDCl3, 75 MHz): δ 147.1 (s, C-3), 111.2 (t, =CH2), 81.0 (s, C-5a), 79.8 (d, C-9a), 72.3/66.7 (2t, C-2,-4), 
54.5/39.8 (2d, C-6,-8), 38.8 (s, C-7), 35.2 (t, C-9), 27.5 (q, 7-Me), 26.2 (t, C-10), 24.9 (q, 5a-Me), 24.0 (q, 7-Me). 
HRMS: m/z calculated for C14H22O2: 222.1619 [M]+; Found: 222.1623. 
 
(5aS,6S,8S,9aR)-5a,7,7-Trimethylhexahydro-2H-6,8-methanobenzo[b][1,4]dioxepin-3(4H)-one (283):  
Following General Procedure C. Colourless solid, 46% yield. [α]
24
𝐷
 = +55.3 (c = 0.55, 
CH2Cl2). mp: 52–55 ºC. IR (ATR): ṽ = 2919 (v, C–H), 1716 (v C=O), 1152 (v C–O) cm–1. 
1H NMR (CDCl3, 300 MHz): δ 4.67–4.28/4.07–3.99 (2m, 4H, 2-,4-H2), 4.00–3.94 (m, 1H, 
9a-H), 2.47–2.36 (m, 1H, 9-H), 2.29–2.19 (m, 1H, 10-H), 2.02–1.92 (m, 2H, 6-,8-H), 1.92–1.83 (m, 1H, 9-H), 1.64 
(d, J = 10.3 Hz, 1H, 10-H), 1.38 (s, 3H, 5a-Me), 1.30 (s, 3H, 7-Me), 0.96 (s, 3H, 7-Me). 13C NMR (CDCl3, 75 MHz): 
δ 213.0 (s, C-3), 80.7 (d, C-9a), 80.3 (s, C-5a), 75.3/70.7 (2t, C-2,-4), 54.4/39.7 (2d, C-6,-8), 38.5 (s, C-7), 34.4 (t, 
C-9), 27.2 (q, 7-Me), 26.8 (t, C-10), 24.6 (q, 5a-Me), 23.8 (q, 7-Me). HRMS: m/z calculated for C13H20O3: 224.1412 
[M]+; Found: 224.1418. Odour description: Rather weak, slightly minty-anisic, anethole, with a wet-towel odour. 
 
4-Methylbenzenesulfonohydrazide (285):[24] 
To a chilled (10–15 ºC) solution of para-toluenesulfonyl chloride (100 g, 525 mmol) in 
THF (175 mL) was added a 85% aqueous hydrazine hydrate solution (68 mL) over a period 
of 20 minutes. Stirring was continued for a further 15 minutes before the mixture was 
transferred into a separatory funnel, the aqueous layer discarded and the organic layer filtered through celite. The 
solution was then triturated with H2O and the colourless precipitate filtered to give 
4-methylbenzenesulfonohydrazide (97 g, quant.) as a colourless solid.  
 
4-Methyl-N'-((1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ylidene)benzenesulfonohydrazide (287):[25] 
To a solution of 4-methylbenzenesulfonohydrazide (15 g) and (R)-camphor (10 g, 
65.69 mmol) in 95% EtOH (100 mL) was added conc. HCl (2 mL) was the solution 
heated at reflux for 2 h. The resulting solution was then cooled in an ice-bath and 
filtered to give 4-methyl-N'-((1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ylidene)benzenesulfonohydrazide 
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(10.9 g, 52%) as a colourless solid. [α]
22
𝐷
 = +12.3 (c = 1.12, EtOH). mp: 164–165 ºC. (lit. mp: 163–164 ºC).[25] 
HRMS: m/z calculated for C17H24N2O2S: 320.1558 [M]+; Found: 320.1570.  
 
(1S,4R)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-ene (288):[25] 
To a solution of 4-methyl-N'-((1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-
ylidene)benzenesulfonohydrazide (26 g) in Et2O (360 mL) was added methyllithium (1.6 N in Et2O, 
130 mL) over a period of 1 h. The solution was allowed to stir overnight before being quenched by the 
addition of H2O (200 mL), followed by extraction with Et2O (3 x 200 mL). The organic extracts were pooled, washed 
with H2O (2 x 200 mL), dried (MgSO4) and concentrated under reduced pressure to a volume of ~50 mL. Pentane 
(100 mL) was added and the solution was concentrated under reduced pressure to a volume of ~50 mL. The 
solution was then eluted through a plug of neutral alumina, followed by fractional distillation to give 
(1S,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ene (5.38 g, 49%) as a volatile colourless solid. [α]
19
𝐷
 = –26.6 (c = 0.51, 
CH2Cl2). IR (ATR): ṽ = 2950 (v C–H), 714 (v C=C) cm-1. 1H NMR (CDCl3, 300 MHz): δ 5.92 (dd, J = 5.8, 3.2 Hz, 
1H, 3-H), 5.66 (d, J = 5.6 Hz, 1H, 2-H), 2.30–2.26 (m, 1H, 4-H), 1.85–1.76 (m, 1H, 5-H), 1.60–1.52 (m, 1H, 6-H), 
1.04 (s, 3H, 1-Me), 1.02–0.87 (m, 2H, 5-,6-H), 0.83 (s, 3H, 7-Me), 0.77 (s, 3H, 7-Me). 13C NMR (CDCl3, 75 MHz): 
δ 139.3 (d, C-2), 133.8 (d, C-3), 56.3/52.5 (2s, C-1,-7), 52.1 (d, C-4), 31.5 (t, C-6), 24.5 (t, C-5), 19.6/19.5 (2q, 
7-Me2), 13.2 (q, 1-Me). HRMS: m/z calculated for C10H16: 136.1252 [M]+; Found: 136.1246.  
 
(1R,2S,3R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptane-2,3-diol (289):  
Following General Procedure E. Colourless solid, 61% yield. Alternatively synthesised from 
(−)-camphorquinone.[26] To a 0 ºC solution of (–)-camphorquinone (3.32 g, 20 mmol) in 
MeOH (100 mL) was added NaBH4 (1.9 g, 50 mmol) over 0.5 h, and stirring continued at 25 ºC for 
0.5 h. The reaction mixture was then concentrated under reduced pressure, taken up in H2O (20 mL) and extracted 
with EtOAc (3 x 40 mL). The combined organic extracts were pooled, dried (MgSO4) and concentrated under 
reduced pressure to give (1R,2S,3R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-diol (1.1 g, 32%) as a colourless 
solid. [α]
23
𝐷
 = –14.9 (c = 0.37, EtOH). mp: 255–258 ºC. (lit. [α]
23
𝐷
 = –17.3 (c = 0.52, EtOH). mp: 255–257 ºC).[26] 
IR (ATR): ṽ = 3353 (v O–H), 2924 (v C–H), 1049 (v C–O) cm–1. 1H NMR (CDCl3, 300 MHz): δ 3.88–3.83/3.65–3.59 
(2m, 2H, 2-,3-H), 2.60–2.55/2.53–2.47 (2m, 2H, 2-,3-OH), 1.80–1.77 (m, 1H, 4-H), 1.72–1.60/1.54–1.40 (2m, 2H, 
5-,6-H), 1.12 (s, 3H, 7-Me), 1.10–0.84 (m, 2H, 5-,6-H), 0.95 (s, 3H, 1-Me), 0.82 (s, 3H, 7-Me). 13C NMR (CDCl3, 
75 MHz): δ 79.7/75.9 (2d, C-2,-3), 51.3 (d, C-4), 48.6/46.3 (2s, C-1,-7), 33.1/24.0 (2t, C-5,-6), 21.8/20.9 (2q, 7-Me2), 
11.0 (q, 1-Me). HRMS: m/z calculated for C10H18O2: 170.1307 [M]+; Found: 170.0887.  
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(5aS,6R,9S,9aR)-6,10,10-Trimethyl-3-methyleneoctahydro-2H-6,9-methanobenzo[b][1,4]dioxepine (291): 
Following General Procedure A. Yellow oil, 69% yield. IR (ATR): ṽ = 2949/2872 (v C–H), 
1108 (v C–O), 912 (v C=CH2) cm–1. 1H NMR (CDCl3, 300 MHz): δ 5.01 (s, 2H, =CH2), 
4.50 (q, J = 12.7, 7.6 Hz, 2H)/3.92 (t, J = 12.6, 2H) (2-,4-H2), 3.53 (d, J = 5.7 Hz, 1H)/3.31 
(d, J = 5.8 Hz, 1H) (5a-,9a-H), 1.81–1.76 (m, 1H, 9-H), 1.75–1.64 (m, 1H, 8-H), 1.53–1.41 (m, 1H, 7-H), 1.15 (s, 3H, 
10-Me), 1.08–0.95 (m, 2H, 7-,8-H), 0.90 (s, 3H, 6-Me), 0.78 (s, 3H, 10-Me). 13C NMR (CDCl3, 75 MHz): δ 145.3 
(s, C-3), 115.1 (t, =CH2), 91.7/88.5 (2d, C-5a,-9a), 76.0/75.9 (2t, C-2,-4), 51.1 (d, C-9), 49.2/46.7 (2s, C-6,-10), 
33.7 (t, C-7), 24.4 (t, C-8), 21.0/20.9 (2q, 10-Me), 11.4 (q, 6-Me). HRMS: m/z calculated for C14H22O2: 222.1620 
[M]+; Found: 222.1611.  
 
(5aS,6R,9S,9aR)-6,10,10-Trimethylhexahydro-2H-6,9-methanobenzo[b][1,4]dioxepin-3(4H)-one (292):  
Following General Procedure C. Colourless solid, 49% yield. [α]
27
𝐷
 = –11.1 (c = 1.00, CH2Cl2). 
mp: 75–77 ºC. IR (ATR): ṽ = 2953/2837 (v C–H), 1708 (v C=O), 1158 (v C–O) cm–1. 1H NMR 
(CDCl3, 300 MHz): δ 4.64–4.52/4.13–4.00 (2m, 4H, 2-,4-H2), 3.62 (d, J = 5.8 Hz, 1H)/3.40 
(d, J = 5.8 Hz, 1H) (5a-,9a-H), 1.90–1.87 (m, 1H, 9-H), 1.79–1.68 (m, 1H, 8-H), 1.55–1.45 (m, 1H, 7-H), 1.22 (s, 3H, 
10-Me), 1.09–0.96 (m, 2H, 7-,8-H), 0.93 (s, 3H, 6-Me), 0.83 (s, 3H, 10-Me). 13C NMR (CDCl3, 75 MHz): δ 213.3 
(s, C-3), 91.4/88.0 (2d, C-5a,-9a), 79.6/79.3 (2t, C-2,-4), 51.0 (d, C-9), 49.3/46.7 (2s, C-6,-10), 33.3 (t, C-7), 24.1 
(t, C-8), 20.9/20.9 (2q, 10-Me), 11.1 (q, 6-Me). HRMS: m/z calculated for C13H20O3: 224.1412 [M]+; Found: 
224.1428. Odour description: Odourless. 
 
(1S,4S,6S)-1-Methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-one (293):[32] 
To a solution of (S)-carvone (5 g, 33.3 mmol) in MeOH (33 mL) was added 4 M NaOH (2.89 mL) at 
0 ºC. To this solution was added 30% H2O2 (4.13 mL, 39.95 mmol) dropwise over a period of 1 h 
at 0 ºC. The mixture was stirred for a further 1 h before being quenched by the addition of a saturated 
aqueous sodium sulphite solution (80 mL) followed by extracted with EtOAc (3 x 150 mL). The 
combined organic extracts were pooled, dried (MgSO4) and concentrated under reduced pressure. The resulting 
residue was then purified by flash chromatography on silica gel (Et2O/hexane; 1:9) to give 
(1S,4S,6S)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-one (4.81 g, 87%) as a yellow oil. IR (ATR): 
ṽ = 2935 (v C–H), 1704 (v C=O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.74–4.71 (m, 1H)/4.67–4.64 (m, 1H) (=CH2), 
3.40–3.37 (m, 1H, 6-H), 2.71–2.59 (m, 1H, 4-H), 2.56–2.46 (m, 1H, 3-H), 2.35–2.26 (m, 1H, 5-H), 2.02–1.80 (m, 2H, 
3-,5-H), 1.66 (s, 3H, 1’-Me), 1.34 (s, 3H, 1-Me). 13C NMR (CDCl3, 75 MHz): δ 204.8 (s, C-2), 146.0 (s, C-1’), 110.1 
(t, =CH2), 60.9 (d, C-6), 58.3 (s, C-1), 41.4 (t, C-3), 34.7 (d, C-4), 28.3 (t, C-5), 20.2 (q, 1’-Me), 14.9 (q, 1-Me). 
HRMS: m/z calculated for C10H14O2: 166.0994 [M]+; Found: 166.0986.  
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(2S,3R,5S)-2,3-Dihydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexanone (295):[37] 
To a solution of (1S,4S,6S)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-one 
(4.04 g, 24.27 mmol) in THF (32 mL) was added conc. H2SO4 (0.5 mL) was the solution heated 
at reflux for 4 h. The solution was then neutralised by the addition of a saturated aqueous solution 
of NaHCO3 (50 mL) followed by extraction with EtOAc (3 x 100 mL). The combined organic 
extracts were pooled, dried (MgSO4) and concentrated under reduced pressure. The resulting residue was then 
purified by flash chromatography on silica gel (EtOAc/hexane; 4:6) to give (2S,3R,5S)-2,3-dihydroxy-2-methyl-5-
(prop-1-en-2-yl)cyclohexanone (3.04 g, 68%) as a yellow oil. [α]
22
𝐷
 = –61.5 (c = 1.04, DCM). IR (ATR): ṽ = 3460 
(v C–H), 1714 (v C=O), 1048 (v C–O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.85–4.83 (m, 1H)/4.81–4.79 (m, 1H) 
(=CH2), 4.25 (s, 1H, OH), 4.09–4.06 (m, 1H, 3-H), 2.98–2.86 (m, 2H, 5-H, OH), 2.62–2.50 (m, 2H, 6-H2), 2.23–2.15 
(m, 1H, 4-H), 1.96–1.84 (m, 1H, 4-H), 1.78 (s, 3H, 1’-Me), 1.42 (s, 3H, 2-Me). 13C NMR (CDCl3, 75 MHz): δ 212.5 
(s, C-1), 146.3 (s, C-1’), 109.8 (t, =CH2), 78.1 (s, C-2), 75.6 (s, C-3), 41.4 (t, C-6), 39.5 (d, C-5), 32.9 (t, C-4), 23.1 
(q, 2-Me), 20.2 (q, 1’-Me). 
 
(2S,3R,5S)-2,3-Dihydroxy-5-isopropyl-2-methylcyclohexanone (297): 
To a solution of (2S,3R,5S)-2,3-dihydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexanone (1.3 g) in 
EtOAc (90 mL) and EtOH (22 mL) was added 10% Pd/C (180 mg) and the solution stirred under 
an atmosphere of H2 for 24 h. The mixture was then filtered through celite, concentrated under 
reduced pressure and the resulting residue purified by flash chromatography on silica gel 
(EtOAc/hexane; 3:7) to give (2S,3R,5S)-2,3-dihydroxy-5-isopropyl-2-methylcyclohexanone (0.98 g, 75%) as a 
yellow oil. IR (ATR): ṽ = 3462 (v C–O), 2958 (v C–H), 1713 (v C=O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 4.25 (s, 1H, 
OH), 4.08–4.04 (m, 1H, 3-H), 2.89 (d, J = 2.0 Hz, 1H, OH), 2.52–2.45 (m, 1H, 6-H), 2.38–2.28 (m, 1H, 6-H), 2.23–
2.04 (m, 2H, 4-,5-H), 1.79–1.57 (m, 2H, 4-,1’-H), 1.39 (s, 3H, 2-Me), 0.94 (dd, J = 6.8, 3.7 Hz, 6H, 1’-Me2). 13C NMR 
(CDCl3, 75 MHz): δ 213.4 (s, C-1), 78.2 (s, C-2), 75.9 (d, C-3), 39.8 (t, C-6), 39.1 (d, C-5), 31.8 (d, C-1’), 31.2 (t, 
C-4), 23.0 (q, 2-Me), 19.3/18.8 (2q, 1’-Me2). HRMS: m/z calculated for C10H18O3: 186.1256 [M]+; Found: 186.1267. 
 
(1S,2S,4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohexane-1,2-diol (302):[43, 47] 
To a solution of (+)-limonene (8.52 g, 62.54 mmol) in DCM (100 mL) was added dropwise mCPBA 
(14.02 g, 62.54 mmol, ≤77% pure) in DCM (400 mL) over a period of 0.5 h. A 5% aqueous solution 
of NaHCO3 (160 mL) was then added and stirring continued for 2.5 h. The mixture was then 
transferred to a separatory funnel and the aqueous layer discarded. The organic phase was 
washed with a saturated aqueous solution of NaHSO3 (100 mL), a saturated aqueous solution of NaHCO3 (100 mL), 
H2O (100 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting residue was then added to 
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a NaOAc/AcOH buffered solution (pH 4, 200 mL) and stirring continued for 48 h. The solution was then extracted 
with EtOAc (3 x 200 mL) and the combined organic extracts pooled, dried (MgSO4) and concentrated under 
reduced pressure. The resulting residue was purified by flash chromatography on silica gel (EtOAc/hexane; 4:6) to 
give (1S,2S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohexane-1,2-diol (5.05 g, 47%) as a colourless solid. [α]
18
𝐷
 = +27.2 
(c = 0.49, CHCl3). mp: 69–71 ºC. (lit. [α]
20
𝐷
 = +18.1 (c = 0.01, CHCl3). mp: 68–70 ºC).[47] IR (ATR): ṽ = 3360 (v O−H), 
2931 (v C−H), 1024 (v C−O), 882 (v C=CH2) cm–1. 1H NMR (CDCl3, 300 MHz): δ 4.75 (s, 2H, =CH2), 3.67–3.63 
(m, 1H, 2-H), 2.34–2.22 (m, 1H, 4-H), 2.00–1.89 (m, 1H, 3-H), 1.84–1.76 (m, 1H, 6-H), 1.74 (s, 3H, 1’-Me), 1.73–
1.63 (m, 1H, 3-H), 1.62–1.50 (m, 3H, 5-H2, 6-H), 1.42 (s, 2H, 1-,2-OH), 1.28 (s, 3H, 1-Me).13C NMR (CDCl3, 
75 MHz): δ 149.2 (s, C-1’), 108.9 (t, =CH2), 73.8 (d, C-2), 71.3 (s, C-1), 37.4 (d, C-4), 33.9/33.6 (2t, C-3,-6), 26.5 
(q, 1-Me), 26.1 (t, C-5), 21.0 (q, 1’-Me). HRMS: m/z calculated for C10H18O2Na: 193.1204 [M+Na]+; Found: 
193.1184. 
 
(1S,2S)-Diethyl 2,2'-((5-isopropyl-2a-methylcyclohex-4-ene-1,2-diyl)bis(oxy))diacetate (303): 
Following General Procedure B. Yellow oil, 12% yield. IR (ATR): ṽ = 2962 
(v C−H), 1753 (v ester C=O), 1119 (v ester C–O), 1121 (v C–O) cm–1. 1H NMR 
(CDCl3, 300 MHz): δ 5.22 (s, 1H, 4’-H), 4.40–4.06 (m, 8H, 2-,3-,1’’-,3’’-H2), 3.66 
(dd, J = 8.8, 6.0 Hz, 1H, 1’-H), 2.54–2.45 (m, 1H, 6’-H), 2.26–2.13 (m, 3H, 3’-H2, 
1’’’-H), 2.11–1.99 (m, 1H, 6’-H), 1.29 (t, J = 7.1 Hz, 6H, 4-,4’’-H3), 1.21 (s, 3H, 2’-Me), 0.99 (d, J = 6.8 Hz, 6H, 
1’’’-Me2). 13C NMR (CDCl3, 75 MHz): δ 171.0/170.9 (2s, C-1,-2’’), 140.8 (s, C-5’), 115.0 (d, C-4’), 81.2 (d, C-1’), 
78.0 (s, C-2’), 68.1/60.6/60.4/60.3 (4t, C-2,-3,-1’’,-3’’), 36.0 (t, C-3’), 34.1 (d, C-1’’’), 30.9 (t, C-6’), 21.2/20.8 (2q, 
1’’’-Me2), 15.6 (q, 2’-Me), 14.0/13.9 (2q, C-4,-4’’). HRMS: m/z calculated for C18H30O6Na: 365.1940 [M+Na]+; Found: 
365.1947. 
 
(5aS,9aS)-8-Isopropyl-5a-methyl-5a,6,9,9a-tetrahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one (304):  
Following General Procedure D. Yellow oil, 8% yield. [α]
22
𝐷
 = +218.6 (c = 0.76, CH2Cl2). 
IR (ATR): ṽ = 2962/2902 (v C–H), 1725 (v C=O), 1122 (v C–O) cm–1. 1H NMR (CDCl3, 
300 MHz): δ 5.29–5.24 (m, 1H, 7-H), 4.51 (d, J = 17 Hz, 1H , 4-H), 4.28 (d, J = 16.6 Hz, 
1H, 2-H), 4.21 (d, J = 16.6 Hz, 1H, 2-H), 4.01 (d, J = 17 Hz, 1H, 4-H), 3.60 (dd, J = 10.7, 6 Hz, 1H, 9a-H), 2.39–
2.28 (m, 1H, 9-H), 2.27–2.12 (m, 3H, 1’-H, 6-H2), 2.05–1.91 (m, 1H, 9-H), 1.25 (s, 3H, 5a-Me), 1.00 (d, J = 6.9 Hz, 
6H, 1’-Me2). 13C NMR (CDCl3, 75 MHz): δ 212.1 (s, C-3), 141.1 (s, C-8), 116.5 (d, C-7), 87.5 (d, C-9a), 78.7 (s, 
C-5a), 77.7 (t, C-2), 70.1 (t, C-4), 39.5 (t, C-6), 34.2 (d, C-1’), 32.3 (t, C-9), 21.5/21.0 (2q, 1’-Me2), 14.2 (q, 5a-Me). 
HRMS: m/z calculated for C13H20O3: 224.1412 [M]+; Found: 224.1403. 
 
 Synthesis of 2-Substituted and 2,3-Annulated 1,4-Dioxepan-6-ones 
188 
 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl methanesulfonate (306):[50, 51] 
To a solution of mesyl chloride (1.39 mL, 17.88 mmol) in pyridine (3 mL) at 0 ºC was added 
(−)-menthol (2 g, 12.79 mmol) in pyridine (3 mL). Stirring was continued for 0.5 h at 0 ºC followed 
by RT overnight. The reaction was then poured into ice-cold 10% HCl (100 mL) and extracted 
with Et2O (3 x 100 mL). The organic extracts were pooled, dried (MgSO4) and concentrated 
under reduced pressure to yield (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl methanesulfonate (2.76 g, 92%) as a 
yellow oil. IR (ATR): ṽ = 2955/2931 (v C–H), 1171 (v C–O) cm-1. Full structural assignment could not be completed. 
1H NMR (CDCl3, 300 MHz): δ 4.60–4.50 (m, 1H), 3.01 (s, 3H), 2.30–2.22 (m, 1H), 2.13–2.02 (m, 1H), 1.77–1.64 
(m, 2H), 1.56–1.37 (m, 2H), 1.34–1.21 (m, 1H), 1.13–0.98 (m, 1H), 0.97–0.80 (m, 10H). 13C NMR (CDCl3, 75 MHz): 
δ 82.7, 47.0, 41.7, 38.6, 33.3, 31.1, 25.3. 22.6, 21.4, 20.4, 15.2.  
 
(3S,6R)-3-Isopropyl-6-methylcyclohex-1-ene (307): [51, 52] 
A solution of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl methanesulfonate (4.00 g, 17.1 mmol) in 
DMSO (15 mL) was added dropwise to a solution of KOtBu (4.78 g, 42.6 mmol, 2.5 equiv) in 
DMSO (15 mL) at RT and the solution then stirred for 1 h at 70 ºC. The residual gum was then taken 
up in H2O (100 mL), extracted with hexane (3 × 100 mL), the organic extracts pooled and dried 
(MgSO4) before being concentrated under reduced pressure to give (3S,6R)-3-Isopropyl-6-methylcyclohex-1-ene 
(2.12 g, 90%) as a yellow oil. [α]
19
𝐷
 = +107.0 (c = 1.07, CH2Cl2). IR (ATR): ṽ = 2955/2925 (v C–H), 724 (v C=C) cm-1. 
1H NMR (CDCl3, 300 MHz): δ 5.54 (s, 2H, 1-,2-H), 2.19–2.06 (m, 1H, 6-H), 1.98–1.90 (m, 1H, 3-H), 1.89–1.79 (m, 
1H, 5-H), 1.76–1.66 (m, 1H, 4-H), 1.63–1.51 (m, 1H, 1’-H), 1.33–1.19 (m, 1H, 4-H), 1.19–1.05 (m, 1H, 5-H), 0.96 
(d, J = 6.9 Hz, 3H, 6-Me), 0.89 (t, J = 6.9 Hz, 6H, 1’-Me2). 13C NMR (CDCl3, 75 MHz): δ 133.9/129.8 (2d, C-1,-2), 
41.9 (d, C-3), 32.2 (d, C-1’), 32.0 (t, C-5), 30.9 (d, C-6), 25.6 (t, C-4), 21.9 (q, 6-Me), 19.5/19.2 (2q, 1’-Me2). HRMS: 
m/z calculated for C10H18: 138.1408 [M]+; Found: 138.1389.  
 
(1R,2R,3S,6R)-3-Isopropyl-6-methylcyclohexane-1,2-diol (308):[49]  
To a solution of (3S,6R)-3-isopropyl-6-methylcyclohex-1-ene (2 g, 14.47 mmol) in DCM (80 mL) at 
0 ºC was added dropwise a solution of mCPBA (4.6 g, 20.53 mmol, ≤77% pure) in DCM (30 mL) 
over a period of 0.5 h. The solution was stirred for 8 h at 0 ºC before being transferred to a 
separatory funnel. The organic phase was washed with a saturated aqueous solution of 
NaHSO3 (100 mL), a saturated aqueous solution of NaHCO3 (100 mL), H2O (100 mL), dried (MgSO4) and 
concentrated under reduced pressure. The resulting residue was then taken up in THF (10 mL), cooled to 0 ºC and 
an ice-cool 3% aqueous solution of H2SO4 (60 mL) was added. The solution was then stirred at 0 ºC for 7 h before 
being quenched by the addition of a saturated aqueous solution of NaHCO3 (100 mL). The mixture was extracted 
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with EtOAc (3 x 100 mL), the organic extracts pooled, dried (MgSO4) and concentrated under reduced pressure. 
The resulting residue was then purified by flash chromatography on silica gel (EtOAc/hexane; 3:7) to give 
(1R,2R,3S,6R)-3-isopropyl-6-methylcyclohexane-1,2-diol (0.85 g, 66%) as a yellow oil. [α]
26
𝐷
 = +37.9 (c = 1.02, 
CHCl3). (lit. [α]
26
𝐷
 = +38.6 (c = 1.01, CHCl3).[49] IR (ATR): ṽ = 3412 (v O–H), 2956/2923 (v C–H) cm–1. 1H NMR 
(CDCl3, 300 MHz): δ 4.01–3.98 (m, 1H, 2-H), 3.71–3.67 (m, 1H, 1-H), 1.94–1.83 (m, 1H, 6-H), 1.69–1.60 (m, 1H, 
5-H), 1.59–1.51 (m, 1H, 1’-H), 1.48–1.32 (m, 3H, 4-H, 1-,2-OH), 1.32–1.19 (m, 3H, 3-,4-,5-H), 1.00–0.93 (m, 9H, 
1’-Me2, 6-Me). 13C NMR (CDCl3, 75 MHz): δ 74.4 (d, C-1), 71.1 (d, C-2), 41.7 (d, C-3), 30.1 (d, C-6), 28.6 (d, C-1’), 
27.6 (t, C-4), 23.6 (t, C-5), 21.2/20.6 (2q, 1’-Me2), 17.5 (q, 6-Me). HRMS: m/z calculated for C10H20O2: 172.1463 
[M]+; Found: 172.1450.  
 
(1R,2R,3S,6R)-Diethyl 2,2'-((3-Isopropyl-6-methylcyclohexane-1,2-diyl)bis(oxy))diacetate (310): 
Following General Procedure B. Yellow oil, 9% yield. [α]
22
𝐷
 = –0.9 (c = 1.16, CH2Cl2). 
IR (ATR): ṽ = 2956/2929 (v C–H), 1754 (v ester C=O), 1197 (v ester C–O), 1119 
(v C–O) cm–1. Full structural assignment could not be completed. 1H NMR (CDCl3, 
300 MHz): δ 4.26–4.04 (m, 8H), 3.85–3.81 (m, 1H), 3.49–3.44 (m, 1H), 1.98–1.85 
(m, 1H), 1.79–1.65 (m, 1H), 1.63–1.53 (m, 1H), 1.43–1.15 (m, 4H), 1.30 (t, J = 7.1 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H), 
1.02–0.89 (m, 9H). 13C NMR (CDCl3, 75 MHz): δ 170.4, 170.2, 80.3, 78.3, 68.6, 67.9, 60.2, 60.2, 41.9, 30.4, 28.0, 
27.9, 23.3., 20.8, 20.5, 17.5, 13.8, 13.7. HRMS: m/z calculated for C18H32O4Na: 367.2096 [M+Na]+; Found: 
367.2054.  
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Chapter 5 – Studies Towards the Synthesis of Isocyclemone Analogues 
 
5.1 – Introduction 
Iso E Super®, produced on an estimated 2500–3000 tonne annual scale, is a commercially available 
odorant mixture used to convey a woody–ambery fragrance.[1] This mixture is composed primarily of 
compound (±)-115 but is also recognised to contain a number of isomeric compounds, with a single 
enantiomer of the minor constituent (±)-116 essentially determining the overall olfactory value of the 
material (Figure 5.1).[2-4] A higher quality material in which the quantity of (±)-116 is enriched is 
commercially available under the name Iso Gamma Super® since it contains ca. 18% of the 
γ-isomer (±)-315.[5] An alternative high-grade material named Georgywood® has additionally been 
introduced to the market, consisting primarily of compound (±)-124. 
 
 
Figure 5.1: Commercially available isocyclemone odorants. 
 
A major concern regarding Iso E Super® is its poor biodegradation and high octanol/water partition 
coefficient, ultimately leading to an accumulation of isocyclemone analogues within the natural 
environment.[4] An environmental study of the Rohr River in Germany reported concentrations of 
compound (±)-115 in the range of 30 to 100 ng/L water.[6] The discovery of biodegradable analogues of 
the isocyclemone scaffold is essential. To achieve this goal, the water solubility and polarity of these 
compounds must be improved.[4] Hicken and Corey recently described that the olfactory receptor(s) 
responsible for binding to isocyclemone odorants can accommodate an oxygen atom at the C–6 
position.[7] A series of enantiopure oxa-analogues were synthesised in Diels–Alder reactions catalysed 
by a chiral oxazaborolidine catalyst, followed by Grignard reaction and subsequent oxidation to furnish 
the completed isocyclemone analogue (Scheme 5.1).  
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The Lewis-acid catalyst which the Diels–Alder reaction relies upon is known as the CBS catalyst 
(Corey-Bakshi-Shibata catalyst).[8-9] This catalyst is derived from the naturally occurring amino acid 
L-proline and finds use in many asymmetric transformations; particularly reduction and cycloaddition 
reactions.[10] The active catalyst (318) is generated from an oxazaborolidine precursor by the in situ 
addition of the strong Lewis-acid aluminium bromide.[11-12] Alternative active forms of the Diels–Alder 
catalyst involve its coordination to strong protic acids such as triflic acid or trifluoromethanesulfonimide, 
aromatic methyl substitution as well as its condensation with alternative boron reagents.[10, 13-16] 
 
 
Scheme 5.1: Synthetic pathway to oxa-Georgyone analogue 144 by Hicken and Corey.[7] 
 
In an effort to improve the polarity of the isocyclemone scaffold the synthesis of a library of oxygenated 
analogues for olfactory analysis was proposed following the synthetic methodology outlined in 
Scheme 5.1 (Figure 5.2). Potential molecular modifications include alternative ring size and 
substituents, as well as analogues differing at the acetyl functionality. As limited Structure-Odour 
Relationship (SOR) research has been conducted on the isocyclemone odorant family, the synthesis 
of experimental analogues can aid in understanding their molecular interactions with olfactory 
receptors. 
 
 
Figure 5.2: Proposed oxa-isocyclemone analogues.   
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5.2 – Results and Discussion 
5.2.1 – Synthesis of Oxazaborolidine Catalyst Precursors  
The synthesis of the major component of the active oxazaborolidine Diels–Alder catalyst was achieved 
beginning from chiral amino acid L-proline (321).[17-19] The initial reaction involved bis-protection of the 
carboxylic acid and amine functionalities. The carboxylic acid moiety of L-proline (321) was protected 
using thionyl chloride to generate an acyl chloride intermediate which was then reacted with methanol 
to give the methylated ester analogue. The crude material obtained from this reaction was taken up in 
toluene and reacted with benzyl bromide using diisopropylethylamine (Hünig's base) to provide the 
bis-protected analogue 322 in 80% yield after vacuum distillation (Scheme 5.2).[19] 
 
The subsequent step involved a Grignard reaction of compound 322 with phenylmagnesium bromide, 
generated in situ from magnesium and bromobenzene. The formation of this reagent was shown to 
require the addition of a catalytic quantity of iodine to aid in removing the passivating layer of 
magnesium oxide. The reaction successfully provided compound 323 as a colourless solid in 42% yield 
after recrystallisation from ethanol.[17, 19] Compound 323 was then debenzylated by hydrogenation over 
Pearlman’s catalyst (Pd(OH2)/C) to yield target compound 324 as a colourless solid in 86% yield after 
recrystallisation from hexane.[18] 
 
 
Scheme 5.2: Synthesis of (S)-diphenyl(pyrrolidin-2-yl)methanol (324) from L-proline (321). 
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Attention turned to the preparation of the boronated section of the oxazaborolidine catalyst. The 
synthesis of cyclic boronic acid trimer 326 by the dehydration of ortho-tolylboronic acid (325) was 
achieved by multiple distillations of a sample of this compound solubilised within benzene.[13] This 
distillation exploits the phenomenon that benzene and water azeotrope together, thus driving the 
equilibrium towards the trimerised compound. The recovered material was recrystallised from benzene 
to provide a sample of 326 which was stored under anhydrous conditions (Scheme 5.3).  
 
 
Scheme 5.3: Synthesis of cyclic boronic acid trimer 326 from ortho-tolylboronic acid (325). 
 
5.2.2 – Synthesis of Diene Precursors – Organolithium Route  
Owing to the perceived difficulty of the synthetic chemistry, coupled with the volatility of the substrate 
compounds, model reactions with cyclohexanone (328) were proposed. The synthetic route first 
explored for the synthesis of the corresponding Diels–Alder reagent 1-vinylcyclohex-1-ene (329) was 
the reaction of cyclohexanone (328) with an organolithium reagent analogous to the synthetic 
methodology of Hicken and Corey.[7] The production of a ca. 1 M vinyllithium in diethylether solution was 
achieved by the action of n-butyllithium on tetravinylstannane (327) (Scheme 5.4).[20] This 
pre-generated reagent was then added to cyclohexanone (328) at −78 ºC, followed by the subsequent 
addition of thionyl chloride and triethylamine.[7] The mechanism for this reaction is hypothesised to 
involve the nucleophilic attack of vinyllithium onto the carbonyl functionality to provide a hydroxyl 
intermediate which is then substituted by a chlorine atom, followed by elimination to furnish the diene 
compound. This reaction was discovered to be unsuccessful in the synthesis of compound 329, 
presumably due to the loss of the minute quantity of volatile product synthesised. Additional synthetic 
pathways that could be performed economically on a larger scale were researched. 
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Scheme 5.4: Failed synthesis of diene compound 329 from cyclohexanone (328). 
 
5.2.3 – Synthesis of Diene Precursors – Grignard Reaction Route  
The subsequent synthetic pathway explored involved a Grignard reaction followed by an elimination 
reaction to provide the diene compound. The reaction between Grignard reagent vinylmagnesium 
bromide and cyclohexanone (328) at 0 ºC was discovered to successfully provide analogue 330 as a 
yellow oil in 29% yield after vacuum distillation (Scheme 5.5).[21-23] Multiple attempts at optimising the 
yield of the Grignard reaction, including using alternative reaction conditions, were unsuccessful. An 
isolated sample of compound 330 was dehydrated using acidic catalyst para-toluenesulphonic acid in 
pentane at reflux temperature to provide target diene compound 329 in 78% yield as a volatile clear 
liquid (Figure 5.3).[23-25] 
 
Scheme 5.5: Synthesis of diene compound 329 from cyclohexanone (328) via Grignard reaction and 
subsequent dehydration.  
 
 
Figure 5.3: Mass spectrum (EI) of compound 329 showing molecular ion at m/z 108. Spectrum indicates  
that isomerisation has occurred during fragmentation. 
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5.2.4 – Synthesis of Diene Precursors – Stille Coupling Route  
An alternative synthetic route was additionally explored owing to the unfavourable yields associated 
with the Grignard reaction in the synthetic sequence delineated in Scheme 5.5. The Stille reaction (or 
Migita-Kosugi-Stille coupling) involves a palladium catalysed coupling reaction of an organostannane 
compound and an electrophile.  
 
 
 
The R2 functionality bonded to the stannane moiety is usually sp2 hybridised and typically consists of 
an allyl or aryl group whilst the R3 functionalities are typically alkyl groups. A tetraorganostannane 
compound readily transfers its first group to an electrophile, the second group transferring about 100 
times slower from the subsequent XSnR3 species, and thus with stoichiometric quantities only the most 
reactive group is transferred.[26] Examples of coupling reactions between organostannanes and 
electrophiles were first published during 1976–1977 by the research groups of Eaborn[27] and 
Kosugi.[28-30] Extensive mechanistic research later published by Stille et al.[31-32] developed the reaction 
to become a standard methodology for chemical synthesis.[33]  
 
The catalytic cycle begins with the oxidative addition of a halide or pseudohalide electrophile to the 
palladium catalyst. This is followed by transmetalation with the stannane compound, followed by 
reductive elimination to yield the coupled product and regenerate the active palladium catalyst 
(Figure 5.4).[26, 33-34] The rigorous anhydrous and air-free conditions required for other palladium 
catalysed reactions can usually be relaxed for the Stille coupling. In some cases water has actually 
been found to promote coupling.[35] Whilst oxygen can also play a beneficial role, it can be involved in 
side reactions and is therefore best excluded unless otherwise specified.[35] 
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Figure 5.4: Simplified catalytic cycle of a Stille coupling reaction.[34] 
 
The newly devised synthetic route involved the enol triflation of the carbonyl functionality followed by a 
coupling reaction with an organostannane compound to provide the required diene. The 
tributylstannane analogue was chosen owing to its reduced toxicity in comparison to smaller alkyl 
substituted analogues such as the trimethylstannanes.[34] The synthesis of tributyl(vinyl)stannane (332) 
from tributylstannane chloride (331) was achieved by heating to reflux with a solution of vinylmagnesium 
bromide in tetrahydrofuran. The reaction successfully provided compound 332 in 68% yield as a clear 
oil after vacuum distillation (Scheme 5.6).[36-37] 
 
 
Scheme 5.6: Synthesis of tributyl(vinyl)stannane (332) from tributylstannane chloride (331). 
 
The synthetic sequence to produce the enol triflate analogue involved the reaction of 
cyclohexanone (328) with the non-nucleophilic base lithium diisopropylamide (LDA) at −78 ºC, 
pre-generated in situ by the action of n-butyllithium on diisopropylamine. This reaction yields an 
intermediate enolate which is trapped by the addition of N-phenyl-bis(trifluoromethanesulfonimide) to 
provide enol triflate analogue 333 in 46% yield as a yellow oil (Scheme 5.7).[23] The subsequent Stille 
coupling of compound 333 with tributyl(vinyl)stannane (332) in tetrahydrofuran using Pd(PhP3)4 as a 
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catalyst and lithium chloride as a rate accelerator successfully provided compound 329 in 34% 
yield.[23, 38-39] Thus, the Grignard reaction synthetic pathway remained the more efficient synthetic route 
with an overall yield of 22.6%, opposed to 15.6% for the Stille coupling synthetic route.  
 
 
Scheme 5.7: Synthesis of diene compound 329 from cyclohexanone (328) via Stille coupling of enol 
triflate analogue 333. 
 
5.2.5 – Catalyst Generation and Diels–Alder Experiment 
The synthesis of oxazaborolidine compound 334 was achieved by refluxing a solution of 
(S)-diphenyl(pyrrolidine-2-yl)methanol (324) and 2,4,6-tri-o-tolyl-1,3,5,2,4,6-trioxatriborinane (326) in 
anhydrous toluene in a flask attached to a pressure-equalising dropping funnel filled with activated 4Å 
molecular sieves and functioning as a Soxhlet extractor, followed by azeotropic distillation of multiple 
additions of anhydrous toluene (Scheme 5.8).[7] The active oxazaborolidine catalyst (318) was then 
prepared from a dichloromethane solution of compound 334 by the addition of a solution of aluminium 
bromide in dibromomethane (ratio of 334 to AlBr3; 2:1).[12] Once activated, the oxazaborolidine catalyst 
is reported to be stable in solution between a temperature range of −20 to −78 ºC.[10]  
 
A single Diels–Alder reaction between diene compound 329 and (E)-2-methyl-2-butenal (317) was 
attempted (Scheme 5.9). The reaction appeared to proceed smoothly, but owing to the reaction having 
to be manually chilled at −25 ºC, the temperature is believed to have fluctuated beyond the stability 
range of the active oxazaborolidine catalyst thereby aborting the reaction before completion. 13C NMR 
analysis of the recovered material revealed that a new aldehyde peak was present at δ 206.4 ppm, but 
also that a substantial quantity of (E)-2-methyl-2-butenal (317) remained unreacted (Figure 5.5). Owing 
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to time constraints, further experimentation was not attempted. This reaction is expected to proceed to 
completion with optimisation and the use of a mechanical chiller.  
 
 
Scheme 5.8: Preparation of the (S)-(−)-o-tolyl-CBS-oxazaborolidine Diels–Alder catalyst (318) from 
(S)-diphenyl(pyrrolidin-2-yl)methanol (324) and 2,4,6-tri-o-tolyl-1,3,5,2,4,6-trioxatriborinane (326). 
 
 
 
Figure 5.5: 13C NMR (CDCl3, 75 MHz) spectra of (E)-2-methyl-2-butenal (317, top) and the crude material 
obtained from reaction displayed in Scheme 5.9 (bottom), displaying a new aldehyde peak at δ 206.4 ppm. 
 
 
 
Scheme 5.9: Diels–Alder reaction between diene compound 329 and (E)-2-methyl-2-butenal (317) using  
318 as a chiral catalyst. 
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5.3 – Experimental 
(S)-Methyl 1-benzylpyrrolidine-2-carboxylate (322):[19] 
A solution of L-proline (23.04 g, 200 mmol) and MeOH (400 mL) was cooled to 0 ºC and 
thionyl chloride (17.5 mL, 240 mmol) was added dropwise over 0.25 h. The solution was 
warmed to RT before being held at reflux for 2 h. The solution was then concentrated under 
reduced pressure followed by co-evaporation with toluene (3 x 80 mL). The resulting residue 
was dissolved in toluene (200 mL) and diisopropylethylamine (170.8 mL) was added at RT. The solution was cooled 
to 0 ºC and benzyl bromide (26.16 mL) was added over 0.25 h and the mixture then heated at reflux for 24 h. The 
reaction was quenched by the addition of a saturated solution of NaHCO3 (400 mL) followed by extraction with 
EtOAc (3 x 300 mL). The combined organic extracts were pooled, dried (MgSO4) and concentrated under reduced 
pressure to give a yellow oil which was purified by vacuum distillation (100 ºC, 0.5 torr) to give 
(S)-methyl 1-benzylpyrrolidine-2-carboxylate (35 g, 80%) as a viscous clear oil. 1H NMR (CDCl3, 300 MHz): δ 7.35–
7.22 (m, 5H), 3.89 (d, J = 12.8 Hz, 1H), 3.58 (d, J = 12.8 Hz, 1H), 3.66 (s, 2H), 3.26 (dd, J = 8.7, 6.3 Hz, 1H), 3.09–
3.03 (m, 1H), 2.44–2.36 (m, 1H), 2.20–2.07 (m, 1H), 2.03–1.88 (m, 1H), 1.86–1.75 (m, 1H). 13C NMR (CDCl3, 
75 MHz): δ 173.7, 137.8, 128.5, 127.5, 126.4, 64.5, 58.0, 52.5, 50.9, 28.7, 22.4. 
 
(S)-(1-Benzylpyrrolidin-2-yl)diphenylmethanol (323):[19] 
To a mixture of magnesium filings (9.76 g, 400 mmol), iodine (32 mg) and 
THF (160 mL) was added bromobenzene (13.47 mL, 128 mmol) and the mixture 
warmed until a reaction had initiated. A further amount of bromobenzene (28.64 mL, 
272 mmol) was then added over 0.5 h and the reaction heated at reflux for 0.5 h. The 
mixture was cooled to 5–10 ºC and a solution of (S)-methyl 1-benzylpyrrolidine-
2-carboxylate (35 g, 160 mmol) in THF (64 mL) was added dropwise over 0.25 h. The mixture was stirred at RT for 
16 h, cooled to 0 ºC and quenched by the addition of conc. HCl (320 mL). The mixture was then stirred for an 
additional 2 h before being concentrated under reduced pressure. The residual solid was taken up in a mixture of 
EtOAc (500 mL) and 4 M NaOH (1 L) and the phases separated. The aqueous phase was extracted with EtOAc 
(3 x 500 mL). The organic extracts were pooled, dried (MgSO4) and concentrated under reduced pressure to give 
a tan solid that was recrystallised from EtOH to give (S)-(1-benzylpyrrolidin-2-yl)diphenylmethanol (23 g, 42%) as 
a colourless solid. mp: 121–122 ºC. (lit. mp: 118.8–119.6 ºC (EtOH)).[19] IR (ATR): ṽ = 3250 (v O–H) cm-1. 1H NMR 
(CDCl3, 300 MHz): δ 7.77–7.70 (m, 2H), 7.62–7.56 (m, 2H), 7.34–7.02 (m, 11H), 4.94 (s, 1H), 4.02–3.95 (m, 1H), 
3.24 (d, J = 12.6 Hz, 1H), 3.03 (d, J = 12.6 Hz, 1H), 2.97–2.89 (m, 1H), 2.41–2.31 (m, 1H), 2.05–1.90 (m, 1H), 
1.83–1.51 (m, 3H). 13C NMR (CDCl3, 75 MHz): δ 148.0, 146.6, 139.6, 128.5, 128.1, 128.1, 128.0, 126.8, 126.3, 
126.2, 125.6, 125.5, 77.9, 70.6, 60.5, 55.5, 29.8, 24.1. 
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(S)-Diphenyl(pyrrolidin-2-yl)methanol (324):[18] 
A solution of (S)-(1-benzylpyrrolidin-2-yl)diphenylmethanol (6.92 g, 20 mmol) in MeOH 
(120 mL) was hydrogenated under an atmosphere of H2 over 20% Pd(OH)2/C (1.4 g) for 
24 h. The reaction mixture was filtered through a pad of celite before taken up in 
EtOAc (80 mL) and 1 M NaOH (80 mL). The phases were separated and the aqueous phase extracted with EtOAc 
(3 x 80 mL). The organic extracts were pooled, dried (MgSO4) and concentrated under reduced pressure to yield 
a crude solid which was recrystallised from hexane to give (S)-diphenyl(pyrrolidin-2-yl)methanol (4.35 g, 86%) as 
a colourless solid. mp: 78–79 ºC. (lit. mp: 75.5–76.5 ºC (CHCl3/hexane)).[18] IR (ATR): ṽ = 3369 (v O–H), 
2959/2887/2835 (v C–H) cm-1. 1H NMR (CDCl3, 75 MHz): δ 7.65–7.59 (m, 2H), 7.58–7.52 (m, 2H), 7.37–7.27 (m, 
4H), 7.25–7.17 (m, 2H), 4.29 (t, J = 7.4 Hz, 1H), 3.10–2.91 (m, 2H), 1.85–1.53 (m, 4H). 13C NMR (CDCl3, 75 MHz): 
δ 148.1, 145.3, 128.1, 127.8, 126.3, 126.2, 125.7, 125.4, 77.0, 64.3, 46.6, 26.2, 25.4.  
 
2,4,6-Tri-o-tolyl-1,3,5,2,4,6-trioxatriborinane (326):[13] 
o-Tolylboronic acid (0.75 g, 0.55 mmol) was dehydrated by azeotropic distillation with 
benzene (3 x 20 mL). The residual solid was then recrystallised from benzene to give 
2,4,6-tri-o-tolyl-1,3,5,2,4,6-trioxatriborinane (quant.) as a colourless solid. 
 
  
 
1-Vinylcyclohex-1-ene (329): 
1H NMR (CDCl3, 300 MHz): δ 6.35 (dd, J = 17.5, 10.7 Hz, 1H), 5.80–5.74 (m, 1H), 5.07 (d, J = 17.3 Hz, 
1H), 4.89 (d, J = 10.5 Hz, 1H), 2.19–2.09 (m, 4H), 1.75–1.56 (m, 4H). 13C NMR (CDCl3, 75 MHz): δ 140.2, 
136.0, 129.8, 109.5, 25.7, 23.7, 22.5, 22.3. 
 
Via vinyllithium and elimination reaction:[7] 
To tetravinylstannane (0.3 mL, 1.65 mmol) was slowly added n-butyllithium (3.6 mL, 5.77 mmol, 1.6 M in hexane). 
The mixture was stirred at RT for 3.5 h, concentrated under reduced pressure and the residual solid washed with 
pentane (3 x 1.5 mL). The residual solid was then dissolved in Et2O (3 mL) to give a ca. 1 M solution of vinyllithium. 
γ-Butyrolactone (259 mg, 3 mmol) was cooled to –78 ºC before a 1 M vinyllithium in Et2O solution (3 mL) was added 
and the mixture stirred at –78 ºC for 0.5 h. To this mixture was then added thionyl chloride (0.22 mL, 3 mmol) 
followed by triethylamine (0.88 mL, 6.33 mmol). The mixture was then warmed to 0 ºC over 1 h and then stirred at 
0 ºC for 0.5 h. The reaction was quenched with a saturated solution of NaHCO3 (3.5 mL) and H2O (3.5 mL), the 
phases separated and the aqueous phase extracted with Et2O (3 x 5 mL). The organic extracts were pooled, dried 
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(MgSO4) and concentrated under reduced pressure. The reaction methodology failed to yield 
1-vinylcyclohex-1-ene. 
 
Via dehydration of 1-vinylcyclohexanol:[23-25] 
To a solution of 1-vinylcyclohexanol (300 mg, 2.37 mmol) in pentane (1.5 mL) was added para-toluenesulfonic acid 
(67 mg) and the mixture held at reflux for 5 h. The organic solution was washed with H2O (50 mL), dried (MgSO4) 
and concentrated under reduced pressure to yield 1-vinylcyclohex-1-ene (200 mg, 78%) as a clear oil.  
 
Via Stille coupling of cyclohex-1-en-1-yl trifluoromethanesulfonate:[23] 
To a solution of lithium chloride (2.05 g, 40.5 mmol) in THF (60 mL) was added Pd(PPh3)4 (192 mg, 0.168 mmol) 
and the mixture stirred for 0.25 h. A solution of cyclohex-1-en-1-yl trifluoromethanesulfonate (1.86 g, 8.1 mmol) 
and tributyl(vinyl)stannane (2.58 g, 8.1 mmol) in THF (45 mL) was added and the mixture heated at reflux for 48 h. 
The mixture was extracted with hexane (150 mL), the organic extracts pooled, washed with a saturated solution of 
NaHCO3 (100 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting residue was distilled 
under vacuum (50 ºC, 0.2 torr) to yield 1-vinylcyclohex-1-ene (301 mg, 34%) as a clear oil.  
 
rac-1-Vinylcyclohexanol (330):[21-23] 
To a solution of cyclohexanone (4.9 g, 50 mmol) in THF (60 mL) was added vinylmagnesium bromide 
(100 mL, 1 M in THF, 2 equiv) over 0.5 h at 35 ºC. The reaction mixture was then held at reflux for 2 h 
before being quenched by the addition of a 50% saturated solution of ammonium chloride (160 mL) 
and left for 0.5 h followed by concentration under reduced pressure. The resulting residue was taken up in 
H2O (300 mL) and extracted with Et2O (3 x 200 mL). The organic extracts were pooled, dried (MgSO4) and 
concentrated under reduced pressure to give a crude oil which was vacuum distilled to yield 1-vinylcyclohexanol 
(1.8 g, 29%) as a yellow oil. IR (ATR): ṽ = 3367 (v O–H), 2929 (v C–H), 959 (v C=CH2) cm-1. 1H NMR (CDCl3, 
300 MHz): δ 5.99 (dd, J = 17.3, 10.7 Hz, 1H), 5.25 (dd, J = 17.3, 1.3 Hz, 1H), 5.05 (dd, J = 10.7, 1.3 Hz, 1H), 1.77–
1.19 (m, 10H). 13C NMR (CDCl3, 75 MHz): δ 145.8, 111.0, 71.3, 37.1, 25.2, 21.6. HRMS: m/z calculated for C8H14O: 
126.1045 [M]+; Found: 126.1049.  
 
Tributyl(vinyl)stannane (332):[36] 
To vinylmagnesium bromide (61 mL, 1 M in THF, 61 mmol) was added tributylstannane 
chloride (10.75 g, 33 mmol) dissolved in THF (9 mL) at a rate that a gentle reflux was 
maintained. The reaction was then held at reflux for 19 h, cooled to RT and quenched by the addition of a saturated 
solution of NH4Cl (20 mL). The aqueous layer was extracted with Et2O (3 x 100 mL) and the residual oil fractionally 
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distilled under vacuum (80 ºC, 0.5 torr) to give tributyl(vinyl)stannane (7.16 g, 68%) as a clear oil. IR (ATR): 
ṽ = 2956/2925 (v C–H) cm-1. 1H NMR: (CDCl3, 300MHz): δ 6.54-6.42 (m, 1H), 6.20–6.13 (m, 1H), 5.72–5.63 (m, 
1H), 1.66–1.44 (m, 6H), 1.39–1.26 (m, 6H), 1.02–1.79 (m, 15H). 13C NMR (CDCl3, 75 MHz): δ 139.2, 133.6, 29.1, 
27.2, 13.6, 9.3. 
 
Cyclohex-1-en-1-yl trifluoromethanesulfonate (333):[23] 
n-Butyllithium (29.6 mL, 47.29 mmol, 1.6 M in hexanes) was added to a solution of diisopropylamine 
(4.6 g, 45.48 mmol) in THF (50 mL) at 0 ºC. After ten minutes the solution was cooled to –78 ºC and 
cyclohexanone (3.3 g, 33.66 mmol) in THF (50 mL) was added dropwise. The reaction was stirred 
at –78 ºC for 2 h at which point N-phenyl-bis(trifluoromethanesulfonimide) (15.62 g, 43.76 mmol, 
1.3 equiv) in THF (40 mL) was added. The solution was then stirred at 0 ºC for 3 h and then at RT overnight. The 
reaction was quenched by the addition of H2O (200 mL) and extracted with EtOAc (4 x 200 mL). The organic 
extracts were pooled, dried (MgSO4) and concentrated under reduced pressure to yield a viscous orange oil that 
was purified by vacuum distillation at (80 ºC, 0.5 torr) to give cyclohex-1-en-1-yl trifluoromethanesulfonate (3.57 g, 
46%) as a viscous clear oil. IR (ATR): ṽ = 2943 (v C–H), 1200/1139 (v C–F3) cm-1. 1H NMR (CDCl3, 300 MHz): 
δ 5.79–5.74 (m, 1H), 2.36–2.29 (m, 2H), 2.23–2.15 (m, 2H), 1.84–1.74 (m, 2H), 1.66–1.57 (m, 2H). 13C NMR 
(CDCl3, 75 MHz): δ 149.3, 118.5 (q, J = 320.2 Hz), 118.3, 27.5, 23.7, 22.5, 20.9. HRMS: m/z calculated for 
C7H9F3O3S: 230.0225 [M]+; Found: 230.0231.  
 
(S)-3,3-Diphenyl-1-(o-tolyl)hexahydropyrrolo[1,2-c][1,3,2]oxazaborole (334):[7]  
To flask fitted with a pressure-equalising dropped funnel filled with 4Å molecular sieves 
(functioning as a soxhlet extractor) was added (S)-diphenyl(pyrrolidin-2-yl)methanol (159 mg, 
0.625 mmol), 2,4,6-tri-o-tolyl-1,3,5,2,4,6-trioxatriborinane (73 mg, 0.209 mmol) and toluene 
(20 mL). The resulting solution was held at reflux for 3 h. The pressure-equalising dropping 
funnel was replaced with a distillation device and the reaction was distilled to a volume of 
ca. 5 mL. The distillation was repeated three times with the addition of toluene (3 x 5 mL). The reaction was then 
cooled to RT and concentrated under high vacuum (0.1 torr) for 1 h. The resulting residue was then dissolved in 
DCM (2.4 mL) to provide a ca. 0.25 M solution of (S)-3,3-diphenyl-1-(o-tolyl)hexahydropyrrolo[1,2-
c][1,3,2]oxazaborole. 
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1,2-Dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalene-2-carbaldehyde (335): 
A solution of (S)-3,3-diphenyl-1-(o-tolyl)hexahydropyrrolo[1,2-c][1,3,2]oxazaborole (1.8 mL, 
ca. 0.25 M in DCM, 0.45 mmol) was cooled to –25 ºC before a solution of aluminium bromide 
(0.225 mL, 1 M in CH2Br2, 0.225 mmol) was added. The resulting solution was stirred at 
−25 ºC for 0.5 h and (E)-2-methyl-2-butenal (0.217 mL, 2.25 mmol) was added. A solution of 1-vinylcyclohex-1-ene 
(230 mg, 2.13 mmol) in DCM (2 mL) was then added over a period of 3 h. The reaction was stirred overnight at 
−25 ºC and quenched by the addition of triethylamine (0.15 mL). The reaction was taken up in H2O (30 mL) and 
extracted with EtOAc (3 x 30 mL). The organic extracts were pooled, dried (MgSO4) and concentrated under 
reduced pressure. This reaction failed to yield 1,2-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalene-
2-carbaldehyde.  
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Chapter 6 – Conclusions and Recommendation for Future Research  
 
6.1 – Conclusions 
The benzo[b][1,4]dioxepin-3-one analogues displayed in Figure 6.1 are powerful marine fragrances. 
The marine odorant family remains small and narrowly defined in chemical structure, and is therefore 
amenable for studies into structure-odour correlations. Kraft et al.[1] revealed that more potent odorants 
could be synthesised than had been previously hypothesised, and a computational olfactophore model 
was generated. In a second study it was discovered that potency, and therefore receptor binding 
strength, was increased when the seven-substituted alkyl groups were replaced with conjugated olefinic 
substituents.[2] A revised receptor model was produced which placed the aliphatic hydrophobe in the 
plane of the aromatic binding site and 7.23 Å from its centre. The modified olfactophore model consisted 
of two hydrogen-bond acceptors that anchor the molecule into the receptor, aromatic and aliphatic 
binding sites and six excluded volumes inaccessible to the ligand. The revised model could bind both 
pseudo-twist-boat and pseudo-half-chair conformers of the heterocyclic ring system.[2] 
 
 
Figure 6.1: Selected benzo[b][1,4]dioxepin-3-one analogues. 
 
Researchers at Firmenich recently targeted the role of the carbonyl functionality in marine odorant 
perception. A qualitative marine-ozone olfactophore model consisting of only one hydrogen-bond 
acceptor, one aliphatic hydrophobe and one aromatic binding site was proposed.[3] Both receptor 
models agreed on the requirement of at least one potent hydrogen-bond acceptor, for which a carbonyl 
functionality has now been independently confirmed to be optimal in two studies.[3-4] It was also 
described that the 5H-1,4-dioxepin-6(7H)-one moiety of the original molecular template could be 
replaced by a 2,3-dihydrofuran-2-carbaldehyde unit leading to compound 54, for which potent marine 
notes were reported (Figure 6.1).[3] The five-membered ring system of compound 54 required one ether 
linkage to sustain marine characteristics, thereby supporting the requirement for a second 
hydrogen-bond acceptor within the receptor model.  
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The strongest aromatic benzo[b][1,4]dioxepin-3-one odorants feature substitution at the seven-position. 
Unexpectedly it was discovered that the aliphatic benzo[b][1,4]dioxepin-3-one analogues that displayed 
marine notes were those that were substituted at the six- and nine-positions. The threo-configured 
analogue 204, which superimposes favourably onto the molecular structure of Calone 1951® (50), was 
virtually devoid of marine fragrance (Figure 6.2). This indicated a repulsion of the hydrophobic 
cyclohexyl ring system from the marine odorant receptor. The erythro-configured analogues 225 and 
227, but not their Δ8–9 unsaturated counterpart (219), were found to contain marine notes. Molecular 
modelling revealed that the carbocyclic ring system of compound 219 is bent at a shallower angle than 
that of the saturated compounds (225 and 227) and therefore does not avoid the same amount of 
repulsive interaction. The fact that analogue 206 is devoid of marine fragrance is likely due to a positive 
hydrophobic interaction at the position adjacent to the ether oxygen atoms (positions six and nine), 
which was more correctly targeted by (R)-configured methyl substitution.  
 
 
Figure 6.2: Aliphatic benzo[b][1,4]dioxepin-3-one and 1,4-dioxepan-6-one analogues. 
 Description following compound name describes marine odour character. 
 
To offer additional evidence of an aliphatic hydrophobe at this spacial position, two Δ8–9 unsaturated 
analogues bearing halogen substitution were synthesised and evaluated (compounds 230 and 233, 
Figure 6.2). Whilst these analogues both contained unsaturation within their carbocyclic ring systems, 
it was revealed that the larger size and increased polarisability of the halogen substituents was sufficient 
to resist repulsion from the olfactory receptor. This could presumably be due to increased molecular 
bonding to the putative hydrophobic binding pocket of the olfactory receptor.  
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Owing to the postulate that the cyclohexyl ring system was being repelled from the aromatic binding 
site of the olfactory receptor, a series of 1,4-dioxepan-6-one analogues were synthesised and evaluated 
(Figure 6.2). The two parent compounds, 269 and 275, both contained marine notes, albeit weak in 
comparison to compounds 230 and 233, possibly due to a lack of effective hydrophobic interaction.  
 
Importantly, all marine odorant receptor models feature an aromatic binding site. Our research into the 
effects of the dearomatisation of the benzo[b][1,4]dioxepin-3-one template has successfully revealed 
that the models were correct in assuming that the aromatic binding site is not just a molecular spacer, 
but an essential binding feature. The aromatic binding site of the G protein-coupled receptor may rely 
on CH−π interactions for ligand binding,[5-7] albeit with limited insight into G protein-coupled odorant 
receptors it remains somewhat speculative at this time to further discuss any specific interaction with a 
hypothetical marine odorant receptor. 
 
6.2 – Recommendation for Future Research  
Should the synthesis of aliphatic benzo[b][1,4]dioxepin-3-one analogues be further explored, the most 
obvious route for increasing marine receptor binding strength would be the synthesis of 
erythro-configured analogues containing alkyl substitution at the six-position (type 336, Figure 6.3). A 
bulky tertiary-butyl group may offer increased binding capabilities, as may ethyl or propyl groups, 
depending on the size and location of the hydrophobic binding pocket. Synthetic access to a range of 
such compounds could be via the Suzuki reaction of a halogenated precursor compound, as shown to 
be viable in Scheme 3.12. Targeted enantioselective synthesis would be required to effectively probe 
any residual binding to the receptor(s) owing to threshold differences discovered between the 
stereoisomeric configurations. With regard to the instability, functional group sensitivity and all-round 
impotency of the aliphatic benzo[b][1,4]dioxepin-3-one scaffold it is unlikely that further research would 
be fruitful.  
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Other potential aromatic benzo[b][1,4]dioxepin-3-one analogues to investigate include the proposed 
scaffolds 337−340 (Figure 6.3). Scaffold 337 would comprise of sulphur atom substitution at the ether 
oxygen atoms located within the heterocyclic ring system. As the analysis of previously synthesised 
analogues clearly indicates that chemical modification at any position of the molecule has a significant 
effect on odorant characteristics, the decreased electronegativity, larger atom size and reduced ability 
to hydrogen-bond may render the thionated derivatives interesting analogues to study. An unsuccessful 
synthesis of an analogue of type 337 was attempted in an SN2 sulphonation of a bis-lithiated benzene 
intermediate by the addition of elemental sulphur, followed the addition of an alkylating agent.[8-9] 
Unsuccessfully attempts were also made at the sulphonation of the carbonyl functionality using 
Lawesson's reagent, as the resulting thioketone oligomerised.[9] 
 
 
Figure 6.3: Proposed scaffolds for new marine odorants.  
 
An additional class of derivatives for potential exploration are those of type 338, a ring-expanded 
analogue of the marine odorant template (Figure 6.3). An analogue of compound 338 that was devoid 
of the carbonyl osmophore was synthesised and found to contain minor marine nuances.[4] Potential 
modifications of the scaffold include the synthesis of vicinal bis-carbonyl analogues. It should be noted 
that six-membered analogues of the benzo[b][1,4]dioxepin-3-one template have been previously 
isolated as synthetic impurities and are reported to be odourless.[10] 
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Analogues containing alternative aromatic ring systems to the standard benzenoid system may offer an 
opportunity to further probe the aromatic binding site of the olfactory receptor, as well as lead to 
interesting new odorant molecules (type 339, Figure 6.3). The most obvious choice for an aromatic ring 
exchange would be with a pyridine heterocycle, as the unusual marine odorant Maritima® 
(60, Figure 1.18) features such a system.  
 
The most viable choice for the synthesis of potent new marine odorants would be compounds related 
to type 340, the scaffold recently developed by Gaudin et al.[3] (Figure 6.3). To date, only limited 
analogues of this scaffold have been synthesised and evaluated. It was reported that methyl substitution 
at the two-position hindered binding to the marine receptor, hypothesised to be due to interference with 
the carbonyl osmophore.[3] Analogues bearing substitution at the three-position may potentially offer 
additional binding capabilities to the hydrophobic binding pocket that offered the six- and nine-
substituted aliphatic benzo[b][1,4]dioxepin-3-one analogues (225, 227, 230, 233) marine nuances. The 
synthesis of analogues of type 340 bearing alkenyl substitution at the five- and six-positions may also 
lead to potent new marine odorants with additional nuances.  
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General Experimental Conditions 
Unless otherwise noted, all materials obtained from commercial suppliers were used as received. All reactions 
were carried out under an atmosphere of nitrogen unless otherwise noted. Dichloromethane (DCM) was dried and 
distilled from CaH2; tetrahydrofuran (THF) was dried and distilled from sodium/benzophenone ketyl. 
N,N-dimethylformamide (DMF) was dried and distilled under reduced pressure from CaH2. Thin layer 
chromatography was carried out on aluminium-backed SiO2 gel TLC plates (60 F254), which were visualised with 
either KMnO4 dip (KMnO4, K2CO3, NaOH, H2O) or iodine stain. Flash column chromatography was carried out with 
Davisil LC35a SiO2 (40–63 μm). Silica was deactivated by flushing with a triethylamine solution (5% v/v) prior to 
flash chromatography. NMR spectra were obtained with a Bruker Avance III 300 MHz spectrometer or Agilent DD2 
500 MHz spectrometer, and the residual solvent peaks from the deuterated solvents (CDCl3: 1H δ = 7.27 ppm, 
13C δ = 77.0 ppm; d6-DMSO: 1H δ = 2.5 ppm, 13C δ = 128 ppm) were used as a reference. EI-HRMS spectra were 
recorded with a Waters GCT Premier (HR-TOFMS) instrument equipped with an Agilent 7890 GC. CI-HRMS 
spectra were recorded with a Bruker autoflex speed (MALDI-TOF) instrument or AB Sciex Qstar Elite (QTOF). 
FT-IR spectra were obtained with a Perkin–Elmer Spectrum 100 spectrometer. Melting points were recorded with 
a Stuart SMP10 melting-point apparatus.  
 
Crystals suitable for single-crystal X-ray diffraction were obtained by recrystallisation from methanol 
(compound 167) or from EtOAc/hexane (compound 173 and 204). Using a drop of Nujol (inert oil), crystals were 
mounted onto a nylon loop, and then they were transferred into a stream of cold nitrogen. For the mounting of 
compound 173, the crystals had been previously cooled with nitrogen to prevent their melting. The reflections were 
collected with a D8 Bruker diffractometer (compounds 167 and 173) equipped with an APEX-II area detector and 
a 1 μS microsource; or with a STOE IPDS-2(T) diffractometer (compound 204) equipped with an image plate 
detector and a fine-focus sealed tube source. In all three cases, a graphite-monochromator and Mo-Kα radiation 
(λ = 0.71073 Å) were used. For compounds 167 and 173, data collection was carried out in φ- and ω-scan modes 
using SMART software, SAINT was used to process the data, and the absorption corrections were done with 
SADABS. For compound 204, data collection was carried out in ω-scan mode, and the data was processed with 
X-Area. The structures were solved with direct methods, and were refined with full-matrix least-squares methods 
on F2 using the SHELX-TL package. Thermal ellipsoid plots were created with ORTEP-3 v2.02.  
 
Olfactory evaluations were performed by expert perfumers on blotter using a 10% solution of the sample substance 
in dipropylene glycol (DPG). The odour thresholds were determined by GC-Olfactometry: Different dilutions of the 
sample substance were injected into a gas chromatograph in descending order of concentration until the panellist 
failed to detect the respective substance at the sniffing port. The panellist smelled in blind and pressed a button on 
perceiving an odour. If the recorded time matched the retention time, the sample was further diluted. The last 
concentration detected at the correct retention time was the individual odour threshold. The reported threshold 
values are the geometrical mean values of the individual odour thresholds of the different panellists. 
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Crystal Structure Data for Compounds 167, 173 and 204 
 
Crystals from methanol. 
 
Table 1. Crystal data and structure refinement for compound 167. 
 
Empirical formula C9H14O3 
Formula weight 170.20 
Temperature 200(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P 21/n 
Unit cell dimensions a = 6.7129(11) Å a  = 90º. 
b = 17.188(3) Å b  = 113.725(3)º. 
 c = 8.1744(12) Å g = 90º.  
 Volume 863.5(2) Å3 
Z 4 
Density (calculated) 1.309 Mg/m3 
Absorption coefficient 0.097 mm-1 
F(000) 368 
Crystal size 0.149 x 0.143 x 0.101 mm3 
Theta range for data collection 2.370 to 35.081º. 
Index ranges -10<=h<=10, -27<=k<=27, -13<=l<=13 
Reflections collected 27340 
Independent reflections 3805 [R(int) = 0.0450] 
Completeness to theta = 35.081º 99.4 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7469 and 0.6698 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3805 / 0 / 109 
Goodness-of-fit on F2 1.068 
Final R indices [I>2sigma(I)] R1 = 0.0416, wR2 = 0.1219 
R indices (all data) R1 = 0.0546, wR2 = 0.1290 
Largest diff. peak and hole 0.281 and -0.264 e.Å-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103) for  167. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
x y z U(eq) 
 
 
O(1) 
 
11294(2) 
 
3707(1) 
 
6331(2) 
 
64(1) 
O(2) 11682(1) 1744(1) 6803(1) 33(1) 
O(3) 7283(1) 2288(1) 5976(1) 29(1) 
C(1) 10447(2) 3076(1) 6179(1) 36(1) 
C(2) 11329(2) 2372(1) 5586(1) 39(1) 
C(3) 9870(1) 1235(1) 6433(1) 25(1) 
C(4) 10741(1) 484(1) 7454(1) 31(1) 
C(5) 8904(1) -89(1) 7186(1) 34(1) 
C(6) 7166(1) 275(1) 7691(1) 35(1) 
C(7) 6321(1) 1030(1) 6663(1) 32(1) 
C(8) 8173(1) 1595(1) 6983(1) 24(1) 
C(9) 8513(1) 2970(1) 6653(1) 33(1) 
 
 
 
 
 
Table 3. Bond lengths [Å] and angles [º] for 167. 
 
 
O(1)-C(1) 
 
1.2080(11) 
 
C(3)-C(8) 
 
1.5152(10) 
O(2)-C(2) 1.4207(11) C(3)-C(4) 1.5189(10) 
O(2)-C(3) 1.4294(9) C(4)-C(5) 1.5242(12) 
O(3)-C(9) 1.4125(10) C(5)-C(6) 1.5202(13) 
O(3)-C(8) 1.4348(8) C(6)-C(7) 1.5265(12) 
C(1)-C(9) 1.5081(13) C(7)-C(8) 1.5148(11) 
C(1)-C(2) 1.5102(14)   
 
C(2)-O(2)-C(3) 
 
115.42(6) 
 
C(3)-C(4)-C(5) 
 
111.11(6) 
C(9)-O(3)-C(8) 114.91(6) C(6)-C(5)-C(4) 111.06(7) 
O(1)-C(1)-C(9) 119.96(9) C(5)-C(6)-C(7) 110.88(7) 
O(1)-C(1)-C(2) 121.58(10) C(8)-C(7)-C(6) 110.67(6) 
C(9)-C(1)-C(2) 118.41(7) O(3)-C(8)-C(7) 108.07(6) 
O(2)-C(2)-C(1) 111.11(8) O(3)-C(8)-C(3) 111.03(6) 
O(2)-C(3)-C(8) 111.36(6) C(7)-C(8)-C(3) 110.42(6) 
O(2)-C(3)-C(4) 107.29(6) O(3)-C(9)-C(1) 115.25(7) 
C(8)-C(3)-C(4) 110.72(6)   
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Table 4. Anisotropic displacement parameters (Å2x 103)for 167. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
 
O(1) 
 
61(1) 
 
36(1) 
 
98(1) 
 
-1(1) 
 
35(1) 
 
-16(1) 
O(2) 23(1) 33(1) 44(1) 8(1) 15(1) 2(1) 
O(3) 23(1) 24(1) 34(1) 3(1) 5(1) 3(1) 
C(1) 33(1) 31(1) 39(1) 6(1) 9(1) -3(1) 
C(2) 38(1) 37(1) 47(1) 10(1) 24(1) -1(1) 
C(3) 23(1) 26(1) 29(1) 1(1) 11(1) 2(1) 
C(4) 27(1) 26(1) 39(1) 3(1) 13(1) 5(1) 
C(5) 36(1) 25(1) 41(1) 0(1) 14(1) 1(1) 
C(6) 34(1) 30(1) 43(1) 4(1) 19(1) -2(1) 
C(7) 22(1) 32(1) 44(1) 3(1) 14(1) 0(1) 
C(8) 20(1) 24(1) 26(1) 1(1) 8(1) 3(1) 
C(9) 33(1) 24(1) 38(1) 0(1) 10(1) 2(1) 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters 
(Å2x 103) for 167.  
 x y z U(eq) 
 
H(2A) 
 
10286 
 
2209 
 
4384 
 
46 
H(2B) 12718 2509 5504 46 
H(3) 9195 1119 5124 30 
H(4A) 11515 602 8742 37 
H(4B) 11795 246 7036 37 
H(5A) 8243 -255 5920 41 
H(5B) 9502 -557 7931 41 
H(6A) 7783 383 8990 41 
H(6B) 5945 -95 7423 41 
H(7A) 5585 916 5370 39 
H(7B) 5242 1269 7052 39 
H(8) 8862 1729 8283 28 
H(9A) 9035 2967 7972 39 
H(9B) 7541 3426 6204 39 
 
Table 6. Torsion 
 
angles 
 
[º] for 167. 
  
 
C(3)-O(2)-C(2)-C(1) 89.58(9) C(9)-O(3)-C(8)-C(3) -84.17(8) 
O(1)-C(1)-C(2)-O(2) 127.32(10) C(6)-C(7)-C(8)-O(3) 179.58(6) 
C(9)-C(1)-C(2)-O(2) -50.29(11) C(6)-C(7)-C(8)-C(3) 57.96(9) 
C(2)-O(2)-C(3)-C(8) -76.75(8) O(2)-C(3)-C(8)-O(3) 62.91(7) 
C(2)-O(2)-C(3)-C(4) 161.94(7) C(4)-C(3)-C(8)-O(3) -177.80(6) 
O(2)-C(3)-C(4)-C(5) 178.23(6) O(2)-C(3)-C(8)-C(7) -177.24(6) 
C(8)-C(3)-C(4)-C(5) 56.52(9) C(4)-C(3)-C(8)-C(7) -57.95(8) 
C(3)-C(4)-C(5)-C(6) -55.13(10) C(8)-O(3)-C(9)-C(1) 80.51(9) 
C(4)-C(5)-C(6)-C(7) 55.04(10) O(1)-C(1)-C(9)-O(3) 163.07(9) 
C(5)-C(6)-C(7)-C(8) -56.62(10) C(2)-C(1)-C(9)-O(3) -19.28(11) 
C(9)-O(3)-C(8)-C(7) 154.59(7)   
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Crystals from ethyl acetate/hexane. 
 
Table 1. Crystal data and structure refinement for compound 173.  
 
Empirical formula C9H14O3 
Formula weight 170.20 
Temperature 200(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group C 2/c 
Unit cell dimensions a = 21.883(3) Å a  = 90º. 
b = 9.2836(12) Å b  = 104.695(11)º.  
c = 8.7905(14) Å g  = 90º. 
Volume 1727.4(4) Å3 
Z 8 
Density (calculated) 1.309 Mg/m3 
Absorption coefficient 0.097 mm-1 
F(000) 736 
Crystal size 0.215 x 0.154 x 0.117 mm3 
Theta range for data collection 1.924 to 32.549º. 
Index ranges -32<=h<=32, -14<=k<=14, -13<=l<=13 
Reflections collected 19527 
Independent reflections 3110 [R(int) = 0.0309] 
Completeness to theta = 35.549º 99.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7464 and 0.6631 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3110 / 0 / 110 
Goodness-of-fit on F2 1.078 
Final R indices [I>2sigma(I)] R1 = 0.0422, wR2 = 0.1241 
R indices (all data) R1 = 0.0502, wR2 = 0.1282 
Extinction coefficient 0.0044(10) 
Largest diff. peak and hole 0.348 and -0.219 e.Å-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103)for 173. U(eq) is defined as one third of the trace of the orthogonalized Uij 
 tensor. 
x y z U(eq) 
 
 
O(1) 
 
1388(1) 
 
2429(1) 
 
483(1) 
 
60(1) 
O(2) 672(1) 5776(1) -119(1) 30(1) 
O(3) 1940(1) 5775(1) -633(1) 31(1) 
C(1) 1366(1) 3676(1) 65(1) 34(1) 
C(2) 742(1) 4383(1) -729(1) 36(1) 
C(3) 919(1) 6934(1) -872(1) 28(1) 
C(4) 596(1) 8317(1) -565(1) 36(1) 
C(5) 789(1) 8782(1) 1161(1) 35(1) 
C(6) 1507(1) 8871(1) 1759(1) 37(1) 
C(7) 1814(1) 7438(1) 1508(1) 29(1) 
C(8) 1634(1) 7046(1) -235(1) 27(1) 
C(9) 1970(1) 4547(1) 338(1) 32(1) 
 
 
 
  
Table 3. Bond lengths [Å] and angles [º] for 173. 
 
O(1)-C(1) 
 
1.2119(13) 
 
C(3)-C(4) 
 
1.5236(13) 
O(2)-C(2) 1.4230(12) C(3)-C(8) 1.5259(13) 
O(2)-C(3) 1.4376(12) C(4)-C(5) 1.5297(15) 
O(3)-C(9) 1.4159(12) C(5)-C(6) 1.5283(15) 
O(3)-C(8) 1.4431(11) C(6)-C(7) 1.5314(13) 
C(1)-C(2) 1.5155(15) C(7)-C(8) 1.5257(13) 
C(1)-C(9) 1.5156(15)   
 
C(2)-O(2)-C(3) 
 
114.67(7) 
 
C(3)-C(4)-C(5) 
 
112.91(8) 
C(9)-O(3)-C(8) 117.75(7) C(6)-C(5)-C(4) 110.97(9) 
O(1)-C(1)-C(2) 121.06(11) C(5)-C(6)-C(7) 110.73(8) 
O(1)-C(1)-C(9) 119.68(11) C(8)-C(7)-C(6) 109.93(8) 
C(2)-C(1)-C(9) 119.26(8) O(3)-C(8)-C(7) 114.90(7) 
O(2)-C(2)-C(1) 112.97(8) O(3)-C(8)-C(3) 110.52(7) 
O(2)-C(3)-C(4) 107.64(8) C(7)-C(8)-C(3) 111.33(7) 
O(2)-C(3)-C(8) 110.65(7) O(3)-C(9)-C(1) 115.43(8) 
C(4)-C(3)-C(8) 110.93(8)   
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Table 4. Anisotropic displacement parameters (Å2x 103)for 173.The anisotropic 
displacement factor exponent takes the form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
 
O(1) 
 
83(1) 
 
30(1) 
 
70(1) 
 
10(1) 
 
24(1) 
 
0(1) 
O(2) 26(1) 31(1) 36(1) -5(1) 12(1) -2(1) 
O(3) 30(1) 32(1) 34(1) 0(1) 15(1) 3(1) 
C(1) 46(1) 27(1) 32(1) -1(1) 16(1) 1(1) 
C(2) 31(1) 33(1) 47(1) -11(1) 14(1) -6(1) 
C(3) 29(1) 32(1) 23(1) 2(1) 5(1) 5(1) 
C(4) 40(1) 35(1) 30(1) 5(1) 3(1) 14(1) 
C(5) 38(1) 32(1) 35(1) -2(1) 7(1) 11(1) 
C(6) 39(1) 27(1) 41(1) -7(1) 7(1) -1(1) 
 
C(7) 24(1) 29(1) 32(1) -3(1) 5(1) -1(1) 
C(8) 28(1) 26(1) 30(1) 3(1) 12(1) 0(1) 
C(9) 33(1) 31(1) 32(1) 0(1) 6(1) 9(1) 
 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters 
(Å2x 103) for 173.  
 x y z U(eq) 
 
H(9A) 
 
709 
 
4464 
 
-1870 
 
44 
H(9B) 392 3760 -596 44 
H(8) 817 6752 -2030 34 
H(7A) 132 8175 -885 43 
H(7B) 701 9098 -1222 43 
H(6A) 602 9735 1272 42 
H(6B) 623 8081 1805 42 
H(5A) 1622 9112 2893 44 
H(5B) 1669 9647 1193 44 
H(4A) 2279 7519 1886 35 
H(4B) 1671 6670 2119 35 
H(3) 1774 7868 -801 32 
H(2A) 2089 4864 1450 39 
H(2B) 2310 3909 177 39 
 
Table 6. Torsion 
 
angles 
 
[º] for 173. 
  
 
C(3)-O(2)-C(2)-C(1) 88.19(10) C(9)-O(3)-C(8)-C(3) -82.28(9) 
O(1)-C(1)-C(2)-O(2) 134.45(11) C(6)-C(7)-C(8)-O(3) 174.96(7) 
C(9)-C(1)-C(2)-O(2) -45.54(13) C(6)-C(7)-C(8)-C(3) -58.45(10) 
C(2)-O(2)-C(3)-C(4) 158.47(8) O(2)-C(3)-C(8)-O(3) 64.84(9) 
C(2)-O(2)-C(3)-C(8) -80.18(9) C(4)-C(3)-C(8)-O(3) -175.76(7) 
O(2)-C(3)-C(4)-C(5) 68.52(11) O(2)-C(3)-C(8)-C(7) -64.11(9) 
C(8)-C(3)-C(4)-C(5) -52.66(12) C(4)-C(3)-C(8)-C(7) 55.29(10) 
C(3)-C(4)-C(5)-C(6) 53.05(12) C(8)-O(3)-C(9)-C(1) 78.15(10) 
C(4)-C(5)-C(6)-C(7) -55.58(12) O(1)-C(1)-C(9)-O(3) 158.82(10) 
C(5)-C(6)-C(7)-C(8) 58.48(11) C(2)-C(1)-C(9)-O(3) -21.19(13) 
C(9)-O(3)-C(8)-C(7) 44.72(11)   
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Crystals from ethyl acetate/hexane. 
 
The crystal is a twin (Twin law for transforming hkl(1) to hkl(2): -0.52870 0.00011 -0.76224 0.00195 -0.99917 
-0.00088 -0.94190 -0.00454 0.53014). 
 
Table 1.  Crystal data and structure refinement for compound 204. 
 
Empirical formula  C10H16O3 
Formula weight  184.23 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 8.1940(8) Å a = 90º. 
 b = 6.1852(4) Å b = 96.136(9)º. 
 c = 9.7655(11) Å g = 90º. 
Volume 492.10(8) Å3 
Z 2 
Density (calculated) 1.243 Mg/m3 
Absorption coefficient 0.090 mm-1 
F(000) 200 
Crystal size 0.600 x 0.150 x 0.080 mm3 
Theta range for data collection 2.500 to 27.997º. 
Index ranges -10<=h<=10, -8<=k<=8, -12<=l<=12 
Reflections collected 8618 
Independent reflections 8618 
Completeness to theta = 27.997º 99.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8618 / 1 / 120 
Goodness-of-fit on F2 1.123 
Final R indices [I>2sigma(I)] R1 = 0.0482, wR2 = 0.1245 
R indices (all data) R1 = 0.0596, wR2 = 0.1307 
Absolute structure parameter 0.3(8) 
Largest diff. peak and hole 0.184 and -0.194 e.Å-3 
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 204.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y z U(eq) 
 
O(1) 7830(4) 10705(6) 2221(3) 47(1) 
O(2) 6468(3) 7342(4) 4818(2) 27(1) 
O(3) 8748(3) 10819(4) 5767(2) 28(1) 
C(1) 7661(4) 10097(6) 3377(4) 29(1) 
C(2) 7313(5) 7729(6) 3645(3) 29(1) 
C(3) 7492(4) 7290(6) 6109(3) 24(1) 
C(4) 6617(4) 5984(6) 7129(3) 29(1) 
C(5) 7617(4) 5828(6) 8541(4) 30(1) 
C(6) 8030(5) 8096(6) 9093(4) 33(1) 
C(7) 8881(4) 9447(6) 8066(3) 30(1) 
C(8) 7854(4) 9562(5) 6673(3) 24(1) 
C(9) 7788(5) 11657(6) 4580(4) 30(1) 
C(10) 6686(5) 4523(8) 9540(4) 41(1) 
 
Table 3.   Bond lengths [Å] and angles [º] for 204. 
 
O(1)-C(1)  1.212(4) C(3)-C(4)  1.520(4) 
O(2)-C(2)  1.421(4) C(3)-C(8)  1.526(5) 
O(2)-C(3)  1.438(4) C(4)-C(5)  1.530(5) 
O(3)-C(9)  1.426(4) C(5)-C(6)  1.527(6) 
O(3)-C(8)  1.437(4) C(5)-C(10)  1.531(5) 
C(1)-C(9)  1.516(5) C(6)-C(7)  1.529(5) 
C(1)-C(2)  1.520(5) C(7)-C(8)  1.523(4) 
    
C(2)-O(2)-C(3) 114.9(2) C(6)-C(5)-C(4) 109.7(3) 
C(9)-O(3)-C(8) 115.1(3) C(6)-C(5)-C(10) 111.5(3) 
O(1)-C(1)-C(9) 121.3(4) C(4)-C(5)-C(10) 110.6(3) 
O(1)-C(1)-C(2) 120.1(3) C(5)-C(6)-C(7) 111.7(3) 
C(9)-C(1)-C(2) 118.6(3) C(8)-C(7)-C(6) 111.3(3) 
O(2)-C(2)-C(1) 114.7(3) O(3)-C(8)-C(7) 107.8(3) 
O(2)-C(3)-C(4) 108.3(3) O(3)-C(8)-C(3) 111.6(3) 
O(2)-C(3)-C(8) 111.6(3) C(7)-C(8)-C(3) 110.3(3) 
C(4)-C(3)-C(8) 109.9(3) O(3)-C(9)-C(1) 112.6(3) 
C(3)-C(4)-C(5) 112.3(3)   
 
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters (Å2x 103)for 204.  The anisotropic 
displacement factor exponent takes the form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 U11 U22 U33 U23 U13 U12 
 
O(1) 64(2)  47(2) 31(1)  5(1) 12(1)  -10(2) 
O(2) 26(1)  30(1) 25(1)  -1(1) 1(1)  -4(1) 
O(3) 26(1)  28(1) 30(1)  3(1) 1(1)  -5(1) 
C(1) 23(2)  34(2) 31(2)  2(2) 3(1)  1(1) 
C(2) 34(2)  30(2) 25(2)  -3(1) 4(1)  2(2) 
C(3) 21(1)  25(2) 26(2)  0(1) 1(1)  0(1) 
C(4) 31(2)  25(2) 30(2)  -2(1) 5(1)  -4(2) 
C(5) 31(2)  29(2) 31(2)  5(2) 3(1)  5(2) 
C(6) 37(2)  36(2) 25(2)  -1(2) 1(1)  2(2) 
C(7) 30(2)  30(2) 28(2)  -4(2) -1(1)  -2(2) 
C(8) 22(1)  23(2) 27(2)  0(1) 4(1)  -1(1) 
C(9) 33(2)  24(2) 33(2)  3(1) 4(1)  1(1) 
C(10) 49(2)  39(2) 36(2)  9(2) 8(2)  2(2) 
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for 204. 
 x  y  z  U(eq) 
 
H(2A) 6653 7128 2824 35 
H(2B) 8368 6938 3762 35 
H(3) 8552 6561 5971 29 
H(4A) 6403 4509 6759 34 
H(4B) 5545 6667 7236 34 
H(5) 8669 5061 8427 36 
H(6A) 8755 7984 9968 40 
H(6B) 7007 8832 9288 40 
H(7A) 9069 10928 8435 36 
H(7B) 9962 8800 7949 36 
H(8) 6793 10305 6786 29 
H(9A) 8286 13025 4301 36 
H(9B) 6672 11990 4820 36 
H(10A) 5647 5246 9659 62 
H(10B) 7353 4418 10432 62 
H(10C) 6464 3069 9167 62 
 
 
Table 6.  Torsion angles [º] for 204. 
 
C(3)-O(2)-C(2)-C(1) -82.6(4) C(9)-O(3)-C(8)-C(7) -161.3(3) 
O(1)-C(1)-C(2)-O(2) -154.2(3) C(9)-O(3)-C(8)-C(3) 77.4(3) 
C(9)-C(1)-C(2)-O(2) 25.7(5) C(6)-C(7)-C(8)-O(3) -179.0(3) 
C(2)-O(2)-C(3)-C(4) -156.6(3) C(6)-C(7)-C(8)-C(3) -56.9(4) 
C(2)-O(2)-C(3)-C(8) 82.4(3) O(2)-C(3)-C(8)-O(3) -62.5(3) 
O(2)-C(3)-C(4)-C(5) 179.8(3) C(4)-C(3)-C(8)-O(3) 177.4(3) 
C(8)-C(3)-C(4)-C(5) -58.1(4) O(2)-C(3)-C(8)-C(7) 177.7(3) 
C(3)-C(4)-C(5)-C(6) 56.1(4) C(4)-C(3)-C(8)-C(7) 57.5(3) 
C(3)-C(4)-C(5)-C(10) 179.4(3) C(8)-O(3)-C(9)-C(1) -88.1(4) 
C(4)-C(5)-C(6)-C(7) -54.2(4) O(1)-C(1)-C(9)-O(3) -135.4(4) 
C(10)-C(5)-C(6)-C(7) -177.0(3) C(2)-C(1)-C(9)-O(3) 44.6(4) 
C(5)-C(6)-C(7)-C(8) 55.7(4)   
 
Symmetry transformations used to generate equivalent atoms:  
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